_golden	chemical_id	chemical_name	disease_id	disease_name	form_sentence	original_job_id	pmid	relation_pair_id	sentence_id	uniq_id	verify_relationship_gold	verify_relationship_gold_reason
TRUE	D012701	"<span class=""chemical"">5-HT</span>"	D011605	"<span class=""disease"">psychotic disorders</span>"	"These animal models were considered to reflect the positive symptoms of schizophrenia, and the above evidence suggests that altered <span class=""chemical"">5-HT</span>6 receptors are involved in the pathophysiology of <span class=""disease"">psychotic disorders</span>."	762850.0	20705401.0	20705401_D012701_D011605		bcv_easy_68_sent_dev_set_762850	"no_relation
"	The receptors to 5-HT6 are related to psychotic disorders, not 5-HT itself.
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D012594	"<span class=""disease"">localized scleroderma</span>"	"Case reports of 11 patients with severe, extensive <span class=""disease"">localized scleroderma</span> who were treated with <span class=""chemical"">D-penicillamine</span> are summarized in this article."	762850.0	2334179.0	2334179_D010396_D012594		bcv_easy_2399_sent_dev_set_762850	"no_relation
"	D-penicillamine was used to treat the patients.
TRUE	D015016	"<span class=""chemical"">yohimbine</span>"	D019964	"<span class=""disease"">affective disorders</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or <span class=""disease"">affective disorders</span> who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."	762850.0	1535072.0	1535072_D015016_D019964		bcv_easy_642_sent_dev_set_762850	"no_relation
"	"The sentence says the affective disorders were caused by ""serotonin reuptake blockers"". Yohimbine was used to try and treat the patients."
TRUE	D002118	"<span class=""chemical"">calcium</span>"	D013035	"<span class=""disease"">muscle spasms</span>"	"While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with <span class=""disease"">muscle spasms</span> and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."	762850.0	8492347.0	8492347_D002118_D013035		bcv_easy_1271_sent_dev_set_762850	"no_relation
"	The sentence says calcium supplementation cannot be used to treat muscle spasms and tetany.
TRUE	D064730	"<span class=""chemical"">dexrazoxane</span>"	D006402	"<span class=""disease"">hematologic toxicity</span>"	"Clinical trials in patients with brain metastases combining <span class=""chemical"">dexrazoxane</span> and high doses of etoposide is ongoing with the aim of improving efficacy without aggravating <span class=""disease"">hematologic toxicity</span>."	762850.0	15897593.0	15897593_D064730_D006402		bcv_easy_2793_sent_dev_set_762850	"no_relation
"	Dexrazoxane is being used to try and make the patients better without making hematologic toxicity worse. The sentence does not say that dexrazoxane causes hematologic toxicity.
TRUE	D003404	"<span class=""chemical"">creatinine</span>"	D006973	"<span class=""disease"">hypertension</span>"	"We used time-to-event analysis to identify potential predictors of decrease in renal function including age, baseline ejection fraction, baseline <span class=""chemical"">creatinine</span>, low systolic blood pressure (<100 mm Hg), history of <span class=""disease"">hypertension</span>, diabetes, and use of antiplatelet, diuretic, and beta-blocker therapy."	762850.0	10539815.0	10539815_D003404_D006973		bcv_easy_306_sent_dev_set_762850	"no_relation
"	Creatinine and hypertension were studied as potential predictors of decreased renal (kidney) function.
TRUE	C071741	"<span class=""chemical"">remifentanil</span>"	D010146	"<span class=""disease"">pain</span>"	"CONCLUSIONS: During induction of anaesthesia with TCI of propofol and <span class=""chemical"">remifentanil</span>, a significant reduction in propofol infusion <span class=""disease"">pain</span> was achieved without significant complications by prior administration of <span class=""chemical"">remifentanil</span> at a target Ce of 4 ng ml(-1)."	762850.0	18006530.0	18006530_C071741_D010146		bcv_easy_2437_sent_dev_set_762850	"no_relation
"	Remifentanil reduces the pain caused by propofol.
TRUE	C012052	"<span class=""chemical"">amisulpride</span>"	D006973	"<span class=""disease"">hypertensive</span>"	"CONCLUSIONS: As of March 24, 2005, this is the first reported case of <span class=""chemical"">amisulpride</span>- and tiapride-induced <span class=""disease"">hypertensive</span> crisis in a patient with pheochromocytoma."	762850.0	15811908.0	15811908_C012052_D006973		bcv_easy_808_sent_dev_set_762850	"yes_direct
"	This sentence talks about the first case of amisulpride induced hypertensive crisis.
TRUE	D002211	"<span class=""chemical"">capsaicin</span>"	D010146	"<span class=""disease"">painful</span>"	"A small amount of <span class=""chemical"">capsaicin</span> was administered subcutaneously in the right forehead to evoke a burning <span class=""disease"">painful</span> sensation in the first division of the trigeminal nerve."	762850.0	9514561.0	9514561_D002211_D010146		bcv_easy_2013_sent_dev_set_762850	"yes_direct
"	Capsaicin (the chemical that makes chilis spicy), when put under your skin, causes pain.
TRUE	D003630	"<span class=""chemical"">daunorubicin</span>"	D000163	"<span class=""disease"">AIDS</span>"	"We report a non-randomized Phase II clinical trial to assess the efficacy and safety of liposomal <span class=""chemical"">daunorubicin</span> (DaunoXome) in the treatment of <span class=""disease"">AIDS</span> related Kaposi's sarcoma."	762850.0	8305357.0	8305357_D003630_D000163		bcv_easy_125_sent_dev_set_762850	"no_relation
"	Daunorubicin is being studied as a way to treat AIDS related Kaposi's sarcoma.
TRUE	D000241	"<span class=""chemical"">adenosine</span>"	D059787|D059350	"<span class=""disease"">acute and chronic pain</span>"	"BACKGROUND: Preclinical studies of intrathecal <span class=""chemical"">adenosine</span> suggest it may be effective in the treatment of <span class=""disease"">acute and chronic pain</span> in humans, and preliminary studies in volunteers and patients with a Swedish formulation of <span class=""chemical"">adenosine</span> suggests it may be effective in hypersensitivity states but not with acute noxious stimulation."	762850.0	11752998.0	11752998_D000241_D059787|D059350		bcv_easy_3089_sent_dev_set_762850	"no_relation
"	Adenosine might be able to treat acute and chronic pain.
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."	762850.0	6892185.0	6892185_D010830_D015878		bcv_easy_1548_sent_dev_set_762850	"yes_direct
"	Eserine and carbachol cause mydriasis.
TRUE	C084178	"<span class=""chemical"">telmisartan</span>"	D006973	"<span class=""disease"">hypertension</span>"	"Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of <span class=""chemical"">telmisartan</span> and amlodipine versus amlodipine monotherapy in Indian adults with stage II <span class=""disease"">hypertension</span>."	762850.0	18201582.0	18201582_C084178_D006973		bcv_easy_2744_sent_dev_set_762850	"no_relation
"	Telmisartan is being used in patients with stage II hypertension. It seems it is being tested as a treatment.
TRUE	D004329	"<span class=""chemical"">droperidol</span>"	D004342	"<span class=""disease"">drug allergies</span>"	"We report the case of a previously healthy 19-year-old man with no known <span class=""disease"">drug allergies</span> in whom angioedema with significant tongue swelling and protrusion developed within 10 minutes of the administration of a single IV dose of <span class=""chemical"">droperidol</span>."	762850.0	8599504.0	8599504_D004329_D004342		bcv_easy_1324_sent_dev_set_762850	"no_relation
"	Droperidol causes angioedema and tongue swelling, but the patient had no prior drug allergies.
TRUE	D006493	"<span class=""chemical"">heparin</span>"	D006470	"<span class=""disease"">hemorrhage</span>"	"Clinical manifestations of this disorder include <span class=""disease"">hemorrhage</span> or, more frequently, thromboembolic events in patients receiving <span class=""chemical"">heparin</span>."	762850.0	6615052.0	6615052_D006493_D006470		bcv_easy_3021_sent_dev_set_762850	"yes_direct
"	"The sentence does not follow the ""[chemical]-induced [other disease] causes [highlighted disease]"" structure, so  heparin-induced [other disease] causes hemorrhage is wrong. Patients developed hemorrhage after receiving heparin, so the correct choice is ""heparin directly contributes to or causes hemorrhage."""
TRUE	D014700	"<span class=""chemical"">Verapamil</span>"	D001281	"<span class=""disease"">AF</span>"	"RESULTS: <span class=""chemical"">Verapamil</span> caused <span class=""disease"">AF</span> promotion in six dogs, increasing mean duration of <span class=""disease"">AF</span> induced by burst pacing, from 8+/-4 s (mean+/-S.E.) to 95+/-39 s (P<0.01 vs. control) at a loading dose of 0.1 mg/kg and 228+/-101 s (P<0.0005 vs. control) at a dose of 0.2 mg/kg."	762850.0	11282081.0	11282081_D014700_D001281		bcv_easy_1715_sent_dev_set_762850	"yes_direct
"	
TRUE	D004298	"<span class=""chemical"">dopamine</span>"	D002389	"<span class=""disease"">catatonia</span>"	"In the pinealectomized chick, pretreatment with <span class=""chemical"">dopamine</span> increased the duration of <span class=""disease"">catatonia</span> (DOC) after ketamine, but pretreatment with norepinephrine did not."	762850.0	6540303.0	6540303_D004298_D002389		bcv_easy_967_sent_dev_set_762850	"yes_direct
"	Dopamine made the duration of catatonia longer, which means dopamine made catatonia worse.
TRUE	D000082	"<span class=""chemical"">acetaminophen</span>"	D064420	"<span class=""disease"">toxicity</span>"	"To further our understanding of the mechanism of CS cytoprotection, we examined in rats and mice the protective abilities of CS and the non-hydrolyzable ether form of CS, gamma-cholesteryloxybutyric acid, tris salt (CSE) against <span class=""chemical"">acetaminophen</span>-, adriamycin-, carbon tetrachloride-, chloroform- and galactosamine-induced <span class=""disease"">toxicity</span>."	762850.0	9067481.0	9067481_D000082_D064420		bcv_easy_2720_sent_dev_set_762850	"yes_direct
"	Five chemicals, including acetaminophen, induced (caused) toxicity.
TRUE	D016861	"<span class=""chemical"">cyclooxygenase inhibitors</span>"	D020521	"<span class=""disease"">stroke</span>"	"Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, <span class=""disease"">stroke</span>, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>."	762850.0	16586083.0	16586083_D016861_D020521		bcv_easy_291_sent_dev_set_762850	"yes_direct
"	Cyclooxygenase inhibitors cause four diseases including stroke.
TRUE	D000109	"<span class=""chemical"">acetylcholine</span>"	D023921	"<span class=""disease"">coronary artery stenosis</span>"	"Coronary spasm was induced by intracoronary injection of <span class=""chemical"">acetylcholine</span>, and no fixed <span class=""disease"">coronary artery stenosis</span> was documented on angiograms in all patients."	762850.0	11078231.0	11078231_D000109_D023921		bcv_easy_1807_sent_dev_set_762850	"no_relation
"	No fixed coronary artery stenosis was observed in patients who were injected with acetylcholine.
TRUE	D014147	"<span class=""chemical"">tramadol</span>"	D006212	"<span class=""disease"">hallucinations</span>"	"Fifty-six days after initiation of the treatment the patient presented <span class=""disease"">hallucinations</span> that only stopped after the withdrawal of psycho-active drugs and <span class=""chemical"">tramadol</span>."	762850.0	8766220.0	8766220_D014147_D006212		bcv_easy_1658_sent_dev_set_762850	"yes_direct
"	The hallucinations only went away after psycho-active drugs and tramadol were taken away.
TRUE	D000638	"<span class=""chemical"">Amiodarone</span>"	D011014	"<span class=""disease"">pneumonitis</span>"	"<span class=""chemical"">Amiodarone</span> is an effective antiarrhythmic agent whose utility is limited by many side-effects, the most problematic being <span class=""disease"">pneumonitis</span>."	762850.0	1595783.0	1595783_D000638_D011014		bcv_easy_3183_sent_dev_set_762850	"yes_direct
"	Pneumonitis is a side effect of amiodarone.
TRUE	D017374	"<span class=""chemical"">paroxetine</span>"	D059350	"<span class=""disease"">chronic pain</span>"	"This drug was initiated in association with <span class=""chemical"">paroxetine</span> and dosulepine hydrochloride in a tetraparetic patient with <span class=""disease"">chronic pain</span>."	762850.0	8766220.0	8766220_D017374_D059350		bcv_easy_1657_sent_dev_set_762850	"no_relation
"	A patient with chronic pain was given paroxetine, but the sentence does not say paroxetine caused the pain.
TRUE	D002945	"<span class=""chemical"">cisplatin</span>"	D058186	"<span class=""disease"">acute renal injury</span>"	"The nephroprotective effect of coenzyme Q10 was investigated in mice with <span class=""disease"">acute renal injury</span> induced by a single i.p. injection of <span class=""chemical"">cisplatin</span> (5 mg/kg)."	762850.0	20510337.0	20510337_D002945_D058186		bcv_easy_1046_sent_dev_set_762850	"yes_direct
"	Acute renal injury was induced by cisplatin injection.
TRUE	D010878	"<span class=""chemical"">piperacillin</span>"	D006311	"<span class=""disease"">Ototoxicity</span>"	"<span class=""disease"">Ototoxicity</span> occurred in four (9.5%) of 42 netilmicin and <span class=""chemical"">piperacillin</span> and in 12 (22%) of 54 tobramycin and <span class=""chemical"">piperacillin</span>-treated patients."	762850.0	3535719.0	3535719_D010878_D006311		bcv_easy_773_sent_dev_set_762850	"yes_direct
"	Some of the patients receiving piperacillin developed ototoxicity.
TRUE	D010665	"<span class=""chemical"">PPA</span>"	D006973	"<span class=""disease"">hypertensive</span>"	"These results suggest that <span class=""chemical"">PPA</span>/caffeine can lead to cerebral hemorrhage in previously <span class=""disease"">hypertensive</span> animals when administered in greater than the allowed dosage."	762850.0	6695415.0	6695415_D010665_D006973		bcv_easy_1498_sent_dev_set_762850	"no_relation
"	"The ""previously"" implies that the animals already had hypertension before they were given PPA."
TRUE	D000666	"<span class=""chemical"">amphotericin B</span>"	D007008	"<span class=""disease"">hypokalemia</span>"	"Spironolactone: is it a novel drug for the prevention of <span class=""chemical"">amphotericin B</span>-related <span class=""disease"">hypokalemia</span> in cancer patients?"	762850.0	11868798.0	11868798_D000666_D007008		bcv_easy_1118_sent_dev_set_762850	"yes_direct
"	
TRUE	C034753	"<span class=""chemical"">benzylacyclouridine/BAU</span>"	D007970	"<span class=""disease"">leukopenia</span>"	"Because of the clinical toxicities associated with chronic Urd administration, the ability of <span class=""chemical"">benzylacyclouridine</span> (<span class=""chemical"">BAU</span>) to effect, in vivo, AZT-induced anemia and <span class=""disease"">leukopenia</span> was assessed."	762850.0	2257294.0	2257294_C034753_D007970		bcv_easy_2854_sent_dev_set_762850	"no_relation
"	"Leukopenia was caused by ""AZT""."
TRUE	D002083	"<span class=""chemical"">BHA</span>"	D010212	"<span class=""disease"">squamous cell papilloma</span>"	"In groups given 2% <span class=""chemical"">BHA</span>, although marked hyperplastic changes of the forestomach epithelium were observed in all animals, co-administration of 0.25% RA significantly (P less than 0.05) increased the incidence of forestomach tumors (<span class=""disease"">squamous cell papilloma</span> and carcinoma) to 60% (9/15, 2 rats with carcinoma) from 15% (3/20, one rat with carcinoma) in the group given RA-free water."	762850.0	3131282.0	3131282_D002083_D010212		bcv_easy_24_sent_dev_set_762850	"yes_direct
"	Giving BHA together with RA caused squamous cell papillomas. Remember if a chemical only works in combination with other chemicals, then the correct choice is that the chemical can cause the disease.
TRUE	D013835	"<span class=""chemical"">TPP</span>"	D014899	"<span class=""disease"">Wernicke's encephalopathy</span>"	"We found that the above-mentioned patient and one of the diabetic kindreds with no history of <span class=""disease"">Wernicke's encephalopathy</span> had abnormal transketolase as determined by its Km for <span class=""chemical"">TPP</span>."	762850.0	3762968.0	3762968_D013835_D014899		bcv_easy_1369_sent_dev_set_762850	"no_relation
"	
TRUE	D004110	"<span class=""chemical"">diltiazem</span>"	D062787	"<span class=""disease"">overdose</span>"	"It should be considered early in cases of cardiac arrest after <span class=""chemical"">diltiazem</span> <span class=""disease"">overdose</span>."	762850.0	12101159.0	12101159_D004110_D062787		bcv_easy_834_sent_dev_set_762850	"yes_direct
"	You can overdose on the drug diltiazem.
TRUE	D012110	"<span class=""chemical"">Reserpine</span>"	D014202	"<span class=""disease"">tremor</span>"	"<span class=""chemical"">Reserpine</span> also produced <span class=""disease"">tremor</span> and catalepsy, which are signs suggestive of Parkinson's disease."	762850.0	11999899.0	11999899_D012110_D014202		bcv_easy_2175_sent_dev_set_762850	"yes_direct
"	
TRUE	C018370	"<span class=""chemical"">PREGS</span>"	D000647	"<span class=""disease"">amnesia</span>"	"The memory-enhancing effects of <span class=""chemical"">PREGS</span> and its analogs were tested in the passive avoidance task using the model of scopolamine-induced <span class=""disease"">amnesia</span>."	762850.0	11860495.0	11860495_C018370_D000647		bcv_easy_3086_sent_dev_set_762850	"no_relation
"	The amnesia was caused by scopolamine.
TRUE	D001590	"<span class=""chemical"">benztropine</span>"	D010302	"<span class=""disease"">parkinsonism</span>"	"In a 12-week controlled study ethopropazine was compared to <span class=""chemical"">benztropine</span> in the treatment of <span class=""disease"">parkinsonism</span> induced by fluphenazine enanthate in 60 schizophrenic outpatients."	762850.0	33969.0	33969_D001590_D010302		bcv_easy_2138_sent_dev_set_762850	"no_relation
"	Benztropine is being studied as a treatment for parkinsonism.
TRUE	D015119	"<span class=""chemical"">epsilon-aminocaproic acid</span>"	D012851	"<span class=""disease"">cerebral sinus thrombosis</span>"	"Although increased risk of thromboembolic disease has been reported during treatment with <span class=""chemical"">epsilon-aminocaproic acid</span>, <span class=""disease"">cerebral sinus thrombosis</span> has not been previously described."	762850.0	2339463.0	2339463_D015119_D012851		bcv_easy_43_sent_dev_set_762850	"no_relation
"	The sentence says no known cases of epsilon-aminocaproic acid causing cerebral sinus thrombosis existed before. Although we might want to say that this sentence is reporting the first case, the relation between epsilon-aminocaproic acid and cerebral sinus thrombosis is not explicit here.
TRUE	D010878	"<span class=""chemical"">piperacillin sodium</span>"	D007239	"<span class=""disease"">infections</span>"	"We prospectively compared the efficacy and safety of netilmicin sulfate or tobramycin sulfate in conjunction with <span class=""chemical"">piperacillin sodium</span> in 118 immunocompromised patients with presumed severe <span class=""disease"">infections</span>."	762850.0	3535719.0	3535719_D010878_D007239		bcv_easy_768_sent_dev_set_762850	"no_relation
"	The text seems to say that piperacillin sodium was being tested as a treatment.
TRUE	D004317	"<span class=""chemical"">ADR/adriamycin</span>"	D002318	"<span class=""disease"">cardiovascular toxicity</span>"	"The use of <span class=""chemical"">adriamycin</span> (<span class=""chemical"">ADR</span>) in cancer chemotherapy has been limited due to its cumulative <span class=""disease"">cardiovascular toxicity</span>."	762850.0	9952311.0	9952311_D004317_D002318		bcv_easy_1186_sent_dev_set_762850	"yes_direct
"	
TRUE	D013467	"<span class=""chemical"">sulindac</span>"	D007681	"<span class=""disease"">renal papillary necrosis/RPN</span>"	"A 31-year-old man with rheumatoid arthritis, who had previously been treated with <span class=""chemical"">sulindac</span>, fenoprofen calcium, high dose salicylates and gold salts, developed <span class=""disease"">renal papillary necrosis</span> (<span class=""disease"">RPN</span>) 4 months after institution of naproxen therapy."	762850.0	6699841.0	6699841_D013467_D007681		bcv_easy_840_sent_dev_set_762850	"no_relation
"	"The patient developed renal papillary necrosis only after starting naproxen therapy. The sentence says the man was ""previously treated with sulindac"", which implies that sulindac was not taken at the same time as naproxen."
TRUE	D010862	"<span class=""chemical"">pilocarpine</span>"	D012640	"<span class=""disease"">seizures</span>"	"Steroids with the 3-hydroxy group in the alpha-position and 5-H in the alpha- or beta-configurations were highly effective in protecting against <span class=""chemical"">pilocarpine</span> (416 mg/kg, s.c.)-induced limbic motor <span class=""disease"">seizures</span> and status epilepticus (ED50 values, 7.0-18.7 mg/kg, i.p.)."	762850.0	9121607.0	9121607_D010862_D012640		bcv_easy_2104_sent_dev_set_762850	"yes_direct
"	
TRUE	D000082	"<span class=""chemical"">paracetamol</span>"	D006525	"<span class=""disease"">viral hepatitis</span>"	"Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived fulminant hepatic failure after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with fulminant hepatic failure due to <span class=""disease"">viral hepatitis</span> whether or not they survived."	762850.0	7007443.0	7007443_D000082_D006525		bcv_easy_1359_sent_dev_set_762850	"no_relation
"	Paracetamol overdose causes fulminant hepatic (liver) failure. The text does not say what caused the viral hepatitis.
TRUE	D016202	"<span class=""chemical"">NMDA/N-methyl-D-aspartate</span>"	D012559	"<span class=""disease"">schizophrenia</span>"	"The glutamatergic <span class=""chemical"">N-methyl-D-aspartate</span> (<span class=""chemical"">NMDA</span>) receptor has been implicated in the pathophysiology of <span class=""disease"">schizophrenia</span>."	762850.0	20727411.0	20727411_D016202_D012559		bcv_easy_2627_sent_dev_set_762850	"no_relation
"	The NMDA receptor is involved in schizophrenia, not the chemical NMDA.
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D008105	"<span class=""disease"">primary biliary cirrhosis</span>"	"A case of polymyositis in a patient with <span class=""disease"">primary biliary cirrhosis</span> treated with <span class=""chemical"">D-penicillamine</span>."	762850.0	8268147.0	8268147_D010396_D008105		bcv_easy_2535_sent_dev_set_762850	"no_relation
"	D-penicillamine seems to have been used to treat primary biliary cirrhosis.
TRUE	D011692	"<span class=""chemical"">puromycin aminonucleoside/PAN</span>"	D058186	"<span class=""disease"">Acute experimental models of renal damage</span>"	"<span class=""disease"">Acute experimental models of renal damage</span> to the proximal tubular, glomerular, and papillary regions of the rat were produced by administration of hexachloro-1:3-butadiene (HCBD), <span class=""chemical"">puromycin aminonucleoside</span> (<span class=""chemical"">PAN</span>), and 2-bromoethylamine (BEA), respectively."	762850.0	3653576.0	3653576_D011692_D058186		bcv_easy_1663_sent_dev_set_762850	"yes_direct
"	Three chemicals all produced acute experimental models of renal damage.
TRUE	D013619	"<span class=""chemical"">Tacrine</span>"	D012640	"<span class=""disease"">seizures</span>"	"<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic <span class=""disease"">seizures</span> and delayed hippocampal damage."	762850.0	19944736.0	19944736_D013619_D012640		bcv_easy_1618_sent_dev_set_762850	"yes_direct
"	
TRUE	D020123	"<span class=""chemical"">sirolimus</span>"	D011565	"<span class=""disease"">psoriasis</span>"	"Activated peripheral blood T cells from patients with <span class=""disease"">psoriasis</span> tended to exhibit greater spontaneous or dexamethasone-induced apoptosis than did normal T cells, particularly in the presence of <span class=""chemical"">sirolimus</span>."	762850.0	10328196.0	10328196_D020123_D011565		bcv_easy_3112_sent_dev_set_762850	"no_relation
"	Sirolimus made T cells undergo apoptosis (cell death) faster, but sirolimus is not stated to have caused psoriasis.
TRUE	C107135	"<span class=""chemical"">everolimus</span>"	D009190	"<span class=""disease"">MDS/myelodysplastic syndrome</span>"	"We report on a combination of <span class=""chemical"">everolimus</span> and tacrolimus in 24 patients (median age, 62 years) with either <span class=""disease"">myelodysplastic syndrome</span> (<span class=""disease"">MDS</span>; n = 17) or acute myeloid leukemia (AML; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors."	762850.0	19135948.0	19135948_C107135_D009190		bcv_easy_161_sent_dev_set_762850	"no_relation
"	Everolimus was used in patients with myelodysplastic syndrome, but the text does not say everolimus caused MDS.
TRUE	D013390	"<span class=""chemical"">succinylcholine</span>"	D063806	"<span class=""disease"">myalgia</span>"	"In conclusion, there is no evidence for an inflammatory origin of <span class=""chemical"">succinylcholine</span>-associated <span class=""disease"">myalgia</span>."	762850.0	12760988.0	12760988_D013390_D063806		bcv_easy_3068_sent_dev_set_762850	"yes_direct
"	"The sentence says that there is no evidence for an ""inflammatory origin"" of myalgia caused by succinylcholine. This does not mean that succinylcholine cannot cause myalgia."
TRUE	D000809	"<span class=""chemical"">angiotensin</span>"	D009404	"<span class=""disease"">NS/nephrotic syndrome</span>"	"Plasma concentration and urine excretion of the renin-<span class=""chemical"">angiotensin</span> system proteins are altered in rats with <span class=""disease"">nephrotic syndrome</span> (<span class=""disease"">NS</span>)."	762850.0	9154656.0	9154656_D000809_D009404		bcv_easy_2019_sent_dev_set_762850	"no_relation
"	The renin-angiotensin system protein levels were different in rats with nephrotic syndrome.
TRUE	C024224	"<span class=""chemical"">naloxazone</span>"	D007035	"<span class=""disease"">hypothermia</span>"	"Pretreatment with <span class=""chemical"">naloxazone</span> significantly blocked morphine analgesia, catalepsy and <span class=""disease"">hypothermia</span> at a dose which completely eliminated high-affinity binding in brain membranes."	762850.0	6308526.0	6308526_C024224_D007035		bcv_easy_2753_sent_dev_set_762850	"no_relation
"	Naloxazone made hypothermia better.
TRUE	C005618	"<span class=""chemical"">benzoylecgonine</span>"	D003693	"<span class=""disease"">EDDs</span>"	"<span class=""disease"">EDDs</span> had concentrations of cocaine and <span class=""chemical"">benzoylecgonine</span> in autopsy blood that were similar to those for controls."	762850.0	8988571.0	8988571_C005618_D003693		bcv_easy_3013_sent_dev_set_762850	"no_relation
"	
TRUE	D008625	"<span class=""chemical"">Tiopronin</span>"	D001172	"<span class=""disease"">RA</span>"	"Compared to healthy controls a lower DR5 frequency was observed in patients with <span class=""disease"">RA</span> except for the <span class=""chemical"">Tiopronin</span> related nephritis group."	762850.0	3084782.0	3084782_D008625_D001172		bcv_easy_3042_sent_dev_set_762850	"no_relation
"	
TRUE	D008094	"<span class=""chemical"">lithium</span>"	D014262	"<span class=""disease"">tricuspid regurgitation</span>"	"A newborn with massive <span class=""disease"">tricuspid regurgitation</span>, atrial flutter, congestive heart failure, and a high serum <span class=""chemical"">lithium</span> level is described."	762850.0	6794356.0	6794356_D008094_D014262		bcv_easy_2_sent_dev_set_762850	"no_relation
"	Although the newborn had both tricuspid regurgitation and high blood lithium levels, the sentence does not say that the lithium is what caused the tricuspid regurgitation.
TRUE	C020976	"<span class=""chemical"">azelastine</span>"	D013651	"<span class=""disease"">altered taste perception</span>"	"Drowsiness and <span class=""disease"">altered taste perception</span> were increased significantly over placebo only in the high-dose <span class=""chemical"">azelastine</span> group."	762850.0	3057041.0	3057041_C020976_D013651		bcv_easy_974_sent_dev_set_762850	"yes_direct
"	Azelastine caused drowsiness and altered taste perception whereas the placebo (no chemical given) did not.
TRUE	D011433	"<span class=""chemical"">propranolol</span>"	D011928	"<span class=""disease"">Raynaud's phenomenon</span>"	"Other adverse reactions significantly linked with active drugs include impaired glucose tolerance in men and women and gout in men, associated with bendrofluazide treatment, and <span class=""disease"">Raynaud's phenomenon</span> and dyspnoea in men and women taking <span class=""chemical"">propranolol</span>."	762850.0	6115999.0	6115999_D011433_D011928		bcv_easy_864_sent_dev_set_762850	"yes_direct
"	Raynaud's phenomenon is given as an example of an adverse reaction linked with drugs (in this case propranolol).
TRUE	D004837	"<span class=""chemical"">adrenaline</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Intravenous pretreatment of the rats with diazepam, although causing no change in the <span class=""chemical"">adrenaline</span>-induced pressor effect, did enhance the <span class=""chemical"">adrenaline</span>-induced reflex <span class=""disease"">bradycardia</span>."	762850.0	2894433.0	2894433_D004837_D001919		bcv_easy_2376_sent_dev_set_762850	"yes_direct
"	
TRUE	D000431	"<span class=""chemical"">alcohol</span>"	D000437	"<span class=""disease"">alcohol abuse</span>"	"The patient had a history of <span class=""disease"">alcohol abuse</span>; <span class=""chemical"">alcohol</span> intake as well as withdrawal can also cause seizures."	762850.0	11573852.0	11573852_D000431_D000437		bcv_easy_102_sent_dev_set_762850	"no_relation
"	Alcohol is mentioned as something that might cause seizures. The sentence does not say that alcohol causes alcohol abuse!
TRUE	C047426	"<span class=""chemical"">venlafaxine</span>"	D020230	"<span class=""disease"">Serotonin syndrome</span>"	"<span class=""disease"">Serotonin syndrome</span> from <span class=""chemical"">venlafaxine</span>-tranylcypromine interaction."	762850.0	8888541.0	8888541_C047426_D020230		bcv_easy_2054_sent_dev_set_762850	"yes_direct
"	
TRUE	D013438	"<span class=""chemical"">thiol</span>"	D008175	"<span class=""disease"">lung cancer</span>"	"The protective effect of oral administration of the <span class=""chemical"">thiol</span> compound sodium 2-mercaptoethane sulphonate (MESNA) against urothelial toxicity induced by ifosfamide (IF) was tested in a group of 45 patients with inoperable <span class=""disease"">lung cancer</span> under treatment with IF (2250 mg/m2 on days 2-5) as part of a polychemotherapy regimen repeated in a 4-week cycle."	762850.0	6402369.0	6402369_D013438_D008175		bcv_easy_3143_sent_dev_set_762850	"no_relation
"	The subject of the sentence is sodium 2-mercaptoethane sulphonate, not thiol.
TRUE	D006493	"<span class=""chemical"">heparin</span>"	D013923	"<span class=""disease"">thromboembolism</span>"	"MEASUREMENTS: Platelet counts, onset of objectively determined <span class=""disease"">thromboembolism</span>, results of <span class=""chemical"">heparin</span>-induced platelet factor 4 antibody tests, and outcomes."	762850.0	11827497.0	11827497_D006493_D013923		bcv_easy_2916_sent_dev_set_762850	"no_relation
"	The sentence lists some things that were measured.
TRUE	D007980	"<span class=""chemical"">L-dihydroxyphenylalanine</span>"	D020258	"<span class=""disease"">neurotoxicity</span>"	"Here we show that the recently reported ability of <span class=""chemical"">L-dihydroxyphenylalanine</span> to reverse the protective effect of alpha-methyl-para-tyrosine on METH-induced DA <span class=""disease"">neurotoxicity</span> is also confounded by drug effects on body temperature."	762850.0	20533999.0	20533999_D007980_D020258		bcv_easy_2637_sent_dev_set_762850	"no_relation
"	"Neurotoxicity was induced by ""METH""."
TRUE	D017963	"<span class=""chemical"">azithromycin</span>"	D006606	"<span class=""disease"">hiccups</span>"	"Possible <span class=""chemical"">azithromycin</span>-associated <span class=""disease"">hiccups</span>."	762850.0	15985056.0	15985056_D017963_D006606		bcv_easy_545_sent_dev_set_762850	"yes_direct
"	"The sentence suggests that azithromycin likely causes hiccups through the use of ""possible""."
TRUE	D015632	"<span class=""chemical"">MPTP</span>"	D010300	"<span class=""disease"">Parkinson's disease</span>"	"Compound 1 is a potent A(2A)/A(1) receptor antagonist in vitro (A(2A) K(i) = 4.1 nM; A(1) K(i) = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of <span class=""disease"">Parkinson's disease</span> including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and <span class=""chemical"">MPTP</span>-treated non-human primate model."	762850.0	20973483.0	20973483_D015632_D010300		bcv_easy_265_sent_dev_set_762850	"no_relation
"	
TRUE	D016642	"<span class=""chemical"">bupropion</span>"	D012892	"<span class=""disease"">sleep deprivation</span>"	"This case report describes a generalized seizure associated with sustained-release <span class=""chemical"">bupropion</span> use and <span class=""disease"">sleep deprivation</span>."	762850.0	12745515.0	12745515_D016642_D012892		bcv_easy_2004_sent_dev_set_762850	"no_relation
"	The sentence says bupropion causes seizure and sleep deprivation causes seizure, but does not say bupropion causes sleep deprivation.
TRUE	D011034	"<span class=""chemical"">epipodophyllotoxin</span>"	D066126	"<span class=""disease"">cardiac toxicity</span>"	"PURPOSE: The anthracyclines daunorubicin and doxorubicin and the <span class=""chemical"">epipodophyllotoxin</span> etoposide are potent DNA cleavage-enhancing drugs that are widely used in clinical oncology; however, myelosuppression and <span class=""disease"">cardiac toxicity</span> limit their use."	762850.0	15897593.0	15897593_D011034_D066126		bcv_easy_2770_sent_dev_set_762850	"no_relation
"	"The chemical ""etoposide"" is a kind of ""epipodophyllotoxin"". The sentence says that etoposide causes cardiac toxicity, but the sentence does not say all epipodophyllotoxins cause cardiac toxicity!"
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D001145	"<span class=""disease"">ventricular arrhythmias</span>"	"Although intravenous <span class=""chemical"">caffeine</span> is generally well tolerated, the clinician should be aware of the potential for unpredictable and serious <span class=""disease"">ventricular arrhythmias</span>."	762850.0	18997632.0	18997632_D002110_D001145		bcv_easy_368_sent_dev_set_762850	"yes_direct
"	Serious ventricular arrhythmias can result from taking caffeine.
TRUE	D008790	"<span class=""chemical"">metoprolol</span>"	D006327	"<span class=""disease"">heart block</span>"	"A seventy-eight-year-old woman presented with complete <span class=""disease"">heart block</span> and refractory hypotension two days after a therapeutic dose of sustained-release verapamil with concomitant use of <span class=""chemical"">metoprolol</span>."	762850.0	7785794.0	7785794_D008790_D006327		bcv_easy_2230_sent_dev_set_762850	"yes_direct
"	The woman developed a heart block after taking two chemicals together (verapamil and metoprolol).
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D006333	"<span class=""disease"">cardiac failure</span>"	"One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 MMC and only 150 mg m-2 <span class=""chemical"">doxorubicin</span>."	762850.0	3137399.0	3137399_D004317_D006333		bcv_easy_2589_sent_dev_set_762850	"yes_direct
"	
TRUE	D018818	"<span class=""chemical"">fenoldopam</span>"	D009369	"<span class=""disease"">tumor</span>"	"Arteritis induced in rats by vasodilators, <span class=""chemical"">fenoldopam</span> and theophylline, was examined immunohistochemically for expressions of inducible type of nitric oxide synthase (iNOS), basic fibroblast growth factor (bFGF) and <span class=""disease"">tumor</span> growth factor-beta1 (TGF-beta1)."	762850.0	12180796.0	12180796_D018818_D009369		bcv_easy_1109_sent_dev_set_762850	"no_relation
"	"Some rats which had been given fenoldopam were examined for a kind of protein (""tumor growth factor-beta1""). Here the word ""tumor"" is not being used to refer to the disease, but is rather part of the name of a protein (""tumor growth factor-beta1"")."
TRUE	D005047	"<span class=""chemical"">etoposide</span>"	D066126	"<span class=""disease"">cardiac toxicity</span>"	"PURPOSE: The anthracyclines daunorubicin and doxorubicin and the epipodophyllotoxin <span class=""chemical"">etoposide</span> are potent DNA cleavage-enhancing drugs that are widely used in clinical oncology; however, myelosuppression and <span class=""disease"">cardiac toxicity</span> limit their use."	762850.0	15897593.0	15897593_D005047_D066126		bcv_easy_2774_sent_dev_set_762850	"yes_direct
"	
TRUE	D008874	"<span class=""chemical"">midazolam</span>"	D006606	"<span class=""disease"">hiccups</span>"	"Corticosteroids (dexamethasone and methylprednisolone), benzodiazepines (<span class=""chemical"">midazolam</span>) and general anaesthesia have been the specific agents mentioned most frequently in the literature as being associated with the development of <span class=""disease"">hiccups</span>."	762850.0	15985056.0	15985056_D008874_D006606		bcv_easy_554_sent_dev_set_762850	"yes_direct
"	"""Benzodiazepines"" are a category of chemicals. Midazolam is mentioned as a specific example of a ""benzodiazepine"" that is known to cause hiccups."
TRUE	D008775	"<span class=""chemical"">methylprednisolone</span>"	D006323	"<span class=""disease"">asystole</span>"	"We report a case of hypotension, bradycardia, and <span class=""disease"">asystole</span> after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode."	762850.0	10074612.0	10074612_D008775_D006323		bcv_easy_1727_sent_dev_set_762850	"yes_direct
"	Methylprednisolone caused three different diseases in this patient.
TRUE	D005045	"<span class=""chemical"">etomidate</span>"	D009207	"<span class=""disease"">myoclonus</span>"	"Remifentanil pretreatment reduces <span class=""disease"">myoclonus</span> after <span class=""chemical"">etomidate</span>."	762850.0	16563323.0	16563323_D005045_D009207		bcv_easy_523_sent_dev_set_762850	"yes_direct
"	Remifentanil makes myoclonus caused by etomidate better.
TRUE	C045645	"<span class=""chemical"">CLZ</span>"	D006261	"<span class=""disease"">headache</span>"	"Seven out of 12 subjects experienced <span class=""disease"">headache</span> of a short duration accompanying facial flush in one and nausea in one, especially after ingestion of <span class=""chemical"">CLZ</span>."	762850.0	7596955.0	7596955_C045645_D006261		bcv_easy_202_sent_dev_set_762850	"yes_direct
"	Eating CLZ caused headaches in 7 of 12 patients.
TRUE	C037663	"<span class=""chemical"">ropivacaine</span>"	D012640	"<span class=""disease"">seizures</span>"	"The cumulative doses of levobupivacaine and <span class=""chemical"">ropivacaine</span> that produced <span class=""disease"">seizures</span> were similar and were larger than those of bupivacaine."	762850.0	11524350.0	11524350_C037663_D012640		bcv_easy_1454_sent_dev_set_762850	"yes_direct
"	
TRUE	D013739	"<span class=""chemical"">testosterone</span>"	D006966	"<span class=""disease"">hyperprolactinemia</span>"	"Serum <span class=""chemical"">testosterone</span> concentration increased with pubertal status but was not affected by <span class=""disease"">hyperprolactinemia</span>."	762850.0	20331935.0	20331935_D013739_D006966		bcv_easy_1924_sent_dev_set_762850	"no_relation
"	
TRUE	D002794	"<span class=""chemical"">choline</span>"	D000544	"<span class=""disease"">AD/Alzheimer's disease</span>"	"The <span class=""chemical"">choline</span> acetyltransferase (ChAT) activator, which enhances cholinergic transmission via an augmentation of the enzymatic production of acetylcholine (ACh), is an important factor in the treatment of <span class=""disease"">Alzheimer's disease</span> (<span class=""disease"">AD</span>)."	762850.0	16428827.0	16428827_D002794_D000544		bcv_easy_539_sent_dev_set_762850	"no_relation
"	"The ""choline acetyltransferase activator"" (a protein) and not ""choline"" itself is important to treating Alzheimer's disease."
TRUE	D004967	"<span class=""chemical"">oestrogen</span>"	D005705	"<span class=""disease"">gallbladder disease</span>"	"Long-term <span class=""chemical"">oestrogen</span>-only HT significantly increased the risk of venous thrombo-embolism, stroke and <span class=""disease"">gallbladder disease</span> (after one to two years, three years and seven years' use respectively), but did not significantly increase the risk of breast cancer."	762850.0	19370593.0	19370593_D004967_D005705		bcv_easy_175_sent_dev_set_762850	"yes_direct
"	Oestrogen increased the risk of gallbladder disease.
TRUE	D002738	"<span class=""chemical"">chloroquine</span>"	D015354	"<span class=""disease"">deterioration of vision</span>"	"A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive <span class=""disease"">deterioration of vision</span>, easy fatiguability, dyspnoea, dizziness progressing to syncopal attacks."	762850.0	1628552.0	1628552_D002738_D015354		bcv_easy_1438_sent_dev_set_762850	"yes_direct
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"INTERPRETATION: Although this preliminary analysis has low power, in this cohort of women at low-to-normal risk of <span class=""disease"">breast cancer</span>, the postulated protective effects of <span class=""chemical"">tamoxifen</span> are not yet apparent."	762850.0	9672273.0	9672273_D013629_D001943		bcv_easy_595_sent_dev_set_762850	"no_relation
"	Tamoxifen's protective (beneficial) effects on breast cancer are not yet clear according to this sentence.
TRUE	D011188	"<span class=""chemical"">potassium</span>"	D007008	"<span class=""disease"">hypokalemia</span>"	"In conclusion we found that thiazide diuretics cause <span class=""disease"">hypokalemia</span> and depletion of body <span class=""chemical"">potassium</span>."	762850.0	6942642.0	6942642_D011188_D007008		bcv_easy_998_sent_dev_set_762850	"no_relation
"	"Hypokalemia is caused by ""thiazide diuretics""."
TRUE	D012293	"<span class=""chemical"">rifampin</span>"	D014376	"<span class=""disease"">tuberculosis</span>"	"Light chain proteinuria and cellular mediated immunity in <span class=""chemical"">rifampin</span> treated patients with <span class=""disease"">tuberculosis</span>."	762850.0	804391.0	804391_D012293_D014376		bcv_easy_3185_sent_dev_set_762850	"no_relation
"	Rifampin was given to patients with tuberculosis, but the sentence does not say rifampin caused their tuberculosis.
TRUE	D006024	"<span class=""chemical"">glycopyrronium</span>"	D001919	"<span class=""disease"">bradycardias</span>"	"Use of <span class=""chemical"">glycopyrronium</span> 5 micrograms kg-1 provided greater cardiovascular stability and, given 1 min before the edrophonium, was sufficient to minimize early, edrophonium-induced <span class=""disease"">bradycardias</span>."	762850.0	2917114.0	2917114_D006024_D001919		bcv_easy_39_sent_dev_set_762850	"no_relation
"	Glycopyrronium had a beneficial effect on bradycardias.
TRUE	D002998	"<span class=""chemical"">clonazepam</span>"	D009207	"<span class=""disease"">myoclonic jerks</span>"	"Of the benzodiazepines, <span class=""chemical"">clonazepam</span> (0.1-0.3 mg/kg) was found to be several fold more potent than diazepam (0.3-3 mg/kg) in blocking the <span class=""disease"">myoclonic jerks</span>."	762850.0	6118280.0	6118280_D002998_D009207		bcv_easy_1583_sent_dev_set_762850	"no_relation
"	Clonazepam blocked myoclonic jerks.
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D009202	"<span class=""disease"">cardiomyopathy</span>"	"Dose-effect and structure-function relationships in <span class=""chemical"">doxorubicin</span> <span class=""disease"">cardiomyopathy</span>."	762850.0	7282516.0	7282516_D004317_D009202		bcv_easy_705_sent_dev_set_762850	"yes_direct
"	"The ""dose-effect"" and ""structure-function relationships"" refer to that between doxorubicin and cardiomyopathy. Therefore we can conclude that different doses of doxorubicin have different effects on cardiomyopathy, and that therefore doxorubicin causes cardiomyopathy."
TRUE	D003024	"<span class=""chemical"">clozapine</span>"	D013981	"<span class=""disease"">tic-like symptoms</span>"	"However, there are two case reports that show <span class=""disease"">tic-like symptoms</span>, including motor and phonic variants, occurring during treatment with quetiapine or <span class=""chemical"">clozapine</span>."	762850.0	16225977.0	16225977_D003024_D013981		bcv_easy_2976_sent_dev_set_762850	"yes_direct
"	Two reports showed that tic-like symptoms arose during clozapine treatment.
TRUE	C059896	"<span class=""chemical"">SC-48334</span>"	D007153	"<span class=""disease"">immunodeficiency</span>"	"The mean <span class=""chemical"">SC-48334</span> steady-state trough level (4.04 +/- 0.99 micrograms/ml) was below the in vitro inhibitory concentration for human <span class=""disease"">immunodeficiency</span> virus (HIV)."	762850.0	7905523.0	7905523_C059896_D007153		bcv_easy_2126_sent_dev_set_762850	"no_relation
"	"SC-48334 concentration was not high enough to inhibit ""human immunodeficiency virus"". Immunodeficiency is not discussed as a disease here. It is part of ""human immunodeficiency virus""."
TRUE	D010389	"<span class=""chemical"">pemoline</span>"	D062787	"<span class=""disease"">overdose</span>"	"The possibility of choreoathetoid movements should be considered in patients presenting after <span class=""chemical"">pemoline</span> <span class=""disease"">overdose</span>."	762850.0	9022662.0	9022662_D010389_D062787		bcv_easy_330_sent_dev_set_762850	"yes_direct
"	
TRUE	C033457	"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>"	D056486	"<span class=""disease"">hepatitis</span>"	"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>-induced fulminant <span class=""disease"">hepatitis</span> in a pregnant woman. A case report."	762850.0	3411101.0	3411101_C033457_D056486		bcv_easy_2695_sent_dev_set_762850	"yes_direct
"	Induced means caused.
TRUE	D000255	"<span class=""chemical"">ATP</span>"	D009765	"<span class=""disease"">obese</span>"	"In conclusion, HFD-induced <span class=""disease"">obese</span> rats are highly sensitized to doxorubicin-induced cardiotoxicity by substantially downregulating cardiac mitochondrial <span class=""chemical"">ATP</span> generation, increasing oxidative stress and downregulating the JAK/STAT3 pathway."	762850.0	18674790.0	18674790_D000255_D009765		bcv_easy_491_sent_dev_set_762850	"no_relation
"	
TRUE	D017374	"<span class=""chemical"">paroxetine</span>"	D009459	"<span class=""disease"">neuroleptic malignant syndrome</span>"	"Possible <span class=""disease"">neuroleptic malignant syndrome</span> related to concomitant treatment with <span class=""chemical"">paroxetine</span> and alprazolam."	762850.0	16720068.0	16720068_D017374_D009459		bcv_easy_276_sent_dev_set_762850	"yes_direct
"	The sentence says that treatment with paroxetine and alprazolam possibly causes neuroleptic malignant syndrome.
TRUE	D003520	"<span class=""chemical"">Cyclophosphamide</span>"	D059265	"<span class=""disease"">visceral pain</span>"	"<span class=""chemical"">Cyclophosphamide</span>-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of <span class=""disease"">visceral pain</span>."	762850.0	10840460.0	10840460_D003520_D059265		bcv_easy_2866_sent_dev_set_762850	"no_relation
"	
TRUE	D005680	"<span class=""chemical"">gamma-aminobutyric acid/GABA</span>"	D007022	"<span class=""disease"">hypotension</span>"	"High doses of isoniazid increase <span class=""disease"">hypotension</span> induced by vasodilators and change the accompanying reflex tachycardia to bradycardia, an interaction attributed to decreased synthesis of brain <span class=""chemical"">gamma-aminobutyric acid</span> (<span class=""chemical"">GABA</span>)."	762850.0	9915601.0	9915601_D005680_D007022		bcv_easy_1197_sent_dev_set_762850	"no_relation
"	"Hypotension is caused by ""vasodilators"" (chemicals that make blood vessels wider) and made worse by the chemical ""isoniazid""."
TRUE	D000319	"<span class=""chemical"">beta-adrenergic blocking drugs</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>."	762850.0	6127992.0	6127992_D000319_D001919		bcv_easy_851_sent_dev_set_762850	"yes_direct
"	
TRUE	D010068	"<span class=""chemical"">oxacillin</span>"	D013203|D016470	"<span class=""disease"">Staphylococcus aureus bacteremia</span>"	"A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of <span class=""disease"">Staphylococcus aureus bacteremia</span>, developed renal failure and diffuse, symmetric, palpable purpuric lesions on his feet."	762850.0	11337188.0	11337188_D010068_D013203|D016470		bcv_easy_2749_sent_dev_set_762850	"no_relation
"	Oxacillin was used to treat staphylococcus aureus bacteremia.
TRUE	D006046	"<span class=""chemical"">gold</span>"	D003872	"<span class=""disease"">dermatitis</span>"	"A strong association has been found between nephritis and <span class=""disease"">dermatitis</span> due to Tiopronin (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between <span class=""disease"">dermatitis</span> due to <span class=""chemical"">gold</span> thiosulphate and B35."	762850.0	3084782.0	3084782_D006046_D003872		bcv_easy_3040_sent_dev_set_762850	"no_relation
"	"""Gold"" is part of ""gold thiosulphate"", which is a very different chemical than ""gold""! Dermatitis is caused by ""gold thiosulphate"", not ""gold""."
TRUE	D008094	"<span class=""chemical"">Li</span>"	D001480	"<span class=""disease"">EPS</span>"	"Similarly, <span class=""disease"">EPS</span>-related adverse events with QTP + <span class=""chemical"">Li</span>/DVP (21.4%) were no different than with PBO + <span class=""chemical"">Li</span>/DVP (19.2%)."	762850.0	17042884.0	17042884_D008094_D001480		bcv_easy_227_sent_dev_set_762850	"no_relation
"	The EPS related events are no different when chemical QTP is given and when PBO is given. The sentence does not contain enough information to say that lithium (Li) causes EPS related adverse events.
TRUE	D012110	"<span class=""chemical"">reserpine</span>"	D014202	"<span class=""disease"">tremor</span>"	"Pretreatment with <span class=""chemical"">reserpine</span> (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in <span class=""disease"">tremor</span> and catalepsy, whereas MK-801 (0.1 mg/kg) injection 90 min before the test reversed the effects of <span class=""chemical"">reserpine</span>."	762850.0	11999899.0	11999899_D012110_D014202		bcv_easy_2190_sent_dev_set_762850	"yes_direct
"	Giving reserpine 24 hours prior caused tremor.
TRUE	D014810	"<span class=""chemical"">Vitamin E</span>"	D009203	"<span class=""disease"">MI</span>"	"The heart tissue antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione transferase and glutathione reductase activities, non-enzymic antioxidants such as cerruloplasmin, Vitamin C, <span class=""chemical"">Vitamin E</span> and glutathione levels were altered in <span class=""disease"">MI</span> rats."	762850.0	16584858.0	16584858_D014810_D009203		bcv_easy_514_sent_dev_set_762850	"no_relation
"	Vitamin E levels were changed in MI rats.
TRUE	D005839	"<span class=""chemical"">gentamicin</span>"	D009956	"<span class=""disease"">tubular necrosis</span>"	"In Group II, P did not prevent <span class=""chemical"">gentamicin</span>-ARF (maximal decrease in CCr at day 9.89%, P less than 0.001; peak lysozymuria, 1863 +/- 321 micrograms/day; and <span class=""disease"">tubular necrosis</span> score, 3.9 +/- 0.1)."	762850.0	2709684.0	2709684_D005839_D009956		bcv_easy_2614_sent_dev_set_762850	"no_relation
"	"The ""tubular necrosis score"" was a measurement used to quantify whether ""P"" prevented ""gentamicin-ARF"". The text never says ""gentamicin"" is related to ""tubular necrosis""."
TRUE	D043343	"<span class=""chemical"">TP</span>"	D011471	"<span class=""disease"">prostate cancer</span>"	"In L-W rats, <span class=""chemical"">TP</span> acted as a tumor enhancement agent, with primary emphasis on the development of <span class=""disease"">prostate cancer</span>."	762850.0	3461217.0	3461217_D043343_D011471		bcv_easy_3155_sent_dev_set_762850	"yes_direct
"	TP enhances tumors, especially the development of prostate cancer. Therefore we can conclude that TP can cause prostate cancer.
TRUE	D010672	"<span class=""chemical"">phenytoin</span>"	D011605	"<span class=""disease"">psychosis</span>"	"The case of a nonepileptic patient who developed <span class=""disease"">psychosis</span> following <span class=""chemical"">phenytoin</span> treatment for trigeminal neuralgia is described."	760841.0	14698717.0	14698717_D010672_D011605		bcv_easy_3152_sent_train_set_revised_760841	"yes_direct
"	The patient developed psychosis after receiving phenytoin.
TRUE	D001379	"<span class=""chemical"">azathioprine</span>"	D009369	"<span class=""disease"">cancers</span>"	"There have been several long-term studies of patients with rheumatoid arthritis treated with <span class=""chemical"">azathioprine</span> and cyclophosphamide and the incidence of most of the common <span class=""disease"">cancers</span> is not increased."	760841.0	3970039.0	3970039_D001379_D009369		bcv_easy_2200_sent_train_set_revised_760841	"no_relation
"	Azathioprine had no effect on cancer prevalence in the patients.
TRUE	D011433	"<span class=""chemical"">propranolol</span>"	D016584	"<span class=""disease"">panic disorders</span>"	"The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and <span class=""chemical"">propranolol</span> (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with <span class=""disease"">panic disorders</span> and agoraphobia were investigated in a double-blind, randomized and crossover design."	760841.0	6387529.0	6387529_D011433_D016584		bcv_easy_174_sent_train_set_revised_760841	"no_relation
"	The sentence says that the effects of diazepam and propranolol on patients was investigated. The sentence does not state what the effect was.
TRUE	D004837	"<span class=""chemical"">adrenaline</span>"	D001281	"<span class=""disease"">atrial fibrillation</span>"	"An increase in blood pressure, accompanied by <span class=""disease"">atrial fibrillation</span>, agitation, incomprehensible shouts and loss of consciousness, was observed in an elderly, ASA classification group II, cardiovascularly medicated male, 12 min after performance of axillary block with mepivacaine 850 mg containing <span class=""chemical"">adrenaline</span> 0.225 mg, for correction of Dupuytren's contracture."	760841.0	9698967.0	9698967_D004837_D001281		bcv_easy_762_sent_train_set_revised_760841	"yes_direct
"	Giving mepivacaine and adrenaline together caused the male patient to experience atrial fibrillation.
TRUE	D007654	"<span class=""chemical"">ketoconazole</span>"	D006973	"<span class=""disease"">hypertension</span>"	"In both cases normal plasma and urinary free cortisol levels had been achieved following <span class=""chemical"">ketoconazole</span> therapy, yet continuous blood pressure monitoring demonstrated <span class=""disease"">hypertension</span> 31 (patient 1) and 52 weeks (patient 2) after treatment."	760841.0	2632720.0	2632720_D007654_D006973		bcv_easy_58_sent_train_set_revised_760841	"yes_direct
"	Long-term patient monitoring showed that both patients had hypertension after receiving ketoconazole therapy.
TRUE	D002945	"<span class=""chemical"">cisplatin</span>"	D064420	"<span class=""disease"">toxicity</span>"	"We initiated a phase I/II trial to determine the response and <span class=""disease"">toxicity</span> of escalating paclitaxel doses combined with fixed-dose <span class=""chemical"">cisplatin</span> with granulocyte colony-stimulating factor support in patients with untreated locally advanced inoperable head and neck carcinoma."	760841.0	8643971.0	8643971_D002945_D064420		bcv_easy_2217_sent_train_set_revised_760841	"no_relation
"	The sentence says that the response and toxicity of paclitaxel with cisplatin was studied, but does not say what the result was.
TRUE	D012964	"<span class=""chemical"">na</span>"	D012640	"<span class=""disease"">Seizure</span>"	"METHODS: Cholinergic convulsant sensitivity was examined in alcohol-<span class=""chemical"">na</span>  ve Withdrawal <span class=""disease"">Seizure</span>-Prone (WSP) and-Resistant (WSR) mice."	760841.0	12198388.0	12198388_D012964_D012640		bcv_easy_847_sent_train_set_revised_760841	"no_relation
"	"""na"" does not represent a chemical in this context. There seems to be an error with ""alcohol-na ve"" since ""ve"" is not a word."
TRUE	D014031	"<span class=""chemical"">tobramycin sulfate</span>"	D006311	"<span class=""disease"">ototoxicity</span>"	"Gentamicin sulfate and <span class=""chemical"">tobramycin sulfate</span> continue to demonstrate <span class=""disease"">ototoxicity</span> and nephrotoxicity in both animal and clinical studies."	760841.0	7420681.0	7420681_D014031_D006311		bcv_easy_2055_sent_train_set_revised_760841	"yes_direct
"	Tobramycin sulfate causes ototoxicity in animals and humans.
TRUE	D014700	"<span class=""chemical"">Verapamil</span>"	D006973	"<span class=""disease"">hypertensive</span>"	"<span class=""chemical"">Verapamil</span> withdrawal as a possible cause of myocardial infarction in a <span class=""disease"">hypertensive</span> woman with a normal coronary angiogram."	760841.0	3173179.0	3173179_D014700_D006973		bcv_easy_1910_sent_train_set_revised_760841	"no_relation
"	Verapamil was used by a woman with hypertension, but the sentence does not say that verapamil causes hypertension.
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D014693	"<span class=""disease"">ventricular fibrillation</span>"	"We describe a 25-year-old woman with pre-existing mitral valve prolapse who developed intractable <span class=""disease"">ventricular fibrillation</span> after consuming a ""natural energy"" guarana health drink containing a high concentration of <span class=""chemical"">caffeine</span>."	760841.0	11419773.0	11419773_D002110_D014693		bcv_easy_298_sent_train_set_revised_760841	"yes_direct
"	She developed ventricular fibrillation after consuming the health drink containing caffeine.
TRUE	D000082	"<span class=""chemical"">acetaminophen</span>"	D007676	"<span class=""disease"">ESRD</span>"	"The possibility that habitual use of <span class=""chemical"">acetaminophen</span> alone increases the risk of <span class=""disease"">ESRD</span> has not been clearly demonstrated, but cannot be dismissed."	760841.0	8669433.0	8669433_D000082_D007676		bcv_easy_698_sent_train_set_revised_760841	"no_relation
"	"The sentence says that it is not known whether acetaminophen causes ESRD, but that it is also not impossible. Therefore we do not know whether acetaminophen causes ESRD, and therefore the answer is that ""the sentence does not say that acetaminophen contributes to or causes ESRD""."
TRUE	D010862	"<span class=""chemical"">pilocarpine</span>"	D002544	"<span class=""disease"">Infarcts in substantia nigra pars reticulata</span>"	"<span class=""disease"">Infarcts in substantia nigra pars reticulata</span> were evoked by prolonged <span class=""chemical"">pilocarpine</span>-induced status epilepticus."	760841.0	8410052.0	8410052_D010862_D002544		bcv_easy_229_sent_train_set_revised_760841	"yes_indirect
"	"This sentence follows the structure of ""[chemical]-induced [other disease] causes [highlighted disease]"". Status epilepticus is what is actually causing ""infarcts in substantia nigra pars reticulata""."
TRUE	D000628	"<span class=""chemical"">aminophylline</span>"	D012131	"<span class=""disease"">respiratory failure</span>"	"The effects of <span class=""chemical"">aminophylline</span> on the ventricular fibrillation threshold during normal acid-base conditions and during <span class=""disease"">respiratory failure</span> were studied in anesthetized open chest dogs."	760841.0	234669.0	234669_D000628_D012131		bcv_easy_2792_sent_train_set_revised_760841	"no_relation
"	The sentence says that the effects were studied, but does not say if there were any effects.
TRUE	C027260	"<span class=""chemical"">4'-0-tetrahydropyranyladriamycin/Pirarubicin</span>"	D009369	"<span class=""disease"">tumors</span>"	"A Phase I study of intravenous (IV) bolus <span class=""chemical"">4'-0-tetrahydropyranyladriamycin</span> (<span class=""chemical"">Pirarubicin</span>) was done in 55 patients in good performance status with refractory <span class=""disease"">tumors</span>."	760841.0	2224762.0	2224762_C027260_D009369		bcv_easy_2221_sent_train_set_revised_760841	"no_relation
"	The study of Pirarubicin was done in patients with existing tumors, but there is no stated link between Pirarubicin and tumors.
TRUE	C558899	"<span class=""chemical"">lopinavir/ritonavir</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"One of the twins developed complete heart block and dilated cardiomyopathy related to <span class=""chemical"">lopinavir/ritonavir</span> therapy, a boosted protease-inhibitor agent, while the other twin developed mild <span class=""disease"">bradycardia</span>."	760841.0	19820426.0	19820426_C558899_D001919		bcv_easy_1711_sent_train_set_revised_760841	"yes_direct
"	The second twin developed bradycardia as a result of lopinavir/ritonavir.
TRUE	D011346	"<span class=""chemical"">prochlorperazine</span>"	D017109	"<span class=""disease"">akathisia</span>"	"Intravenous administration of <span class=""chemical"">prochlorperazine</span> by 15-minute infusion versus 2-minute bolus does not affect the incidence of <span class=""disease"">akathisia</span>: a prospective, randomized, controlled trial."	760841.0	11679859.0	11679859_D011346_D017109		bcv_easy_834_sent_train_set_revised_760841	"no_relation
"	Prochlorperazine has no effect on akathisia.
TRUE	D005283	"<span class=""chemical"">Fentanyl</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"<span class=""chemical"">Fentanyl</span> did reduce minor intraoperative movement but had no sevoflurane-sparing effect and increased respiratory depression, hypotension and <span class=""disease"">bradycardia</span>."	760841.0	18544179.0	18544179_D005283_D001919		bcv_easy_2375_sent_train_set_revised_760841	"yes_direct
"	Fentanyl increased bradycardia.
TRUE	D003042	"<span class=""chemical"">cocaine</span>"	D005921	"<span class=""disease"">glomerulonephritis</span>"	"These 13 included cases of malignant hypertension, thrombotic microangiopathy, lupus nephritis, Henoch-Schonlein nephritis, crescentic <span class=""disease"">glomerulonephritis</span>, and <span class=""chemical"">cocaine</span>-related acute renal failure."	760841.0	11391224.0	11391224_D003042_D005921		bcv_easy_814_sent_train_set_revised_760841	"no_relation
"	"Cocaine is causing ""acute renal failure"", not glomerulonephritis."
TRUE	D015740	"<span class=""chemical"">CGRP</span>"	D008881	"<span class=""disease"">migraine</span>"	"Plasma <span class=""chemical"">CGRP</span> concentration increased significantly (P<0.01) during the <span class=""disease"">migraine</span> attack and returned to baseline after the cessation of the <span class=""disease"">migraine</span>."	760841.0	14659530.0	14659530_D015740_D008881		bcv_easy_349_sent_train_set_revised_760841	"no_relation
"	"Here ""CGRP"" is part of ""Plasma CGRP concentration"". The migraine seemed to cause the increase in CGRP levels, and not the other way around."
TRUE	C106791	"<span class=""chemical"">telithromycin</span>"	D056486	"<span class=""disease"">toxic hepatitis/hepatitis</span>"	"Based on a score of 8 on the Naranjo adverse drug reaction probability scale, <span class=""chemical"">telithromycin</span> was the probable cause of acute <span class=""disease"">hepatitis</span> in this patient, and pathological findings suggested drug-induced <span class=""disease"">toxic hepatitis</span>."	760841.0	17919553.0	17919553_C106791_D056486		bcv_easy_2550_sent_train_set_revised_760841	"yes_direct
"	Telithromycin was the likely cause of hepatitis in the patient.
TRUE	D001920	"<span class=""chemical"">bradykinin</span>"	D006973	"<span class=""disease"">hypertension</span>"	"Role of activation of <span class=""chemical"">bradykinin</span> B2 receptors in disruption of the blood-brain barrier during acute <span class=""disease"">hypertension</span>."	760841.0	8955532.0	8955532_D001920_D006973		bcv_easy_1892_sent_train_set_revised_760841	"no_relation
"	"Here ""bradykinin"" is part of ""bradykinin B2 receptors"", because the activated receptors are disrupting the blood-brain barrier somehow."
TRUE	D013390	"<span class=""chemical"">suxamethonium</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Comparison of i.v. glycopyrrolate and atropine in the prevention of <span class=""disease"">bradycardia</span> and arrhythmias following repeated doses of <span class=""chemical"">suxamethonium</span> in children."	760841.0	6466532.0	6466532_D013390_D001919		bcv_easy_3049_sent_train_set_revised_760841	"yes_direct
"	Suxamethonium causes bradycardia, and the sentence says two other chemicals (glycopyrrolate and atropine) are being used to try and prevent the bradycardia.
TRUE	C060802	"<span class=""chemical"">fangchinoline</span>"	D013927	"<span class=""disease"">thrombosis</span>"	"Effects of tetrandrine and <span class=""chemical"">fangchinoline</span> on experimental <span class=""disease"">thrombosis</span> in mice and human platelet aggregation."	760841.0	10193204.0	10193204_C060802_D013927		bcv_easy_253_sent_train_set_revised_760841	"no_relation
"	The sentence is a fragment, and does not explicitly say that negative effects of fangchinoline exist, rather that the effects were tested.
TRUE	D004164	"<span class=""chemical"">bisphosphonate</span>"	D058186	"<span class=""disease"">acute renal failure</span>"	"Massive proteinuria and <span class=""disease"">acute renal failure</span> after oral <span class=""chemical"">bisphosphonate</span> (alendronate) administration in a patient with focal segmental glomerulosclerosis."	760841.0	18754075.0	18754075_D004164_D058186		bcv_easy_1641_sent_train_set_revised_760841	"yes_direct
"	Patient developed acute renal failure after taking bisphosphonate.
TRUE	D000082	"<span class=""chemical"">acetaminophen</span>"	D007676	"<span class=""disease"">chronic renal failure/ESRD</span>"	"However, three case control studies, one each in North Carolina, northern Maryland, and West Berlin, Germany, showed that habitual use of <span class=""chemical"">acetaminophen</span> is also associated with <span class=""disease"">chronic renal failure</span> and <span class=""disease"">ESRD</span>, with a relative risk in the range of 2 to 4."	760841.0	8669433.0	8669433_D000082_D007676		bcv_easy_695_sent_train_set_revised_760841	"yes_direct
"	Habitual use of acetaminophen causes chronic renal failure.
TRUE	D009569	"<span class=""chemical"">NO</span>"	D009437	"<span class=""disease"">neuropathic pain</span>"	"Therefore, concomitant administration of small doses of bradykinin receptor antagonists and <span class=""chemical"">NO</span> synthase inhibitors can be effective in alleviation of <span class=""disease"">neuropathic pain</span>, even in hospital care."	760841.0	19300402.0	19300402_D009569_D009437		bcv_easy_2907_sent_train_set_revised_760841	"no_relation
"	"The sentence says small doses of ""NO synthase inhibitors"" (a category of chemicals) removes neuropathic pain."
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D006973	"<span class=""disease"">hypertension</span>"	"Analysis was performed on 61 women with chemotherapy-responsive metastatic breast cancer receiving 96-h infusional <span class=""chemical"">cyclophosphamide</span> as part of a triple sequential high-dose regimen to assess association between presence of peritransplant congestive heart failure (CHF) and the following pretreatment characteristics: presence of electrocardiogram (EKG) abnormalities, age, <span class=""disease"">hypertension</span>, prior cardiac history, smoking, diabetes mellitus, prior use of anthracyclines, and left-sided chest irradiation."	760841.0	15325671.0	15325671_D003520_D006973		bcv_easy_2919_sent_train_set_revised_760841	"no_relation
"	An analysis was done to see if congestive heart failure had anything to do with some pretreatment characteristics, including hypertension. The sentence never says what the conclusions of the analysis were, or whether cyclophosphamide causes hypertension.
TRUE	C524754	"<span class=""chemical"">maltolyl p-coumarate</span>"	D009410	"<span class=""disease"">neuronal death</span>"	"Taking these in vitro and in vivo results together, our study suggests that <span class=""chemical"">maltolyl p-coumarate</span> is a potentially effective candidate against Alzheimer's disease that is characterized by wide spread <span class=""disease"">neuronal death</span> and progressive decline of cognitive function."	760841.0	17600377.0	17600377_C524754_D009410		bcv_easy_1560_sent_train_set_revised_760841	"no_relation
"	"Maltolyl p-coumarate is treating Alzheimer's disease, and not causing one of the symptoms (""neuronal death"") of Alzheimer's disease."
TRUE	D000109	"<span class=""chemical"">acetylcholine</span>"	D014202	"<span class=""disease"">tremors</span>"	"Binding of nicotine to nicotinic <span class=""chemical"">acetylcholine</span> receptors (nAChRs) elicits a series of dose-dependent behaviors that go from altered exploration, sedation, and <span class=""disease"">tremors</span>, to seizures and death."	760841.0	15275829.0	15275829_D000109_D014202		bcv_easy_1512_sent_train_set_revised_760841	"no_relation
"	"Here ""acetylcholine"" is part of ""nicotinic acetylcholine receptors"". Nicotine binding to these receptors causes tremors, but acetylcholine itself does not."
TRUE	D012964	"<span class=""chemical"">na</span>"	D006509	"<span class=""disease"">HBV infected/HBV mono-infected</span>"	"Thirty-five lamivudine-<span class=""chemical"">na</span>  ve <span class=""disease"">HBV infected</span> patients with or without HIV co-infection were studied: 15 chronic <span class=""disease"">HBV mono-infected</span> patients and 20 HBV-HIV co-infected patients."	760841.0	17854040.0	17854040_D012964_D006509		bcv_easy_1578_sent_train_set_revised_760841	"no_relation
"	"""na"" is not being used as a chemical in this context, because ""ve"" is not a word. There seems to be a missing letter between ""na"" and ""ve""."
TRUE	D004837	"<span class=""chemical"">epinephrine/EP</span>"	D013927	"<span class=""disease"">thrombosis</span>"	"The present study was undertaken to investigate the effects of TET and FAN on the experimental <span class=""disease"">thrombosis</span> induced by collagen plus <span class=""chemical"">epinephrine</span> (<span class=""chemical"">EP</span>) in mice, and platelet aggregation and blood coagulation in vitro."	760841.0	10193204.0	10193204_D004837_D013927		bcv_easy_262_sent_train_set_revised_760841	"yes_direct
"	"Thrombosis was ""induced by"" (caused by) collagen and epinephrine."
TRUE	D006854	"<span class=""chemical"">hydrocortisone</span>"	D009202	"<span class=""disease"">myocardial injury</span>"	"Effects of acetylsalicylic acid, dipyridamole, and <span class=""chemical"">hydrocortisone</span> on epinephrine-induced <span class=""disease"">myocardial injury</span> in dogs."	760841.0	983936.0	983936_D006854_D009202		bcv_easy_1098_sent_train_set_revised_760841	"no_relation
"	"Myocardial injury is caused by ""epinephrine"". We do not know what the effect of hydrocortisone on myocardial injury is."
TRUE	D002784	"<span class=""chemical"">cholesterol</span>"	D003072	"<span class=""disease"">cognitive dysfunctions</span>"	"Therefore, DCE may prove to be a useful remedy for the management of <span class=""disease"">cognitive dysfunctions</span> on account of its multifarious beneficial effects such as, memory improving property, <span class=""chemical"">cholesterol</span> lowering property and anticholinesterase activity."	760841.0	16755009.0	16755009_D002784_D003072		bcv_easy_978_sent_train_set_revised_760841	"no_relation
"	"The sentence lists some ""beneficial effects"" of DCE, such as ""cholesterol lowering property"". The sentence does not say cholesterol causes cognitive dysfunctions."
TRUE	D012964	"<span class=""chemical"">sodium</span>"	D016055	"<span class=""disease"">volume retention</span>"	"Doxorubicin-induced nephropathy leads to epithelial <span class=""chemical"">sodium</span> channel (ENaC)-dependent <span class=""disease"">volume retention</span> and renal fibrosis."	760841.0	18768591.0	18768591_D012964_D016055		bcv_easy_1653_sent_train_set_revised_760841	"no_relation
"	"The sentence says nephropathy caused by doxorubicin leads to volume retention that is dependent on ""epithelial sodium channels"", a kind of protein. It does not say sodium causes volume retention."
TRUE	D002945	"<span class=""chemical"">cisplatin</span>"	D028361	"<span class=""disease"">mitochondrial toxicity</span>"	"In conclusion <span class=""disease"">mitochondrial toxicity</span> is an early common event both in paclitaxel and <span class=""chemical"">cisplatin</span> induced neurotoxicity."	760841.0	18809400.0	18809400_D002945_D028361		bcv_easy_2259_sent_train_set_revised_760841	"yes_indirect
"	"This sentence follows the ""[chemical]-induced [other disease] causes [highlighted disease]"" structure. Therefore the correct answer is ""cisplatin-induced [neurotoxicity] causes mitochondrial toxicity""."
TRUE	D009020	"<span class=""chemical"">morphine</span>"	D059787	"<span class=""disease"">acute pain</span>"	"Enhancement of <span class=""chemical"">morphine</span> antinociception by dextromethorphan was seen in both males and females in the <span class=""disease"">acute pain</span> models, with the magnitude of this effect being greater in males."	760841.0	18221780.0	18221780_D009020_D059787		bcv_easy_1595_sent_train_set_revised_760841	"no_relation
"	The effect was enhanced by dextromethorphan in a model of acute pain. The sentence does not say morphine causes acute pain. Fun fact: morphine is actually a very strong painkiller that is similar to opium and heroin.
TRUE	D016202	"<span class=""chemical"">NMDA</span>"	D059787	"<span class=""disease"">acute pain</span>"	"These findings demonstrate a sexually-dimorphic interaction between <span class=""chemical"">NMDA</span> antagonists and morphine in a persistent pain model that can be distinguished from those observed in <span class=""disease"">acute pain</span> models."	760841.0	18221780.0	18221780_D016202_D059787		bcv_easy_1597_sent_train_set_revised_760841	"no_relation
"	"""NMDA antagonists"" are interacting with morphine. The study is done in a ""acute pain"" model, but the sentence does not say that NMDA causes acute pain."
TRUE	D000431	"<span class=""chemical"">alcohol</span>"	D005483	"<span class=""disease"">flushing of the face</span>"	"In less than 1 hour after the ingestion of <span class=""chemical"">alcohol</span>, he developed malaise with <span class=""disease"">flushing of the face</span>, tachycardia, and dyspnea."	760841.0	19657887.0	19657887_D000431_D005483		bcv_easy_1805_sent_train_set_revised_760841	"yes_direct
"	Ingesting alcohol causes your face to flush (but you already knew that!).
TRUE	D004298	"<span class=""chemical"">dopamine</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"They suggest that, in normal conscious rats, the central tachycardia of bromocriptine appears to predominate and to mask the <span class=""disease"">bradycardia</span> of this agonist at peripheral <span class=""chemical"">dopamine</span> D2 receptors."	760841.0	10721819.0	10721819_D004298_D001919		bcv_easy_1391_sent_train_set_revised_760841	"no_relation
"	"Here ""dopamine"" is part of ""dopamine D2 receptors"", which is a kind of protein."
TRUE	D006220	"<span class=""chemical"">haloperidol</span>"	D011595	"<span class=""disease"">psychomotor agitation</span>"	"RESULTS: For the 60 patients who completed phase A, standard-dose <span class=""chemical"">haloperidol</span> was efficacious and superior to both low-dose <span class=""chemical"">haloperidol</span> and placebo for scores on the Brief Psychiatric Rating Scale psychosis factor and on <span class=""disease"">psychomotor agitation</span>."	760841.0	9812111.0	9812111_D006220_D011595		bcv_easy_2042_sent_train_set_revised_760841	"no_relation
"	Haloperidol seemed to have a positive effect on psychomotor agitation.
TRUE	D005283	"<span class=""chemical"">fentanyl</span>"	D010149	"<span class=""disease"">postoperative pain</span>"	"CONCLUSION: As <span class=""chemical"">fentanyl</span> exacerbated postoperative nausea and vomiting without an improvement in <span class=""disease"">postoperative pain</span> and also had adverse cardiorespiratory effects, it appears to be an unnecessary and possibly detrimental supplement to sevoflurane in day surgery."	760841.0	18544179.0	18544179_D005283_D010149		bcv_easy_2381_sent_train_set_revised_760841	"no_relation
"	Fentanyl made postoperative nausea and vomiting worse, but did not improve postoperative pain. The sentence does not say that fentanyl originally caused the postoperative pain!
TRUE	D009582	"<span class=""chemical"">Nitrofurantoins</span>"	D000853	"<span class=""disease"">anophthalmia</span>"	"<span class=""chemical"">Nitrofurantoins</span> were associated with <span class=""disease"">anophthalmia</span> or microphthalmos (AOR = 3.7; 95% CI, 1.1-12.2), hypoplastic left heart syndrome (AOR = 4.2; 95% CI, 1.9-9.1), atrial septal defects (AOR = 1.9; 95% CI, 1.1-3.4), and cleft lip with cleft palate (AOR = 2.1; 95% CI, 1.2-3.9)."	760841.0	19884587.0	19884587_D009582_D000853		bcv_easy_2185_sent_train_set_revised_760841	"yes_direct
"	Nitrofurantoins cause anophthalmia.
TRUE	D004177	"<span class=""chemical"">metamizol</span>"	D059350	"<span class=""disease"">chronic pain</span>"	"These findings show a significant interaction between morphine and <span class=""chemical"">metamizol</span> in chronically treated rats, suggesting that this combination could be useful for the treatment of <span class=""disease"">chronic pain</span>."	760841.0	12063090.0	12063090_D004177_D059350		bcv_easy_1462_sent_train_set_revised_760841	"no_relation
"	Metamizol is said to be useful for treating chronic pain.
TRUE	D007608	"<span class=""chemical"">kainic acid</span>"	D001930	"<span class=""disease"">hippocampal injury</span>"	"Estrogens protect ovariectomized rats from <span class=""disease"">hippocampal injury</span> induced by <span class=""chemical"">kainic acid</span>-induced status epilepticus (SE)."	760841.0	12757899.0	12757899_D007608_D001930		bcv_easy_1482_sent_train_set_revised_760841	"yes_indirect
"	"This follows the ""[chemical]-induced [other disease] caused [highlighted disease]"" format, so the correct answer is ""kainic acid-induced [status epilepticus] causes hippocampal injury""."
TRUE	D008775	"<span class=""chemical"">methylprednisolone</span>"	D020250	"<span class=""disease"">nausea, vomiting</span>"	"CONCLUSIONS: The administration of <span class=""chemical"">methylprednisolone</span> and gentamicin in the posterior sub-Tenon's space was related to a high incidence of side effects including <span class=""disease"">nausea, vomiting</span>, and headache."	760841.0	17466854.0	17466854_D008775_D020250		bcv_easy_1538_sent_train_set_revised_760841	"yes_direct
"	Methylprednisolone causes nausea and vomiting as a side effect.
TRUE	D002220	"<span class=""chemical"">carbamazepine</span>"	D051437	"<span class=""disease"">renal failure</span>"	"We report a patient in whom hypersensitivity to <span class=""chemical"">carbamazepine</span> presented with generalized erythroderma, a severe leukemoid reaction, eosinophilia, hyponatremia, and <span class=""disease"">renal failure</span>."	760841.0	2522601.0	2522601_D002220_D051437		bcv_easy_1930_sent_train_set_revised_760841	"yes_direct
"	Carbamazepine caused many diseases in this patient.
TRUE	D019386	"<span class=""chemical"">alendronate</span>"	D011507	"<span class=""disease"">proteinuria</span>"	"Massive <span class=""disease"">proteinuria</span> and acute renal failure after oral bisphosphonate (<span class=""chemical"">alendronate</span>) administration in a patient with focal segmental glomerulosclerosis."	760841.0	18754075.0	18754075_D019386_D011507		bcv_easy_1645_sent_train_set_revised_760841	"yes_direct
"	Patient developed proteinuria after taking alendronate.
TRUE	D002443	"<span class=""chemical"">ceftriaxone</span>"	D056486	"<span class=""disease"">hepatitis</span>"	"Acute <span class=""disease"">hepatitis</span>, autoimmune hemolytic anemia, and erythroblastocytopenia induced by <span class=""chemical"">ceftriaxone</span>."	760841.0	9625142.0	9625142_D002443_D056486		bcv_easy_241_sent_train_set_revised_760841	"yes_direct
"	Induced means caused by.
TRUE	D009568	"<span class=""chemical"">nitrendipine</span>"	D006978	"<span class=""disease"">renovascular hypertension</span>"	"The effect of a 6-week treatment with the calcium channel blocker <span class=""chemical"">nitrendipine</span> or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two-kidney, one clip <span class=""disease"">renovascular hypertension</span>."	760841.0	1639466.0	1639466_D009568_D006978		bcv_easy_3086_sent_train_set_revised_760841	"no_relation
"	The sentence gives no conclusion regarding the result of the study.
TRUE	C030852	"<span class=""chemical"">vinorelbine</span>"	D002289	"<span class=""disease"">nonsmall cell lung carcinoma</span>"	"Gemcitabine plus <span class=""chemical"">vinorelbine</span> in <span class=""disease"">nonsmall cell lung carcinoma</span> patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group."	760841.0	10526274.0	10526274_C030852_D002289		bcv_easy_269_sent_train_set_revised_760841	"no_relation
"	The sentence says vinorelbine was used in patients with lung carcinoma, but does not say whether vinorelbine is treating or causing the cancer.
TRUE	D005283	"<span class=""chemical"">fentanyl</span>"	D016055	"<span class=""disease"">retention of urine</span>"	"Bladder <span class=""disease"">retention of urine</span> as a result of continuous intravenous infusion of <span class=""chemical"">fentanyl</span>: 2 case reports."	760841.0	11581460.0	11581460_D005283_D016055		bcv_easy_299_sent_train_set_revised_760841	"yes_direct
"	Using fentanyl caused retention or urine.
TRUE	D018817	"<span class=""chemical"">MDMA</span>"	D003072	"<span class=""disease"">impaired social and emotional judgement processes</span>"	"<span class=""chemical"">MDMA</span> polydrug users show process-specific central executive impairments coupled with <span class=""disease"">impaired social and emotional judgement processes</span>."	760841.0	16574712.0	16574712_D018817_D003072		bcv_easy_371_sent_train_set_revised_760841	"yes_direct
"	People who take MDMA (and other drugs) develop impaired social and emotional judgement processes.
TRUE	D007980	"<span class=""chemical"">Levodopa</span>"	D004421	"<span class=""disease"">dystonia</span>"	"<span class=""chemical"">Levodopa</span>-induced oromandibular <span class=""disease"">dystonia</span> in progressive supranuclear palsy."	761593.0	12691807.0	12691807_D007980_D004421		bcv_easy_330_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008619	"<span class=""chemical"">mepivacaine</span>"	D009135	"<span class=""disease"">muscle damage</span>"	"In addition to <span class=""disease"">muscle damage</span>, severe damage was also seen in harderian glands, especially after exposure to <span class=""chemical"">mepivacaine</span> and lidocaine plus epinephrine."	761593.0	4038130.0	4038130_D008619_D009135		bcv_easy_395_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004917	"<span class=""chemical"">erythromycin</span>"	D008133	"<span class=""disease"">Prolongation of QT interval</span>"	"<span class=""disease"">Prolongation of QT interval</span>, torsades de pointes, and sudden cardiac death have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors."	761593.0	9545159.0	9545159_D004917_D008133		bcv_easy_258_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D014202	"<span class=""disease"">tremor</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine."	761593.0	6892185.0	6892185_D002217_D014202		bcv_easy_1055_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D017035	"<span class=""chemical"">pravastatin</span>"	D009220	"<span class=""disease"">inflammatory myopathy</span>"	"A case of acute <span class=""disease"">inflammatory myopathy</span> associated with the use of <span class=""chemical"">pravastatin</span>, a new hydrophilic 3-hydroxy-3 methylglutaril coenzyme A reductase inhibitor, is reported."	761593.0	7604176.0	7604176_D017035_D009220		bcv_easy_809_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002119	"<span class=""chemical"">calcium carbon-ate</span>"	D053040	"<span class=""disease"">nephrolithiasis</span>"	"One case of acute hypercalcaemia and two of recurrent <span class=""disease"">nephrolithiasis</span> are reported in patients who had regularly consumed large amounts of <span class=""chemical"">calcium carbon-ate</span>-sodium bicarbonate powders for more than 20 years."	761593.0	625456.0	625456_D002119_D053040		bcv_easy_48_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004317	"<span class=""chemical"">adriamycin</span>"	D015470	"<span class=""disease"">acute myeloblastic leukemia</span>"	"1 of the 10 monkeys developed <span class=""disease"">acute myeloblastic leukemia</span> after receiving 324 mg/m2 of <span class=""chemical"">adriamycin</span>; the 10th monkey is alive and well 26 months after the last dose of drug."	761593.0	6769133.0	6769133_D004317_D015470		bcv_easy_941_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001971	"<span class=""chemical"">bromocriptine</span>"	D011605	"<span class=""disease"">psychosis</span>"	"Two multigravida patients with no prior psychiatric history were seen with postpartum <span class=""disease"">psychosis</span>, having received <span class=""chemical"">bromocriptine</span> for inhibition of lactation."	761593.0	3686155.0	3686155_D001971_D011605		bcv_easy_558_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D006221	"<span class=""chemical"">halothane</span>"	D056486	"<span class=""disease"">hepatitis</span>"	"This supports and extends previous evidence for a mechanism by which enflurane and/or isoflurane could produce a hypersensitivity condition similar to that of <span class=""chemical"">halothane</span> <span class=""disease"">hepatitis</span> either alone or subsequent to <span class=""chemical"">halothane</span> administration."	761593.0	7647582.0	7647582_D006221_D056486		bcv_easy_919_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003520	"<span class=""chemical"">Cyclophosphamide</span>"	D001749	"<span class=""disease"">bladder tumor</span>"	"CONCLUSIONS: <span class=""chemical"">Cyclophosphamide</span> associated <span class=""disease"">bladder tumor</span> is an aggressive disease."	761593.0	8911359.0	8911359_D003520_D001749		bcv_easy_436_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008713	"<span class=""chemical"">methimazole</span>"	D011537	"<span class=""disease"">itching</span>"	"A 43-year-old woman had severe jaundice and <span class=""disease"">itching</span> 1 month after receiving <span class=""chemical"">methimazole</span> (10 mg tid) and propranolol (20 mg tid) for treatment of hyperthyroidism."	761593.0	14982270.0	14982270_D008713_D011537		bcv_easy_546_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D014202	"<span class=""disease"">tremor</span>"	"On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."	761593.0	6892185.0	6892185_D010830_D014202		bcv_easy_1051_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D011441	"<span class=""chemical"">PTU/propylthiouracil</span>"	D014657	"<span class=""disease"">vasculitis</span>"	"The diagnosis of <span class=""chemical"">propylthiouracil</span> (<span class=""chemical"">PTU</span>)-associated <span class=""disease"">vasculitis</span> was made by observation of consistent clinical features, the detection of elevated ANA and ANCA in the blood, and the observed clinical resolution of symptoms following withdrawal of <span class=""chemical"">PTU</span>."	761593.0	16418614.0	16418614_D011441_D014657		bcv_easy_94_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004837	"<span class=""chemical"">epinephrine</span>"	D017202	"<span class=""disease"">myocardial ischemia</span>"	"The role of <span class=""chemical"">epinephrine</span> in eliciting <span class=""disease"">myocardial ischemia</span> was examined in patients with coronary artery disease."	761593.0	3413271.0	3413271_D004837_D017202		bcv_easy_848_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C047781	"<span class=""chemical"">Lamotrigine</span>"	D009207	"<span class=""disease"">myoclonus</span>"	"<span class=""chemical"">Lamotrigine</span> associated with exacerbation or de novo <span class=""disease"">myoclonus</span> in idiopathic generalized epilepsies."	761593.0	16157917.0	16157917_C047781_D009207		bcv_easy_1005_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D017180	"<span class=""disease"">ventricular tachycardia</span>"	"We describe a patient with no previous history of cardiac disease or arrhythmia who developed sustained bigeminy and 2 brief runs of <span class=""disease"">ventricular tachycardia</span> after <span class=""chemical"">caffeine</span> administration."	761593.0	18997632.0	18997632_D002110_D017180		bcv_easy_122_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014700	"<span class=""chemical"">verapamil</span>"	D007022	"<span class=""disease"">hypotension</span>"	"Three patients with ischaemic heart disease developed profound cardiac failure, <span class=""disease"">hypotension</span> and bradycardia during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs."	761593.0	6127992.0	6127992_D014700_D007022		bcv_easy_469_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005473	"<span class=""chemical"">fluoxetine</span>"	D062788	"<span class=""disease"">adenomyosis</span>"	"Histological studies revealed 11 cases of <span class=""disease"">adenomyosis</span>, all within the noncastrated group receiving <span class=""chemical"">fluoxetine</span>."	761593.0	9098464.0	9098464_D005473_D062788		bcv_easy_1036_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004656	"<span class=""chemical"">enalapril</span>"	D051437	"<span class=""disease"">decreased renal function</span>"	"Older age was associated with a greater risk of developing <span class=""disease"">decreased renal function</span> in both groups, but significantly more so in the <span class=""chemical"">enalapril</span> group (<span class=""chemical"">enalapril</span>: risk ratio [RR] 1.42 per 10 years, 95% confidence interval [CI] 1.32-1.52 with <span class=""chemical"">enalapril</span>; placebo: RR 1.18, 95% CI 1.12-1.25)."	761593.0	10539815.0	10539815_D004656_D051437		bcv_easy_765_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D017693	"<span class=""chemical"">sodium bicarbonate</span>"	D006934	"<span class=""disease"">hypercalcaemia</span>"	"One case of acute <span class=""disease"">hypercalcaemia</span> and two of recurrent nephrolithiasis are reported in patients who had regularly consumed large amounts of calcium carbon-ate-<span class=""chemical"">sodium bicarbonate</span> powders for more than 20 years."	761593.0	625456.0	625456_D017693_D006934		bcv_easy_49_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C014282	"<span class=""chemical"">cirazoline</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Both the pressor and <span class=""disease"">bradycardia</span> effects of <span class=""chemical"">cirazoline</span> were abolished in chronic prazosin treated SHR (n = 4) as compared to the untreated SHR (n = 4)."	761593.0	1355091.0	1355091_C014282_D001919		bcv_easy_1079_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000583	"<span class=""chemical"">amikacin</span>"	D007674	"<span class=""disease"">nephrotoxicity</span>"	"To evaluate <span class=""chemical"">amikacin</span>-associated <span class=""disease"">nephrotoxicity</span> in an adult hematology/oncology population, a prospective, randomized, open-label trial was conducted at a university-affiliated medical center."	761593.0	18356633.0	18356633_D000583_D007674		bcv_easy_698_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010042	"<span class=""chemical"">ouabain</span>"	D001145	"<span class=""disease"">arrhythmia</span>"	"This study was designed to evaluate the effects of pilocarpine and explore the underlying ionic mechanism, using both aconitine-induced rat and <span class=""chemical"">ouabain</span>-induced guinea pig <span class=""disease"">arrhythmia</span> models."	761593.0	19721134.0	19721134_D010042_D001145		bcv_easy_34_sent_work_dev_set_761593	"yes_direct
"	"Two animal models were used in this study. One was a rat model where arrhythmia was induced by ""aconitine"". The second was a guinea pig model induced by ""ouabain""."
TRUE	C019248	"<span class=""chemical"">Pamidronate</span>"	D006996	"<span class=""disease"">hypocalcemia</span>"	"<span class=""chemical"">Pamidronate</span> treatment is associated with considerable risk for <span class=""disease"">hypocalcemia</span>, even in cases of initially severe hypercalcemia."	761593.0	16006300.0	16006300_C019248_D006996		bcv_easy_709_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004977	"<span class=""chemical"">ethambutol</span>"	D009901	"<span class=""disease"">Bilateral optic neuropathy</span>"	"<span class=""disease"">Bilateral optic neuropathy</span> due to combined <span class=""chemical"">ethambutol</span> and isoniazid treatment."	761593.0	384871.0	384871_D004977_D009901		bcv_easy_570_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D017180	"<span class=""disease"">ventricular tachycardia</span>"	"A case of <span class=""disease"">ventricular tachycardia</span> related to <span class=""chemical"">caffeine</span> pretreatment."	761593.0	18997632.0	18997632_D002110_D017180		bcv_easy_119_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008727	"<span class=""chemical"">methotrexate</span>"	D056784	"<span class=""disease"">leukoencephalopathy</span>"	"BACKGROUND: A transient <span class=""disease"">leukoencephalopathy</span> mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood leukaemia."	761593.0	17682013.0	17682013_D008727_D056784		bcv_easy_779_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C534628	"<span class=""chemical"">SCH 23390</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by fluphenazine, <span class=""chemical"">SCH 23390</span> or sulpiride."	761593.0	1687392.0	1687392_C534628_D002375		bcv_easy_861_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003630	"<span class=""chemical"">daunorubicin</span>"	D015431	"<span class=""disease"">weight loss</span>"	"RESULTS: Nontoxic doses of dexrazoxane reduced myelosuppression and <span class=""disease"">weight loss</span> from <span class=""chemical"">daunorubicin</span> and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced myelosuppression, <span class=""disease"">weight loss</span>, nor the in vitro cytotoxicity from doxorubicin."	761593.0	15897593.0	15897593_D003630_D015431		bcv_easy_983_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009020	"<span class=""chemical"">morphine</span>"	D002375	"<span class=""disease"">cataleptic</span>"	"Pre-treatment with ketamine produced cross-tolerance to <span class=""chemical"">morphine</span>, whereas pretreatment with <span class=""chemical"">morphine</span> did not induce cross-tolerance to ketamine but rather augmented the <span class=""disease"">cataleptic</span> response; this augmentation was attributed to residual <span class=""chemical"">morphine</span> in the brain."	761593.0	2716967.0	2716967_D009020_D002375		bcv_easy_740_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C033457	"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>"	D056486	"<span class=""disease"">hepatitis</span>"	"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>-induced fulminant <span class=""disease"">hepatitis</span> in a pregnant woman. A case report."	761593.0	3411101.0	3411101_C033457_D056486		bcv_easy_1215_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D015742	"<span class=""chemical"">propofol</span>"	D010146	"<span class=""disease"">pain</span>"	"We hypothesized that <span class=""chemical"">propofol</span> infusion <span class=""disease"">pain</span> might be prevented by infusing remifentanil before starting the <span class=""chemical"">propofol</span> infusion in a clinical setting where target-controlled infusions (TCI) of both drugs were used."	761593.0	18006530.0	18006530_D015742_D010146		bcv_easy_5_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013619	"<span class=""chemical"">Tacrine</span>"	D001930	"<span class=""disease"">hippocampal damage</span>"	"<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic seizures and delayed <span class=""disease"">hippocampal damage</span>."	761593.0	19944736.0	19944736_D013619_D001930		bcv_easy_630_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009543	"<span class=""chemical"">nifedipine/Adalat</span>"	D013684	"<span class=""disease"">telangiectasia</span>"	"Five months after starting <span class=""chemical"">nifedipine</span> (<span class=""chemical"">Adalat</span>), two patients developed photodistributed facial <span class=""disease"">telangiectasia</span>, which became more noticeable with time."	761593.0	8251368.0	8251368_D009543_D013684		bcv_easy_453_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014859	"<span class=""chemical"">warfarin</span>"	D018366	"<span class=""disease"">LV Cutaneous lesions</span>"	"The results of skin lesion biopsies were available in 3 patients, confirming <span class=""disease"">LV Cutaneous lesions</span> resolved in all patients after <span class=""chemical"">warfarin</span> was discontinued."	761593.0	16047871.0	16047871_D014859_D018366		bcv_easy_1184_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004837	"<span class=""chemical"">epinephrine</span>"	D017202	"<span class=""disease"">myocardial ischemia</span>"	"Both <span class=""chemical"">epinephrine</span> and exercise produced <span class=""disease"">myocardial ischemia</span> as evidenced by ST segment depression and angina."	761593.0	3413271.0	3413271_D004837_D017202		bcv_easy_852_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009569	"<span class=""chemical"">nitric oxide/NO</span>"	D020326	"<span class=""disease"">migraine without aura</span>"	"In recent years, increasing evidence has suggested that the messenger molecule <span class=""chemical"">nitric oxide</span> (<span class=""chemical"">NO</span>) is involved in pain mechanisms of <span class=""disease"">migraine without aura</span>."	761593.0	10524660.0	10524660_D009569_D020326		bcv_easy_603_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001971	"<span class=""chemical"">bromocriptine</span>"	D011605	"<span class=""disease"">psychosis</span>"	"These cases demonstrate that <span class=""chemical"">bromocriptine</span> may cause <span class=""disease"">psychosis</span> even when given in low doses."	761593.0	3686155.0	3686155_D001971_D011605		bcv_easy_561_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C092292	"<span class=""chemical"">ziprasidone</span>"	D009459	"<span class=""disease"">NMS</span>"	"This case is the earliest (second day of treatment) <span class=""disease"">NMS</span> due to <span class=""chemical"">ziprasidone</span> reported in the literature."	761593.0	17366349.0	17366349_C092292_D009459		bcv_easy_57_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003915	"<span class=""chemical"">DM</span>"	D003072	"<span class=""disease"">cognitive deterioration</span>"	"This report describes a case of <span class=""disease"">cognitive deterioration</span> resulting from prolonged use of <span class=""chemical"">DM</span>."	761593.0	7803371.0	7803371_D003915_D003072		bcv_easy_1243_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016861	"<span class=""chemical"">cyclooxygenase inhibitors</span>"	D006973	"<span class=""disease"">hypertension</span>"	"Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, stroke, <span class=""disease"">hypertension</span> and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>."	761593.0	16586083.0	16586083_D016861_D006973		bcv_easy_1148_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."	761593.0	6892185.0	6892185_D002217_D004830		bcv_easy_1038_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007649	"<span class=""chemical"">ketamine</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"Previous studies demonstrated that both <span class=""chemical"">ketamine</span> and morphine induced analgesia and <span class=""disease"">catalepsy</span> in the rat."	761593.0	2716967.0	2716967_D007649_D002375		bcv_easy_736_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>."	761593.0	6892185.0	6892185_D010830_D015878		bcv_easy_1058_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014147	"<span class=""chemical"">tramadol</span>"	D006212	"<span class=""disease"">hallucinations</span>"	"Nightmares and <span class=""disease"">hallucinations</span> after long-term intake of <span class=""chemical"">tramadol</span> combined with antidepressants."	761593.0	8766220.0	8766220_D014147_D006212		bcv_easy_96_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D008103	"<span class=""disease"">cirrhosis of the liver</span>"	"It is concluded that solid evidence exists of hepatic injury due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, cholestatic hepatitis and micronodular <span class=""disease"">cirrhosis of the liver</span>."	761593.0	3962737.0	3962737_D000638_D008103		bcv_easy_289_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001556	"<span class=""chemical"">alpha-benzene hexachloride</span>"	D006528	"<span class=""disease"">hepatomas</span>"	"Peroxisomes in <span class=""disease"">hepatomas</span> and hyperplastic preneoplastic liver lesions induced in mice by 500 ppm <span class=""chemical"">alpha-benzene hexachloride</span> were examined histochemically and electron microscopically."	761593.0	85485.0	85485_D001556_D006528		bcv_easy_379_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005283	"<span class=""chemical"">fentanyl</span>"	D009127	"<span class=""disease"">rigidity</span>"	"Post-operative <span class=""disease"">rigidity</span> after <span class=""chemical"">fentanyl</span> administration."	761593.0	3780697.0	3780697_D005283_D009127		bcv_easy_785_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005472	"<span class=""chemical"">5-fluorouracil</span>"	D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), <span class=""chemical"">5-fluorouracil</span> and its derivative carmofur, and capecitabine."	761593.0	17682013.0	17682013_D005472_D056784		bcv_easy_783_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D014202	"<span class=""disease"">tremor</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated."	761593.0	6892185.0	6892185_D010830_D014202		bcv_easy_1041_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D012293	"<span class=""chemical"">rifampicin</span>"	D058186	"<span class=""disease"">Acute renal failure</span>"	"<span class=""disease"">Acute renal failure</span> subsequent to the administration of <span class=""chemical"">rifampicin</span>. A follow-up study of cases reported earlier."	761593.0	982002.0	982002_D012293_D058186		bcv_easy_335_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D014202	"<span class=""disease"">tremor</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>."	761593.0	6892185.0	6892185_D010830_D014202		bcv_easy_1059_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003276	"<span class=""chemical"">oral contraceptives</span>"	D008113	"<span class=""disease"">liver tumors</span>"	"Etiologic factors in the pathogenesis of <span class=""disease"">liver tumors</span> associated with <span class=""chemical"">oral contraceptives</span>."	761593.0	188339.0	188339_D003276_D008113		bcv_easy_421_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004737	"<span class=""chemical"">enflurane</span>"	D056486	"<span class=""disease"">hepatic injury</span>"	"Two halogenated anesthetics, <span class=""chemical"">enflurane</span> and isoflurane, have been associated with an allergic-type <span class=""disease"">hepatic injury</span> both alone and following previous exposure to halothane."	761593.0	7647582.0	7647582_D004737_D056486		bcv_easy_910_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003975	"<span class=""chemical"">diazepam</span>"	D001259	"<span class=""disease"">incoordination</span>"	"Both verapamil (10 mg/kg i.p.) and NH4Ac pretreatment enhanced morphine analgesia- and <span class=""chemical"">diazepam</span>-induced muscular <span class=""disease"">incoordination</span> and antagonized amphetamine-induced motor activity, and neither verapamil nor NH4Ac affected the convulsant action of metrazol."	761593.0	6323692.0	6323692_D003975_D001259		bcv_easy_372_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004837	"<span class=""chemical"">epinephrine</span>"	D017202	"<span class=""disease"">myocardial ischemia</span>"	"However, the mechanisms of <span class=""disease"">myocardial ischemia</span> induced by <span class=""chemical"">epinephrine</span> were significantly different from those of exercise."	761593.0	3413271.0	3413271_D004837_D017202		bcv_easy_853_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007649	"<span class=""chemical"">Ketamine</span>"	D011605	"<span class=""disease"">psychosis</span>"	"<span class=""chemical"">Ketamine</span> elicited <span class=""disease"">psychosis</span> like psychopathology."	761593.0	20727411.0	20727411_D007649_D011605		bcv_easy_225_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D015215	"<span class=""chemical"">AZT</span>"	D002311	"<span class=""disease"">cardiac dilation</span>"	"In contrast, <span class=""chemical"">AZT</span>-treated FasL Tg mice developed <span class=""disease"">cardiac dilation</span> and depressed cardiac function in a dose-dependent manner, with concomitant inflammatory infiltration of both ventricles."	761593.0	17943461.0	17943461_D015215_D002311		bcv_easy_503_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010068	"<span class=""chemical"">oxacillin</span>"	D018366	"<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span>"	"<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span> associated with <span class=""chemical"">oxacillin</span>."	761593.0	11337188.0	11337188_D010068_D018366		bcv_easy_301_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin/DXR/Adriamycin</span>"	D009202	"<span class=""disease"">cardiomyopathy/myocardial disease/CM</span>"	"The <span class=""disease"">cardiomyopathy</span> (<span class=""disease"">CM</span>) produced by the anticancer drug <span class=""chemical"">doxorubicin</span> (<span class=""chemical"">DXR</span>) (<span class=""chemical"">Adriamycin</span>) provides a unique opportunity to analyze dose-effect and structure-function relationships during development of <span class=""disease"">myocardial disease</span>."	761593.0	7282516.0	7282516_D004317_D009202		bcv_easy_59_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003915	"<span class=""chemical"">dextromethorphan</span>"	D003072	"<span class=""disease"">Cognitive deterioration</span>"	"<span class=""disease"">Cognitive deterioration</span> from long-term abuse of <span class=""chemical"">dextromethorphan</span>: a case report."	761593.0	7803371.0	7803371_D003915_D003072		bcv_easy_1242_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C047426	"<span class=""chemical"">venlafaxine</span>"	D020230	"<span class=""disease"">Serotonin syndrome</span>"	"<span class=""disease"">Serotonin syndrome</span> from <span class=""chemical"">venlafaxine</span>-tranylcypromine interaction."	761593.0	8888541.0	8888541_C047426_D020230		bcv_easy_1101_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009288	"<span class=""chemical"">naproxen</span>"	D007681	"<span class=""disease"">renal papillary necrosis/RPN</span>"	"A 31-year-old man with rheumatoid arthritis, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed <span class=""disease"">renal papillary necrosis</span> (<span class=""disease"">RPN</span>) 4 months after institution of <span class=""chemical"">naproxen</span> therapy."	761593.0	6699841.0	6699841_D009288_D007681		bcv_easy_1253_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C076029	"<span class=""chemical"">olanzapine</span>"	D001714	"<span class=""disease"">Hypomania</span>"	"<span class=""disease"">Hypomania</span>-like syndrome induced by <span class=""chemical"">olanzapine</span>."	761593.0	10565806.0	10565806_C076029_D001714		bcv_easy_126_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000728	"<span class=""chemical"">androgen</span>"	D020181	"<span class=""disease"">obstructive sleep apnea syndrome</span>"	"Development of the <span class=""disease"">obstructive sleep apnea syndrome</span> must be considered a possible side effect of <span class=""chemical"">androgen</span> therapy."	761593.0	6732043.0	6732043_D000728_D020181		bcv_easy_1161_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005473	"<span class=""chemical"">fluoxetine hydrochloride</span>"	D006966	"<span class=""disease"">hyperprolactinemia</span>"	"A murine model of adenomyosis: the effects of <span class=""disease"">hyperprolactinemia</span> induced by <span class=""chemical"">fluoxetine hydrochloride</span>, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats."	761593.0	9098464.0	9098464_D005473_D006966		bcv_easy_1031_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D018967	"<span class=""chemical"">Risperidone</span>"	D010468	"<span class=""disease"">visual disturbances</span>"	"<span class=""chemical"">Risperidone</span>-associated, benign transient <span class=""disease"">visual disturbances</span> in schizophrenic patients with a past history of LSD abuse."	761593.0	12013711.0	12013711_D018967_D010468		bcv_easy_149_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005283	"<span class=""chemical"">fentanyl</span>"	D009127	"<span class=""disease"">rigidity</span>"	"A case of thoraco-abdominal <span class=""disease"">rigidity</span> leading to respiratory failure is described in the post-operative period in an elderly patient who received a moderate dose of <span class=""chemical"">fentanyl</span>."	761593.0	3780697.0	3780697_D005283_D009127		bcv_easy_787_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013619	"<span class=""chemical"">Tacrine</span>"	D012640	"<span class=""disease"">seizures</span>"	"<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic <span class=""disease"">seizures</span> and delayed hippocampal damage."	761593.0	19944736.0	19944736_D013619_D012640		bcv_easy_629_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004837	"<span class=""chemical"">epinephrine</span>"	D017202	"<span class=""disease"">myocardial ischemia</span>"	"Mechanisms of <span class=""disease"">myocardial ischemia</span> induced by <span class=""chemical"">epinephrine</span>: comparison with exercise-induced ischemia."	761593.0	3413271.0	3413271_D004837_D017202		bcv_easy_846_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004977	"<span class=""chemical"">Ethambutol</span>"	D014786	"<span class=""disease"">visual loss</span>"	"INTRODUCTION: <span class=""chemical"">Ethambutol</span> is used in the treatment of tuberculosis, which is still prevalent in Southeast Asia, and can be associated with permanent <span class=""disease"">visual loss</span>."	761593.0	16710500.0	16710500_D004977_D014786		bcv_easy_339_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005047	"<span class=""chemical"">Etoposide</span>"	D009203	"<span class=""disease"">myocardial infarction</span>"	"<span class=""chemical"">Etoposide</span>-related <span class=""disease"">myocardial infarction</span>."	761593.0	7619765.0	7619765_D005047_D009203		bcv_easy_552_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014191	"<span class=""chemical"">tranylcypromine</span>"	D020230	"<span class=""disease"">serotonin syndrome</span>"	"We report a venlafaxine-MAOI interaction that resulted in the <span class=""disease"">serotonin syndrome</span> in a 23-y-old male who was taking <span class=""chemical"">tranylcypromine</span> for depression."	761593.0	8888541.0	8888541_D014191_D020230		bcv_easy_1109_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D018817	"<span class=""chemical"">MDMA</span>"	D008569	"<span class=""disease"">impaired memory functioning/memory impairments</span>"	"While the use of <span class=""chemical"">MDMA</span> in quantities that may be considered ""moderate"" is not associated with <span class=""disease"">impaired memory functioning</span>, heavy use of <span class=""chemical"">MDMA</span> use may lead to long lasting <span class=""disease"">memory impairments</span>."	761593.0	16574713.0	16574713_D018817_D008569		bcv_easy_317_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008012	"<span class=""chemical"">lidocaine</span>"	D012640	"<span class=""disease"">seizures</span>"	"Chronic carbamazepine inhibits the development of local anesthetic <span class=""disease"">seizures</span> kindled by cocaine and <span class=""chemical"">lidocaine</span>."	761593.0	2790457.0	2790457_D008012_D012640		bcv_easy_682_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008625	"<span class=""chemical"">Tiopronin</span>"	D009393	"<span class=""disease"">nephritis</span>"	"A strong association has been found between <span class=""disease"">nephritis</span> and dermatitis due to <span class=""chemical"">Tiopronin</span> (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between dermatitis due to gold thiosulphate and B35."	761593.0	3084782.0	3084782_D008625_D009393		bcv_easy_670_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000643	"<span class=""chemical"">NH4CL</span>"	D003128	"<span class=""disease"">coma</span>"	"Ammonia <span class=""disease"">coma</span> was produced in rats within 10 to 15 minutes of an intraperitonealinjection of 1.7 mmol <span class=""chemical"">NH4CL</span>."	761593.0	761833.0	761833_D000643_D003128		bcv_easy_457_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D017963	"<span class=""chemical"">azithromycin</span>"	D006606	"<span class=""disease"">hiccups</span>"	"Possible <span class=""chemical"">azithromycin</span>-associated <span class=""disease"">hiccups</span>."	761593.0	15985056.0	15985056_D017963_D006606		bcv_easy_815_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013390	"<span class=""chemical"">succinylcholine</span>"	D001049	"<span class=""disease"">apnoea</span>"	"Fifteen patients demonstrating unexpected prolonged <span class=""disease"">apnoea</span> lasting several hours after <span class=""chemical"">succinylcholine</span> have been treated by a new preparation of human serum cholinesterase."	761593.0	871943.0	871943_D013390_D001049		bcv_easy_207_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000319	"<span class=""chemical"">beta-adrenergic blocking drugs</span>"	D006333	"<span class=""disease"">cardiac failure</span>"	"Three patients with ischaemic heart disease developed profound <span class=""disease"">cardiac failure</span>, hypotension and bradycardia during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>."	761593.0	6127992.0	6127992_D000319_D006333		bcv_easy_471_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C047426	"<span class=""chemical"">venlafaxine</span>"	D020230	"<span class=""disease"">serotonin syndrome</span>"	"We report a <span class=""chemical"">venlafaxine</span>-MAOI interaction that resulted in the <span class=""disease"">serotonin syndrome</span> in a 23-y-old male who was taking tranylcypromine for depression."	761593.0	8888541.0	8888541_C047426_D020230		bcv_easy_1110_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D006220	"<span class=""chemical"">Haloperidol</span>"	D003072	"<span class=""disease"">cognitive impairment</span>"	"CONCLUSION: <span class=""chemical"">Haloperidol</span> produced a clear profile of <span class=""disease"">cognitive impairment</span> that was not worsened by concomitant sertraline administration."	761593.0	8617710.0	8617710_D006220_D003072		bcv_easy_1194_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by carbachol and <span class=""chemical"">eserine</span>."	761593.0	6892185.0	6892185_D010830_D004830		bcv_easy_1061_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004917	"<span class=""chemical"">erythromycin</span>"	D016171	"<span class=""disease"">torsades de pointes</span>"	"Prolongation of QT interval, <span class=""disease"">torsades de pointes</span>, and sudden cardiac death have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors."	761593.0	9545159.0	9545159_D004917_D016171		bcv_easy_259_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004041	"<span class=""chemical"">fat</span>"	D009765	"<span class=""disease"">obesity</span>"	"In the current study, we investigated whether a physiological intervention by feeding 40% high <span class=""chemical"">fat</span> diet (HFD), which induces <span class=""disease"">obesity</span> in male Sprague-Dawley rats (250-275 g), sensitizes to doxorubicin-induced cardiotoxicity."	761593.0	18674790.0	18674790_D004041_D009765		bcv_easy_871_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001971	"<span class=""chemical"">Bromocriptine</span>"	D011605	"<span class=""disease"">psychosis</span>"	"<span class=""chemical"">Bromocriptine</span> given in high doses has been associated with <span class=""disease"">psychosis</span> in patients receiving the drug for Parkinson's disease."	761593.0	3686155.0	3686155_D001971_D011605		bcv_easy_559_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007538	"<span class=""chemical"">isoniazid</span>"	D009901	"<span class=""disease"">Bilateral optic neuropathy</span>"	"<span class=""disease"">Bilateral optic neuropathy</span> due to combined ethambutol and <span class=""chemical"">isoniazid</span> treatment."	761593.0	384871.0	384871_D007538_D009901		bcv_easy_569_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004917	"<span class=""chemical"">erythromycin</span>"	D016757	"<span class=""disease"">sudden cardiac death</span>"	"Prolongation of QT interval, torsades de pointes, and <span class=""disease"">sudden cardiac death</span> have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors."	761593.0	9545159.0	9545159_D004917_D016757		bcv_easy_257_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016685	"<span class=""chemical"">Mitomycin C</span>"	D006463	"<span class=""disease"">Hemolytic Uremic Syndrome/HUS</span>"	"<span class=""chemical"">Mitomycin C</span> associated <span class=""disease"">Hemolytic Uremic Syndrome</span> (<span class=""disease"">HUS</span>) is a potentially fatal but uncommon condition that is not yet widely recognised."	761593.0	3108839.0	3108839_D016685_D006463		bcv_easy_798_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008775	"<span class=""chemical"">methylprednisolone</span>"	D006323	"<span class=""disease"">asystole</span>"	"Hypotension, bradycardia, and <span class=""disease"">asystole</span> after high-dose intravenous <span class=""chemical"">methylprednisolone</span> in a monitored patient."	761593.0	10074612.0	10074612_D008775_D006323		bcv_easy_1085_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014635	"<span class=""chemical"">sodium valproate/VPA</span>"	D007177	"<span class=""disease"">SIADH/syndrome of inappropriate secretion of antidiuretic hormone</span>"	"We report the case of a 62-year-old man who was administered <span class=""chemical"">sodium valproate</span> (<span class=""chemical"">VPA</span>) and who subsequently developed the <span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span> (<span class=""disease"">SIADH</span>)."	761593.0	11195262.0	11195262_D014635_D007177		bcv_easy_159_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014700	"<span class=""chemical"">verapamil</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs."	761593.0	6127992.0	6127992_D014700_D001919		bcv_easy_476_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001556	"<span class=""chemical"">alpha-benzene hexachloride</span>"	D006528	"<span class=""disease"">hepatoma</span>"	"Changes in peroxisomes in preneoplastic liver and <span class=""disease"">hepatoma</span> of mice induced by <span class=""chemical"">alpha-benzene hexachloride</span>."	761593.0	85485.0	85485_D001556_D006528		bcv_easy_378_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013866	"<span class=""chemical"">6-thioguanine</span>"	D006504	"<span class=""disease"">veno-occlusive disease of the liver</span>"	"Clinically reversible <span class=""disease"">veno-occlusive disease of the liver</span> developed in a 23-year-old man with acute lymphocytic leukemia after 10 months of maintenance therapy with <span class=""chemical"">6-thioguanine</span>."	761593.0	7053705.0	7053705_D013866_D006504		bcv_easy_1213_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010672	"<span class=""chemical"">diphenylhydantoin/DPH</span>"	D002526	"<span class=""disease"">cerebellar dysfunction</span>"	"Among the common side effects of <span class=""chemical"">diphenylhydantoin</span> (<span class=""chemical"">DPH</span>) overdose, the most frequently encountered neurological signs are those of <span class=""disease"">cerebellar dysfunction</span>."	761593.0	430165.0	430165_D010672_D002526		bcv_easy_592_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C092292	"<span class=""chemical"">ziprasidone</span>"	D009459	"<span class=""disease"">NMS</span>"	"Although conventional neuroleptics are more frequently associated with <span class=""disease"">NMS</span>, atypical antipsychotic drugs like <span class=""chemical"">ziprasidone</span> may also be a cause."	761593.0	17366349.0	17366349_C092292_D009459		bcv_easy_54_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D006331	"<span class=""disease"">cardiac dysfunction</span>"	"A LD(10) dose (8 mg <span class=""chemical"">doxorubicin</span>/kg, ip) administered on day 43 of the HFD feeding regimen led to higher cardiotoxicity, <span class=""disease"">cardiac dysfunction</span>, lipid peroxidation, and 80% mortality in the obese (OB) rats in the absence of any significant renal or hepatic toxicity."	761593.0	18674790.0	18674790_D004317_D006331		bcv_easy_875_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010672	"<span class=""chemical"">DPH</span>"	D010291	"<span class=""disease"">hemiparesis</span>"	"Two patients are presented who suffered progressive <span class=""disease"">hemiparesis</span> due to <span class=""chemical"">DPH</span> overdose."	761593.0	430165.0	430165_D010672_D010291		bcv_easy_595_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C092292	"<span class=""chemical"">ziprasidone</span>"	D009459	"<span class=""disease"">NMS</span>"	"The patient is a 24-year-old male with a history of schizophrenia who developed signs and symptoms of <span class=""disease"">NMS</span> after 2 days of treatment with an 80-mg/day dose of orally administrated <span class=""chemical"">ziprasidone</span>."	761593.0	17366349.0	17366349_C092292_D009459		bcv_easy_55_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007530	"<span class=""chemical"">Isoflurane</span>"	D002779|D056486	"<span class=""disease"">cholestatic hepatitis</span>"	"CONCLUSIONS: <span class=""chemical"">Isoflurane</span>, a common anesthetic agent, can cause severe <span class=""disease"">cholestatic hepatitis</span>."	761593.0	11847945.0	11847945_D007530_D002779|D056486		bcv_easy_118_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000728	"<span class=""chemical"">androgen</span>"	D020181	"<span class=""disease"">obstructive sleep apnea</span>"	"A rechallenge with <span class=""chemical"">androgen</span> produced symptoms of <span class=""disease"">obstructive sleep apnea</span> that abated upon withdrawal of the hormone."	761593.0	6732043.0	6732043_D000728_D020181		bcv_easy_1159_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016861	"<span class=""chemical"">cyclooxygenase inhibitors</span>"	D009203	"<span class=""disease"">myocardial infarction</span>"	"Randomised clinical trials and observational studies have shown an increased risk of <span class=""disease"">myocardial infarction</span>, stroke, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>."	761593.0	16586083.0	16586083_D016861_D009203		bcv_easy_1149_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010830	"<span class=""chemical"">eserine</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."	761593.0	6892185.0	6892185_D010830_D015878		bcv_easy_1050_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D011718	"<span class=""chemical"">pyrazinamide</span>"	D000857	"<span class=""disease"">dysosmia</span>"	"Recurrent <span class=""disease"">dysosmia</span> induced by <span class=""chemical"">pyrazinamide</span>."	761593.0	19674115.0	19674115_D011718_D000857		bcv_easy_665_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002701	"<span class=""chemical"">chloramphenicol</span>"	D000741	"<span class=""disease"">aplastic anemia</span>"	"This was the second report of fatal <span class=""disease"">aplastic anemia</span> after topical treatment with <span class=""chemical"">chloramphenicol</span> for ocular conditions, although two cases of reversible bone marrow hypoplasia have also been reported."	761593.0	7072798.0	7072798_D002701_D000741		bcv_easy_177_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010634	"<span class=""chemical"">PB</span>"	D008107	"<span class=""disease"">liver damage</span>"	"Our findings illustrate that <span class=""chemical"">PB</span> may be associated with chronic <span class=""disease"">liver damage</span>, which may lead to more serious and deleterious consequences."	761593.0	17574447.0	17574447_D010634_D008107		bcv_easy_1208_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014191	"<span class=""chemical"">tranylcypromine</span>"	D020230	"<span class=""disease"">Serotonin syndrome</span>"	"<span class=""disease"">Serotonin syndrome</span> from venlafaxine-<span class=""chemical"">tranylcypromine</span> interaction."	761593.0	8888541.0	8888541_D014191_D020230		bcv_easy_1100_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005476	"<span class=""chemical"">fluphenazine</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"Dopamine antagonist <span class=""chemical"">fluphenazine</span>, D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced <span class=""disease"">catalepsy</span>."	761593.0	1687392.0	1687392_D005476_D002375		bcv_easy_858_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D011718	"<span class=""chemical"">pyrazinamide</span>"	D000857	"<span class=""disease"">olfactory disorder</span>"	"We report a case of reversible <span class=""disease"">olfactory disorder</span> related to <span class=""chemical"">pyrazinamide</span> in a woman, with a positive rechallenge."	761593.0	19674115.0	19674115_D011718_D000857		bcv_easy_668_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010665	"<span class=""chemical"">Phenylpropanolamine/Dexatrim</span>"	D009203	"<span class=""disease"">myocardial infarction</span>"	"Case report: <span class=""chemical"">Dexatrim</span> (<span class=""chemical"">Phenylpropanolamine</span>) as a cause of <span class=""disease"">myocardial infarction</span>."	761593.0	12734532.0	12734532_D010665_D009203		bcv_easy_598_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."	761593.0	6892185.0	6892185_D002217_D004830		bcv_easy_1048_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003276	"<span class=""chemical"">oral contraception</span>"	D002819	"<span class=""disease"">Chorea</span>"	"<span class=""disease"">Chorea</span> associated with <span class=""chemical"">oral contraception</span>."	761593.0	3123611.0	3123611_D003276_D002819		bcv_easy_388_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D018967	"<span class=""chemical"">risperidone</span>"	D010468	"<span class=""disease"">visual disturbances</span>"	"They both reported short episodes of transient <span class=""disease"">visual disturbances</span>, which appeared immediately after starting treatment with <span class=""chemical"">risperidone</span>."	761593.0	12013711.0	12013711_D018967_D010468		bcv_easy_155_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C047781	"<span class=""chemical"">LTG</span>"	D009207	"<span class=""disease"">MJ</span>"	"In three patients, <span class=""chemical"">LTG</span> exacerbated <span class=""disease"">MJ</span> in a dose-dependent manner with early aggravation during titration."	761593.0	16157917.0	16157917_C047781_D009207		bcv_easy_1008_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C047781	"<span class=""chemical"">LTG</span>"	D009207	"<span class=""disease"">myoclonic status/MJ</span>"	"In two patients, <span class=""chemical"">LTG</span> exacerbated <span class=""disease"">MJ</span> in a delayed but more severe manner, with <span class=""disease"">myoclonic status</span> that only ceased after <span class=""chemical"">LTG</span> withdrawal."	761593.0	16157917.0	16157917_C047781_D009207		bcv_easy_1010_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003520	"<span class=""chemical"">Cyclophosphamide</span>"	D001749	"<span class=""disease"">bladder cancer</span>"	"<span class=""chemical"">Cyclophosphamide</span> associated <span class=""disease"">bladder cancer</span>--a highly aggressive disease: analysis of 12 cases."	761593.0	8911359.0	8911359_D003520_D001749		bcv_easy_433_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D014202	"<span class=""disease"">tremor</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."	761593.0	6892185.0	6892185_D002217_D014202		bcv_easy_1037_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D017285	"<span class=""disease"">polymyositis</span>"	"We report a patient with primary biliary cirrhosis, who developed <span class=""disease"">polymyositis</span> while receiving <span class=""chemical"">D-penicillamine</span> therapy."	761593.0	8268147.0	8268147_D010396_D017285		bcv_easy_837_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002701	"<span class=""chemical"">chloramphenicol</span>"	D000741	"<span class=""disease"">aplastic anemia</span>"	"A 73-year-old woman died of <span class=""disease"">aplastic anemia</span> less than two months after undergoing cataract extraction and beginning topical therapy with <span class=""chemical"">chloramphenicol</span>."	761593.0	7072798.0	7072798_D002701_D000741		bcv_easy_174_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001393	"<span class=""chemical"">azole</span>"	D016757	"<span class=""disease"">sudden cardiac death</span>"	"Prolongation of QT interval, torsades de pointes, and <span class=""disease"">sudden cardiac death</span> have been reported after concomitant administration with erythromycin or <span class=""chemical"">azole</span> antifungal agents, but not with other CYP3A4 inhibitors."	761593.0	9545159.0	9545159_D001393_D016757		bcv_easy_260_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008094	"<span class=""chemical"">lithium</span>"	D054537	"<span class=""disease"">atrioventricular (AV) block</span>"	"In the present case, complete <span class=""disease"">atrioventricular (AV) block</span> with syncopal attacks developed secondary to <span class=""chemical"">lithium</span> therapy, necessitating permanent pacemaker implantation."	761593.0	18441470.0	18441470_D008094_D054537		bcv_easy_531_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003907	"<span class=""chemical"">dexamethasone</span>"	D009422	"<span class=""disease"">neurological dysfunctions</span>"	"After <span class=""chemical"">dexamethasone</span> treatment, children showed a higher rate of minor <span class=""disease"">neurological dysfunctions</span>."	761593.0	15814210.0	15814210_D003907_D009422		bcv_easy_1259_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016861	"<span class=""chemical"">cyclooxygenase inhibitors</span>"	D006333	"<span class=""disease"">heart failure</span>"	"Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, stroke, hypertension and <span class=""disease"">heart failure</span> during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>."	761593.0	16586083.0	16586083_D016861_D006333		bcv_easy_1146_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005839	"<span class=""chemical"">gentamicin</span>"	D058186	"<span class=""disease"">acute renal failure</span>"	"In this study we postulated that during <span class=""disease"">acute renal failure</span> induced by <span class=""chemical"">gentamicin</span> the transient or dynamic response of blood vessels could be affected, and that antioxidants can prevent the changes in dynamic responses of blood vessels."	761593.0	19893084.0	19893084_D005839_D058186		bcv_easy_324_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000324	"<span class=""chemical"">ACTH</span>"	D004421	"<span class=""disease"">dystonia</span>"	"A <span class=""disease"">dystonia</span>-like syndrome after neuropeptide (MSH/<span class=""chemical"">ACTH</span>) stimulation of the rat locus ceruleus."	761593.0	2840807.0	2840807_D000324_D004421		bcv_easy_492_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000728	"<span class=""chemical"">androgens</span>"	D020181	"<span class=""disease"">syndrome of obstructive sleep apnea</span>"	"We documented airway occlusion during sleep and an abnormally high supraglottic resistance while awake in a 54-yr-old woman who had developed physical changes and the <span class=""disease"">syndrome of obstructive sleep apnea</span> while being administered exogenous <span class=""chemical"">androgens</span>."	761593.0	6732043.0	6732043_D000728_D020181		bcv_easy_1158_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D006220	"<span class=""chemical"">haloperidol</span>"	D003072	"<span class=""disease"">Impairment of cognitive function</span>"	"RESULTS: <span class=""disease"">Impairment of cognitive function</span> was observed 6 to 8 hours after administration of <span class=""chemical"">haloperidol</span> on Day 2 but was not evident 23 hours after dosing."	761593.0	8617710.0	8617710_D006220_D003072		bcv_easy_1193_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008094	"<span class=""chemical"">lithium</span>"	D012804	"<span class=""disease"">Sinus node dysfunction</span>"	"<span class=""disease"">Sinus node dysfunction</span> has been reported most frequently among the adverse cardiovascular effects of <span class=""chemical"">lithium</span>."	761593.0	18441470.0	18441470_D008094_D012804		bcv_easy_530_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014635	"<span class=""chemical"">sodium valproate</span>"	D007177	"<span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span>"	"Contribution of <span class=""chemical"">sodium valproate</span> to the <span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span>."	761593.0	11195262.0	11195262_D014635_D007177		bcv_easy_158_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008012	"<span class=""chemical"">lidocaine</span>"	D009135	"<span class=""disease"">muscle damage</span>"	"In addition to <span class=""disease"">muscle damage</span>, severe damage was also seen in harderian glands, especially after exposure to mepivacaine and <span class=""chemical"">lidocaine</span> plus epinephrine."	761593.0	4038130.0	4038130_D008012_D009135		bcv_easy_397_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D005921	"<span class=""disease"">glomerulonephritis/RPGN</span>"	"A 67-year-old woman with rheumatoid arthritis presented rapidly progressive <span class=""disease"">glomerulonephritis</span> (<span class=""disease"">RPGN</span>) after 5 months of <span class=""chemical"">D-penicillamine</span> (250 mg/day) treatment."	761593.0	8267029.0	8267029_D010396_D005921		bcv_easy_499_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014700	"<span class=""chemical"">verapamil</span>"	D006333	"<span class=""disease"">cardiac failure</span>"	"Three patients with ischaemic heart disease developed profound <span class=""disease"">cardiac failure</span>, hypotension and bradycardia during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs."	761593.0	6127992.0	6127992_D014700_D006333		bcv_easy_473_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007530	"<span class=""chemical"">isoflurane</span>"	D002779|D056486	"<span class=""disease"">cholestatic hepatitis</span>"	"Acute <span class=""disease"">cholestatic hepatitis</span> after exposure to <span class=""chemical"">isoflurane</span>."	761593.0	11847945.0	11847945_D007530_D002779|D056486		bcv_easy_115_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D015119	"<span class=""chemical"">epsilon-aminocaproic acid</span>"	D020225|D020227	"<span class=""disease"">sagittal and left transverse sinus thrombosis</span>"	"We describe a 42-year-old woman who developed superior <span class=""disease"">sagittal and left transverse sinus thrombosis</span> associated with prolonged <span class=""chemical"">epsilon-aminocaproic acid</span> therapy for menorrhagia."	761593.0	2339463.0	2339463_D015119_D020225|D020227		bcv_easy_209_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine."	761593.0	6892185.0	6892185_D002217_D015878		bcv_easy_1060_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014640	"<span class=""chemical"">vancomycin</span>"	D006311	"<span class=""disease"">ototoxicity</span>"	"Thrombophlebitis occurred only with infusion through peripheral cannulae; nephrotoxicity and <span class=""disease"">ototoxicity</span> were confined to patients receiving an aminoglycoside plus <span class=""chemical"">vancomycin</span>."	761593.0	3934126.0	3934126_D014640_D006311		bcv_easy_1144_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002752	"<span class=""chemical"">chlorthalidone</span>"	D018879	"<span class=""disease"">ventricular ectopic beats</span>"	"Compared to amiloride treatment, the <span class=""chemical"">chlorthalidone</span> phase was associated with an increased frequency of <span class=""disease"">ventricular ectopic beats</span> (24-hour Holter monitoring) and a higher Lown grading, increased upslope and duration of the monophasic action potential, prolonged ventricular effective refractory period, and increased electrical instability during programmed ventricular stimulation."	761593.0	3732088.0	3732088_D002752_D018879		bcv_easy_23_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002927	"<span class=""chemical"">cimetidine</span>"	D007172	"<span class=""disease"">impotence</span>"	"Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking <span class=""chemical"">cimetidine</span> and in all cases these changes disappeared when <span class=""chemical"">cimetidine</span> was replaced by ranitidine."	761593.0	6150641.0	6150641_D002927_D007172		bcv_easy_326_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016685	"<span class=""chemical"">MMC</span>"	D006333	"<span class=""disease"">cardiac failure</span>"	"One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 <span class=""chemical"">MMC</span> and only 150 mg m-2 doxorubicin."	761593.0	3137399.0	3137399_D016685_D006333		bcv_easy_1200_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009288	"<span class=""chemical"">naproxen</span>"	D007681	"<span class=""disease"">Renal papillary necrosis</span>"	"<span class=""disease"">Renal papillary necrosis</span> due to <span class=""chemical"">naproxen</span>."	761593.0	6699841.0	6699841_D009288_D007681		bcv_easy_1244_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C019248	"<span class=""chemical"">pamidronate</span>"	D006996	"<span class=""disease"">hypocalcemia</span>"	"The 2 patients with the higher serum calcium concentrations received <span class=""chemical"">pamidronate</span> intravenously (60 and 30 mg, respectively), which caused severe <span class=""disease"">hypocalcemia</span>."	761593.0	16006300.0	16006300_C019248_D006996		bcv_easy_707_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D056486	"<span class=""disease"">hepatic injury</span>"	"It is concluded that solid evidence exists of <span class=""disease"">hepatic injury</span> due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, cholestatic hepatitis and micronodular cirrhosis of the liver."	761593.0	3962737.0	3962737_D000638_D056486		bcv_easy_292_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009074	"<span class=""chemical"">MSH</span>"	D004421	"<span class=""disease"">dystonia</span>"	"A <span class=""disease"">dystonia</span>-like syndrome after neuropeptide (<span class=""chemical"">MSH</span>/ACTH) stimulation of the rat locus ceruleus."	761593.0	2840807.0	2840807_D009074_D004421		bcv_easy_493_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004456	"<span class=""chemical"">echothiophate iodide</span>"	D018908	"<span class=""disease"">muscle weakness</span>"	"A patient developed a severe cholinergic syndrome from the use of <span class=""chemical"">echothiophate iodide</span> ophthalmic drops, presented with profound <span class=""disease"">muscle weakness</span> and was initially given the diagnosis of myasthenia gravis."	761593.0	7650771.0	7650771_D004456_D018908		bcv_easy_1165_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by <span class=""chemical"">carbachol</span> and eserine."	761593.0	6892185.0	6892185_D002217_D004830		bcv_easy_1056_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010068	"<span class=""chemical"">oxacillin</span>"	D051437	"<span class=""disease"">renal failure</span>"	"A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of Staphylococcus aureus bacteremia, developed <span class=""disease"">renal failure</span> and diffuse, symmetric, palpable purpuric lesions on his feet."	761593.0	11337188.0	11337188_D010068_D051437		bcv_easy_302_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013874	"<span class=""chemical"">thiopental</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"GABA involvement in naloxone induced reversal of <span class=""disease"">respiratory paralysis</span> produced by <span class=""chemical"">thiopental</span>."	761593.0	2893236.0	2893236_D013874_D012133		bcv_easy_438_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008775	"<span class=""chemical"">methylprednisolone</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"We report a case of hypotension, <span class=""disease"">bradycardia</span>, and asystole after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode."	761593.0	10074612.0	10074612_D008775_D001919		bcv_easy_1089_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D011692	"<span class=""chemical"">PAN</span>"	D034141	"<span class=""disease"">hypoalbuminemia</span>"	"After 7 days, <span class=""chemical"">PAN</span> treatment induced significant proteinuria, <span class=""disease"">hypoalbuminemia</span>, decreased urinary sodium excretion, and extensive ascites."	761593.0	15075188.0	15075188_D011692_D034141		bcv_easy_1094_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C017367	"<span class=""chemical"">carmofur</span>"	D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), 5-fluorouracil and its derivative <span class=""chemical"">carmofur</span>, and capecitabine."	761593.0	17682013.0	17682013_C017367_D056784		bcv_easy_782_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D017693	"<span class=""chemical"">sodium bicarbonate</span>"	D053040	"<span class=""disease"">nephrolithiasis</span>"	"One case of acute hypercalcaemia and two of recurrent <span class=""disease"">nephrolithiasis</span> are reported in patients who had regularly consumed large amounts of calcium carbon-ate-<span class=""chemical"">sodium bicarbonate</span> powders for more than 20 years."	761593.0	625456.0	625456_D017693_D053040		bcv_easy_51_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005476	"<span class=""chemical"">fluphenazine</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by <span class=""chemical"">fluphenazine</span>, SCH 23390 or sulpiride."	761593.0	1687392.0	1687392_D005476_D002375		bcv_easy_862_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005047	"<span class=""chemical"">etoposide</span>"	D009203	"<span class=""disease"">myocardial infarction</span>"	"The occurrence of a <span class=""disease"">myocardial infarction</span> is reported after chemotherapy containing <span class=""chemical"">etoposide</span>, in a man with no risk factors for coronary heart disease."	761593.0	7619765.0	7619765_D005047_D009203		bcv_easy_554_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010068	"<span class=""chemical"">Oxacillin</span>"	D018366	"<span class=""disease"">leucocytoclastic vasculitis</span>"	"<span class=""chemical"">Oxacillin</span> should be included among the drugs that can cause <span class=""disease"">leucocytoclastic vasculitis</span>."	761593.0	11337188.0	11337188_D010068_D018366		bcv_easy_305_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010396	"<span class=""chemical"">Penicillamine</span>"	D005921	"<span class=""disease"">glomerulonephritis</span>"	"<span class=""chemical"">Penicillamine</span>-induced rapidly progressive <span class=""disease"">glomerulonephritis</span> in a patient with rheumatoid arthritis."	761593.0	8267029.0	8267029_D010396_D005921		bcv_easy_496_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016685	"<span class=""chemical"">Mitomycin C</span>"	D006463	"<span class=""disease"">hemolytic uremic syndrome</span>"	"<span class=""chemical"">Mitomycin C</span> associated <span class=""disease"">hemolytic uremic syndrome</span>."	761593.0	3108839.0	3108839_D016685_D006463		bcv_easy_797_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."	761593.0	6892185.0	6892185_D002217_D015878		bcv_easy_1042_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005473	"<span class=""chemical"">Fluoxetine</span>"	D006966	"<span class=""disease"">hyperprolactinemia</span>"	"DESIGN: <span class=""chemical"">Fluoxetine</span>, a serotonin reuptake inhibitor, was given to Wistar Albino rats for 98 days to produce <span class=""disease"">hyperprolactinemia</span>."	761593.0	9098464.0	9098464_D005473_D006966		bcv_easy_1034_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C056299	"<span class=""chemical"">Abbott-53693</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"On the other hand, the pressor effects of <span class=""chemical"">Abbott-53693</span> were similar in both groups of SHR, but the accompanying <span class=""disease"">bradycardia</span> was greater in SHR with chronic prazosin treatment than without such treatment."	761593.0	1355091.0	1355091_C056299_D001919		bcv_easy_1081_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001971	"<span class=""chemical"">bromocriptine</span>"	D011605	"<span class=""disease"">psychosis</span>"	"Postpartum <span class=""disease"">psychosis</span> induced by <span class=""chemical"">bromocriptine</span>."	761593.0	3686155.0	3686155_D001971_D011605		bcv_easy_555_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D006333	"<span class=""disease"">cardiac failure</span>"	"One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 MMC and only 150 mg m-2 <span class=""chemical"">doxorubicin</span>."	761593.0	3137399.0	3137399_D004317_D006333		bcv_easy_1199_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008727	"<span class=""chemical"">methotrexate</span>"	D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with <span class=""chemical"">methotrexate</span> (intrathecal, systemic), 5-fluorouracil and its derivative carmofur, and capecitabine."	761593.0	17682013.0	17682013_D008727_D056784		bcv_easy_781_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013866	"<span class=""chemical"">6-thioguanine</span>"	D006504	"<span class=""disease"">Hepatic veno-occlusive disease</span>"	"<span class=""disease"">Hepatic veno-occlusive disease</span> caused by <span class=""chemical"">6-thioguanine</span>."	761593.0	7053705.0	7053705_D013866_D006504		bcv_easy_1211_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D015742	"<span class=""chemical"">propofol</span>"	D010146	"<span class=""disease"">pain</span>"	"Remifentanil-related complications were assessed during the remifentanil infusion, and <span class=""disease"">pain</span> caused by <span class=""chemical"">propofol</span> was evaluated using a four-point scale during the <span class=""chemical"">propofol</span> infusion."	761593.0	18006530.0	18006530_D015742_D010146		bcv_easy_8_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007530	"<span class=""chemical"">isoflurane</span>"	D002779|D056486	"<span class=""disease"">cholestatic hepatitis</span>"	"OBJECTIVE: To report a case of acute <span class=""disease"">cholestatic hepatitis</span> following exposure to the inhalational anesthetic <span class=""chemical"">isoflurane</span>."	761593.0	11847945.0	11847945_D007530_D002779|D056486		bcv_easy_116_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D014202	"<span class=""disease"">tremor</span>"	"On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."	761593.0	6892185.0	6892185_D002217_D014202		bcv_easy_1047_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D017963	"<span class=""chemical"">azithromycin</span>"	D006606	"<span class=""disease"">hiccups</span>"	"CASE SUMMARY: A 76-year-old man presented with persistent <span class=""disease"">hiccups</span> after beginning <span class=""chemical"">azithromycin</span> for the treatment of pharyngitis."	761593.0	15985056.0	15985056_D017963_D006606		bcv_easy_817_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D015632	"<span class=""chemical"">MPTP</span>"	D020734	"<span class=""disease"">parkinsonian</span>"	"A group of four monkeys was rendered <span class=""disease"">parkinsonian</span> with the toxin <span class=""chemical"">MPTP</span>."	761593.0	8106150.0	8106150_D015632_D020734		bcv_easy_1113_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002217	"<span class=""chemical"">carbachol</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."	761593.0	6892185.0	6892185_D002217_D015878		bcv_easy_1052_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D003276	"<span class=""chemical"">Oral Contraceptives</span>"	D008113	"<span class=""disease"">Liver Tumors</span>"	"The Registry for <span class=""disease"">Liver Tumors</span> Associated with <span class=""chemical"">Oral Contraceptives</span> at the University of California, Irvine, has clearly identified 27 cases."	761593.0	188339.0	188339_D003276_D008113		bcv_easy_424_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004298	"<span class=""chemical"">dopamine</span>"	D002389	"<span class=""disease"">catatonia</span>"	"In the pinealectomized chick, pretreatment with <span class=""chemical"">dopamine</span> increased the duration of <span class=""disease"">catatonia</span> (DOC) after ketamine, but pretreatment with norepinephrine did not."	761593.0	6540303.0	6540303_D004298_D002389		bcv_easy_485_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005472	"<span class=""chemical"">5-FU/5-fluorouracil</span>"	D002637	"<span class=""disease"">chest pain</span>"	"We report a case of a patient with colon carcinoma and liver metastasis who presented <span class=""disease"">chest pain</span> after <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) administration."	761593.0	3952818.0	3952818_D005472_D002637		bcv_easy_997_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014635	"<span class=""chemical"">VPA</span>"	D007177	"<span class=""disease"">SIADH</span>"	"We consider this episode of <span class=""disease"">SIADH</span> to be the result of a combination of factors including a weakness of the central nervous system and the long-term administration of <span class=""chemical"">VPA</span>."	761593.0	11195262.0	11195262_D014635_D007177		bcv_easy_162_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D015228	"<span class=""disease"">hypertriglyceridaemia</span>"	"Compared with the placebo group, there was a significantly increased risk of vascular events and <span class=""disease"">hypertriglyceridaemia</span> among women on <span class=""chemical"">tamoxifen</span>."	761593.0	9672273.0	9672273_D013629_D015228		bcv_easy_313_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008012	"<span class=""chemical"">lidocaine</span>"	D012640	"<span class=""disease"">seizures</span>"	"Chronic oral CBZ inhibited the development of both <span class=""chemical"">lidocaine</span>- and cocaine-induced <span class=""disease"">seizures</span>, but had little effect on the fully developed local anesthetic <span class=""disease"">seizures</span>."	761593.0	2790457.0	2790457_D008012_D012640		bcv_easy_685_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008094	"<span class=""chemical"">Lithium</span>"	D011141	"<span class=""disease"">polyuria</span>"	"<span class=""chemical"">Lithium</span> induced nephrogenic diabetes insipidus is considered to be reversible on cessation of therapy but <span class=""disease"">polyuria</span> persisted in this patient for ten years after <span class=""chemical"">lithium</span> was stopped."	761593.0	9226773.0	9226773_D008094_D011141		bcv_easy_200_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009543	"<span class=""chemical"">nifedipine</span>"	D013684	"<span class=""disease"">telangiectasia</span>"	"Photodistributed <span class=""chemical"">nifedipine</span>-induced facial <span class=""disease"">telangiectasia</span>."	761593.0	8251368.0	8251368_D009543_D013684		bcv_easy_452_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004656	"<span class=""chemical"">enalapril</span>"	D051437	"<span class=""disease"">decreased renal function</span>"	"Diuretic therapy was likewise associated with a greater risk of <span class=""disease"">decreased renal function</span> in the <span class=""chemical"">enalapril</span> group (RR 1.89, 95% CI 1.70-2.08) than in the placebo group (RR 1.35, 95% CI 1.09-1.66)."	761593.0	10539815.0	10539815_D004656_D051437		bcv_easy_767_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016861	"<span class=""chemical"">cyclooxygenase inhibitors</span>"	D020521	"<span class=""disease"">stroke</span>"	"Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, <span class=""disease"">stroke</span>, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>."	761593.0	16586083.0	16586083_D016861_D020521		bcv_easy_1147_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D005996	"<span class=""chemical"">Glyceryl trinitrate</span>"	D020326	"<span class=""disease"">migraine without aura</span>"	"<span class=""chemical"">Glyceryl trinitrate</span> induces attacks of <span class=""disease"">migraine without aura</span> in sufferers of migraine with aura."	761593.0	10524660.0	10524660_D005996_D020326		bcv_easy_601_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D014282	"<span class=""chemical"">trihexyphenidyl hydrochloride</span>"	D001919	"<span class=""disease"">Bradycardia</span>"	"<span class=""disease"">Bradycardia</span> due to <span class=""chemical"">trihexyphenidyl hydrochloride</span>."	761593.0	3769769.0	3769769_D014282_D001919		bcv_easy_250_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D016685	"<span class=""chemical"">mitomycin C</span>"	D051437	"<span class=""disease"">renal failure</span>"	"It consists of microangiopathic hemolytic anemia, thrombocytopenia and progressive <span class=""disease"">renal failure</span> associated with <span class=""chemical"">mitomycin C</span> treatment and affects about 10% of patients treated with this agent."	761593.0	3108839.0	3108839_D016685_D051437		bcv_easy_800_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D011441	"<span class=""chemical"">PTU</span>"	D014657	"<span class=""disease"">vasculitis</span>"	"<span class=""chemical"">PTU</span>-associated <span class=""disease"">vasculitis</span> in a girl with Turner Syndrome and Graves' disease."	761593.0	16418614.0	16418614_D011441_D014657		bcv_easy_93_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D002779|D056486	"<span class=""disease"">cholestatic hepatitis</span>"	"It is concluded that solid evidence exists of hepatic injury due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, <span class=""disease"">cholestatic hepatitis</span> and micronodular cirrhosis of the liver."	761593.0	3962737.0	3962737_D000638_D002779|D056486		bcv_easy_293_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004317	"<span class=""chemical"">ADR</span>"	D028361	"<span class=""disease"">mitochondrial structural and functional impairment</span>"	"Knowing that heart mitochondria represent almost 40% of heart muscle by weight, we conclude that the deteriorating effects of <span class=""chemical"">ADR</span> on cardiovascular function involve <span class=""disease"">mitochondrial structural and functional impairment</span>."	761593.0	9952311.0	9952311_D004317_D028361		bcv_easy_796_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007069	"<span class=""chemical"">ifosfamide</span>"	D001002	"<span class=""disease"">anuria</span>"	"We strongly suspect that this lethal <span class=""disease"">anuria</span> was mainly due to <span class=""chemical"">ifosfamide</span>, occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension."	761593.0	2320800.0	2320800_D007069_D001002		bcv_easy_411_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000319	"<span class=""chemical"">beta-adrenergic blocking drugs</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>."	761593.0	6127992.0	6127992_D000319_D001919		bcv_easy_472_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D008775	"<span class=""chemical"">methylprednisolone</span>"	D006323	"<span class=""disease"">asystole</span>"	"We report a case of hypotension, bradycardia, and <span class=""disease"">asystole</span> after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode."	761593.0	10074612.0	10074612_D008775_D006323		bcv_easy_1088_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000082	"<span class=""chemical"">paracetamol</span>"	D017114	"<span class=""disease"">fulminant hepatic failure</span>"	"Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived <span class=""disease"">fulminant hepatic failure</span> after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with <span class=""disease"">fulminant hepatic failure</span> due to viral hepatitis whether or not they survived."	761593.0	7007443.0	7007443_D000082_D017114		bcv_easy_342_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D001393	"<span class=""chemical"">azole</span>"	D008133	"<span class=""disease"">Prolongation of QT interval</span>"	"<span class=""disease"">Prolongation of QT interval</span>, torsades de pointes, and sudden cardiac death have been reported after concomitant administration with erythromycin or <span class=""chemical"">azole</span> antifungal agents, but not with other CYP3A4 inhibitors."	761593.0	9545159.0	9545159_D001393_D008133		bcv_easy_255_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000420	"<span class=""chemical"">Salbutamol</span>"	D013617	"<span class=""disease"">SIAT</span>"	"CONCLUSION: <span class=""chemical"">Salbutamol</span> is presented here as a possible trigger for <span class=""disease"">SIAT</span>."	761593.0	20552622.0	20552622_D000420_D013617		bcv_easy_45_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C092292	"<span class=""chemical"">ziprasidone</span>"	D009459	"<span class=""disease"">Neuroleptic malignant syndrome</span>"	"<span class=""disease"">Neuroleptic malignant syndrome</span> induced by <span class=""chemical"">ziprasidone</span> on the second day of treatment."	761593.0	17366349.0	17366349_C092292_D009459		bcv_easy_52_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007069	"<span class=""chemical"">ifosfamide</span>"	D001002	"<span class=""disease"">anuria</span>"	"A sixty-year-old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with <span class=""disease"">anuria</span>, the day after 5 g/m2 bolus <span class=""chemical"">ifosfamide</span>."	761593.0	2320800.0	2320800_D007069_D001002		bcv_easy_404_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D013874	"<span class=""chemical"">thiopental</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"These data suggest naloxone reverses <span class=""disease"">respiratory paralysis</span> produced by <span class=""chemical"">thiopental</span> and involves GABA in its action."	761593.0	2893236.0	2893236_D013874_D012133		bcv_easy_449_sent_work_dev_set_761593	"yes_direct
"	
TRUE	C056299	"<span class=""chemical"">Abbott-53693</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"The pressor responses and <span class=""disease"">bradycardia</span> to the alpha 1-agonist cirazoline (0.6 and 2 micrograms kg-1 i.v.), the alpha 2-agonist <span class=""chemical"">Abbott-53693</span> (1 and 3 micrograms kg-1 i.v.), and noradrenaline (0.1 and 1.0 micrograms kg-1 i.v.) were determined in conscious SHR with and without chronic prazosin pretreatment."	761593.0	1355091.0	1355091_C056299_D001919		bcv_easy_1074_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D000319	"<span class=""chemical"">beta-adrenergic blocking drugs</span>"	D007022	"<span class=""disease"">hypotension</span>"	"Three patients with ischaemic heart disease developed profound cardiac failure, <span class=""disease"">hypotension</span> and bradycardia during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>."	761593.0	6127992.0	6127992_D000319_D007022		bcv_easy_474_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D004977	"<span class=""chemical"">ethambutol</span>"	D009901	"<span class=""disease"">optic neuropathy</span>"	"CLINICAL PICTURE: Three patients with <span class=""chemical"">ethambutol</span>-associated toxic <span class=""disease"">optic neuropathy</span> are described."	761593.0	16710500.0	16710500_D004977_D009901		bcv_easy_340_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D018879	"<span class=""disease"">ventricular ectopy</span>"	"Intravenous <span class=""chemical"">caffeine</span> is commonly used to improve seizure duration and quality in such patients and is generally well tolerated aside from occasional reports of relatively benign <span class=""disease"">ventricular ectopy</span>."	761593.0	18997632.0	18997632_D002110_D018879		bcv_easy_120_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D009627	"<span class=""chemical"">nomifensine</span>"	D006948	"<span class=""disease"">hyperactivity</span>"	"The <span class=""disease"">hyperactivity</span> induced by <span class=""chemical"">nomifensine</span> in mice remained unaffected by fluvoxamine."	761593.0	2576810.0	2576810_D009627_D006948		bcv_easy_1178_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D017285	"<span class=""disease"">Polymyositis</span>"	"<span class=""disease"">Polymyositis</span>/dermatomyositis can develop as one of the autoimmune complications of <span class=""chemical"">D-penicillamine</span> treatment, but its exact pathogenesis remains unclear."	761593.0	8268147.0	8268147_D010396_D017285		bcv_easy_836_sent_work_dev_set_761593	"yes_direct
"	
TRUE	D007660	"<span class=""chemical"">Ketoprofen</span>"	D013345	"<span class=""disease"">SAH</span>"	"<span class=""chemical"">Ketoprofen</span> but not acetaminophen impaired platelet function in patients with <span class=""disease"">SAH</span>."	761593.0	10414674.0	10414674_D007660_D013345		bcv_easy_901_sent_work_dev_set_761593	"no_relation
"	
TRUE	C012655	"<span class=""chemical"">nimesulide</span>"	D014581	"<span class=""disease"">urticaria</span>"	"In this study we investigated tolerability and reliability of <span class=""chemical"">nimesulide</span> and paracetamol in a very large number of patients with an exclusive well-documented history of NSAID-induced <span class=""disease"">urticaria</span>/angioedema."	761593.0	11694026.0	11694026_C012655_D014581		bcv_easy_641_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000082	"<span class=""chemical"">paracetamol</span>"	D001744	"<span class=""disease"">bladder calculi</span>"	"Additionally, 20 to 25% of <span class=""chemical"">paracetamol</span>-treated rats developed hyperplasia of the bladder epithelium, which was not coincident with the presence of <span class=""disease"">bladder calculi</span>."	761593.0	4090988.0	4090988_D000082_D001744		bcv_easy_282_sent_work_dev_set_761593	"no_relation
"	
TRUE	D010830	"<span class=""chemical"">physostigmine</span>"	D004409	"<span class=""disease"">dyskinetic</span>"	"Several drugs, including clonidine, <span class=""chemical"">physostigmine</span>, methysergide, 5-MDOT, propranolol, and MK-801, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology."	761593.0	8106150.0	8106150_D010830_D004409		bcv_easy_1121_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated <span class=""chemical"">doxorubicin</span> and cyclophosphamide compared with conventional <span class=""chemical"">doxorubicin</span> and cyclophosphamide in a randomized, multicenter trial of metastatic <span class=""disease"">breast cancer</span>."	761593.0	11230490.0	11230490_D004317_D001943		bcv_easy_130_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014147	"<span class=""chemical"">Tramadol</span>"	D009369	"<span class=""disease"">cancer</span>"	"<span class=""chemical"">Tramadol</span> is a weak opioid with effects on adrenergic and serotonergic neurotransmission that is used to treat <span class=""disease"">cancer</span> pain and chronic non malignant pain."	761593.0	8766220.0	8766220_D014147_D009369		bcv_easy_98_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004008	"<span class=""chemical"">diclofenac sodium</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"Gastrointestinal tolerability of etoricoxib in <span class=""disease"">rheumatoid arthritis</span> patients: results of the etoricoxib vs <span class=""chemical"">diclofenac sodium</span> gastrointestinal tolerability and effectiveness trial (EDGE-II)."	761593.0	17965424.0	17965424_D004008_D001172		bcv_easy_924_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011188	"<span class=""chemical"">potassium</span>"	D003327	"<span class=""disease"">coronary disease</span>"	"Diuretics, <span class=""chemical"">potassium</span> and arrhythmias in hypertensive <span class=""disease"">coronary disease</span>."	761593.0	3732088.0	3732088_D011188_D003327		bcv_easy_13_sent_work_dev_set_761593	"no_relation
"	
TRUE	C422649	"<span class=""chemical"">etoricoxib</span>"	D001172	"<span class=""disease"">RA</span>"	"PATIENTS AND METHODS: A total of 4086 patients (mean age 60.8 years) diagnosed with <span class=""disease"">RA</span> were enrolled and received <span class=""chemical"">etoricoxib</span> 90 mg daily (n = 2032) or diclofenac 75 mg twice daily (n = 2054)."	761593.0	17965424.0	17965424_C422649_D001172		bcv_easy_927_sent_work_dev_set_761593	"no_relation
"	
TRUE	C004742	"<span class=""chemical"">daidzein</span>"	D000647	"<span class=""disease"">amnesia</span>"	"Administration of <span class=""chemical"">daidzein</span> (4.5 mg/kg body weight) to mice was shown significantly to reverse scopolamine-induced <span class=""disease"">amnesia</span>, according to the results of a Y-maze test."	761593.0	16428827.0	16428827_C004742_D000647		bcv_easy_66_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015647	"<span class=""chemical"">SKF 38393</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"D-1 agonist <span class=""chemical"">SKF 38393</span> or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by fluphenazine, SCH 23390 or sulpiride."	761593.0	1687392.0	1687392_D015647_D002375		bcv_easy_863_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D001943	"<span class=""disease"">MBC</span>"	"PATIENTS AND METHODS: Two hundred ninety-seven patients with <span class=""disease"">MBC</span> and no prior chemotherapy for metastatic disease were randomized to receive either 60 mg/m(2) of Myocet (M) or conventional doxorubicin (A), in combination with 600 mg/m(2) of <span class=""chemical"">cyclophosphamide</span> (C), every 3 weeks until disease progression or unacceptable toxicity."	761593.0	11230490.0	11230490_D003520_D001943		bcv_easy_140_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015215	"<span class=""chemical"">AZT</span>"	D000163	"<span class=""disease"">AIDS</span>"	"We have used a murine model of <span class=""disease"">AIDS</span>, infection of female C57BL/6 mice with LP-BM5 murine leukaemia (MuLV) virus, to determine if <span class=""chemical"">AZT</span>-induced anaemia is due, in part, to decreased responsiveness of erythropoietic precursors (BFU-e) to erythropoietin (EPO)."	761593.0	2004015.0	2004015_D015215_D000163		bcv_easy_215_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007660	"<span class=""chemical"">ketoprofen</span>"	D013345	"<span class=""disease"">aneurysmal subarachnoid hemorrhage/SAH</span>"	"Patients with <span class=""disease"">aneurysmal subarachnoid hemorrhage</span> (<span class=""disease"">SAH</span>) were randomized to receive either <span class=""chemical"">ketoprofen</span>, 100 mg, three times a day (<span class=""chemical"">ketoprofen</span> group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day (acetaminophen group, n = 9) starting immediately after the diagnosis of aneurysmal <span class=""disease"">SAH</span>."	761593.0	10414674.0	10414674_D007660_D013345		bcv_easy_894_sent_work_dev_set_761593	"no_relation
"	
TRUE	C065179	"<span class=""chemical"">Atorvastatin</span>"	D006973	"<span class=""disease"">hypertension</span>"	"<span class=""chemical"">Atorvastatin</span> prevented and reversed dexamethasone-induced <span class=""disease"">hypertension</span> in the rat."	761593.0	16820346.0	16820346_C065179_D006973		bcv_easy_69_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000082	"<span class=""chemical"">paracetamol</span>"	D006525	"<span class=""disease"">viral hepatitis</span>"	"Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived fulminant hepatic failure after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with fulminant hepatic failure due to <span class=""disease"">viral hepatitis</span> whether or not they survived."	761593.0	7007443.0	7007443_D000082_D006525		bcv_easy_344_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002118	"<span class=""chemical"">calcium</span>"	D003866	"<span class=""disease"">depression</span>"	"Addition of excess <span class=""chemical"">calcium</span> reversed the <span class=""disease"">depression</span> in both tissues, but <span class=""chemical"">calcium</span>-independent catecholamine release by acetaldehyde was not blocked by NH4Ac."	761593.0	6323692.0	6323692_D002118_D003866		bcv_easy_364_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005680	"<span class=""chemical"">GABA</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"Naloxone (2.5 mg/kg, i.v.) reversed <span class=""disease"">respiratory paralysis</span>, glutamate and <span class=""chemical"">GABA</span> levels to control values in brain stem and cortex with no changes in caudate or cerebellum."	761593.0	2893236.0	2893236_D005680_D012133		bcv_easy_446_sent_work_dev_set_761593	"no_relation
"	
TRUE	D017311	"<span class=""chemical"">amlodipine</span>"	D006973	"<span class=""disease"">hypertension</span>"	"OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of a new fixed-dose combination (FDC) of telmisartan 40 mg + <span class=""chemical"">amlodipine</span> 5 mg (T+A) compared with <span class=""chemical"">amlodipine</span> 5-mg monotherapy (A) in adult Indian patients with stage II <span class=""disease"">hypertension</span>."	761593.0	18201582.0	18201582_D017311_D006973		bcv_easy_888_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001058	"<span class=""chemical"">Apomorphine</span>"	D010300	"<span class=""disease"">Parkinson's disease</span>"	"<span class=""chemical"">Apomorphine</span> was the first dopaminergic drug ever used to treat symptoms of <span class=""disease"">Parkinson's disease</span>."	761593.0	11009181.0	11009181_D001058_D010300		bcv_easy_190_sent_work_dev_set_761593	"no_relation
"	
TRUE	C012655	"<span class=""chemical"">nimesulide</span>"	D014581	"<span class=""disease"">urticaria</span>"	"A single-placebo-controlled oral challenge procedure with <span class=""chemical"">nimesulide</span> or paracetamol was applied to 829 patients with a history of NSAID-induced <span class=""disease"">urticaria</span>/angioedema."	761593.0	11694026.0	11694026_C012655_D014581		bcv_easy_645_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011224	"<span class=""chemical"">prazosin</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"The pressor responses and <span class=""disease"">bradycardia</span> to the alpha 1-agonist cirazoline (0.6 and 2 micrograms kg-1 i.v.), the alpha 2-agonist Abbott-53693 (1 and 3 micrograms kg-1 i.v.), and noradrenaline (0.1 and 1.0 micrograms kg-1 i.v.) were determined in conscious SHR with and without chronic <span class=""chemical"">prazosin</span> pretreatment."	761593.0	1355091.0	1355091_D011224_D001919		bcv_easy_1075_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002216	"<span class=""chemical"">captopril</span>"	D011507	"<span class=""disease"">proteinuria</span>"	"Also, <span class=""chemical"">captopril</span> treatment failed to potentiate or facilitate development of massive <span class=""disease"">proteinuria</span> invoked by puromycin aminonucleoside in SHR."	761593.0	6454943.0	6454943_D002216_D011507		bcv_easy_589_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002220	"<span class=""chemical"">CBZ</span>"	D012640	"<span class=""disease"">seizure</span>"	"Chronic <span class=""chemical"">CBZ</span> also decreased the incidence of <span class=""disease"">seizure</span>-related mortality in the cocaine-injected rats."	761593.0	2790457.0	2790457_D002220_D012640		bcv_easy_686_sent_work_dev_set_761593	"no_relation
"	
TRUE	D012964	"<span class=""chemical"">sodium</span>"	D034141	"<span class=""disease"">hypoalbuminemia</span>"	"After 7 days, PAN treatment induced significant proteinuria, <span class=""disease"">hypoalbuminemia</span>, decreased urinary <span class=""chemical"">sodium</span> excretion, and extensive ascites."	761593.0	15075188.0	15075188_D012964_D034141		bcv_easy_1097_sent_work_dev_set_761593	"no_relation
"	
TRUE	D012254	"<span class=""chemical"">ribavirin</span>"	D000257	"<span class=""disease"">adenovirus disease</span>"	"Although intravenous <span class=""chemical"">ribavirin</span> was not effective for all children with severe <span class=""disease"">adenovirus disease</span> in this series or in the literature, therapy is unlikely to be of benefit if begun late in the course of the infection."	761593.0	12093990.0	12093990_D012254_D000257		bcv_easy_246_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"INTERPRETATION: Although this preliminary analysis has low power, in this cohort of women at low-to-normal risk of <span class=""disease"">breast cancer</span>, the postulated protective effects of <span class=""chemical"">tamoxifen</span> are not yet apparent."	761593.0	9672273.0	9672273_D013629_D001943		bcv_easy_314_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">L-dopa</span>"	D003128	"<span class=""disease"">coma</span>"	"Bilateral nephrectomy eliminated the beneficial effect of <span class=""chemical"">L-dopa</span> on blood and brain ammonia and the ammonia <span class=""disease"">coma</span> was not prevented."	761593.0	761833.0	761833_D007980_D003128		bcv_easy_463_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009020	"<span class=""chemical"">Morphine</span>"	D001523	"<span class=""disease"">behavioral disorders</span>"	"<span class=""chemical"">Morphine</span> dose-dependently reversed these <span class=""disease"">behavioral disorders</span>."	761593.0	10840460.0	10840460_D009020_D001523		bcv_easy_320_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008687	"<span class=""chemical"">metformin</span>"	D014652	"<span class=""disease"">vascular dysfunction</span>"	"The antidiabetic drug <span class=""chemical"">metformin</span> can diminish apoptosis induced by oxidative stress in endothelial cells and prevent <span class=""disease"">vascular dysfunction</span> even in nondiabetic patients."	761593.0	20164825.0	20164825_D008687_D014652		bcv_easy_268_sent_work_dev_set_761593	"no_relation
"	
TRUE	D017374	"<span class=""chemical"">paroxetine</span>"	D059350	"<span class=""disease"">chronic pain</span>"	"This drug was initiated in association with <span class=""chemical"">paroxetine</span> and dosulepine hydrochloride in a tetraparetic patient with <span class=""disease"">chronic pain</span>."	761593.0	8766220.0	8766220_D017374_D059350		bcv_easy_100_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D066126	"<span class=""disease"">cardiotoxicity</span>"	"CONCLUSION: Myocet improves the therapeutic index of doxorubicin by significantly reducing <span class=""disease"">cardiotoxicity</span> and grade 4 neutropenia and provides comparable antitumor efficacy, when used in combination with <span class=""chemical"">cyclophosphamide</span> as first-line therapy for MBC."	761593.0	11230490.0	11230490_D003520_D066126		bcv_easy_142_sent_work_dev_set_761593	"no_relation
"	
TRUE	C032151	"<span class=""chemical"">cibenzoline</span>"	D001145	"<span class=""disease"">ventricular arrhythmias</span>"	"Antiarrhythmic plasma concentrations of <span class=""chemical"">cibenzoline</span> on canine <span class=""disease"">ventricular arrhythmias</span>."	761593.0	2435991.0	2435991_C032151_D001145		bcv_easy_425_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002220	"<span class=""chemical"">CBZ</span>"	D012640	"<span class=""disease"">seizures</span>"	"Repeated i.p. injection of <span class=""chemical"">CBZ</span> (15 mg/kg) also was without effect on the development of lidocaine- or cocaine-kindled <span class=""disease"">seizures</span>."	761593.0	2790457.0	2790457_D002220_D012640		bcv_easy_689_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011224	"<span class=""chemical"">prazosin</span>"	D009127	"<span class=""disease"">muscular rigidity</span>"	"Such an induced <span class=""disease"">muscular rigidity</span> by the narcotic agent was significantly antagonized or even reduced by prior electrolytic lesions of the locus coeruleus or pretreatment with the alpha-adrenoceptor blocker, <span class=""chemical"">prazosin</span>."	761593.0	2564649.0	2564649_D011224_D009127		bcv_easy_1162_sent_work_dev_set_761593	"no_relation
"	
TRUE	D010433	"<span class=""chemical"">metrazol</span>"	D000699	"<span class=""disease"">analgesia</span>"	"Both verapamil (10 mg/kg i.p.) and NH4Ac pretreatment enhanced morphine <span class=""disease"">analgesia</span>- and diazepam-induced muscular incoordination and antagonized amphetamine-induced motor activity, and neither verapamil nor NH4Ac affected the convulsant action of <span class=""chemical"">metrazol</span>."	761593.0	6323692.0	6323692_D010433_D000699		bcv_easy_376_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001262	"<span class=""chemical"">atenolol</span>"	D001145	"<span class=""disease"">arrhythmia</span>"	"The <span class=""disease"">arrhythmia</span> resolved after therapy with <span class=""chemical"">atenolol</span>, but recurred a year later."	761593.0	20552622.0	20552622_D001262_D001145		bcv_easy_43_sent_work_dev_set_761593	"no_relation
"	
TRUE	D006493	"<span class=""chemical"">Unfractionated heparin sodium/UFH</span>"	D013927	"<span class=""disease"">thrombosis</span>"	"BACKGROUND: <span class=""chemical"">Unfractionated heparin sodium</span> (<span class=""chemical"">UFH</span>) or low-molecular weight heparin (LMWH) is used in anticoagulant protocols at several institutions to prevent <span class=""disease"">thrombosis</span> after liver transplantation."	761593.0	18589141.0	18589141_D006493_D013927		bcv_easy_491_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008687	"<span class=""chemical"">metformin</span>"	D007674	"<span class=""disease"">nephrotoxicity</span>"	"Thus, our study suggests that pleiotropic effects of <span class=""chemical"">metformin</span> can lessen gentamicin <span class=""disease"">nephrotoxicity</span> and improve mitochondrial homeostasis."	761593.0	20164825.0	20164825_D008687_D007674		bcv_easy_273_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004052	"<span class=""chemical"">diethylnitrosamine</span>"	D063646	"<span class=""disease"">carcinogenic</span>"	"Anti-<span class=""disease"">carcinogenic</span> action of phenobarbital given simultaneously with <span class=""chemical"">diethylnitrosamine</span> in the rat."	761593.0	3780814.0	3780814_D004052_D063646		bcv_easy_712_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000086	"<span class=""chemical"">acetazolamide</span>"	D007674	"<span class=""disease"">renal impairment</span>"	"Acute confusion induced by <span class=""chemical"">acetazolamide</span> is a well known adverse drug reaction in patients with <span class=""disease"">renal impairment</span>."	761593.0	10692744.0	10692744_D000086_D007674		bcv_easy_989_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004298	"<span class=""chemical"">dopamine</span>"	D003128	"<span class=""disease"">coma</span>"	"Thus, the reduction in blood and brain ammonia and the prevention of ammonia <span class=""disease"">coma</span> after L-dopa, can be accounted for by the peripheral effect of <span class=""chemical"">dopamine</span> on renal function rather than its central action."	761593.0	761833.0	761833_D004298_D003128		bcv_easy_465_sent_work_dev_set_761593	"no_relation
"	
TRUE	D012254	"<span class=""chemical"">ribavirin</span>"	D006482	"<span class=""disease"">infection with hemorrhagic fever viruses</span>"	"Intravenous <span class=""chemical"">ribavirin</span> is the treatment of choice for <span class=""disease"">infection with hemorrhagic fever viruses</span>."	761593.0	12093990.0	12093990_D012254_D006482		bcv_easy_238_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015725	"<span class=""chemical"">fluconazole</span>"	D001145	"<span class=""disease"">ventricular arrhythmias</span>"	"Serial electrocardiographic monitoring may be considered when <span class=""chemical"">fluconazole</span> is administered in patients who are at risk for <span class=""disease"">ventricular arrhythmias</span>."	761593.0	11302406.0	11302406_D015725_D001145		bcv_easy_544_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000082	"<span class=""chemical"">acetaminophen</span>"	D013345	"<span class=""disease"">SAH</span>"	"Ketoprofen but not <span class=""chemical"">acetaminophen</span> impaired platelet function in patients with <span class=""disease"">SAH</span>."	761593.0	10414674.0	10414674_D000082_D013345		bcv_easy_902_sent_work_dev_set_761593	"no_relation
"	
TRUE	D017035	"<span class=""chemical"">pravastatin</span>"	D006937	"<span class=""disease"">hypercholesterolemia</span>"	"He assumed <span class=""chemical"">pravastatin</span> (20 mg/day) because of <span class=""disease"">hypercholesterolemia</span>."	761593.0	7604176.0	7604176_D017035_D006937		bcv_easy_810_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013792	"<span class=""chemical"">thalidomide</span>"	D002292	"<span class=""disease"">renal cell carcinoma</span>"	"CONCLUSION: These results are consistent with a low level of activity of <span class=""chemical"">thalidomide</span> in <span class=""disease"">renal cell carcinoma</span>."	761593.0	12448656.0	12448656_D013792_D002292		bcv_easy_386_sent_work_dev_set_761593	"no_relation
"	
TRUE	C018370	"<span class=""chemical"">pregnenolone sulphate</span>"	D000647	"<span class=""disease"">amnesic</span>"	"Steroid structure and pharmacological properties determine the anti-<span class=""disease"">amnesic</span> effects of <span class=""chemical"">pregnenolone sulphate</span> in the passive avoidance task in rats."	761593.0	11860495.0	11860495_C018370_D000647		bcv_easy_1227_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">levodopa</span>"	D010300	"<span class=""disease"">idiopathic Parkinson's disease</span>"	"Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced <span class=""chemical"">levodopa</span>-induced peak dose involuntary movements in 16 patients with <span class=""disease"">idiopathic Parkinson's disease</span>."	761593.0	458486.0	458486_D007980_D010300		bcv_easy_109_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014269	"<span class=""chemical"">trifluoroacetyl</span>"	D056486	"<span class=""disease"">hepatitis</span>"	"An antibody response to a protein-bound biotransformation product (<span class=""chemical"">trifluoroacetyl</span> adduct) has been detected on halothane <span class=""disease"">hepatitis</span> patients."	761593.0	7647582.0	7647582_D014269_D056486		bcv_easy_913_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D007674	"<span class=""disease"">renal involvement</span>"	"Since 1989, she had been suffering from systemic lupus erythematosus (SLE) with <span class=""disease"">renal involvement</span> and undergone periods of treatment with azathioprine and <span class=""chemical"">cyclophosphamide</span>."	761593.0	12739036.0	12739036_D003520_D007674		bcv_easy_296_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004052	"<span class=""chemical"">diethylnitrosamine/DEN</span>"	D063646	"<span class=""disease"">carcinogenesis</span>"	"The present work has been planned in order to elucidate the effect of phenobarbital (PB: 15 mg per rat of ingested dose) on <span class=""disease"">carcinogenesis</span> when it is administered simultaneously with <span class=""chemical"">diethylnitrosamine</span> (<span class=""chemical"">DEN</span>: 10 mg/kg/day)."	761593.0	3780814.0	3780814_D004052_D063646		bcv_easy_714_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005492	"<span class=""chemical"">folic acid</span>"	D064420	"<span class=""disease"">toxicity</span>"	"This observation prompted a Phase I clinical study of lometrexol given with <span class=""chemical"">folic acid</span> supplementation which has confirmed that the <span class=""disease"">toxicity</span> of lometrexol can be markedly reduced by <span class=""chemical"">folic acid</span> supplementation."	761593.0	8958188.0	8958188_D005492_D064420		bcv_easy_185_sent_work_dev_set_761593	"no_relation
"	
TRUE	C095756	"<span class=""chemical"">AIDA</span>"	D009127	"<span class=""disease"">muscle rigidity</span>"	"<span class=""chemical"">AIDA</span> in doses of 7.5-15 microg/0.5 microl diminished the haloperidol-induced <span class=""disease"">muscle rigidity</span>."	761593.0	12231232.0	12231232_C095756_D009127		bcv_easy_479_sent_work_dev_set_761593	"no_relation
"	
TRUE	C507346	"<span class=""chemical"">AMN082</span>"	D018476	"<span class=""disease"">akinetic</span>"	"In a more complex task commonly used to evaluate major <span class=""disease"">akinetic</span> symptoms of PD patients, 5 mg/kg <span class=""chemical"">AMN082</span> reverses the increased reaction time to respond to a cue of bilateral 6-OHDA-lesioned rats."	761593.0	19940105.0	19940105_C507346_D018476		bcv_easy_1238_sent_work_dev_set_761593	"no_relation
"	
TRUE	D006046	"<span class=""chemical"">gold</span>"	D009393	"<span class=""disease"">nephritis</span>"	"A strong association has been found between <span class=""disease"">nephritis</span> and dermatitis due to Tiopronin (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between dermatitis due to <span class=""chemical"">gold</span> thiosulphate and B35."	761593.0	3084782.0	3084782_D006046_D009393		bcv_easy_674_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007649	"<span class=""chemical"">Ketamine</span>"	D012559	"<span class=""disease"">schizophrenia</span>"	"<span class=""chemical"">Ketamine</span> induces activation changes in healthy subjects similar to those observed in patients with <span class=""disease"">schizophrenia</span>, particularly in frontal and temporal brain regions."	761593.0	20727411.0	20727411_D007649_D012559		bcv_easy_226_sent_work_dev_set_761593	"no_relation
"	
TRUE	D010634	"<span class=""chemical"">PB</span>"	D009369	"<span class=""disease"">tumor</span>"	"In DEN + <span class=""chemical"">PB</span> treated rats, the survival was prolonged and the <span class=""disease"">tumor</span> incidence decreased as compared with the results obtained by DEN alone."	761593.0	3780814.0	3780814_D010634_D009369		bcv_easy_720_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007650	"<span class=""chemical"">Ketanserin</span>"	D009127	"<span class=""disease"">muscle rigidity</span>"	"<span class=""chemical"">Ketanserin</span> pretreatment reverses alfentanil-induced <span class=""disease"">muscle rigidity</span>."	761593.0	3115150.0	3115150_D007650_D009127		bcv_easy_228_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">Naloxone</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"<span class=""chemical"">Naloxone</span> (2.5 mg/kg, i.v.) reversed <span class=""disease"">respiratory paralysis</span>, glutamate and GABA levels to control values in brain stem and cortex with no changes in caudate or cerebellum."	761593.0	2893236.0	2893236_D009270_D012133		bcv_easy_447_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001379	"<span class=""chemical"">azathioprine</span>"	D007674	"<span class=""disease"">renal involvement</span>"	"Since 1989, she had been suffering from systemic lupus erythematosus (SLE) with <span class=""disease"">renal involvement</span> and undergone periods of treatment with <span class=""chemical"">azathioprine</span> and cyclophosphamide."	761593.0	12739036.0	12739036_D001379_D007674		bcv_easy_297_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014031	"<span class=""chemical"">tobramicyn</span>"	D064420	"<span class=""disease"">toxicity</span>"	"OBJECTIVE: To evaluate the effect of dosage regimen (once-daily vs. twice-daily) of <span class=""chemical"">tobramicyn</span> on steady-state serum concentrations and <span class=""disease"">toxicity</span>."	761593.0	9875685.0	9875685_D014031_D064420		bcv_easy_1026_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005492	"<span class=""chemical"">folic acid</span>"	D064420	"<span class=""disease"">toxicity</span>"	"Preclinical murine studies demonstrated that the <span class=""disease"">toxicity</span> of lometrexol can be prevented by low dose <span class=""chemical"">folic acid</span> administration, i.e. for 7 days prior to and 7 days following a single bolus dose."	761593.0	8958188.0	8958188_D005492_D064420		bcv_easy_183_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002216	"<span class=""chemical"">captopril</span>"	D006973	"<span class=""disease"">hypertensive</span>"	"Contribution of the sympathetic nervous system to salt-sensitivity in lifetime <span class=""chemical"">captopril</span>-treated spontaneously <span class=""disease"">hypertensive</span> rats."	761593.0	8586822.0	8586822_D002216_D006973		bcv_easy_1188_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013467	"<span class=""chemical"">sulindac</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with <span class=""chemical"">sulindac</span>, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis (RPN) 4 months after institution of naproxen therapy."	761593.0	6699841.0	6699841_D013467_D001172		bcv_easy_1250_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D017180	"<span class=""disease"">VT</span>"	"Six percent of the patients had a nonfatal recurrence of <span class=""disease"">VT</span> and were successfully managed by continuing <span class=""chemical"">amiodarone</span> at a higher dose or by the addition of a conventional antiarrhythmic drug."	761593.0	6637851.0	6637851_D000638_D017180		bcv_easy_1018_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014635	"<span class=""chemical"">VPA</span>"	D004830	"<span class=""disease"">tonic-clonic convulsions</span>"	"He had been taking <span class=""chemical"">VPA</span> for treatment of idiopathic generalized <span class=""disease"">tonic-clonic convulsions</span> since he was 56 years old."	761593.0	11195262.0	11195262_D014635_D004830		bcv_easy_160_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000617	"<span class=""chemical"">aminoglycoside</span>"	D006402|D009369	"<span class=""disease"">hematologic/oncologic disorder</span>"	"Forty patients with a diagnosis consistent with a <span class=""disease"">hematologic/oncologic disorder</span> that required treatment with an <span class=""chemical"">aminoglycoside</span> were randomized to either conventional or extended-interval amikacin."	761593.0	18356633.0	18356633_D000617_D006402|D009369		bcv_easy_699_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003630	"<span class=""chemical"">daunorubicin</span>"	D001855	"<span class=""disease"">myelosuppression</span>"	"RESULTS: Nontoxic doses of dexrazoxane reduced <span class=""disease"">myelosuppression</span> and weight loss from <span class=""chemical"">daunorubicin</span> and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced <span class=""disease"">myelosuppression</span>, weight loss, nor the in vitro cytotoxicity from doxorubicin."	761593.0	15897593.0	15897593_D003630_D001855		bcv_easy_977_sent_work_dev_set_761593	"yes_direct
"	Daunorubicin causes weight loss and myelosuppression. Dexrazoxane made the myelosuppression and weight loss better.
TRUE	D064730	"<span class=""chemical"">dexrazoxane</span>"	D009362	"<span class=""disease"">metastases</span>"	"Clinical trials in patients with brain <span class=""disease"">metastases</span> combining <span class=""chemical"">dexrazoxane</span> and high doses of etoposide is ongoing with the aim of improving efficacy without aggravating hematologic toxicity."	761593.0	15897593.0	15897593_D064730_D009362		bcv_easy_985_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002122	"<span class=""chemical"">calcium chloride</span>"	D014202	"<span class=""disease"">tremor</span>"	"The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated."	761593.0	6892185.0	6892185_D002122_D014202		bcv_easy_1044_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000583	"<span class=""chemical"">Amikacin</span>"	D009503	"<span class=""disease"">febrile neutropenia</span>"	"<span class=""chemical"">Amikacin</span> is an aminoglycoside commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections."	761593.0	18356633.0	18356633_D000583_D009503		bcv_easy_694_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014282	"<span class=""chemical"">trihexyphenidyl hydrochloride</span>"	D012559	"<span class=""disease"">schizophrenic</span>"	"A chronic <span class=""disease"">schizophrenic</span> patient was treated with an anticholinergic drug, <span class=""chemical"">trihexyphenidyl hydrochloride</span>."	761593.0	3769769.0	3769769_D014282_D012559		bcv_easy_251_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D008180	"<span class=""disease"">systemic lupus erythematosus/SLE</span>"	"Since 1989, she had been suffering from <span class=""disease"">systemic lupus erythematosus</span> (<span class=""disease"">SLE</span>) with renal involvement and undergone periods of treatment with azathioprine and <span class=""chemical"">cyclophosphamide</span>."	761593.0	12739036.0	12739036_D003520_D008180		bcv_easy_295_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005557	"<span class=""chemical"">formalin</span>"	D010146	"<span class=""disease"">pain</span>"	"Their ester prodrugs 6 and 8 were orally active in three models of <span class=""disease"">pain</span>: reversal of <span class=""chemical"">formalin</span>-induced paw licking, carrageenan-induced thermal hyperalgesia, and capsaicin-induced mechanical hyperalgesia."	761593.0	15974569.0	15974569_D005557_D010146		bcv_easy_420_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002110	"<span class=""chemical"">caffeine</span>"	D006331	"<span class=""disease"">cardiac disease</span>"	"We describe a patient with no previous history of <span class=""disease"">cardiac disease</span> or arrhythmia who developed sustained bigeminy and 2 brief runs of ventricular tachycardia after <span class=""chemical"">caffeine</span> administration."	761593.0	18997632.0	18997632_D002110_D006331		bcv_easy_124_sent_work_dev_set_761593	"no_relation
"	
TRUE	C400082	"<span class=""chemical"">bortezomib</span>"	D009101	"<span class=""disease"">MM</span>"	"The results suggest that <span class=""chemical"">bortezomib</span> in combination with cyclophosphamide at 900 mg/m(2) and dexamethasone is an effective induction treatment for patients with newly diagnosed <span class=""disease"">MM</span> that warrants further investigation."	761593.0	19274460.0	19274460_C400082_D009101		bcv_easy_578_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">L-dopa</span>"	D003128	"<span class=""disease"">coma</span>"	"This <span class=""disease"">coma</span> was prevented with 1.68 mmol <span class=""chemical"">L-dopa</span> given by gastric intubation 15 minutes before the ammonium salt injection."	761593.0	761833.0	761833_D007980_D003128		bcv_easy_460_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011899	"<span class=""chemical"">ranitidine</span>"	D007172	"<span class=""disease"">impotence</span>"	"Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking cimetidine and in all cases these changes disappeared when cimetidine was replaced by <span class=""chemical"">ranitidine</span>."	761593.0	6150641.0	6150641_D011899_D007172		bcv_easy_325_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005996	"<span class=""chemical"">Glyceryl trinitrate</span>"	D020325	"<span class=""disease"">migraine with aura</span>"	"<span class=""chemical"">Glyceryl trinitrate</span> induces attacks of migraine without aura in sufferers of <span class=""disease"">migraine with aura</span>."	761593.0	10524660.0	10524660_D005996_D020325		bcv_easy_600_sent_work_dev_set_761593	"no_relation
"	
TRUE	C018370	"<span class=""chemical"">PREGS</span>"	D000647	"<span class=""disease"">amnesic</span>"	"Moreover, <span class=""chemical"">PREGS</span> is able to reverse the <span class=""disease"">amnesic</span>-like effects of NMDAR and GABA(A)R ligands."	761593.0	11860495.0	11860495_C018370_D000647		bcv_easy_1229_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005472	"<span class=""chemical"">5-FU/5-fluorouracil</span>"	D009362	"<span class=""disease"">metastasis</span>"	"We report a case of a patient with colon carcinoma and liver <span class=""disease"">metastasis</span> who presented chest pain after <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) administration."	761593.0	3952818.0	3952818_D005472_D009362		bcv_easy_996_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002122	"<span class=""chemical"">calcium chloride</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>."	761593.0	6892185.0	6892185_D002122_D015878		bcv_easy_1049_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and <span class=""chemical"">cyclophosphamide</span> compared with conventional doxorubicin and <span class=""chemical"">cyclophosphamide</span> in a randomized, multicenter trial of metastatic <span class=""disease"">breast cancer</span>."	761593.0	11230490.0	11230490_D003520_D001943		bcv_easy_131_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000638	"<span class=""chemical"">Amiodarone</span>"	D017180	"<span class=""disease"">VT/ventricular tachycardia</span>"	"<span class=""chemical"">Amiodarone</span> was administered to 154 patients who had sustained, symptomatic <span class=""disease"">ventricular tachycardia</span> (<span class=""disease"">VT</span>) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs."	761593.0	6637851.0	6637851_D000638_D017180		bcv_easy_1014_sent_work_dev_set_761593	"no_relation
"	
TRUE	C047781	"<span class=""chemical"">LTG/lamotrigine</span>"	C562694	"<span class=""disease"">IGE/idiopathic generalized epilepsies</span>"	"Five patients with <span class=""disease"">idiopathic generalized epilepsies</span> (<span class=""disease"">IGE</span>) treated with <span class=""chemical"">lamotrigine</span> (<span class=""chemical"">LTG</span>) experienced exacerbation or de novo appearance of myoclonic jerks (MJ)."	761593.0	16157917.0	16157917_C047781_C562694		bcv_easy_1006_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008713	"<span class=""chemical"">methimazole</span>"	D006980	"<span class=""disease"">hyperthyroidism</span>"	"A 43-year-old woman had severe jaundice and itching 1 month after receiving <span class=""chemical"">methimazole</span> (10 mg tid) and propranolol (20 mg tid) for treatment of <span class=""disease"">hyperthyroidism</span>."	761593.0	14982270.0	14982270_D008713_D006980		bcv_easy_550_sent_work_dev_set_761593	"no_relation
"	
TRUE	C004742	"<span class=""chemical"">Daidzein</span>"	D000647	"<span class=""disease"">amnesia</span>"	"<span class=""chemical"">Daidzein</span> activates choline acetyltransferase from MC-IXC cells and improves drug-induced <span class=""disease"">amnesia</span>."	761593.0	16428827.0	16428827_C004742_D000647		bcv_easy_62_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005557	"<span class=""chemical"">formalin</span>"	D006930	"<span class=""disease"">thermal hyperalgesia/mechanical hyperalgesia</span>"	"Their ester prodrugs 6 and 8 were orally active in three models of pain: reversal of <span class=""chemical"">formalin</span>-induced paw licking, carrageenan-induced <span class=""disease"">thermal hyperalgesia</span>, and capsaicin-induced <span class=""disease"">mechanical hyperalgesia</span>."	761593.0	15974569.0	15974569_D005557_D006930		bcv_easy_419_sent_work_dev_set_761593	"no_relation
"	
TRUE	D020117	"<span class=""chemical"">Cisapride</span>"	D015835	"<span class=""disease"">gastrointestinal motility disorders</span>"	"<span class=""chemical"">Cisapride</span>, a cytochrome P450 3A4 (CYP3A4) substrate, is widely prescribed for the treatment of <span class=""disease"">gastrointestinal motility disorders</span>."	761593.0	9545159.0	9545159_D020117_D015835		bcv_easy_254_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015215	"<span class=""chemical"">AZT</span>"	D000163	"<span class=""disease"">AIDS</span>"	"<span class=""chemical"">AZT</span> has induced a macrocytic anemia in <span class=""disease"">AIDS</span> patients on long term <span class=""chemical"">AZT</span> therapy."	761593.0	9209318.0	9209318_D015215_D000163		bcv_easy_906_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013835	"<span class=""chemical"">thiamine pyrophosphate/TPP</span>"	D003920	"<span class=""disease"">diabetic</span>"	"We studied a thiamine-dependent enzyme, transketolase, from fibroblasts of a <span class=""disease"">diabetic</span> patient who developed Wernicke's encephalopathy when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [high Km for <span class=""chemical"">thiamine pyrophosphate</span> (<span class=""chemical"">TPP</span>)], as previously reported in postalcoholic Wernicke-Korsakoff syndrome."	761593.0	3762968.0	3762968_D013835_D003920		bcv_easy_729_sent_work_dev_set_761593	"no_relation
"	
TRUE	C009166	"<span class=""chemical"">retinyl acetate</span>"	D013274	"<span class=""disease"">forestomach carcinogenesis</span>"	"Co-carcinogenic effect of <span class=""chemical"">retinyl acetate</span> on <span class=""disease"">forestomach carcinogenesis</span> of male F344 rats induced with butylated hydroxyanisole."	761593.0	3131282.0	3131282_C009166_D013274		bcv_easy_347_sent_work_dev_set_761593	"no_relation
"	
TRUE	C097949	"<span class=""chemical"">1,25-dihydroxyvitamin D</span>"	D058186	"<span class=""disease"">acute renal insufficiency</span>"	"RESULTS: The 3 patients had <span class=""disease"">acute renal insufficiency</span>, relative metabolic alkalosis, and low parathyroid hormone (PTH), PTH-related peptide, and <span class=""chemical"">1,25-dihydroxyvitamin D</span> concentrations."	761593.0	16006300.0	16006300_C097949_D058186		bcv_easy_705_sent_work_dev_set_761593	"no_relation
"	
TRUE	C071741	"<span class=""chemical"">Remifentanil</span>"	D010146	"<span class=""disease"">pain</span>"	"<span class=""chemical"">Remifentanil</span>-related complications were assessed during the <span class=""chemical"">remifentanil</span> infusion, and <span class=""disease"">pain</span> caused by propofol was evaluated using a four-point scale during the propofol infusion."	761593.0	18006530.0	18006530_C071741_D010146		bcv_easy_9_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000617	"<span class=""chemical"">aminoglycoside</span>"	D009503	"<span class=""disease"">febrile neutropenia</span>"	"Amikacin is an <span class=""chemical"">aminoglycoside</span> commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections."	761593.0	18356633.0	18356633_D000617_D009503		bcv_easy_695_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002122	"<span class=""chemical"">calcium chloride</span>"	D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>."	761593.0	6892185.0	6892185_D002122_D004830		bcv_easy_1054_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008687	"<span class=""chemical"">Metformin</span>"	D058186	"<span class=""disease"">acute renal failure</span>"	"<span class=""chemical"">Metformin</span> treatment fully blocked gentamicin-mediated <span class=""disease"">acute renal failure</span>."	761593.0	20164825.0	20164825_D008687_D058186		bcv_easy_271_sent_work_dev_set_761593	"no_relation
"	
TRUE	C037689	"<span class=""chemical"">benzamide</span>"	D010300	"<span class=""disease"">idiopathic Parkinson's disease</span>"	"Tiapride, a substituted <span class=""chemical"">benzamide</span> derivative closely related to metoclopramide, reduced levodopa-induced peak dose involuntary movements in 16 patients with <span class=""disease"">idiopathic Parkinson's disease</span>."	761593.0	458486.0	458486_C037689_D010300		bcv_easy_103_sent_work_dev_set_761593	"no_relation
"	
TRUE	D006046	"<span class=""chemical"">gold</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and <span class=""chemical"">gold</span> salts, developed renal papillary necrosis (RPN) 4 months after institution of naproxen therapy."	761593.0	6699841.0	6699841_D006046_D001172		bcv_easy_1245_sent_work_dev_set_761593	"no_relation
"	
TRUE	D018967	"<span class=""chemical"">risperidone</span>"	D001480	"<span class=""disease"">EPS</span>"	"Two schizophrenic patients, who had a prior history of LSD abuse and who had previously developed <span class=""disease"">EPS</span> with classic antipsychotics, were successfully treated with <span class=""chemical"">risperidone</span>."	761593.0	12013711.0	12013711_D018967_D001480		bcv_easy_151_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002752	"<span class=""chemical"">chlorthalidone</span>"	D003324	"<span class=""disease"">coronary artery disease</span>"	"Thus, myocardial electrical excitability was measured in patients with mild essential hypertension and known <span class=""disease"">coronary artery disease</span> after 8 weeks of treatment with a potassium-conserving diuretic (amiloride) and a similar period on a potassium-losing diuretic (<span class=""chemical"">chlorthalidone</span>) in a randomised study."	761593.0	3732088.0	3732088_D002752_D003324		bcv_easy_20_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003345	"<span class=""chemical"">corticosterone</span>"	D009422	"<span class=""disease"">neuropathy</span>"	"Although low concentrations (less than or equal to 50 ppm) of <span class=""chemical"">corticosterone</span> had beneficial effects on TOTP-induced <span class=""disease"">neuropathy</span>, greater than or equal to 200 ppm exacerbated clinical signs in chickens given either TOTP or DFP."	761593.0	3961813.0	3961813_D003345_D009422		bcv_easy_520_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009543	"<span class=""chemical"">nifedipine</span>"	D000788	"<span class=""disease"">Prinzmetal's angina</span>"	"Clinical electrocardiographic evolution was similar to that observed in <span class=""disease"">Prinzmetal's angina</span>, and chest pain promptly resolved with <span class=""chemical"">nifedipine</span>."	761593.0	3952818.0	3952818_D009543_D000788		bcv_easy_999_sent_work_dev_set_761593	"no_relation
"	
TRUE	C507346	"<span class=""chemical"">AMN082</span>"	D010300	"<span class=""disease"">PD</span>"	"In a more complex task commonly used to evaluate major akinetic symptoms of <span class=""disease"">PD</span> patients, 5 mg/kg <span class=""chemical"">AMN082</span> reverses the increased reaction time to respond to a cue of bilateral 6-OHDA-lesioned rats."	761593.0	19940105.0	19940105_C507346_D010300		bcv_easy_1239_sent_work_dev_set_761593	"no_relation
"	
TRUE	C422649	"<span class=""chemical"">etoricoxib</span>"	D005767	"<span class=""disease"">GI AEs</span>"	"The cumulative discontinuation rate due to <span class=""disease"">GI AEs</span> was significantly lower with <span class=""chemical"">etoricoxib</span> than diclofenac (5.2 vs 8.5 events per 100 patient-years, respectively; hazard ratio 0.62 (95% CI: 0.47, 0.81; p<or=0.001))."	761593.0	17965424.0	17965424_C422649_D005767		bcv_easy_930_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009599	"<span class=""chemical"">nitroprusside</span>"	D007511	"<span class=""disease"">ischemia</span>"	"Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before <span class=""disease"">ischemia</span>, the other receiving 650 micrograms/kg b.w. of the hypotensive drug <span class=""chemical"">nitroprusside</span> at a flow rate of 103 microliters/min intravenously during <span class=""disease"">ischemia</span>, although in this latter group malondialdehyde was significantly higher."	761593.0	7710775.0	7710775_D009599_D007511		bcv_easy_950_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D066126	"<span class=""disease"">cardiotoxicity</span>"	"Reduced <span class=""disease"">cardiotoxicity</span> and preserved antitumor efficacy of liposome-encapsulated <span class=""chemical"">doxorubicin</span> and cyclophosphamide compared with conventional <span class=""chemical"">doxorubicin</span> and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer."	761593.0	11230490.0	11230490_D004317_D066126		bcv_easy_132_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001262	"<span class=""chemical"">atenolol</span>"	D001145	"<span class=""disease"">arrhythmia</span>"	"After stopping the beta-agonist, and after a week with the <span class=""chemical"">atenolol</span>, the <span class=""disease"">arrhythmia</span> disappeared."	761593.0	20552622.0	20552622_D001262_D001145		bcv_easy_44_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">L-dopa</span>"	D020734	"<span class=""disease"">parkinsonian</span>"	"We have studied the regional cerebral blood flow (rCBF) changes induced by the execution of a finger-to-thumb opposition motor task in the supplementary and primary motor cortex of two groups of <span class=""disease"">parkinsonian</span> patients on <span class=""chemical"">L-dopa</span> medication, the first one without <span class=""chemical"">L-dopa</span> induced dyskinesia (n = 23) and the other with moderate peak-dose dyskinesia (n = 15), and of a group of 14 normal subjects."	761593.0	9549528.0	9549528_D007980_D020734		bcv_easy_891_sent_work_dev_set_761593	"no_relation
"	
TRUE	D064704	"<span class=""chemical"">levofloxacin</span>"	D012852	"<span class=""disease"">sinusitis</span>"	"PURPOSE: To evaluate the efficacy and safety of <span class=""chemical"">levofloxacin</span> (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial <span class=""disease"">sinusitis</span>."	761593.0	9564988.0	9564988_D064704_D012852		bcv_easy_679_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002945	"<span class=""chemical"">cisplatin</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"A sixty-year-old woman with advanced <span class=""disease"">breast cancer</span>, previously treated with <span class=""chemical"">cisplatin</span>, developed an irreversible lethal renal failure with anuria, the day after 5 g/m2 bolus ifosfamide."	761593.0	2320800.0	2320800_D002945_D001943		bcv_easy_407_sent_work_dev_set_761593	"no_relation
"	
TRUE	D063325	"<span class=""chemical"">Tiapride</span>"	D004409	"<span class=""disease"">involuntary movements</span>"	"<span class=""chemical"">Tiapride</span>, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa-induced peak dose <span class=""disease"">involuntary movements</span> in 16 patients with idiopathic Parkinson's disease."	761593.0	458486.0	458486_D063325_D004409		bcv_easy_108_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003520	"<span class=""chemical"">cyclophosphamide</span>"	D009101	"<span class=""disease"">myeloma</span>"	"DSMM XI study: dose definition for intravenous <span class=""chemical"">cyclophosphamide</span> in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed <span class=""disease"">myeloma</span>."	761593.0	19274460.0	19274460_D003520_D009101		bcv_easy_573_sent_work_dev_set_761593	"no_relation
"	
TRUE	D018698	"<span class=""chemical"">glutamate</span>"	D020336	"<span class=""disease"">spastic paraparesis</span>"	"These data indicate that IT morphine induces <span class=""disease"">spastic paraparesis</span> with a concomitant increase in CSF <span class=""chemical"">glutamate</span>, which is involved in NMDA receptor activation."	761593.0	15673851.0	15673851_D018698_D020336		bcv_easy_88_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008790	"<span class=""chemical"">metoprolol</span>"	D017202	"<span class=""disease"">myocardial ischemia</span>"	"CONCLUSION: During dobutamine stress testing, <span class=""chemical"">metoprolol</span> attenuates or eliminates evidence of <span class=""disease"">myocardial ischemia</span>."	761593.0	11079278.0	11079278_D008790_D017202		bcv_easy_1187_sent_work_dev_set_761593	"no_relation
"	
TRUE	D012254	"<span class=""chemical"">ribavirin</span>"	D007239	"<span class=""disease"">infection</span>"	"Although intravenous <span class=""chemical"">ribavirin</span> was not effective for all children with severe adenovirus disease in this series or in the literature, therapy is unlikely to be of benefit if begun late in the course of the <span class=""disease"">infection</span>."	761593.0	12093990.0	12093990_D012254_D007239		bcv_easy_247_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">Levodopa</span>"	D010300	"<span class=""disease"">Parkinson's disease</span>"	"<span class=""chemical"">Levodopa</span>-induced dyskinesias have been reported in <span class=""disease"">Parkinson's disease</span> and multiple system atrophy."	761593.0	12691807.0	12691807_D007980_D010300		bcv_easy_333_sent_work_dev_set_761593	"no_relation
"	
TRUE	C032151	"<span class=""chemical"">Cibenzoline</span>"	D001145	"<span class=""disease"">arrhythmias</span>"	"<span class=""chemical"">Cibenzoline</span> suppressed all the <span class=""disease"">arrhythmias</span>, and the minimum effective plasma concentrations for <span class=""disease"">arrhythmias</span> induced by 24-h coronary ligation, 48-h coronary ligation, digitalis, and adrenaline were 1.9 +/- 0.9 (by 8 mg/kg i.v.), 1.6 +/- 0.5 (by 8 mg/kg i.v.), 0.6 +/- 0.2 (by 2 mg/kg i.v.), and 3.5 +/- 1.3 (by 5 mg/kg i.v.) micrograms/ml, respectively (mean +/- SDM, n = 6-7)."	761593.0	2435991.0	2435991_C032151_D001145		bcv_easy_429_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007660	"<span class=""chemical"">ketoprofen</span>"	D017542	"<span class=""disease"">aneurysmal</span>"	"Patients with aneurysmal subarachnoid hemorrhage (SAH) were randomized to receive either <span class=""chemical"">ketoprofen</span>, 100 mg, three times a day (<span class=""chemical"">ketoprofen</span> group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day (acetaminophen group, n = 9) starting immediately after the diagnosis of <span class=""disease"">aneurysmal</span> SAH."	761593.0	10414674.0	10414674_D007660_D017542		bcv_easy_893_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008687	"<span class=""chemical"">Metformin</span>"	D007674	"<span class=""disease"">nephropathy</span>"	"<span class=""chemical"">Metformin</span> prevents experimental gentamicin-induced <span class=""disease"">nephropathy</span> by a mitochondria-dependent pathway."	761593.0	20164825.0	20164825_D008687_D007674		bcv_easy_267_sent_work_dev_set_761593	"no_relation
"	
TRUE	D020117	"<span class=""chemical"">cisapride</span>"	D006973	"<span class=""disease"">hypertension</span>"	"A possible drug interaction occurred in a 45-year-old woman who was taking <span class=""chemical"">cisapride</span> for gastroesophageal reflux disorder and diltiazem, an agent that has inhibitory effect on CYP3A4, for <span class=""disease"">hypertension</span>."	761593.0	9545159.0	9545159_D020117_D006973		bcv_easy_262_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002939	"<span class=""chemical"">ciprofloxacin</span>"	D009369	"<span class=""disease"">cancer</span>"	"Five patients with <span class=""disease"">cancer</span> who developed acute renal failure that followed treatment with <span class=""chemical"">ciprofloxacin</span> are described and an additional 15 cases reported in the literature are reviewed."	761593.0	8494478.0	8494478_D002939_D009369		bcv_easy_845_sent_work_dev_set_761593	"no_relation
"	
TRUE	D016291	"<span class=""chemical"">MK-801</span>"	D004409	"<span class=""disease"">dyskinetic</span>"	"Several drugs, including clonidine, physostigmine, methysergide, 5-MDOT, propranolol, and <span class=""chemical"">MK-801</span>, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology."	761593.0	8106150.0	8106150_D016291_D004409		bcv_easy_1120_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004317	"<span class=""chemical"">doxorubicin</span>"	D009765	"<span class=""disease"">obese</span>"	"In conclusion, HFD-induced <span class=""disease"">obese</span> rats are highly sensitized to <span class=""chemical"">doxorubicin</span>-induced cardiotoxicity by substantially downregulating cardiac mitochondrial ATP generation, increasing oxidative stress and downregulating the JAK/STAT3 pathway."	761593.0	18674790.0	18674790_D004317_D009765		bcv_easy_883_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002927	"<span class=""chemical"">cimetidine</span>"	D056486|D006402	"<span class=""disease"">hepatic or hematologic toxicity</span>"	"Treatment with high doses of <span class=""chemical"">cimetidine</span> (one to 60 months; median, 11 months) or ranitidine (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with <span class=""chemical"">cimetidine</span> therapy."	761593.0	6150641.0	6150641_D002927_D056486|D006402		bcv_easy_327_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014147	"<span class=""chemical"">Tramadol</span>"	D010146	"<span class=""disease"">pain</span>"	"<span class=""chemical"">Tramadol</span> is a weak opioid with effects on adrenergic and serotonergic neurotransmission that is used to treat cancer <span class=""disease"">pain</span> and chronic non malignant <span class=""disease"">pain</span>."	761593.0	8766220.0	8766220_D014147_D010146		bcv_easy_97_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015647	"<span class=""chemical"">SKF 38393</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"Combination of <span class=""chemical"">SKF 38393</span> with quinpirole did not cause potentiated inhibitory effect on <span class=""disease"">catalepsy</span> induced by dopamine antagonists."	761593.0	1687392.0	1687392_D015647_D002375		bcv_easy_867_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000082	"<span class=""chemical"">paracetamol</span>"	D014581	"<span class=""disease"">urticaria</span>"	"Taken together, our results confirm the good tolerability of nimesulide and <span class=""chemical"">paracetamol</span> in patients who experienced <span class=""disease"">urticaria</span>/angioedema caused by NSAIDs."	761593.0	11694026.0	11694026_D000082_D014581		bcv_easy_648_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005492	"<span class=""chemical"">folic acid</span>"	D064420	"<span class=""disease"">toxicity</span>"	"Associated studies demonstrated that lometrexol plasma pharmacokinetics were not altered by <span class=""chemical"">folic acid</span> administration indicating that supplementation is unlikely to reduce <span class=""disease"">toxicity</span> by enhancing lometrexol plasma clearance."	761593.0	8958188.0	8958188_D005492_D064420		bcv_easy_188_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004317	"<span class=""chemical"">Doxorubicin</span>"	D009765	"<span class=""disease"">OB</span>"	"<span class=""chemical"">Doxorubicin</span> toxicokinetics studies revealed no change in accumulation of <span class=""chemical"">doxorubicin</span> and doxorubicinol (toxic metabolite) in the normal diet-fed (ND) and <span class=""disease"">OB</span> hearts."	761593.0	18674790.0	18674790_D004317_D009765		bcv_easy_878_sent_work_dev_set_761593	"no_relation
"	
TRUE	C053571	"<span class=""chemical"">iopentol</span>"	D014693	"<span class=""disease"">ventricular fibrillation</span>"	"Frequencies of <span class=""disease"">ventricular fibrillation</span> were significantly lower (p less than 0.05) after <span class=""chemical"">iopentol</span> (0%) and iohexol (3%) than after metrizoate (22%)."	761593.0	2980315.0	2980315_C053571_D014693		bcv_easy_167_sent_work_dev_set_761593	"no_relation
"	
TRUE	D064730	"<span class=""chemical"">dexrazoxane</span>"	D015431	"<span class=""disease"">weight loss</span>"	"RESULTS: Nontoxic doses of <span class=""chemical"">dexrazoxane</span> reduced myelosuppression and <span class=""disease"">weight loss</span> from daunorubicin and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, <span class=""chemical"">dexrazoxane</span> neither reduced myelosuppression, <span class=""disease"">weight loss</span>, nor the in vitro cytotoxicity from doxorubicin."	761593.0	15897593.0	15897593_D064730_D015431		bcv_easy_976_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008774	"<span class=""chemical"">methylphenidate</span>"	D000544	"<span class=""disease"">Alzheimer's disease</span>"	"An 82-year-old man with treatment-resistant depression and early <span class=""disease"">Alzheimer's disease</span> was started on <span class=""chemical"">methylphenidate</span>."	761593.0	12907924.0	12907924_D008774_D000544		bcv_easy_399_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004656	"<span class=""chemical"">enalapril</span>"	D018487	"<span class=""disease"">Left Ventricular Dysfunction</span>"	"METHOD: We analyzed data from the Studies of <span class=""disease"">Left Ventricular Dysfunction</span> (SOLVD), a randomized, double-blind, placebo-controlled trial of <span class=""chemical"">enalapril</span> for the treatment of CHF."	761593.0	10539815.0	10539815_D004656_D018487		bcv_easy_753_sent_work_dev_set_761593	"no_relation
"	
TRUE	C400082	"<span class=""chemical"">bortezomib</span>"	D009101	"<span class=""disease"">MM/multiple myeloma</span>"	"A clinical trial was initiated to evaluate the recommended dose of cyclophosphamide in combination with <span class=""chemical"">bortezomib</span> and dexamethasone as induction treatment before stem cell transplantation for younger patients with newly diagnosed <span class=""disease"">multiple myeloma</span> (<span class=""disease"">MM</span>)."	761593.0	19274460.0	19274460_C400082_D009101		bcv_easy_575_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009288	"<span class=""chemical"">naproxen</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis (RPN) 4 months after institution of <span class=""chemical"">naproxen</span> therapy."	761593.0	6699841.0	6699841_D009288_D001172		bcv_easy_1254_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"METHODS: In October, 1992, we started a double-blind placebo-controlled, randomised trial of <span class=""chemical"">tamoxifen</span> in women (mainly in Italy) who did not have <span class=""disease"">breast cancer</span> and who had had a hysterectomy."	761593.0	9672273.0	9672273_D013629_D001943		bcv_easy_309_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004008	"<span class=""chemical"">diclofenac</span>"	D004487	"<span class=""disease"">oedema</span>"	"The incidence of discontinuations for hypertension-related and <span class=""disease"">oedema</span>-related AEs were significantly higher with etoricoxib (2.5% and 1.1% respectively) compared with <span class=""chemical"">diclofenac</span> (1.5% and 0.4% respectively; p<0.001 for hypertension and p<0.01 for <span class=""disease"">oedema</span>)."	761593.0	17965424.0	17965424_D004008_D004487		bcv_easy_931_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001379	"<span class=""chemical"">azathioprine</span>"	D008180	"<span class=""disease"">systemic lupus erythematosus/SLE</span>"	"Since 1989, she had been suffering from <span class=""disease"">systemic lupus erythematosus</span> (<span class=""disease"">SLE</span>) with renal involvement and undergone periods of treatment with <span class=""chemical"">azathioprine</span> and cyclophosphamide."	761593.0	12739036.0	12739036_D001379_D008180		bcv_easy_298_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008238	"<span class=""chemical"">LSD</span>"	D001480	"<span class=""disease"">EPS</span>"	"Two schizophrenic patients, who had a prior history of <span class=""chemical"">LSD</span> abuse and who had previously developed <span class=""disease"">EPS</span> with classic antipsychotics, were successfully treated with risperidone."	761593.0	12013711.0	12013711_D008238_D001480		bcv_easy_153_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004317	"<span class=""chemical"">ADR/adriamycin</span>"	D009369	"<span class=""disease"">cancer</span>"	"The use of <span class=""chemical"">adriamycin</span> (<span class=""chemical"">ADR</span>) in <span class=""disease"">cancer</span> chemotherapy has been limited due to its cumulative cardiovascular toxicity."	761593.0	9952311.0	9952311_D004317_D009369		bcv_easy_792_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002122	"<span class=""chemical"">calcium chloride</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated."	761593.0	6892185.0	6892185_D002122_D015878		bcv_easy_1039_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">naloxone</span>"	D002375	"<span class=""disease"">catalepsy</span>"	"While the mutual potentiation, antagonism and tolerance suggest common mechanisms for the induced <span class=""disease"">catalepsy</span>, differences in latency, rigidity and behavior, asymmetry of cross-tolerance and a widely-different ID50 for <span class=""chemical"">naloxone</span> would argue against an action at a single opioid site."	761593.0	2716967.0	2716967_D009270_D002375		bcv_easy_744_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015119	"<span class=""chemical"">epsilon-aminocaproic acid</span>"	D008595	"<span class=""disease"">menorrhagia</span>"	"We describe a 42-year-old woman who developed superior sagittal and left transverse sinus thrombosis associated with prolonged <span class=""chemical"">epsilon-aminocaproic acid</span> therapy for <span class=""disease"">menorrhagia</span>."	761593.0	2339463.0	2339463_D015119_D008595		bcv_easy_210_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013467	"<span class=""chemical"">sulindac</span>"	D007674	"<span class=""disease"">renal toxicity</span>"	"We review previous reports linking RPN to antiinflammatory drug use and discuss possible advantages of <span class=""chemical"">sulindac</span> in patients who have experienced <span class=""disease"">renal toxicity</span> from other antiinflammatory agents."	761593.0	6699841.0	6699841_D013467_D007674		bcv_easy_1255_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">naloxone</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"GABA involvement in <span class=""chemical"">naloxone</span> induced reversal of <span class=""disease"">respiratory paralysis</span> produced by thiopental."	761593.0	2893236.0	2893236_D009270_D012133		bcv_easy_439_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002794	"<span class=""chemical"">choline</span>"	D000647	"<span class=""disease"">amnesia</span>"	"Daidzein activates <span class=""chemical"">choline</span> acetyltransferase from MC-IXC cells and improves drug-induced <span class=""disease"">amnesia</span>."	761593.0	16428827.0	16428827_D002794_D000647		bcv_easy_61_sent_work_dev_set_761593	"no_relation
"	
TRUE	D017373	"<span class=""chemical"">CPA/cyproterone acetate</span>"	D054556	"<span class=""disease"">venous thromboembolism/VTE</span>"	"OBJECTIVE: To achieve absolute risk estimates of <span class=""disease"">venous thromboembolism</span> (<span class=""disease"">VTE</span>) among women on <span class=""chemical"">cyproterone acetate</span> plus ethinylestradiol (<span class=""chemical"">CPA</span>/EE), and among women on combined oral contraceptives (COCs)."	761593.0	12851669.0	12851669_D017373_D054556		bcv_easy_656_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000662	"<span class=""chemical"">amphetamines</span>"	D012640	"<span class=""disease"">seizure</span>"	"CONCLUSIONS: During this study period, routine plasma screening for cocaine and <span class=""chemical"">amphetamines</span> in adult <span class=""disease"">seizure</span> patients had a low yield."	761593.0	11185967.0	11185967_D000662_D012640		bcv_easy_568_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D014693	"<span class=""disease"">ventricular fibrillation/VF</span>"	"Sixty-nine percent of patients continued treatment with <span class=""chemical"">amiodarone</span> and had no recurrence of symptomatic VT or <span class=""disease"">ventricular fibrillation</span> (<span class=""disease"">VF</span>) over a follow-up of 6 to 52 months (mean +/- standard deviation 14.2 +/- 8.2)."	761593.0	6637851.0	6637851_D000638_D014693		bcv_easy_1017_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002701	"<span class=""chemical"">chloramphenicol</span>"	D002386	"<span class=""disease"">cataract</span>"	"A 73-year-old woman died of aplastic anemia less than two months after undergoing <span class=""disease"">cataract</span> extraction and beginning topical therapy with <span class=""chemical"">chloramphenicol</span>."	761593.0	7072798.0	7072798_D002701_D002386		bcv_easy_173_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007530	"<span class=""chemical"">isoflurane</span>"	D004342	"<span class=""disease"">hypersensitivity</span>"	"This study was performed to determine cross-reactivity between enflurane and <span class=""chemical"">isoflurane</span> with the <span class=""disease"">hypersensitivity</span> induced by halothane."	761593.0	7647582.0	7647582_D007530_D004342		bcv_easy_915_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004656	"<span class=""chemical"">enalapril</span>"	D006333	"<span class=""disease"">CHF</span>"	"METHOD: We analyzed data from the Studies of Left Ventricular Dysfunction (SOLVD), a randomized, double-blind, placebo-controlled trial of <span class=""chemical"">enalapril</span> for the treatment of <span class=""disease"">CHF</span>."	761593.0	10539815.0	10539815_D004656_D006333		bcv_easy_754_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">naloxone</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"These data suggest <span class=""chemical"">naloxone</span> reverses <span class=""disease"">respiratory paralysis</span> produced by thiopental and involves GABA in its action."	761593.0	2893236.0	2893236_D009270_D012133		bcv_easy_451_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011441	"<span class=""chemical"">PTU</span>"	D014424	"<span class=""disease"">Turner Syndrome</span>"	"<span class=""chemical"">PTU</span>-associated vasculitis in a girl with <span class=""disease"">Turner Syndrome</span> and Graves' disease."	761593.0	16418614.0	16418614_D011441_D014424		bcv_easy_92_sent_work_dev_set_761593	"no_relation
"	
TRUE	C065179	"<span class=""chemical"">atorvastatin</span>"	D006973	"<span class=""disease"">hypertension</span>"	"Thus, <span class=""chemical"">atorvastatin</span> prevented and reversed dexamethasone-induced <span class=""disease"">hypertension</span> in the rat."	761593.0	16820346.0	16820346_C065179_D006973		bcv_easy_73_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002216	"<span class=""chemical"">captopril</span>"	D011507	"<span class=""disease"">proteinuria</span>"	"Effect of <span class=""chemical"">captopril</span> on pre-existing and aminonucleoside-induced <span class=""disease"">proteinuria</span> in spontaneously hypertensive rats."	761593.0	6454943.0	6454943_D002216_D011507		bcv_easy_582_sent_work_dev_set_761593	"no_relation
"	
TRUE	C059262	"<span class=""chemical"">cidofovir</span>"	D000257	"<span class=""disease"">adenovirus infection</span>"	"The use of <span class=""chemical"">cidofovir</span> in severe <span class=""disease"">adenovirus infection</span> has been limited by adverse effects, the most significant of which is nephrotoxicity."	761593.0	12093990.0	12093990_C059262_D000257		bcv_easy_241_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004308	"<span class=""chemical"">dosulepine hydrochloride</span>"	D059350	"<span class=""disease"">chronic pain</span>"	"This drug was initiated in association with paroxetine and <span class=""chemical"">dosulepine hydrochloride</span> in a tetraparetic patient with <span class=""disease"">chronic pain</span>."	761593.0	8766220.0	8766220_D004308_D059350		bcv_easy_99_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000109	"<span class=""chemical"">ACh/acetylcholine</span>"	D000544	"<span class=""disease"">AD/Alzheimer's disease</span>"	"The choline acetyltransferase (ChAT) activator, which enhances cholinergic transmission via an augmentation of the enzymatic production of <span class=""chemical"">acetylcholine</span> (<span class=""chemical"">ACh</span>), is an important factor in the treatment of <span class=""disease"">Alzheimer's disease</span> (<span class=""disease"">AD</span>)."	761593.0	16428827.0	16428827_D000109_D000544		bcv_easy_64_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"There is a statistically significant reduction of <span class=""disease"">breast cancer</span> among women receiving <span class=""chemical"">tamoxifen</span> who also used hormone-replacement therapy during the trial: among 390 women on such therapy and allocated to placebo, we found eight cases of <span class=""disease"">breast cancer</span> compared with one case among 362 women allocated to <span class=""chemical"">tamoxifen</span>."	761593.0	9672273.0	9672273_D013629_D001943		bcv_easy_311_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004052	"<span class=""chemical"">DEN</span>"	D009369	"<span class=""disease"">tumor</span>"	"In <span class=""chemical"">DEN</span> + PB treated rats, the survival was prolonged and the <span class=""disease"">tumor</span> incidence decreased as compared with the results obtained by <span class=""chemical"">DEN</span> alone."	761593.0	3780814.0	3780814_D004052_D009369		bcv_easy_719_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013629	"<span class=""chemical"">tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"Prevention of <span class=""disease"">breast cancer</span> with <span class=""chemical"">tamoxifen</span>: preliminary findings from the Italian randomised trial among hysterectomised women. Italian <span class=""chemical"">Tamoxifen</span> Prevention Study."	761593.0	9672273.0	9672273_D013629_D001943		bcv_easy_306_sent_work_dev_set_761593	"no_relation
"	
TRUE	C012655	"<span class=""chemical"">nimesulide</span>"	D014581	"<span class=""disease"">urticaria</span>"	"Tolerability of <span class=""chemical"">nimesulide</span> and paracetamol in patients with NSAID-induced <span class=""disease"">urticaria</span>/angioedema."	761593.0	11694026.0	11694026_C012655_D014581		bcv_easy_637_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000638	"<span class=""chemical"">amiodarone</span>"	D017180	"<span class=""disease"">VT</span>"	"Sixty-nine percent of patients continued treatment with <span class=""chemical"">amiodarone</span> and had no recurrence of symptomatic <span class=""disease"">VT</span> or ventricular fibrillation (VF) over a follow-up of 6 to 52 months (mean +/- standard deviation 14.2 +/- 8.2)."	761593.0	6637851.0	6637851_D000638_D017180		bcv_easy_1016_sent_work_dev_set_761593	"no_relation
"	
TRUE	D001058	"<span class=""chemical"">Apomorphine</span>"	D010300	"<span class=""disease"">Parkinson's disease</span>"	"<span class=""chemical"">Apomorphine</span>: an underutilized therapy for <span class=""disease"">Parkinson's disease</span>."	761593.0	11009181.0	11009181_D001058_D010300		bcv_easy_189_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014443	"<span class=""chemical"">tyrosine</span>"	D009410	"<span class=""disease"">degeneration of dopaminergic neurons</span>"	"To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra (SN), in the present study we used fast cyclic voltammetry, <span class=""chemical"">tyrosine</span> hydroxylase (TH) immunohistochemistry, Perls' iron staining, and high performance liquid chromatography-electrochemical detection to study the <span class=""disease"">degeneration of dopaminergic neurons</span> and increased iron content in the SN of iron dextran overloaded animals."	761593.0	17490790.0	17490790_D014443_D009410		bcv_easy_776_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002216	"<span class=""chemical"">captopril</span>"	D011507	"<span class=""disease"">proteinuria</span>"	"Oral administration of <span class=""chemical"">captopril</span> at 100 mg/kg for 14 days failed to aggravate <span class=""disease"">proteinuria</span> pre-existing in SHR."	761593.0	6454943.0	6454943_D002216_D011507		bcv_easy_588_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013835	"<span class=""chemical"">thiamine pyrophosphate/TPP</span>"	D014899	"<span class=""disease"">Wernicke's encephalopathy</span>"	"We studied a thiamine-dependent enzyme, transketolase, from fibroblasts of a diabetic patient who developed <span class=""disease"">Wernicke's encephalopathy</span> when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [high Km for <span class=""chemical"">thiamine pyrophosphate</span> (<span class=""chemical"">TPP</span>)], as previously reported in postalcoholic Wernicke-Korsakoff syndrome."	761593.0	3762968.0	3762968_D013835_D014899		bcv_easy_723_sent_work_dev_set_761593	"no_relation
"	
TRUE	D003975	"<span class=""chemical"">Diazepam</span>"	D006212	"<span class=""disease"">hallucinations</span>"	"<span class=""chemical"">Diazepam</span>, unless contraindicated or risky, remains the only necessary complementary drug to ketamine as it buffers its cardiovascular response and decreases the duration and intensity of operative and postoperative <span class=""disease"">hallucinations</span>."	761593.0	12091028.0	12091028_D003975_D006212		bcv_easy_991_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008687	"<span class=""chemical"">metformin</span>"	D007674	"<span class=""disease"">kidney dysfunction</span>"	"These in vivo markers of <span class=""disease"">kidney dysfunction</span> and their correction by <span class=""chemical"">metformin</span> were complemented by in vitro studies of mitochondrial function."	761593.0	20164825.0	20164825_D008687_D007674		bcv_easy_272_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013629	"<span class=""chemical"">Tamoxifen</span>"	D001943	"<span class=""disease"">breast cancer</span>"	"BACKGROUND: <span class=""chemical"">Tamoxifen</span> is a candidate chemopreventive agent in <span class=""disease"">breast cancer</span>, although the drug may be associated with the development of endometrial cancer."	761593.0	9672273.0	9672273_D013629_D001943		bcv_easy_308_sent_work_dev_set_761593	"no_relation
"	
TRUE	D012254	"<span class=""chemical"">ribavirin</span>"	D000257	"<span class=""disease"">adenovirus disease</span>"	"DESIGN/METHODS: We retrospectively reviewed the medical records of 5 children treated with intravenous <span class=""chemical"">ribavirin</span> for documented severe <span class=""disease"">adenovirus disease</span>."	761593.0	12093990.0	12093990_D012254_D000257		bcv_easy_243_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014191	"<span class=""chemical"">tranylcypromine</span>"	D003866	"<span class=""disease"">depression</span>"	"We report a venlafaxine-MAOI interaction that resulted in the serotonin syndrome in a 23-y-old male who was taking <span class=""chemical"">tranylcypromine</span> for <span class=""disease"">depression</span>."	761593.0	8888541.0	8888541_D014191_D003866		bcv_easy_1107_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004656	"<span class=""chemical"">enalapril</span>"	D003920	"<span class=""disease"">diabetes</span>"	"By multivariate analysis, in both the placebo and <span class=""chemical"">enalapril</span> groups older age, diuretic therapy, and <span class=""disease"">diabetes</span> were associated with decreased renal function, whereas beta-blocker therapy and higher ejection fraction were renoprotective."	761593.0	10539815.0	10539815_D004656_D003920		bcv_easy_761_sent_work_dev_set_761593	"no_relation
"	
TRUE	D010396	"<span class=""chemical"">D-penicillamine</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"A 67-year-old woman with <span class=""disease"">rheumatoid arthritis</span> presented rapidly progressive glomerulonephritis (RPGN) after 5 months of <span class=""chemical"">D-penicillamine</span> (250 mg/day) treatment."	761593.0	8267029.0	8267029_D010396_D001172		bcv_easy_498_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002122	"<span class=""chemical"">calcium chloride</span>"	D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that <span class=""chemical"">calcium chloride</span> can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and eserine."	761593.0	6892185.0	6892185_D002122_D015878		bcv_easy_1057_sent_work_dev_set_761593	"no_relation
"	
TRUE	D014635	"<span class=""chemical"">Valproate</span>"	D006423	"<span class=""disease"">homonymous hemianopsia</span>"	"Complications were observed in two patients: one had a left <span class=""disease"">homonymous hemianopsia</span> after pallidotomy and another one developed left hemiballistic movements 3 days after subthalamotomy which partly improved within 1 month with <span class=""chemical"">Valproate</span> 1000 mg/day."	761593.0	19234905.0	19234905_D014635_D006423		bcv_easy_201_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015215	"<span class=""chemical"">azidothymidine</span>"	C565469	"<span class=""disease"">immunodeficient</span>"	"Sensitivity of erythroid progenitor colonies to erythropoietin in <span class=""chemical"">azidothymidine</span> treated <span class=""disease"">immunodeficient</span> mice."	761593.0	2004015.0	2004015_D015215_C565469		bcv_easy_213_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">naloxone</span>"	D007022	"<span class=""disease"">hypotension</span>"	"Our experience demonstrates a possible role of <span class=""chemical"">naloxone</span> in the reversal of <span class=""disease"">hypotension</span> resulting from captopril."	761593.0	1928887.0	1928887_D009270_D007022		bcv_easy_514_sent_work_dev_set_761593	"no_relation
"	
TRUE	D000617	"<span class=""chemical"">aminoglycoside</span>"	D013924	"<span class=""disease"">Thrombophlebitis</span>"	"<span class=""disease"">Thrombophlebitis</span> occurred only with infusion through peripheral cannulae; nephrotoxicity and ototoxicity were confined to patients receiving an <span class=""chemical"">aminoglycoside</span> plus vancomycin."	761593.0	3934126.0	3934126_D000617_D013924		bcv_easy_1143_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008727	"<span class=""chemical"">methotrexate</span>"	D007938	"<span class=""disease"">leukaemia</span>"	"BACKGROUND: A transient leukoencephalopathy mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood <span class=""disease"">leukaemia</span>."	761593.0	17682013.0	17682013_D008727_D007938		bcv_easy_780_sent_work_dev_set_761593	"no_relation
"	
TRUE	D013999	"<span class=""chemical"">timolol</span>"	D007008	"<span class=""disease"">hypokalemia</span>"	"The beta adrenergic blocking drug, <span class=""chemical"">timolol</span>, tended to correct the <span class=""disease"">hypokalemia</span> of short-term bendrofluazide treatment in 6 healthy male subjects and although the effect was small it was significant."	761593.0	326460.0	326460_D013999_D007008		bcv_easy_394_sent_work_dev_set_761593	"no_relation
"	
TRUE	D004110	"<span class=""chemical"">diltiazem</span>"	D005764	"<span class=""disease"">gastroesophageal reflux disorder</span>"	"A possible drug interaction occurred in a 45-year-old woman who was taking cisapride for <span class=""disease"">gastroesophageal reflux disorder</span> and <span class=""chemical"">diltiazem</span>, an agent that has inhibitory effect on CYP3A4, for hypertension."	761593.0	9545159.0	9545159_D004110_D005764		bcv_easy_264_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009270	"<span class=""chemical"">naloxone</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"In this study <span class=""chemical"">naloxone</span> reversed <span class=""disease"">respiratory paralysis</span> induced by thiopental in rats."	761593.0	2893236.0	2893236_D009270_D012133		bcv_easy_441_sent_work_dev_set_761593	"no_relation
"	
TRUE	D005680	"<span class=""chemical"">GABA</span>"	D012133	"<span class=""disease"">respiratory paralysis</span>"	"These data suggest naloxone reverses <span class=""disease"">respiratory paralysis</span> produced by thiopental and involves <span class=""chemical"">GABA</span> in its action."	761593.0	2893236.0	2893236_D005680_D012133		bcv_easy_450_sent_work_dev_set_761593	"no_relation
"	
TRUE	D015742	"<span class=""chemical"">propofol</span>"	D008305	"<span class=""disease"">malignant hyperthermia</span>"	"Anesthesia was continued uneventfully with <span class=""chemical"">propofol</span> infusion while all facilities were available to detect and treat <span class=""disease"">malignant hyperthermia</span>."	761593.0	15893386.0	15893386_D015742_D008305		bcv_easy_1225_sent_work_dev_set_761593	"no_relation
"	
TRUE	C422649	"<span class=""chemical"">Etoricoxib</span>"	D005767	"<span class=""disease"">GI AEs</span>"	"CONCLUSIONS: <span class=""chemical"">Etoricoxib</span> 90 mg demonstrated a significantly lower risk for discontinuing treatment due to <span class=""disease"">GI AEs</span> compared with diclofenac 150 mg."	761593.0	17965424.0	17965424_C422649_D005767		bcv_easy_936_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008094	"<span class=""chemical"">lithium</span>"	D001714	"<span class=""disease"">bipolar disorder</span>"	"PATIENTS: One hundred and one patients (28 men and 73 women) with <span class=""disease"">bipolar disorder</span> receiving <span class=""chemical"">lithium</span> maintenance therapy ranging from 1 year's to 32 years' duration."	761593.0	10354657.0	10354657_D008094_D001714		bcv_easy_1132_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008774	"<span class=""chemical"">methylphenidate</span>"	D061218	"<span class=""disease"">treatment-resistant depression</span>"	"An 82-year-old man with <span class=""disease"">treatment-resistant depression</span> and early Alzheimer's disease was started on <span class=""chemical"">methylphenidate</span>."	761593.0	12907924.0	12907924_D008774_D061218		bcv_easy_398_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011224	"<span class=""chemical"">prazosin</span>"	D001919	"<span class=""disease"">bradycardia</span>"	"Furthermore, the <span class=""disease"">bradycardia</span> that accompanied the noradrenaline-induced pressor effect in SHR was similar with and without chronic <span class=""chemical"">prazosin</span> treatment despite a 47-71% reduction of the pressor effect in chronic alpha 1-receptor blocked SHR.(ABSTRACT TRUNCATED AT 400 WORDS)"	761593.0	1355091.0	1355091_D011224_D001919		bcv_easy_1082_sent_work_dev_set_761593	"no_relation
"	
TRUE	D007980	"<span class=""chemical"">levodopa</span>"	D018476	"<span class=""disease"">bradykinesia</span>"	"Pallidal stimulation improves <span class=""disease"">bradykinesia</span> and rigidity to a minor extent; however, its strength seems to be in improving <span class=""chemical"">levodopa</span>-induced dyskinesias."	761593.0	15096016.0	15096016_D007980_D018476		bcv_easy_842_sent_work_dev_set_761593	"no_relation
"	
TRUE	D010396	"<span class=""chemical"">Penicillamine</span>"	D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"<span class=""chemical"">Penicillamine</span>-induced rapidly progressive glomerulonephritis in a patient with <span class=""disease"">rheumatoid arthritis</span>."	761593.0	8267029.0	8267029_D010396_D001172		bcv_easy_497_sent_work_dev_set_761593	"no_relation
"	
TRUE	D002118	"<span class=""chemical"">calcium</span>"	D003329	"<span class=""disease"">coronary spasm</span>"	"These data suggest that <span class=""disease"">coronary spasm</span> may be the cause of cardiotoxicity due to 5-FU, and that <span class=""chemical"">calcium</span> antagonists may probably be used in the prevention or treatment of 5-FU cardiotoxicity."	761593.0	3952818.0	3952818_D002118_D003329		bcv_easy_1002_sent_work_dev_set_761593	"no_relation
"	
TRUE	C018824	"<span class=""chemical"">NH4Ac</span>"	D003866	"<span class=""disease"">depression</span>"	"Addition of excess calcium reversed the <span class=""disease"">depression</span> in both tissues, but calcium-independent catecholamine release by acetaldehyde was not blocked by <span class=""chemical"">NH4Ac</span>."	761593.0	6323692.0	6323692_C018824_D003866		bcv_easy_362_sent_work_dev_set_761593	"no_relation
"	
TRUE	D009705	"<span class=""chemical"">nucleosides</span>"	D002545	"<span class=""disease"">cerebral ischemia</span>"	"Time dependence of plasma malondialdehyde, oxypurines, and <span class=""chemical"">nucleosides</span> during incomplete <span class=""disease"">cerebral ischemia</span> in the rat."	761593.0	7710775.0	7710775_D009705_D002545		bcv_easy_944_sent_work_dev_set_761593	"no_relation
"	
TRUE	D008784	"<span class=""chemical"">methysergide</span>"	D004409	"<span class=""disease"">dyskinetic</span>"	"Several drugs, including clonidine, physostigmine, <span class=""chemical"">methysergide</span>, 5-MDOT, propranolol, and MK-801, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology."	761593.0	8106150.0	8106150_D008784_D004409		bcv_easy_1116_sent_work_dev_set_761593	"no_relation
"	
TRUE	D011899	"<span class=""chemical"">ranitidine</span>"	D056486|D006402	"<span class=""disease"">hepatic or hematologic toxicity</span>"	"Treatment with high doses of cimetidine (one to 60 months; median, 11 months) or <span class=""chemical"">ranitidine</span> (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but <span class=""chemical"">ranitidine</span> therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy."	761593.0	6150641.0	6150641_D011899_D056486|D006402		bcv_easy_328_sent_work_dev_set_761593	"no_relation
"	
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D043183	"<span class=""disease"">irritable bowel syndrome</span>"	"Effects of <span class=""chemical"">cisapride</span> on symptoms and postcibal small-bowel motor function in patients with <span class=""disease"">irritable bowel syndrome</span>."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_0	bcv_devset_test_100_easy_0		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D043183	"<span class=""disease"">IBS/irritable bowel syndrome</span>"	"Our aim was to assess the effects of long-term treatment with a prokinetic agent, <span class=""chemical"">cisapride</span>, on postprandial jejunal motility and symptoms in the <span class=""disease"">irritable bowel syndrome</span> (<span class=""disease"">IBS</span>)."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_2	bcv_devset_test_100_easy_1		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D043183	"<span class=""disease"">IBS</span>"	"METHODS: Thirty-eight patients with <span class=""disease"">IBS</span> (constipation-predominant, n = 17; diarrhoea-predominant, n = 21) underwent 24-h ambulatory jejunal manometry before and after 12 week's treatment [<span class=""chemical"">cisapride</span>, 5 mg three times daily (n = 19) or placebo (n = 19)]."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_3	bcv_devset_test_100_easy_2		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003967	"<span class=""disease"">diarrhoea</span>"	"METHODS: Thirty-eight patients with IBS (constipation-predominant, n = 17; <span class=""disease"">diarrhoea</span>-predominant, n = 21) underwent 24-h ambulatory jejunal manometry before and after 12 week's treatment [<span class=""chemical"">cisapride</span>, 5 mg three times daily (n = 19) or placebo (n = 19)]."		9669632.0	9669632_MESH:D020117_MESH:D003967	9669632_3	bcv_devset_test_100_easy_3		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003248	"<span class=""disease"">constipation</span>"	"METHODS: Thirty-eight patients with IBS (<span class=""disease"">constipation</span>-predominant, n = 17; diarrhoea-predominant, n = 21) underwent 24-h ambulatory jejunal manometry before and after 12 week's treatment [<span class=""chemical"">cisapride</span>, 5 mg three times daily (n = 19) or placebo (n = 19)]."		9669632.0	9669632_MESH:D020117_MESH:D003248	9669632_3	bcv_devset_test_100_easy_4		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003967	"<span class=""disease"">diarrhoea</span>"	"RESULTS: In <span class=""disease"">diarrhoea</span>-predominant patients significant differences in contraction characteristics were observed between the <span class=""chemical"">cisapride</span> and placebo groups."		9669632.0	9669632_MESH:D020117_MESH:D003967	9669632_4	bcv_devset_test_100_easy_5		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003967	"<span class=""disease"">diarrhoea</span>"	"In <span class=""chemical"">cisapride</span>-treated <span class=""disease"">diarrhoea</span>-predominant patients the mean contraction amplitude was higher (29.3 +/- 3.2 versus 24.9 +/- 2.6 mm Hg, <span class=""chemical"">cisapride</span> versus placebo (P < 0.001); pretreatment, 25.7 +/- 6.0 mm Hg), the mean contraction duration longer (3.4 +/- 0.2 versus 3.0 +/- 0.2 sec, <span class=""chemical"">cisapride</span> versus placebo (P < 0.001); pretreatment, 3.1 +/- 0.5 sec), and the mean contraction frequency lower (2.0 +/- 0.2 versus 2.5 +/- 0.4 cont./min, <span class=""chemical"">cisapride</span> versus placebo (P < 0.001); pretreatment, 2.5 +/- 1.1 cont./min] than patients treated with placebo."		9669632.0	9669632_MESH:D020117_MESH:D003967	9669632_5	bcv_devset_test_100_easy_6		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D043183	"<span class=""disease"">IBS</span>"	"Symptom scores relating to the severity of constipation were lower in <span class=""chemical"">cisapride</span>-treated constipation-predominant <span class=""disease"">IBS</span> patients [score, 54 +/- 5 versus 67 +/- 14 mm, <span class=""chemical"">cisapride</span> versus placebo (P < 0.05); pretreatment, 62 +/- 19 mm]."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_8	bcv_devset_test_100_easy_7		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003248	"<span class=""disease"">constipation</span>"	"Symptom scores relating to the severity of <span class=""disease"">constipation</span> were lower in <span class=""chemical"">cisapride</span>-treated <span class=""disease"">constipation</span>-predominant IBS patients [score, 54 +/- 5 versus 67 +/- 14 mm, <span class=""chemical"">cisapride</span> versus placebo (P < 0.05); pretreatment, 62 +/- 19 mm]."		9669632.0	9669632_MESH:D020117_MESH:D003248	9669632_8	bcv_devset_test_100_easy_8		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D003967	"<span class=""disease"">Diarrhoea</span>"	"<span class=""disease"">Diarrhoea</span>-predominant IBS patients had a higher pain score after <span class=""chemical"">cisapride</span> therapy [score, 55 +/- 15 versus 34 +/- 12 mm, <span class=""chemical"">cisapride</span> versus placebo (P < 0.05); pretreatment, 67 +/- 19 mm]."		9669632.0	9669632_MESH:D020117_MESH:D003967	9669632_9	bcv_devset_test_100_easy_9		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D043183	"<span class=""disease"">IBS</span>"	"Diarrhoea-predominant <span class=""disease"">IBS</span> patients had a higher pain score after <span class=""chemical"">cisapride</span> therapy [score, 55 +/- 15 versus 34 +/- 12 mm, <span class=""chemical"">cisapride</span> versus placebo (P < 0.05); pretreatment, 67 +/- 19 mm]."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_9	bcv_devset_test_100_easy_10		
	MESH:D020117	"<span class=""chemical"">cisapride</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"Diarrhoea-predominant IBS patients had a higher <span class=""disease"">pain</span> score after <span class=""chemical"">cisapride</span> therapy [score, 55 +/- 15 versus 34 +/- 12 mm, <span class=""chemical"">cisapride</span> versus placebo (P < 0.05); pretreatment, 67 +/- 19 mm]."		9669632.0	9669632_MESH:D020117_MESH:D010146	9669632_9	bcv_devset_test_100_easy_11		
	MESH:D020117	"<span class=""chemical"">Cisapride</span>"	MESH:D043183	"<span class=""disease"">IBS</span>"	"CONCLUSION: <span class=""chemical"">Cisapride</span> affects jejunal contraction characteristics and some symptoms in <span class=""disease"">IBS</span>."		9669632.0	9669632_MESH:D020117_MESH:D043183	9669632_10	bcv_devset_test_100_easy_12		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D003872	"<span class=""disease"">dermatitis</span>"	"Rosaceiform <span class=""disease"">dermatitis</span> associated with topical <span class=""chemical"">tacrolimus</span> treatment."		20466178.0	20466178_MESH:D016559_MESH:D003872	20466178_0	bcv_devset_test_100_easy_13		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D012393	"<span class=""disease"">rosacea</span>"	"We describe herein 3 patients who developed <span class=""disease"">rosacea</span>-like dermatitis eruptions while using 0.03% or 0.1% <span class=""chemical"">tacrolimus</span> ointment for facial dermatitis."		20466178.0	20466178_MESH:D016559_MESH:D012393	20466178_1	bcv_devset_test_100_easy_14		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D003875	"<span class=""disease"">eruptions</span>"	"We describe herein 3 patients who developed rosacea-like dermatitis <span class=""disease"">eruptions</span> while using 0.03% or 0.1% <span class=""chemical"">tacrolimus</span> ointment for facial dermatitis."		20466178.0	20466178_MESH:D016559_MESH:D003875	20466178_1	bcv_devset_test_100_easy_15		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D003872	"<span class=""disease"">dermatitis</span>"	"We describe herein 3 patients who developed rosacea-like <span class=""disease"">dermatitis</span> eruptions while using 0.03% or 0.1% <span class=""chemical"">tacrolimus</span> ointment for facial dermatitis."		20466178.0	20466178_MESH:D016559_MESH:D003872	20466178_1	bcv_devset_test_100_easy_16		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D005148	"<span class=""disease"">facial dermatitis</span>"	"We describe herein 3 patients who developed rosacea-like dermatitis eruptions while using 0.03% or 0.1% <span class=""chemical"">tacrolimus</span> ointment for <span class=""disease"">facial dermatitis</span>."		20466178.0	20466178_MESH:D016559_MESH:D005148	20466178_1	bcv_devset_test_100_easy_17		
	MESH:C117268	"<span class=""chemical"">pimecrolimus</span>"	MESH:D003872	"<span class=""disease"">dermatitis</span>"	"Continuous topical use of immunomodulators such as tacrolimus or <span class=""chemical"">pimecrolimus</span> should be regarded as a potential cause of rosaceiform <span class=""disease"">dermatitis</span>, although many cases have not been reported."		20466178.0	20466178_MESH:C117268_MESH:D003872	20466178_3	bcv_devset_test_100_easy_18		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D003872	"<span class=""disease"">dermatitis</span>"	"Continuous topical use of immunomodulators such as <span class=""chemical"">tacrolimus</span> or pimecrolimus should be regarded as a potential cause of rosaceiform <span class=""disease"">dermatitis</span>, although many cases have not been reported."		20466178.0	20466178_MESH:D016559_MESH:D003872	20466178_3	bcv_devset_test_100_easy_19		
	MESH:C071741	"<span class=""chemical"">remifentanil</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"Reduction of <span class=""disease"">pain</span> during induction with target-controlled propofol and <span class=""chemical"">remifentanil</span>."		18006530.0	18006530_MESH:C071741_MESH:D010146	18006530_0	bcv_devset_test_100_easy_20		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"Reduction of <span class=""disease"">pain</span> during induction with target-controlled <span class=""chemical"">propofol</span> and remifentanil."		18006530.0	18006530_MESH:D015742_MESH:D010146	18006530_0	bcv_devset_test_100_easy_21		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D010146	"<span class=""disease"">Pain</span>"	"BACKGROUND: <span class=""disease"">Pain</span> on injection of <span class=""chemical"">propofol</span> is unpleasant."		18006530.0	18006530_MESH:D015742_MESH:D010146	18006530_1	bcv_devset_test_100_easy_22		
	MESH:C071741	"<span class=""chemical"">remifentanil</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"We hypothesized that propofol infusion <span class=""disease"">pain</span> might be prevented by infusing <span class=""chemical"">remifentanil</span> before starting the propofol infusion in a clinical setting where target-controlled infusions (TCI) of both drugs were used."		18006530.0	18006530_MESH:C071741_MESH:D010146	18006530_2	bcv_devset_test_100_easy_23		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"We hypothesized that <span class=""chemical"">propofol</span> infusion <span class=""disease"">pain</span> might be prevented by infusing remifentanil before starting the <span class=""chemical"">propofol</span> infusion in a clinical setting where target-controlled infusions (TCI) of both drugs were used."		18006530.0	18006530_MESH:D015742_MESH:D010146	18006530_2	bcv_devset_test_100_easy_24		
	MESH:C071741	"<span class=""chemical"">remifentanil</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"A prospective, randomized, double-blind, placebo-controlled trial was performed to determine the effect-site concentration (Ce) of <span class=""chemical"">remifentanil</span> to prevent the <span class=""disease"">pain</span> without producing complications."		18006530.0	18006530_MESH:C071741_MESH:D010146	18006530_3	bcv_devset_test_100_easy_25		
	MESH:C071741	"<span class=""chemical"">Remifentanil</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"<span class=""chemical"">Remifentanil</span>-related complications were assessed during the <span class=""chemical"">remifentanil</span> infusion, and <span class=""disease"">pain</span> caused by propofol was evaluated using a four-point scale during the propofol infusion."		18006530.0	18006530_MESH:C071741_MESH:D010146	18006530_6	bcv_devset_test_100_easy_26		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"Remifentanil-related complications were assessed during the remifentanil infusion, and <span class=""disease"">pain</span> caused by <span class=""chemical"">propofol</span> was evaluated using a four-point scale during the <span class=""chemical"">propofol</span> infusion."		18006530.0	18006530_MESH:D015742_MESH:D010146	18006530_6	bcv_devset_test_100_easy_27		
	MESH:C071741	"<span class=""chemical"">remifentanil</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"CONCLUSIONS: During induction of anaesthesia with TCI of propofol and <span class=""chemical"">remifentanil</span>, a significant reduction in propofol infusion <span class=""disease"">pain</span> was achieved without significant complications by prior administration of <span class=""chemical"">remifentanil</span> at a target Ce of 4 ng ml(-1)."		18006530.0	18006530_MESH:C071741_MESH:D010146	18006530_11	bcv_devset_test_100_easy_28		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"CONCLUSIONS: During induction of anaesthesia with TCI of <span class=""chemical"">propofol</span> and remifentanil, a significant reduction in <span class=""chemical"">propofol</span> infusion <span class=""disease"">pain</span> was achieved without significant complications by prior administration of remifentanil at a target Ce of 4 ng ml(-1)."		18006530.0	18006530_MESH:D015742_MESH:D010146	18006530_11	bcv_devset_test_100_easy_29		
	MESH:D020123	"<span class=""chemical"">rapamycin</span>"	MESH:D006984	"<span class=""disease"">hypertrophy</span>"	"Cyclosporin A (CsA; 50 mg/kg) and Fujimycine (FK506; 5 mg/kg), but not the related macrolide immunosuppressant <span class=""chemical"">rapamycin</span> (5 mg/kg), caused a reduction of glomerular filtration rate, degenerative changes of proximal tubular epithelium, and <span class=""disease"">hypertrophy</span> of the juxtaglomerular apparatus in male Wistar rats when given for 10 days."		7542793.0	7542793_MESH:D020123_MESH:D006984	7542793_1	bcv_devset_test_100_easy_30		
	MESH:D016572	"<span class=""chemical"">CsA/Cyclosporin A</span>"	MESH:D006984	"<span class=""disease"">hypertrophy</span>"	"<span class=""chemical"">Cyclosporin A</span> (<span class=""chemical"">CsA</span>; 50 mg/kg) and Fujimycine (FK506; 5 mg/kg), but not the related macrolide immunosuppressant rapamycin (5 mg/kg), caused a reduction of glomerular filtration rate, degenerative changes of proximal tubular epithelium, and <span class=""disease"">hypertrophy</span> of the juxtaglomerular apparatus in male Wistar rats when given for 10 days."		7542793.0	7542793_MESH:D016572_MESH:D006984	7542793_1	bcv_devset_test_100_easy_31		
	MESH:D016559	"<span class=""chemical"">FK506</span>"	MESH:D006984	"<span class=""disease"">hypertrophy</span>"	"Cyclosporin A (CsA; 50 mg/kg) and Fujimycine (<span class=""chemical"">FK506</span>; 5 mg/kg), but not the related macrolide immunosuppressant rapamycin (5 mg/kg), caused a reduction of glomerular filtration rate, degenerative changes of proximal tubular epithelium, and <span class=""disease"">hypertrophy</span> of the juxtaglomerular apparatus in male Wistar rats when given for 10 days."		7542793.0	7542793_MESH:D016559_MESH:D006984	7542793_1	bcv_devset_test_100_easy_32		
	MESH:D016572	"<span class=""chemical"">CsA</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The molecular mechanisms of <span class=""chemical"">CsA</span> and FK506 <span class=""disease"">toxicity</span> were investigated."		7542793.0	7542793_MESH:D016572_MESH:D064420	7542793_2	bcv_devset_test_100_easy_33		
	MESH:D016559	"<span class=""chemical"">FK506</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The molecular mechanisms of CsA and <span class=""chemical"">FK506</span> <span class=""disease"">toxicity</span> were investigated."		7542793.0	7542793_MESH:D016559_MESH:D064420	7542793_2	bcv_devset_test_100_easy_34		
	MESH:D014196	"<span class=""chemical"">trazodone</span>"	MESH:D006327	"<span class=""disease"">heart block</span>"	"Complete <span class=""disease"">heart block</span> following a single dose of <span class=""chemical"">trazodone</span>."		6496797.0	6496797_MESH:D014196_MESH:D006327	6496797_0	bcv_devset_test_100_easy_35		
	MESH:D014196	"<span class=""chemical"">trazodone</span>"	MESH:D006327	"<span class=""disease"">heart block</span>"	"Forty minutes after receiving a single starting dose of <span class=""chemical"">trazodone</span>, a patient developed complete <span class=""disease"">heart block</span>."		6496797.0	6496797_MESH:D014196_MESH:D006327	6496797_1	bcv_devset_test_100_easy_36		
	MESH:D005442	"<span class=""chemical"">flumazenil</span>"	MESH:D012640	"<span class=""disease"">Seizure</span>"	"<span class=""disease"">Seizure</span> after <span class=""chemical"">flumazenil</span> administration in a pediatric patient."		7651879.0	7651879_MESH:D005442_MESH:D012640	7651879_0	bcv_devset_test_100_easy_37		
	MESH:D001569	"<span class=""chemical"">benzodiazepines/benzodiazepine</span>"	MESH:D012131	"<span class=""disease"">respiratory depression</span>"	"Flumazenil is a <span class=""chemical"">benzodiazepine</span> receptor antagonist used to reverse sedation and <span class=""disease"">respiratory depression</span> induced by <span class=""chemical"">benzodiazepines</span>."		7651879.0	7651879_MESH:D001569_MESH:D012131	7651879_1	bcv_devset_test_100_easy_38		
	MESH:D005442	"<span class=""chemical"">Flumazenil</span>"	MESH:D012131	"<span class=""disease"">respiratory depression</span>"	"<span class=""chemical"">Flumazenil</span> is a benzodiazepine receptor antagonist used to reverse sedation and <span class=""disease"">respiratory depression</span> induced by benzodiazepines."		7651879.0	7651879_MESH:D005442_MESH:D012131	7651879_1	bcv_devset_test_100_easy_39		
	MESH:D005442	"<span class=""chemical"">flumazenil</span>"	MESH:D012640	"<span class=""disease"">tonic-clonic seizure</span>"	"We report the occurrence of a generalized <span class=""disease"">tonic-clonic seizure</span> in a pediatric patient following the administration of <span class=""chemical"">flumazenil</span>."		7651879.0	7651879_MESH:D005442_MESH:D012640	7651879_5	bcv_devset_test_100_easy_40		
	MESH:D014635	"<span class=""chemical"">Valproic acid</span>"	MESH:D056486	"<span class=""disease"">liver toxicity</span>"	"<span class=""chemical"">Valproic acid</span> I: time course of lipid peroxidation biomarkers, <span class=""disease"">liver toxicity</span>, and <span class=""chemical"">valproic acid</span> metabolite levels in rats."		15858223.0	15858223_MESH:D014635_MESH:D056486	15858223_0	bcv_devset_test_100_easy_41		
	MESH:D005978	"<span class=""chemical"">glutathione</span>"	MESH:D056486	"<span class=""disease"">Liver toxicity</span>"	"<span class=""disease"">Liver toxicity</span> was evaluated based on serum levels of alpha-<span class=""chemical"">glutathione</span> S-transferase (alpha-GST) and by histology."		15858223.0	15858223_MESH:D005978_MESH:D056486	15858223_7	bcv_devset_test_100_easy_42		
	MESH:C075750|MESH:C535011	"<span class=""chemical"">15-F(2t)-IsoP</span>"	MESH:D005234	"<span class=""disease"">steatosis</span>"	"Overall, these findings indicate that VPA treatment results in oxidative stress, as measured by levels of <span class=""chemical"">15-F(2t)-IsoP</span>, which precedes the onset of necrosis, <span class=""disease"">steatosis</span>, and elevated levels of serum alpha-GST."		15858223.0	15858223_MESH:C075750|MESH:C535011_MESH:D005234	15858223_10	bcv_devset_test_100_easy_43		
	MESH:C075750|MESH:C535011	"<span class=""chemical"">15-F(2t)-IsoP</span>"	MESH:D009336	"<span class=""disease"">necrosis</span>"	"Overall, these findings indicate that VPA treatment results in oxidative stress, as measured by levels of <span class=""chemical"">15-F(2t)-IsoP</span>, which precedes the onset of <span class=""disease"">necrosis</span>, steatosis, and elevated levels of serum alpha-GST."		15858223.0	15858223_MESH:C075750|MESH:C535011_MESH:D009336	15858223_10	bcv_devset_test_100_easy_44		
	MESH:D014635	"<span class=""chemical"">VPA</span>"	MESH:D009336	"<span class=""disease"">necrosis</span>"	"Overall, these findings indicate that <span class=""chemical"">VPA</span> treatment results in oxidative stress, as measured by levels of 15-F(2t)-IsoP, which precedes the onset of <span class=""disease"">necrosis</span>, steatosis, and elevated levels of serum alpha-GST."		15858223.0	15858223_MESH:D014635_MESH:D009336	15858223_10	bcv_devset_test_100_easy_45		
	MESH:D014635	"<span class=""chemical"">VPA</span>"	MESH:D005234	"<span class=""disease"">steatosis</span>"	"Overall, these findings indicate that <span class=""chemical"">VPA</span> treatment results in oxidative stress, as measured by levels of 15-F(2t)-IsoP, which precedes the onset of necrosis, <span class=""disease"">steatosis</span>, and elevated levels of serum alpha-GST."		15858223.0	15858223_MESH:D014635_MESH:D005234	15858223_10	bcv_devset_test_100_easy_46		
	MESH:D015215	"<span class=""chemical"">azidothymidine</span>"	MESH:D007153	"<span class=""disease"">immunodeficient</span>"	"Sensitivity of erythroid progenitor colonies to erythropoietin in <span class=""chemical"">azidothymidine</span> treated <span class=""disease"">immunodeficient</span> mice."		2004015.0	2004015_MESH:D015215_MESH:D007153	2004015_0	bcv_devset_test_100_easy_47		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D007239	"<span class=""disease"">infection</span>"	"We have used a murine model of AIDS, <span class=""disease"">infection</span> of female C57BL/6 mice with LP-BM5 murine leukaemia (MuLV) virus, to determine if <span class=""chemical"">AZT</span>-induced anaemia is due, in part, to decreased responsiveness of erythropoietic precursors (BFU-e) to erythropoietin (EPO)."		2004015.0	2004015_MESH:D015215_MESH:D007239	2004015_2	bcv_devset_test_100_easy_48		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D000163	"<span class=""disease"">AIDS</span>"	"We have used a murine model of <span class=""disease"">AIDS</span>, infection of female C57BL/6 mice with LP-BM5 murine leukaemia (MuLV) virus, to determine if <span class=""chemical"">AZT</span>-induced anaemia is due, in part, to decreased responsiveness of erythropoietic precursors (BFU-e) to erythropoietin (EPO)."		2004015.0	2004015_MESH:D015215_MESH:D000163	2004015_2	bcv_devset_test_100_easy_49		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D007938	"<span class=""disease"">leukaemia</span>"	"We have used a murine model of AIDS, infection of female C57BL/6 mice with LP-BM5 murine <span class=""disease"">leukaemia</span> (MuLV) virus, to determine if <span class=""chemical"">AZT</span>-induced anaemia is due, in part, to decreased responsiveness of erythropoietic precursors (BFU-e) to erythropoietin (EPO)."		2004015.0	2004015_MESH:D015215_MESH:D007938	2004015_2	bcv_devset_test_100_easy_50		
	MESH:C030299	"<span class=""chemical"">phenylhydrazine/PHZ</span>"	MESH:D000740	"<span class=""disease"">anaemia</span>"	"The mean plasma levels of EPO observed in AZT treated mice were appropriate for the degree of <span class=""disease"">anaemia</span> observed when compared with <span class=""chemical"">phenylhydrazine</span> (<span class=""chemical"">PHZ</span>) treated mice."		2004015.0	2004015_MESH:C030299_MESH:D000740	2004015_8	bcv_devset_test_100_easy_51		
	MESH:C030299	"<span class=""chemical"">PHZ</span>"	MESH:D000740	"<span class=""disease"">anaemia</span>"	"The numbers of BFU-e and the percentage of bone marrow erythroblasts observed were comparable in AZT and <span class=""chemical"">PHZ</span> treated mice with similar degrees of <span class=""disease"">anaemia</span>."		2004015.0	2004015_MESH:C030299_MESH:D000740	2004015_9	bcv_devset_test_100_easy_52		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D045262	"<span class=""disease"">reticulocytosis</span>"	"However, <span class=""disease"">reticulocytosis</span> was inappropriate for the degree of anaemia observed in <span class=""chemical"">AZT</span> treated infected mice."		2004015.0	2004015_MESH:D015215_MESH:D045262	2004015_10	bcv_devset_test_100_easy_53		
	MESH:C099041	"<span class=""chemical"">tolterodine</span>"	MESH:D053201	"<span class=""disease"">overactive bladder</span>"	"Urinary symptoms and quality of life changes in Thai women with <span class=""disease"">overactive bladder</span> after <span class=""chemical"">tolterodine</span> treatment."		16471092.0	16471092_MESH:C099041_MESH:D053201	16471092_0	bcv_devset_test_100_easy_54		
	MESH:C099041	"<span class=""chemical"">tolterodine</span>"	MESH:D053201	"<span class=""disease"">overactive bladder/OAB</span>"	"OBJECTIVES: To study the urinary symptoms and quality of life changes in Thai women with <span class=""disease"">overactive bladder</span> (<span class=""disease"">OAB</span>) after <span class=""chemical"">tolterodine</span> treatment."		16471092.0	16471092_MESH:C099041_MESH:D053201	16471092_1	bcv_devset_test_100_easy_55		
	MESH:C099041	"<span class=""chemical"">Tolterodine</span>"	MESH:D053201	"<span class=""disease"">OAB</span>"	"CONCLUSION: <span class=""chemical"">Tolterodine</span> was well tolerated and its effects improved the quality of life in Thai women with <span class=""disease"">OAB</span>."		16471092.0	16471092_MESH:C099041_MESH:D053201	16471092_14	bcv_devset_test_100_easy_56		
	MESH:D016572	"<span class=""chemical"">CsA/cyclosporine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoing <span class=""chemical"">cyclosporine</span> (<span class=""chemical"">CsA</span>) or tacrolimus (Tac) <span class=""disease"">toxicity</span>."		11063349.0	11063349_MESH:D016572_MESH:D064420	11063349_1	bcv_devset_test_100_easy_57		
	MESH:D016559	"<span class=""chemical"">Tac/tacrolimus</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoing cyclosporine (CsA) or <span class=""chemical"">tacrolimus</span> (<span class=""chemical"">Tac</span>) <span class=""disease"">toxicity</span>."		11063349.0	11063349_MESH:D016559_MESH:D064420	11063349_1	bcv_devset_test_100_easy_58		
	MESH:D016572	"<span class=""chemical"">CsA</span>"	MESH:D008232	"<span class=""disease"">PTLD/posttransplant lymphoproliferative disorder</span>"	"The indications for switch were chronic <span class=""chemical"">CsA</span> or Tac nephrotoxicity (12), acute <span class=""chemical"">CsA</span> or Tac toxicity (3), severe facial dysmorphism (2), <span class=""disease"">posttransplant lymphoproliferative disorder</span> (<span class=""disease"">PTLD</span>) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016572_MESH:D008232	11063349_4	bcv_devset_test_100_easy_59		
	MESH:D016559	"<span class=""chemical"">Tac</span>"	MESH:C565579	"<span class=""disease"">facial dysmorphism</span>"	"The indications for switch were chronic CsA or <span class=""chemical"">Tac</span> nephrotoxicity (12), acute CsA or <span class=""chemical"">Tac</span> toxicity (3), severe <span class=""disease"">facial dysmorphism</span> (2), posttransplant lymphoproliferative disorder (PTLD) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016559_MESH:C565579	11063349_4	bcv_devset_test_100_easy_60		
	MESH:D016572	"<span class=""chemical"">CsA</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The indications for switch were chronic <span class=""chemical"">CsA</span> or Tac nephrotoxicity (12), acute <span class=""chemical"">CsA</span> or Tac <span class=""disease"">toxicity</span> (3), severe facial dysmorphism (2), posttransplant lymphoproliferative disorder (PTLD) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016572_MESH:D064420	11063349_4	bcv_devset_test_100_easy_61		
	MESH:D016559	"<span class=""chemical"">Tac</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The indications for switch were chronic CsA or <span class=""chemical"">Tac</span> nephrotoxicity (12), acute CsA or <span class=""chemical"">Tac</span> <span class=""disease"">toxicity</span> (3), severe facial dysmorphism (2), posttransplant lymphoproliferative disorder (PTLD) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016559_MESH:D064420	11063349_4	bcv_devset_test_100_easy_62		
	MESH:D016559	"<span class=""chemical"">Tac</span>"	MESH:D008232	"<span class=""disease"">PTLD/posttransplant lymphoproliferative disorder</span>"	"The indications for switch were chronic CsA or <span class=""chemical"">Tac</span> nephrotoxicity (12), acute CsA or <span class=""chemical"">Tac</span> toxicity (3), severe facial dysmorphism (2), <span class=""disease"">posttransplant lymphoproliferative disorder</span> (<span class=""disease"">PTLD</span>) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016559_MESH:D008232	11063349_4	bcv_devset_test_100_easy_63		
	MESH:D016572	"<span class=""chemical"">CsA</span>"	MESH:C565579	"<span class=""disease"">facial dysmorphism</span>"	"The indications for switch were chronic <span class=""chemical"">CsA</span> or Tac nephrotoxicity (12), acute <span class=""chemical"">CsA</span> or Tac toxicity (3), severe <span class=""disease"">facial dysmorphism</span> (2), posttransplant lymphoproliferative disorder (PTLD) in remission (2), and hepatotoxicity in 1."		11063349.0	11063349_MESH:D016572_MESH:C565579	11063349_4	bcv_devset_test_100_easy_64		
	MESH:D020123	"<span class=""chemical"">RAPA</span>"	MESH:D008232	"<span class=""disease"">PTLD</span>"	"<span class=""chemical"">RAPA</span> was discontinued in four patients, because of pneumonia in two, <span class=""disease"">PTLD</span> in one, and oral aphtous ulcers in one."		11063349.0	11063349_MESH:D020123_MESH:D008232	11063349_11	bcv_devset_test_100_easy_65		
	MESH:D020123	"<span class=""chemical"">RAPA</span>"	MESH:D011014	"<span class=""disease"">pneumonia</span>"	"<span class=""chemical"">RAPA</span> was discontinued in four patients, because of <span class=""disease"">pneumonia</span> in two, PTLD in one, and oral aphtous ulcers in one."		11063349.0	11063349_MESH:D020123_MESH:D011014	11063349_11	bcv_devset_test_100_easy_66		
	MESH:D020123	"<span class=""chemical"">RAPA</span>"	MESH:D014456	"<span class=""disease"">aphtous ulcers</span>"	"<span class=""chemical"">RAPA</span> was discontinued in four patients, because of pneumonia in two, PTLD in one, and oral <span class=""disease"">aphtous ulcers</span> in one."		11063349.0	11063349_MESH:D020123_MESH:D014456	11063349_11	bcv_devset_test_100_easy_67		
	MESH:D020123	"<span class=""chemical"">RAPA</span>"	MESH:D011020	"<span class=""disease"">Pneumocystis carinii pneumonia</span>"	"However, when converting patients to <span class=""chemical"">RAPA</span> drug levels should be monitored to avoid over-immunosuppression and adequate antiviral and <span class=""disease"">Pneumocystis carinii pneumonia</span> prophylaxis should be given."		11063349.0	11063349_MESH:D020123_MESH:D011020	11063349_14	bcv_devset_test_100_easy_68		
	MESH:D008784	"<span class=""chemical"">methysergide</span>"	MESH:D020301	"<span class=""disease"">vasospasm</span>"	"A rare case of morbid <span class=""disease"">vasospasm</span>, together with striking angiographic findings, is described secondary to the ingestion of <span class=""chemical"">methysergide</span> by a 48-year-old woman."		3300918.0	3300918_MESH:D008784_MESH:D020301	3300918_1	bcv_devset_test_100_easy_69		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D008881	"<span class=""disease"">migraine</span>"	"Despite the advent of <span class=""chemical"">calcium</span> channel blockers and beta-adrenergic antagonists, ergot preparations continue to play a major role in <span class=""disease"">migraine</span> therapy, so that the danger of St. Anthony's fire persists."		3300918.0	3300918_MESH:D002118_MESH:D008881	3300918_4	bcv_devset_test_100_easy_70		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D004881	"<span class=""disease"">Anthony's fire</span>"	"Despite the advent of <span class=""chemical"">calcium</span> channel blockers and beta-adrenergic antagonists, ergot preparations continue to play a major role in migraine therapy, so that the danger of St. <span class=""disease"">Anthony's fire</span> persists."		3300918.0	3300918_MESH:D002118_MESH:D004881	3300918_4	bcv_devset_test_100_easy_71		
	MESH:D009705	"<span class=""chemical"">nucleosides</span>"	MESH:D002545	"<span class=""disease"">cerebral ischemia</span>"	"Time dependence of plasma malondialdehyde, oxypurines, and <span class=""chemical"">nucleosides</span> during incomplete <span class=""disease"">cerebral ischemia</span> in the rat."		7710775.0	7710775_MESH:D009705_MESH:D002545	7710775_0	bcv_devset_test_100_easy_72		
	MESH:D008315	"<span class=""chemical"">malondialdehyde</span>"	MESH:D002545	"<span class=""disease"">cerebral ischemia</span>"	"Time dependence of plasma <span class=""chemical"">malondialdehyde</span>, oxypurines, and nucleosides during incomplete <span class=""disease"">cerebral ischemia</span> in the rat."		7710775.0	7710775_MESH:D008315_MESH:D002545	7710775_0	bcv_devset_test_100_easy_73		
	MESH:D009705	"<span class=""chemical"">nucleosides</span>"	MESH:D007511	"<span class=""disease"">ischemia</span>"	"During <span class=""disease"">ischemia</span>, a time-dependent increase of plasma oxypurines and <span class=""chemical"">nucleosides</span> was observed."		7710775.0	7710775_MESH:D009705_MESH:D007511	7710775_4	bcv_devset_test_100_easy_74		
	MESH:D008315	"<span class=""chemical"">malondialdehyde</span>"	MESH:D007511	"<span class=""disease"">ischemia</span>"	"Plasma <span class=""chemical"">malondialdehyde</span>, which was present in minimal amount at zero time (0.058 mumol/liter plasma; SD 0.015), increased after 5 min of <span class=""disease"">ischemia</span>, resulting in a fivefold increase after 30 min of carotid occlusion (0.298 mumol/liter plasma; SD 0.078)."		7710775.0	7710775_MESH:D008315_MESH:D007511	7710775_5	bcv_devset_test_100_easy_75		
	MESH:D008315	"<span class=""chemical"">malondialdehyde</span>"	MESH:D007022	"<span class=""disease"">hypotensive</span>"	"Increased plasma <span class=""chemical"">malondialdehyde</span> was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before ischemia, the other receiving 650 micrograms/kg b.w. of the <span class=""disease"">hypotensive</span> drug nitroprusside at a flow rate of 103 microliters/min intravenously during ischemia, although in this latter group <span class=""chemical"">malondialdehyde</span> was significantly higher."		7710775.0	7710775_MESH:D008315_MESH:D007022	7710775_6	bcv_devset_test_100_easy_76		
	MESH:D009599	"<span class=""chemical"">nitroprusside</span>"	MESH:D007511	"<span class=""disease"">ischemia</span>"	"Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before <span class=""disease"">ischemia</span>, the other receiving 650 micrograms/kg b.w. of the hypotensive drug <span class=""chemical"">nitroprusside</span> at a flow rate of 103 microliters/min intravenously during <span class=""disease"">ischemia</span>, although in this latter group malondialdehyde was significantly higher."		7710775.0	7710775_MESH:D009599_MESH:D007511	7710775_6	bcv_devset_test_100_easy_77		
	MESH:D008315	"<span class=""chemical"">malondialdehyde</span>"	MESH:D007511	"<span class=""disease"">ischemia</span>"	"Increased plasma <span class=""chemical"">malondialdehyde</span> was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before <span class=""disease"">ischemia</span>, the other receiving 650 micrograms/kg b.w. of the hypotensive drug nitroprusside at a flow rate of 103 microliters/min intravenously during <span class=""disease"">ischemia</span>, although in this latter group <span class=""chemical"">malondialdehyde</span> was significantly higher."		7710775.0	7710775_MESH:D008315_MESH:D007511	7710775_6	bcv_devset_test_100_easy_78		
	MESH:D009599	"<span class=""chemical"">nitroprusside</span>"	MESH:D007022	"<span class=""disease"">hypotensive</span>"	"Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before ischemia, the other receiving 650 micrograms/kg b.w. of the <span class=""disease"">hypotensive</span> drug <span class=""chemical"">nitroprusside</span> at a flow rate of 103 microliters/min intravenously during ischemia, although in this latter group malondialdehyde was significantly higher."		7710775.0	7710775_MESH:D009599_MESH:D007022	7710775_6	bcv_devset_test_100_easy_79		
	MESH:D008315	"<span class=""chemical"">malondialdehyde</span>"	MESH:D007511	"<span class=""disease"">ischemic</span>"	"The present data indicate that the determination of <span class=""chemical"">malondialdehyde</span>, oxypurines, and nucleosides in peripheral blood, may be used to monitor the metabolic alterations of tissues occurring during <span class=""disease"">ischemic</span> phenomena.(ABSTRACT TRUNCATED AT 250 WORDS)"		7710775.0	7710775_MESH:D008315_MESH:D007511	7710775_7	bcv_devset_test_100_easy_80		
	MESH:D009705	"<span class=""chemical"">nucleosides</span>"	MESH:D007511	"<span class=""disease"">ischemic</span>"	"The present data indicate that the determination of malondialdehyde, oxypurines, and <span class=""chemical"">nucleosides</span> in peripheral blood, may be used to monitor the metabolic alterations of tissues occurring during <span class=""disease"">ischemic</span> phenomena.(ABSTRACT TRUNCATED AT 250 WORDS)"		7710775.0	7710775_MESH:D009705_MESH:D007511	7710775_7	bcv_devset_test_100_easy_81		
	MESH:D004280	"<span class=""chemical"">dobutamine</span>"	MESH:D002312	"<span class=""disease"">hypertrophic cardiomyopathy</span>"	"The 47-year-old female patient, known to have <span class=""disease"">hypertrophic cardiomyopathy</span>, was admitted with biventricular failure and managed aggressively with <span class=""chemical"">dobutamine</span> infusion and other drugs while being assessed for heart transplantation."		15266362.0	15266362_MESH:D004280_MESH:D002312	15266362_2	bcv_devset_test_100_easy_82		
	MESH:D004280	"<span class=""chemical"">dobutamine</span>"	MESH:D051437	"<span class=""disease"">biventricular failure</span>"	"The 47-year-old female patient, known to have hypertrophic cardiomyopathy, was admitted with <span class=""disease"">biventricular failure</span> and managed aggressively with <span class=""chemical"">dobutamine</span> infusion and other drugs while being assessed for heart transplantation."		15266362.0	15266362_MESH:D004280_MESH:D051437	15266362_2	bcv_devset_test_100_easy_83		
	MESH:D004280	"<span class=""chemical"">dobutamine</span>"	MESH:D009205	"<span class=""disease"">myocarditis</span>"	"It is likely that the hypersensitivity (eosinophilic) <span class=""disease"">myocarditis</span> was related to <span class=""chemical"">dobutamine</span> infusion therapy."		15266362.0	15266362_MESH:D004280_MESH:D009205	15266362_6	bcv_devset_test_100_easy_84		
	MESH:D004280	"<span class=""chemical"">dobutamine</span>"	MESH:D004802	"<span class=""disease"">eosinophilic</span>"	"It is likely that the hypersensitivity (<span class=""disease"">eosinophilic</span>) myocarditis was related to <span class=""chemical"">dobutamine</span> infusion therapy."		15266362.0	15266362_MESH:D004280_MESH:D004802	15266362_6	bcv_devset_test_100_easy_85		
	MESH:D004280	"<span class=""chemical"">dobutamine</span>"	MESH:D004342	"<span class=""disease"">hypersensitivity</span>"	"It is likely that the <span class=""disease"">hypersensitivity</span> (eosinophilic) myocarditis was related to <span class=""chemical"">dobutamine</span> infusion therapy."		15266362.0	15266362_MESH:D004280_MESH:D004342	15266362_6	bcv_devset_test_100_easy_86		
	MESH:D002939	"<span class=""chemical"">Ciprofloxacin</span>"	MESH:D000744	"<span class=""disease"">autoimmune hemolytic anemia</span>"	"<span class=""chemical"">Ciprofloxacin</span>-induced acute interstitial nephritis and <span class=""disease"">autoimmune hemolytic anemia</span>."		12911170.0	12911170_MESH:D002939_MESH:D000744	12911170_0	bcv_devset_test_100_easy_87		
	MESH:D002939	"<span class=""chemical"">Ciprofloxacin</span>"	MESH:D000743	"<span class=""disease"">hemolytic anemia</span>"	"<span class=""chemical"">Ciprofloxacin</span> has been associated with several side effects including interstitial nephritis and <span class=""disease"">hemolytic anemia</span>."		12911170.0	12911170_MESH:D002939_MESH:D000743	12911170_1	bcv_devset_test_100_easy_88		
	MESH:D002939	"<span class=""chemical"">ciprofloxacin</span>"	MESH:D000744	"<span class=""disease"">autoimmune hemolytic anemia</span>"	"In this report, we describe a case of <span class=""chemical"">ciprofloxacin</span>-induced interstitial nephritis and <span class=""disease"">autoimmune hemolytic anemia</span>."		12911170.0	12911170_MESH:D002939_MESH:D000744	12911170_3	bcv_devset_test_100_easy_89		
	MESH:D013256	"<span class=""chemical"">steroid</span>"	MESH:D000743	"<span class=""disease"">Hemolytic anemia</span>"	"<span class=""disease"">Hemolytic anemia</span> improved after stopping the drug and initiation of <span class=""chemical"">steroid</span> therapy."		12911170.0	12911170_MESH:D013256_MESH:D000743	12911170_4	bcv_devset_test_100_easy_90		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"Contribution of the sympathetic nervous system to salt-sensitivity in lifetime <span class=""chemical"">captopril</span>-treated spontaneously <span class=""disease"">hypertensive</span> rats."		8586822.0	8586822_MESH:D002216_MESH:D006973	8586822_0	bcv_devset_test_100_easy_91		
	MESH:D017673	"<span class=""chemical"">dietary sodium chloride</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"OBJECTIVE: To test the hypothesis that, in lifetime captopril-treated spontaneously <span class=""disease"">hypertensive</span> rats (SHR), the sympathetic nervous system contributes importantly to the <span class=""disease"">hypertensive</span> effect of <span class=""chemical"">dietary sodium chloride</span> supplementation."		8586822.0	8586822_MESH:D017673_MESH:D006973	8586822_1	bcv_devset_test_100_easy_92		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"OBJECTIVE: To test the hypothesis that, in lifetime <span class=""chemical"">captopril</span>-treated spontaneously <span class=""disease"">hypertensive</span> rats (SHR), the sympathetic nervous system contributes importantly to the <span class=""disease"">hypertensive</span> effect of dietary sodium chloride supplementation."		8586822.0	8586822_MESH:D002216_MESH:D006973	8586822_1	bcv_devset_test_100_easy_93		
	MESH:D013793	"<span class=""chemical"">thallium</span>"	MESH:D023921	"<span class=""disease"">coronary stenosis</span>"	"Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of <span class=""disease"">coronary stenosis</span>: correlation with <span class=""chemical"">thallium</span>-201 single-photon emission tomography."		1564236.0	1564236_MESH:D013793_MESH:D023921	1564236_0	bcv_devset_test_100_easy_94		
	MESH:D004176	"<span class=""chemical"">dipyridamole</span>"	MESH:D023921	"<span class=""disease"">coronary stenosis</span>"	"During <span class=""chemical"">dipyridamole</span>-induced hyperemia, 12 of the 16 dogs with a partial <span class=""disease"">coronary stenosis</span> had a visible area of hypoperfusion by contrast echocardiography."		1564236.0	1564236_MESH:D004176_MESH:D023921	1564236_6	bcv_devset_test_100_easy_95		
	MESH:D013793	"<span class=""chemical"">Thallium</span>"	MESH:D006940	"<span class=""disease"">hyperemia</span>"	"<span class=""chemical"">Thallium</span>-201 SPECT demonstrated a perfusion defect in all 14 dogs analyzed during dipyridamole-induced <span class=""disease"">hyperemia</span>; the size of the perfusion defect correlated with the anatomic area at risk (r = 0.58; p less than 0.03) and with the perfusion defect by contrast echocardiography (r = 0.58; p less than 0.03)."		1564236.0	1564236_MESH:D013793_MESH:D006940	1564236_9	bcv_devset_test_100_easy_96		
	MESH:D008727	"<span class=""chemical"">methotrexate</span>"	MESH:D020521	"<span class=""disease"">cerebrovascular accident</span>"	"BACKGROUND: A transient leukoencephalopathy mimicking <span class=""disease"">cerebrovascular accident</span> has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood leukaemia."		17682013.0	17682013_MESH:D008727_MESH:D020521	17682013_1	bcv_devset_test_100_easy_97		
	MESH:D008727	"<span class=""chemical"">methotrexate</span>"	MESH:D056784	"<span class=""disease"">leukoencephalopathy</span>"	"BACKGROUND: A transient <span class=""disease"">leukoencephalopathy</span> mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood leukaemia."		17682013.0	17682013_MESH:D008727_MESH:D056784	17682013_1	bcv_devset_test_100_easy_98		
	MESH:D008727	"<span class=""chemical"">methotrexate</span>"	MESH:D007938	"<span class=""disease"">leukaemia</span>"	"BACKGROUND: A transient leukoencephalopathy mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood <span class=""disease"">leukaemia</span>."		17682013.0	17682013_MESH:D008727_MESH:D007938	17682013_1	bcv_devset_test_100_easy_99		
	MESH:D008727	"<span class=""chemical"">methotrexate</span>"	MESH:D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with <span class=""chemical"">methotrexate</span> (intrathecal, systemic), 5-fluorouracil and its derivative carmofur, and capecitabine."		17682013.0	17682013_MESH:D008727_MESH:D056784	17682013_6	bcv_devset_test_100_easy_100		
	MESH:D005472	"<span class=""chemical"">5-fluorouracil</span>"	MESH:D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), <span class=""chemical"">5-fluorouracil</span> and its derivative carmofur, and capecitabine."		17682013.0	17682013_MESH:D005472_MESH:D056784	17682013_6	bcv_devset_test_100_easy_101		
	MESH:C110904	"<span class=""chemical"">capecitabine</span>"	MESH:D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), 5-fluorouracil and its derivative carmofur, and <span class=""chemical"">capecitabine</span>."		17682013.0	17682013_MESH:C110904_MESH:D056784	17682013_6	bcv_devset_test_100_easy_102		
	MESH:C017367	"<span class=""chemical"">carmofur</span>"	MESH:D056784	"<span class=""disease"">leukoencephalopathy</span>"	"RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), 5-fluorouracil and its derivative <span class=""chemical"">carmofur</span>, and capecitabine."		17682013.0	17682013_MESH:C017367_MESH:D056784	17682013_6	bcv_devset_test_100_easy_103		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"Yohimbine treatment of <span class=""disease"">sexual side effects</span> induced by <span class=""chemical"">serotonin</span> reuptake blockers."		1535072.0	1535072_MESH:D012701_MESH:D020018	1535072_0	bcv_devset_test_100_easy_104		
	MESH:D015016	"<span class=""chemical"">Yohimbine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"<span class=""chemical"">Yohimbine</span> treatment of <span class=""disease"">sexual side effects</span> induced by serotonin reuptake blockers."		1535072.0	1535072_MESH:D015016_MESH:D020018	1535072_0	bcv_devset_test_100_easy_105		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D007172	"<span class=""disease"">male impotence</span>"	"BACKGROUND: Preclinical and clinical studies suggest that <span class=""chemical"">yohimbine</span> facilitates sexual behavior and may be helpful in the treatment of <span class=""disease"">male impotence</span>."		1535072.0	1535072_MESH:D015016_MESH:D007172	1535072_1	bcv_devset_test_100_easy_106		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"A single case report suggests that <span class=""chemical"">yohimbine</span> may be used to treat the <span class=""disease"">sexual side effects</span> of clomipramine."		1535072.0	1535072_MESH:D015016_MESH:D020018	1535072_2	bcv_devset_test_100_easy_107		
	MESH:D002997	"<span class=""chemical"">clomipramine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"A single case report suggests that yohimbine may be used to treat the <span class=""disease"">sexual side effects</span> of <span class=""chemical"">clomipramine</span>."		1535072.0	1535072_MESH:D002997_MESH:D020018	1535072_2	bcv_devset_test_100_easy_108		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"This study evaluated yohimbine as a treatment for the <span class=""disease"">sexual side effects</span> caused by <span class=""chemical"">serotonin</span> reuptake blockers."		1535072.0	1535072_MESH:D012701_MESH:D020018	1535072_3	bcv_devset_test_100_easy_109		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"This study evaluated <span class=""chemical"">yohimbine</span> as a treatment for the <span class=""disease"">sexual side effects</span> caused by serotonin reuptake blockers."		1535072.0	1535072_MESH:D015016_MESH:D020018	1535072_3	bcv_devset_test_100_easy_110		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or affective disorders who suffered <span class=""disease"">sexual side effects</span> after treatment with <span class=""chemical"">serotonin</span> reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D012701_MESH:D020018	1535072_4	bcv_devset_test_100_easy_111		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D019964	"<span class=""disease"">affective disorders</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or <span class=""disease"">affective disorders</span> who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D015016_MESH:D019964	1535072_4	bcv_devset_test_100_easy_112		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D019964	"<span class=""disease"">affective disorders</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or <span class=""disease"">affective disorders</span> who suffered sexual side effects after treatment with <span class=""chemical"">serotonin</span> reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D012701_MESH:D019964	1535072_4	bcv_devset_test_100_easy_113		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D014256	"<span class=""disease"">trichotillomania</span>"	"METHOD: Six patients with either obsessive compulsive disorder, <span class=""disease"">trichotillomania</span>, anxiety, or affective disorders who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D015016_MESH:D014256	1535072_4	bcv_devset_test_100_easy_114		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D001008	"<span class=""disease"">anxiety</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, <span class=""disease"">anxiety</span>, or affective disorders who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D015016_MESH:D001008	1535072_4	bcv_devset_test_100_easy_115		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D009771	"<span class=""disease"">obsessive compulsive disorder</span>"	"METHOD: Six patients with either <span class=""disease"">obsessive compulsive disorder</span>, trichotillomania, anxiety, or affective disorders who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D015016_MESH:D009771	1535072_4	bcv_devset_test_100_easy_116		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D014256	"<span class=""disease"">trichotillomania</span>"	"METHOD: Six patients with either obsessive compulsive disorder, <span class=""disease"">trichotillomania</span>, anxiety, or affective disorders who suffered sexual side effects after treatment with <span class=""chemical"">serotonin</span> reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D012701_MESH:D014256	1535072_4	bcv_devset_test_100_easy_117		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D001008	"<span class=""disease"">anxiety</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, <span class=""disease"">anxiety</span>, or affective disorders who suffered sexual side effects after treatment with <span class=""chemical"">serotonin</span> reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D012701_MESH:D001008	1535072_4	bcv_devset_test_100_easy_118		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or affective disorders who suffered <span class=""disease"">sexual side effects</span> after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D015016_MESH:D020018	1535072_4	bcv_devset_test_100_easy_119		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D009771	"<span class=""disease"">obsessive compulsive disorder</span>"	"METHOD: Six patients with either <span class=""disease"">obsessive compulsive disorder</span>, trichotillomania, anxiety, or affective disorders who suffered sexual side effects after treatment with <span class=""chemical"">serotonin</span> reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial."		1535072.0	1535072_MESH:D012701_MESH:D009771	1535072_4	bcv_devset_test_100_easy_120		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D001008	"<span class=""disease"">anxiety</span>"	"Side effects of <span class=""chemical"">yohimbine</span> included excessive sweating, increased <span class=""disease"">anxiety</span>, and a wound-up feeling in some patients."		1535072.0	1535072_MESH:D015016_MESH:D001008	1535072_8	bcv_devset_test_100_easy_121		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"CONCLUSION: The results of this study indicate that yohimbine may be an effective treatment for the <span class=""disease"">sexual side effects</span> caused by <span class=""chemical"">serotonin</span> reuptake blockers."		1535072.0	1535072_MESH:D012701_MESH:D020018	1535072_9	bcv_devset_test_100_easy_122		
	MESH:D015016	"<span class=""chemical"">yohimbine</span>"	MESH:D020018	"<span class=""disease"">sexual side effects</span>"	"CONCLUSION: The results of this study indicate that <span class=""chemical"">yohimbine</span> may be an effective treatment for the <span class=""disease"">sexual side effects</span> caused by serotonin reuptake blockers."		1535072.0	1535072_MESH:D015016_MESH:D020018	1535072_9	bcv_devset_test_100_easy_123		
	MESH:D003975	"<span class=""chemical"">Diazepam</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"<span class=""chemical"">Diazepam</span> facilitates reflex <span class=""disease"">bradycardia</span> in conscious rats."		2894433.0	2894433_MESH:D003975_MESH:D001919	2894433_0	bcv_devset_test_100_easy_124		
	MESH:D004837	"<span class=""chemical"">adrenaline</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"Also, reflex <span class=""disease"">bradycardia</span> was produced in rats by intravenous infusion of <span class=""chemical"">adrenaline</span> (1.25-2.5 micrograms kg-1)."		2894433.0	2894433_MESH:D004837_MESH:D001919	2894433_3	bcv_devset_test_100_easy_125		
	MESH:D004837	"<span class=""chemical"">adrenaline</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"Intravenous pretreatment of the rats with diazepam, although causing no change in the <span class=""chemical"">adrenaline</span>-induced pressor effect, did enhance the <span class=""chemical"">adrenaline</span>-induced reflex <span class=""disease"">bradycardia</span>."		2894433.0	2894433_MESH:D004837_MESH:D001919	2894433_4	bcv_devset_test_100_easy_126		
	MESH:D003975	"<span class=""chemical"">diazepam</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"Intravenous pretreatment of the rats with <span class=""chemical"">diazepam</span>, although causing no change in the adrenaline-induced pressor effect, did enhance the adrenaline-induced reflex <span class=""disease"">bradycardia</span>."		2894433.0	2894433_MESH:D003975_MESH:D001919	2894433_4	bcv_devset_test_100_easy_127		
	MESH:D004837	"<span class=""chemical"">adrenaline</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"However, the diazepam enhancement of <span class=""chemical"">adrenaline</span>-induced reflex <span class=""disease"">bradycardia</span> was antagonized by pretreatment of rats with an intravenous dose of picrotoxin (an agent blocks chloride channels by binding to sites associated with the benzodiazepine-GABA-chloride channel macromolecular complex)."		2894433.0	2894433_MESH:D004837_MESH:D001919	2894433_5	bcv_devset_test_100_easy_128		
	MESH:D005680	"<span class=""chemical"">GABA</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"However, the diazepam enhancement of adrenaline-induced reflex <span class=""disease"">bradycardia</span> was antagonized by pretreatment of rats with an intravenous dose of picrotoxin (an agent blocks chloride channels by binding to sites associated with the benzodiazepine-<span class=""chemical"">GABA</span>-chloride channel macromolecular complex)."		2894433.0	2894433_MESH:D005680_MESH:D001919	2894433_5	bcv_devset_test_100_easy_129		
	MESH:D003975	"<span class=""chemical"">diazepam</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"However, the <span class=""chemical"">diazepam</span> enhancement of adrenaline-induced reflex <span class=""disease"">bradycardia</span> was antagonized by pretreatment of rats with an intravenous dose of picrotoxin (an agent blocks chloride channels by binding to sites associated with the benzodiazepine-GABA-chloride channel macromolecular complex)."		2894433.0	2894433_MESH:D003975_MESH:D001919	2894433_5	bcv_devset_test_100_easy_130		
	MESH:D001569	"<span class=""chemical"">benzodiazepine</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"However, the diazepam enhancement of adrenaline-induced reflex <span class=""disease"">bradycardia</span> was antagonized by pretreatment of rats with an intravenous dose of picrotoxin (an agent blocks chloride channels by binding to sites associated with the <span class=""chemical"">benzodiazepine</span>-GABA-chloride channel macromolecular complex)."		2894433.0	2894433_MESH:D001569_MESH:D001919	2894433_5	bcv_devset_test_100_easy_131		
	MESH:D010852	"<span class=""chemical"">picrotoxin</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"However, the diazepam enhancement of adrenaline-induced reflex <span class=""disease"">bradycardia</span> was antagonized by pretreatment of rats with an intravenous dose of <span class=""chemical"">picrotoxin</span> (an agent blocks chloride channels by binding to sites associated with the benzodiazepine-GABA-chloride channel macromolecular complex)."		2894433.0	2894433_MESH:D010852_MESH:D001919	2894433_5	bcv_devset_test_100_easy_132		
	MESH:D003975	"<span class=""chemical"">diazepam</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"The data indicate that <span class=""chemical"">diazepam</span> acts through the benzodiazepine-GABA-chloride channel macromolecular complex within the central nervous system to facilitate reflex <span class=""disease"">bradycardia</span> mediated through baroreceptor reflexes in response to an acute increase in arterial pressure."		2894433.0	2894433_MESH:D003975_MESH:D001919	2894433_6	bcv_devset_test_100_easy_133		
	MESH:D001569	"<span class=""chemical"">benzodiazepine</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"The data indicate that diazepam acts through the <span class=""chemical"">benzodiazepine</span>-GABA-chloride channel macromolecular complex within the central nervous system to facilitate reflex <span class=""disease"">bradycardia</span> mediated through baroreceptor reflexes in response to an acute increase in arterial pressure."		2894433.0	2894433_MESH:D001569_MESH:D001919	2894433_6	bcv_devset_test_100_easy_134		
	MESH:D005680	"<span class=""chemical"">GABA</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"The data indicate that diazepam acts through the benzodiazepine-<span class=""chemical"">GABA</span>-chloride channel macromolecular complex within the central nervous system to facilitate reflex <span class=""disease"">bradycardia</span> mediated through baroreceptor reflexes in response to an acute increase in arterial pressure."		2894433.0	2894433_MESH:D005680_MESH:D001919	2894433_6	bcv_devset_test_100_easy_135		
	MESH:D006220	"<span class=""chemical"">haloperidol</span>"	MESH:D011595	"<span class=""disease"">agitation</span>"	"If <span class=""disease"">agitation</span> becomes marked, high-potency neuroleptics (i.e., <span class=""chemical"">haloperidol</span>) may be effective."		8111719.0	8111719_MESH:D006220_MESH:D011595	8111719_13	bcv_devset_test_100_easy_136		
	MESH:D004298	"<span class=""chemical"">dopamine</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"Fenoldopam is a selective <span class=""chemical"">dopamine</span>-1 (DA1) receptor agonist that causes vasodilatation to the kidney and other organs with DA1 receptors and preserves blood flow to the kidney during induced <span class=""disease"">hypotension</span>."		1969772.0	1969772_MESH:D004298_MESH:D007022	1969772_9	bcv_devset_test_100_easy_137		
	MESH:D010400	"<span class=""chemical"">penicillin-G potassium</span>"	MESH:D004827	"<span class=""disease"">epileptic</span>"	"After a short period of basal activity recording, <span class=""disease"">epileptic</span> focus was induced by injecting 400IU/2 microl <span class=""chemical"">penicillin-G potassium</span> into the left lateral ventricle while the cortical activity was continuously recorded."		18657397.0	18657397_MESH:D010400_MESH:D004827	18657397_4	bcv_devset_test_100_easy_138		
	MESH:D000109	"<span class=""chemical"">acetylcholine</span>"	MESH:D009135	"<span class=""disease"">muscle dysfunction</span>"	"Prednisolone-induced <span class=""disease"">muscle dysfunction</span> is caused more by atrophy than by altered <span class=""chemical"">acetylcholine</span> receptor expression."		10910842.0	10910842_MESH:D000109_MESH:D009135	10910842_0	bcv_devset_test_100_easy_139		
	MESH:D000109	"<span class=""chemical"">acetylcholine</span>"	MESH:D001284	"<span class=""disease"">atrophy</span>"	"Prednisolone-induced muscle dysfunction is caused more by <span class=""disease"">atrophy</span> than by altered <span class=""chemical"">acetylcholine</span> receptor expression."		10910842.0	10910842_MESH:D000109_MESH:D001284	10910842_0	bcv_devset_test_100_easy_140		
	MESH:D011239	"<span class=""chemical"">Prednisolone</span>"	MESH:D001284	"<span class=""disease"">atrophy</span>"	"<span class=""chemical"">Prednisolone</span>-induced muscle dysfunction is caused more by <span class=""disease"">atrophy</span> than by altered acetylcholine receptor expression."		10910842.0	10910842_MESH:D011239_MESH:D001284	10910842_0	bcv_devset_test_100_easy_141		
	MESH:D011239	"<span class=""chemical"">prednisolone</span>"	MESH:D009468	"<span class=""disease"">neuromuscular dysfunction</span>"	"Our results suggest that the <span class=""disease"">neuromuscular dysfunction</span> after <span class=""chemical"">prednisolone</span> is dose-dependent, and derives primarily from muscle atrophy and derives less so from changes in AChR expression."		10910842.0	10910842_MESH:D011239_MESH:D009468	10910842_13	bcv_devset_test_100_easy_142		
	MESH:D011239	"<span class=""chemical"">prednisolone</span>"	MESH:D009133	"<span class=""disease"">muscle atrophy</span>"	"Our results suggest that the neuromuscular dysfunction after <span class=""chemical"">prednisolone</span> is dose-dependent, and derives primarily from <span class=""disease"">muscle atrophy</span> and derives less so from changes in AChR expression."		10910842.0	10910842_MESH:D011239_MESH:D009133	10910842_13	bcv_devset_test_100_easy_143		
	MESH:D000109	"<span class=""chemical"">acetylcholine</span>"	MESH:D009133	"<span class=""disease"">muscle atrophy</span>"	"We suggest that the observed effects are dose-dependent and derive primarily from <span class=""disease"">muscle atrophy</span> and derive less from changes in <span class=""chemical"">acetylcholine</span> receptor expression."		10910842.0	10910842_MESH:D000109_MESH:D009133	10910842_15	bcv_devset_test_100_easy_144		
	MESH:D000666	"<span class=""chemical"">amphotericin B</span>"	MESH:D009369	"<span class=""disease"">cancer</span>"	"Spironolactone: is it a novel drug for the prevention of <span class=""chemical"">amphotericin B</span>-related hypokalemia in <span class=""disease"">cancer</span> patients?"		11868798.0	11868798_MESH:D000666_MESH:D009369	11868798_0	bcv_devset_test_100_easy_145		
	MESH:D013148	"<span class=""chemical"">Spironolactone</span>"	MESH:D009369	"<span class=""disease"">cancer</span>"	"<span class=""chemical"">Spironolactone</span>: is it a novel drug for the prevention of amphotericin B-related hypokalemia in <span class=""disease"">cancer</span> patients?"		11868798.0	11868798_MESH:D013148_MESH:D009369	11868798_0	bcv_devset_test_100_easy_146		
	MESH:D000666	"<span class=""chemical"">amphotericin B</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"Spironolactone: is it a novel drug for the prevention of <span class=""chemical"">amphotericin B</span>-related <span class=""disease"">hypokalemia</span> in cancer patients?"		11868798.0	11868798_MESH:D000666_MESH:D007008	11868798_0	bcv_devset_test_100_easy_147		
	MESH:D013148	"<span class=""chemical"">Spironolactone</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"<span class=""chemical"">Spironolactone</span>: is it a novel drug for the prevention of amphotericin B-related <span class=""disease"">hypokalemia</span> in cancer patients?"		11868798.0	11868798_MESH:D013148_MESH:D007008	11868798_0	bcv_devset_test_100_easy_148		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Selective distal tubular epithelial <span class=""disease"">toxicity</span> seems to be responsible for the profound <span class=""chemical"">potassium</span> wasting that is a major clinical side effect of treatment with AmB."		11868798.0	11868798_MESH:D011188_MESH:D064420	11868798_2	bcv_devset_test_100_easy_149		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Selective distal tubular epithelial <span class=""disease"">toxicity</span> seems to be responsible for the profound potassium wasting that is a major clinical side effect of treatment with <span class=""chemical"">AmB</span>."		11868798.0	11868798_MESH:D000666_MESH:D064420	11868798_2	bcv_devset_test_100_easy_150		
	MESH:D011188	"<span class=""chemical"">Potassium</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"<span class=""chemical"">Potassium</span> depletion also potentiates the tubular <span class=""disease"">toxicity</span> of AmB."		11868798.0	11868798_MESH:D011188_MESH:D064420	11868798_3	bcv_devset_test_100_easy_151		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Potassium depletion also potentiates the tubular <span class=""disease"">toxicity</span> of <span class=""chemical"">AmB</span>."		11868798.0	11868798_MESH:D000666_MESH:D064420	11868798_3	bcv_devset_test_100_easy_152		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"This study was designed to assess the ability of spironolactone to reduce <span class=""chemical"">potassium</span> requirements and to prevent hypokalemia in <span class=""disease"">neutropenic</span> patients on AmB treatment."		11868798.0	11868798_MESH:D011188_MESH:D009503	11868798_4	bcv_devset_test_100_easy_153		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"This study was designed to assess the ability of spironolactone to reduce potassium requirements and to prevent hypokalemia in <span class=""disease"">neutropenic</span> patients on <span class=""chemical"">AmB</span> treatment."		11868798.0	11868798_MESH:D000666_MESH:D009503	11868798_4	bcv_devset_test_100_easy_154		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"This study was designed to assess the ability of spironolactone to reduce potassium requirements and to prevent <span class=""disease"">hypokalemia</span> in neutropenic patients on <span class=""chemical"">AmB</span> treatment."		11868798.0	11868798_MESH:D000666_MESH:D007008	11868798_4	bcv_devset_test_100_easy_155		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"This study was designed to assess the ability of <span class=""chemical"">spironolactone</span> to reduce potassium requirements and to prevent <span class=""disease"">hypokalemia</span> in neutropenic patients on AmB treatment."		11868798.0	11868798_MESH:D013148_MESH:D007008	11868798_4	bcv_devset_test_100_easy_156		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"This study was designed to assess the ability of <span class=""chemical"">spironolactone</span> to reduce potassium requirements and to prevent hypokalemia in <span class=""disease"">neutropenic</span> patients on AmB treatment."		11868798.0	11868798_MESH:D013148_MESH:D009503	11868798_4	bcv_devset_test_100_easy_157		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"This study was designed to assess the ability of spironolactone to reduce <span class=""chemical"">potassium</span> requirements and to prevent <span class=""disease"">hypokalemia</span> in neutropenic patients on AmB treatment."		11868798.0	11868798_MESH:D011188_MESH:D007008	11868798_4	bcv_devset_test_100_easy_158		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D006402	"<span class=""disease"">hematological disorders</span>"	"METHODS: In this study 26 patients with various <span class=""disease"">hematological disorders</span> were randomized to receive either intravenous AmB alone or AmB and oral <span class=""chemical"">spironolactone</span> 100 mg twice daily when developing a proven or suspected fungal infection."		11868798.0	11868798_MESH:D013148_MESH:D006402	11868798_5	bcv_devset_test_100_easy_159		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D006402	"<span class=""disease"">hematological disorders</span>"	"METHODS: In this study 26 patients with various <span class=""disease"">hematological disorders</span> were randomized to receive either intravenous <span class=""chemical"">AmB</span> alone or <span class=""chemical"">AmB</span> and oral spironolactone 100 mg twice daily when developing a proven or suspected fungal infection."		11868798.0	11868798_MESH:D000666_MESH:D006402	11868798_5	bcv_devset_test_100_easy_160		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D009181	"<span class=""disease"">fungal infection</span>"	"METHODS: In this study 26 patients with various hematological disorders were randomized to receive either intravenous <span class=""chemical"">AmB</span> alone or <span class=""chemical"">AmB</span> and oral spironolactone 100 mg twice daily when developing a proven or suspected <span class=""disease"">fungal infection</span>."		11868798.0	11868798_MESH:D000666_MESH:D009181	11868798_5	bcv_devset_test_100_easy_161		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D009181	"<span class=""disease"">fungal infection</span>"	"METHODS: In this study 26 patients with various hematological disorders were randomized to receive either intravenous AmB alone or AmB and oral <span class=""chemical"">spironolactone</span> 100 mg twice daily when developing a proven or suspected <span class=""disease"">fungal infection</span>."		11868798.0	11868798_MESH:D013148_MESH:D009181	11868798_5	bcv_devset_test_100_easy_162		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"CONCLUSION: This study showed that spironolactone can reduce <span class=""chemical"">potassium</span> requirements and prevent hypokalemia by reducing urinary <span class=""chemical"">potassium</span> loss in <span class=""disease"">neutropenic</span> patients on AmB treatment."		11868798.0	11868798_MESH:D011188_MESH:D009503	11868798_9	bcv_devset_test_100_easy_163		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"CONCLUSION: This study showed that spironolactone can reduce potassium requirements and prevent hypokalemia by reducing urinary potassium loss in <span class=""disease"">neutropenic</span> patients on <span class=""chemical"">AmB</span> treatment."		11868798.0	11868798_MESH:D000666_MESH:D009503	11868798_9	bcv_devset_test_100_easy_164		
	MESH:D000666	"<span class=""chemical"">AmB</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"CONCLUSION: This study showed that spironolactone can reduce potassium requirements and prevent <span class=""disease"">hypokalemia</span> by reducing urinary potassium loss in neutropenic patients on <span class=""chemical"">AmB</span> treatment."		11868798.0	11868798_MESH:D000666_MESH:D007008	11868798_9	bcv_devset_test_100_easy_165		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"CONCLUSION: This study showed that <span class=""chemical"">spironolactone</span> can reduce potassium requirements and prevent <span class=""disease"">hypokalemia</span> by reducing urinary potassium loss in neutropenic patients on AmB treatment."		11868798.0	11868798_MESH:D013148_MESH:D007008	11868798_9	bcv_devset_test_100_easy_166		
	MESH:D013148	"<span class=""chemical"">spironolactone</span>"	MESH:D009503	"<span class=""disease"">neutropenic</span>"	"CONCLUSION: This study showed that <span class=""chemical"">spironolactone</span> can reduce potassium requirements and prevent hypokalemia by reducing urinary potassium loss in <span class=""disease"">neutropenic</span> patients on AmB treatment."		11868798.0	11868798_MESH:D013148_MESH:D009503	11868798_9	bcv_devset_test_100_easy_167		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"CONCLUSION: This study showed that spironolactone can reduce <span class=""chemical"">potassium</span> requirements and prevent <span class=""disease"">hypokalemia</span> by reducing urinary <span class=""chemical"">potassium</span> loss in neutropenic patients on AmB treatment."		11868798.0	11868798_MESH:D011188_MESH:D007008	11868798_9	bcv_devset_test_100_easy_168		
	MESH:D020123	"<span class=""chemical"">rapamycin/sirolimus</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Systemic <span class=""disease"">toxicity</span> following administration of <span class=""chemical"">sirolimus</span> (formerly <span class=""chemical"">rapamycin</span>) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes."		10328196.0	10328196_MESH:D020123_MESH:D064420	10328196_0	bcv_devset_test_100_easy_169		
	MESH:D020123	"<span class=""chemical"">rapamycin/sirolimus</span>"	MESH:D011565	"<span class=""disease"">psoriasis</span>"	"Systemic toxicity following administration of <span class=""chemical"">sirolimus</span> (formerly <span class=""chemical"">rapamycin</span>) for <span class=""disease"">psoriasis</span>: association of capillary leak syndrome with apoptosis of lesional lymphocytes."		10328196.0	10328196_MESH:D020123_MESH:D011565	10328196_0	bcv_devset_test_100_easy_170		
	MESH:D020123	"<span class=""chemical"">sirolimus</span>"	MESH:D011565	"<span class=""disease"">psoriasis</span>"	"After 2 individuals with <span class=""disease"">psoriasis</span> developed a capillary leak syndrome following treatment with oral <span class=""chemical"">sirolimus</span> lesional skin cells and activated peripheral blood cells were analyzed for induction of apoptosis."		10328196.0	10328196_MESH:D020123_MESH:D011565	10328196_2	bcv_devset_test_100_easy_171		
	MESH:D020123	"<span class=""chemical"">sirolimus</span>"	MESH:D011565	"<span class=""disease"">psoriasis</span>"	"OBSERVATIONS: A keratome skin specimen from 1 patient with <span class=""chemical"">sirolimus</span>-induced capillary leak syndrome had a 2.3-fold increase in percentage of apoptotic cells (to 48%) compared with an unaffected <span class=""chemical"">sirolimus</span>-treated patient with <span class=""disease"">psoriasis</span> (21%)."		10328196.0	10328196_MESH:D020123_MESH:D011565	10328196_3	bcv_devset_test_100_easy_172		
	MESH:D003907	"<span class=""chemical"">dexamethasone</span>"	MESH:D011565	"<span class=""disease"">psoriasis</span>"	"Activated peripheral blood T cells from patients with <span class=""disease"">psoriasis</span> tended to exhibit greater spontaneous or <span class=""chemical"">dexamethasone</span>-induced apoptosis than did normal T cells, particularly in the presence of sirolimus."		10328196.0	10328196_MESH:D003907_MESH:D011565	10328196_4	bcv_devset_test_100_easy_173		
	MESH:D020123	"<span class=""chemical"">sirolimus</span>"	MESH:D011565	"<span class=""disease"">psoriasis</span>"	"Activated peripheral blood T cells from patients with <span class=""disease"">psoriasis</span> tended to exhibit greater spontaneous or dexamethasone-induced apoptosis than did normal T cells, particularly in the presence of <span class=""chemical"">sirolimus</span>."		10328196.0	10328196_MESH:D020123_MESH:D011565	10328196_4	bcv_devset_test_100_easy_174		
	MESH:D020123	"<span class=""chemical"">sirolimus</span>"	MESH:D005334	"<span class=""disease"">fever</span>"	"CONCLUSIONS: Severe adverse effects of <span class=""chemical"">sirolimus</span> include <span class=""disease"">fever</span>, anemia, and capillary leak syndrome."		10328196.0	10328196_MESH:D020123_MESH:D005334	10328196_5	bcv_devset_test_100_easy_175		
	MESH:D020123	"<span class=""chemical"">sirolimus</span>"	MESH:D000740	"<span class=""disease"">anemia</span>"	"CONCLUSIONS: Severe adverse effects of <span class=""chemical"">sirolimus</span> include fever, <span class=""disease"">anemia</span>, and capillary leak syndrome."		10328196.0	10328196_MESH:D020123_MESH:D000740	10328196_5	bcv_devset_test_100_easy_176		
	MESH:D002354	"<span class=""chemical"">carteolol hydrochloride</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"The attenuating effect of <span class=""chemical"">carteolol hydrochloride</span>, a beta-adrenoceptor antagonist, on neuroleptic-induced <span class=""disease"">catalepsy</span> in rats."		9201797.0	9201797_MESH:D002354_MESH:D002375	9201797_0	bcv_devset_test_100_easy_177		
	MESH:D002354	"<span class=""chemical"">carteolol</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Therefore, the effects of <span class=""chemical"">carteolol</span>, a beta-adrenoceptor antagonist, on haloperidol-induced <span class=""disease"">catalepsy</span> in rats were behaviorally studied and compared with those of propranolol and biperiden, a muscarinic receptor antagonist."		9201797.0	9201797_MESH:D002354_MESH:D002375	9201797_3	bcv_devset_test_100_easy_178		
	MESH:D001712	"<span class=""chemical"">biperiden</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Therefore, the effects of carteolol, a beta-adrenoceptor antagonist, on haloperidol-induced <span class=""disease"">catalepsy</span> in rats were behaviorally studied and compared with those of propranolol and <span class=""chemical"">biperiden</span>, a muscarinic receptor antagonist."		9201797.0	9201797_MESH:D001712_MESH:D002375	9201797_3	bcv_devset_test_100_easy_179		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Therefore, the effects of carteolol, a beta-adrenoceptor antagonist, on haloperidol-induced <span class=""disease"">catalepsy</span> in rats were behaviorally studied and compared with those of <span class=""chemical"">propranolol</span> and biperiden, a muscarinic receptor antagonist."		9201797.0	9201797_MESH:D011433_MESH:D002375	9201797_3	bcv_devset_test_100_easy_180		
	MESH:D002354	"<span class=""chemical"">Carteolol</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"<span class=""chemical"">Carteolol</span>, as well as propranolol and biperiden, inhibited the haloperidol-induced <span class=""disease"">catalepsy</span>."		9201797.0	9201797_MESH:D002354_MESH:D002375	9201797_4	bcv_devset_test_100_easy_181		
	MESH:D001712	"<span class=""chemical"">biperiden</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Carteolol, as well as propranolol and <span class=""chemical"">biperiden</span>, inhibited the haloperidol-induced <span class=""disease"">catalepsy</span>."		9201797.0	9201797_MESH:D001712_MESH:D002375	9201797_4	bcv_devset_test_100_easy_182		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Carteolol, as well as <span class=""chemical"">propranolol</span> and biperiden, inhibited the haloperidol-induced <span class=""disease"">catalepsy</span>."		9201797.0	9201797_MESH:D011433_MESH:D002375	9201797_4	bcv_devset_test_100_easy_183		
	MESH:D004298	"<span class=""chemical"">dopamine</span>"	MESH:D011595	"<span class=""disease"">akathisia</span>"	"These results strongly suggest that carteolol improves haloperidol-induced catalepsy via its beta-adrenoceptor antagonistic activity and is expected to be effective in the treatment of <span class=""disease"">akathisia</span> without attenuating neuroleptic-induced antipsychotic effects due to its postsynaptic <span class=""chemical"">dopamine</span> receptor antagonistic activity."		9201797.0	9201797_MESH:D004298_MESH:D011595	9201797_10	bcv_devset_test_100_easy_184		
	MESH:D002354	"<span class=""chemical"">carteolol</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"These results strongly suggest that <span class=""chemical"">carteolol</span> improves haloperidol-induced <span class=""disease"">catalepsy</span> via its beta-adrenoceptor antagonistic activity and is expected to be effective in the treatment of akathisia without attenuating neuroleptic-induced antipsychotic effects due to its postsynaptic dopamine receptor antagonistic activity."		9201797.0	9201797_MESH:D002354_MESH:D002375	9201797_10	bcv_devset_test_100_easy_185		
	MESH:D002354	"<span class=""chemical"">carteolol</span>"	MESH:D011595	"<span class=""disease"">akathisia</span>"	"These results strongly suggest that <span class=""chemical"">carteolol</span> improves haloperidol-induced catalepsy via its beta-adrenoceptor antagonistic activity and is expected to be effective in the treatment of <span class=""disease"">akathisia</span> without attenuating neuroleptic-induced antipsychotic effects due to its postsynaptic dopamine receptor antagonistic activity."		9201797.0	9201797_MESH:D002354_MESH:D011595	9201797_10	bcv_devset_test_100_easy_186		
	MESH:D006220	"<span class=""chemical"">haloperidol</span>"	MESH:D011595	"<span class=""disease"">akathisia</span>"	"These results strongly suggest that carteolol improves <span class=""chemical"">haloperidol</span>-induced catalepsy via its beta-adrenoceptor antagonistic activity and is expected to be effective in the treatment of <span class=""disease"">akathisia</span> without attenuating neuroleptic-induced antipsychotic effects due to its postsynaptic dopamine receptor antagonistic activity."		9201797.0	9201797_MESH:D006220_MESH:D011595	9201797_10	bcv_devset_test_100_easy_187		
	MESH:D004298	"<span class=""chemical"">dopamine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"These results strongly suggest that carteolol improves haloperidol-induced <span class=""disease"">catalepsy</span> via its beta-adrenoceptor antagonistic activity and is expected to be effective in the treatment of akathisia without attenuating neuroleptic-induced antipsychotic effects due to its postsynaptic <span class=""chemical"">dopamine</span> receptor antagonistic activity."		9201797.0	9201797_MESH:D004298_MESH:D002375	9201797_10	bcv_devset_test_100_easy_188		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated."		6892185.0	6892185_MESH:D010830_MESH:D015878	6892185_1	bcv_devset_test_100_easy_189		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002217_MESH:D015878	6892185_1	bcv_devset_test_100_easy_190		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by carbachol and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002122_MESH:D004830	6892185_1	bcv_devset_test_100_easy_191		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated."		6892185.0	6892185_MESH:D010830_MESH:D014202	6892185_1	bcv_devset_test_100_easy_192		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002217_MESH:D004830	6892185_1	bcv_devset_test_100_easy_193		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002122_MESH:D015878	6892185_1	bcv_devset_test_100_easy_194		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002217_MESH:D014202	6892185_1	bcv_devset_test_100_easy_195		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated."		6892185.0	6892185_MESH:D010830_MESH:D004830	6892185_1	bcv_devset_test_100_easy_196		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated."		6892185.0	6892185_MESH:D002122_MESH:D014202	6892185_1	bcv_devset_test_100_easy_197		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D010830_MESH:D015878	6892185_3	bcv_devset_test_100_easy_198		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D002217_MESH:D015878	6892185_3	bcv_devset_test_100_easy_199		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>."		6892185.0	6892185_MESH:D002122_MESH:D004830	6892185_3	bcv_devset_test_100_easy_200		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D010830_MESH:D014202	6892185_3	bcv_devset_test_100_easy_201		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D002217_MESH:D004830	6892185_3	bcv_devset_test_100_easy_202		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>."		6892185.0	6892185_MESH:D002122_MESH:D015878	6892185_3	bcv_devset_test_100_easy_203		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D002217_MESH:D014202	6892185_3	bcv_devset_test_100_easy_204		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride."		6892185.0	6892185_MESH:D010830_MESH:D004830	6892185_3	bcv_devset_test_100_easy_205		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>."		6892185.0	6892185_MESH:D002122_MESH:D014202	6892185_3	bcv_devset_test_100_easy_206		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>."		6892185.0	6892185_MESH:D010830_MESH:D015878	6892185_4	bcv_devset_test_100_easy_207		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine."		6892185.0	6892185_MESH:D002217_MESH:D015878	6892185_4	bcv_devset_test_100_easy_208		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"It is apparent that <span class=""chemical"">calcium chloride</span> can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by carbachol and eserine."		6892185.0	6892185_MESH:D002122_MESH:D004830	6892185_4	bcv_devset_test_100_easy_209		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>."		6892185.0	6892185_MESH:D010830_MESH:D014202	6892185_4	bcv_devset_test_100_easy_210		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by <span class=""chemical"">carbachol</span> and eserine."		6892185.0	6892185_MESH:D002217_MESH:D004830	6892185_4	bcv_devset_test_100_easy_211		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D015878	"<span class=""disease"">mydriasis</span>"	"It is apparent that <span class=""chemical"">calcium chloride</span> can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and eserine."		6892185.0	6892185_MESH:D002122_MESH:D015878	6892185_4	bcv_devset_test_100_easy_212		
	MESH:D002217	"<span class=""chemical"">carbachol</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine."		6892185.0	6892185_MESH:D002217_MESH:D014202	6892185_4	bcv_devset_test_100_easy_213		
	MESH:D010830	"<span class=""chemical"">eserine</span>"	MESH:D004830	"<span class=""disease"">clonic-tonic convulsions</span>"	"It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by carbachol and <span class=""chemical"">eserine</span>."		6892185.0	6892185_MESH:D010830_MESH:D004830	6892185_4	bcv_devset_test_100_easy_214		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"It is apparent that <span class=""chemical"">calcium chloride</span> can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by carbachol and eserine."		6892185.0	6892185_MESH:D002122_MESH:D014202	6892185_4	bcv_devset_test_100_easy_215		
	MESH:D012110	"<span class=""chemical"">Reserpine</span>"	MESH:D004409	"<span class=""disease"">tardive dyskinesia/orofacial dyskinesia</span>"	"<span class=""chemical"">Reserpine</span> (1 mg/kg), administered once every other day for 4 days, produced increases in <span class=""disease"">orofacial dyskinesia</span>, tongue protrusion and vacuous chewing in mice, which are signs indicative of <span class=""disease"">tardive dyskinesia</span>."		11999899.0	11999899_MESH:D012110_MESH:D004409	11999899_3	bcv_devset_test_100_easy_216		
	MESH:D012110	"<span class=""chemical"">Reserpine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"<span class=""chemical"">Reserpine</span> also produced tremor and <span class=""disease"">catalepsy</span>, which are signs suggestive of Parkinson's disease."		11999899.0	11999899_MESH:D012110_MESH:D002375	11999899_4	bcv_devset_test_100_easy_217		
	MESH:D012110	"<span class=""chemical"">Reserpine</span>"	MESH:D010300	"<span class=""disease"">Parkinson's disease</span>"	"<span class=""chemical"">Reserpine</span> also produced tremor and catalepsy, which are signs suggestive of <span class=""disease"">Parkinson's disease</span>."		11999899.0	11999899_MESH:D012110_MESH:D010300	11999899_4	bcv_devset_test_100_easy_218		
	MESH:D012110	"<span class=""chemical"">Reserpine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"<span class=""chemical"">Reserpine</span> also produced <span class=""disease"">tremor</span> and catalepsy, which are signs suggestive of Parkinson's disease."		11999899.0	11999899_MESH:D012110_MESH:D014202	11999899_4	bcv_devset_test_100_easy_219		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"MK-801 (0.1 mg/kg), administered 30 min before the observation test, prevented the vacuous chewing movements, tongue protrusions and <span class=""disease"">catalepsy</span> induced by <span class=""chemical"">reserpine</span>."		11999899.0	11999899_MESH:D012110_MESH:D002375	11999899_5	bcv_devset_test_100_easy_220		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"<span class=""chemical"">MK-801</span> (0.1 mg/kg), administered 30 min before the observation test, prevented the vacuous chewing movements, tongue protrusions and <span class=""disease"">catalepsy</span> induced by reserpine."		11999899.0	11999899_MESH:D016291_MESH:D002375	11999899_5	bcv_devset_test_100_easy_221		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"However, <span class=""chemical"">MK-801</span> injection produced a significant increase of <span class=""disease"">tremor</span> in reserpine-treated mice."		11999899.0	11999899_MESH:D016291_MESH:D014202	11999899_6	bcv_devset_test_100_easy_222		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"However, MK-801 injection produced a significant increase of <span class=""disease"">tremor</span> in <span class=""chemical"">reserpine</span>-treated mice."		11999899.0	11999899_MESH:D012110_MESH:D014202	11999899_6	bcv_devset_test_100_easy_223		
	MESH:D012110	"<span class=""chemical"">Reserpine</span>"	MESH:D004409	"<span class=""disease"">oral dyskinesia</span>"	"<span class=""chemical"">Reserpine</span> (1 mg/kg), administered 90 min before the test and followed by apomophine injection (0.1 mg/kg) 5 min before the test, did not produce <span class=""disease"">oral dyskinesia</span> in mice."		11999899.0	11999899_MESH:D012110_MESH:D004409	11999899_7	bcv_devset_test_100_easy_224		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"On the other hand, <span class=""chemical"">reserpine</span> induced increases in tremor and <span class=""disease"">catalepsy</span> compared to control mice."		11999899.0	11999899_MESH:D012110_MESH:D002375	11999899_8	bcv_devset_test_100_easy_225		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"On the other hand, <span class=""chemical"">reserpine</span> induced increases in <span class=""disease"">tremor</span> and catalepsy compared to control mice."		11999899.0	11999899_MESH:D012110_MESH:D014202	11999899_8	bcv_devset_test_100_easy_226		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"<span class=""chemical"">MK-801</span> (0.1 mg/kg) administration attenuated the catalepsy and <span class=""disease"">tremor</span> induced by reserpine."		11999899.0	11999899_MESH:D016291_MESH:D014202	11999899_9	bcv_devset_test_100_easy_227		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"MK-801 (0.1 mg/kg) administration attenuated the <span class=""disease"">catalepsy</span> and tremor induced by <span class=""chemical"">reserpine</span>."		11999899.0	11999899_MESH:D012110_MESH:D002375	11999899_9	bcv_devset_test_100_easy_228		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"<span class=""chemical"">MK-801</span> (0.1 mg/kg) administration attenuated the <span class=""disease"">catalepsy</span> and tremor induced by reserpine."		11999899.0	11999899_MESH:D016291_MESH:D002375	11999899_9	bcv_devset_test_100_easy_229		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"MK-801 (0.1 mg/kg) administration attenuated the catalepsy and <span class=""disease"">tremor</span> induced by <span class=""chemical"">reserpine</span>."		11999899.0	11999899_MESH:D012110_MESH:D014202	11999899_9	bcv_devset_test_100_easy_230		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"Pretreatment with reserpine (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in <span class=""disease"">tremor</span> and catalepsy, whereas <span class=""chemical"">MK-801</span> (0.1 mg/kg) injection 90 min before the test reversed the effects of reserpine."		11999899.0	11999899_MESH:D016291_MESH:D014202	11999899_10	bcv_devset_test_100_easy_231		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Pretreatment with <span class=""chemical"">reserpine</span> (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in tremor and <span class=""disease"">catalepsy</span>, whereas MK-801 (0.1 mg/kg) injection 90 min before the test reversed the effects of <span class=""chemical"">reserpine</span>."		11999899.0	11999899_MESH:D012110_MESH:D002375	11999899_10	bcv_devset_test_100_easy_232		
	MESH:D016291	"<span class=""chemical"">MK-801</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"Pretreatment with reserpine (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in tremor and <span class=""disease"">catalepsy</span>, whereas <span class=""chemical"">MK-801</span> (0.1 mg/kg) injection 90 min before the test reversed the effects of reserpine."		11999899.0	11999899_MESH:D016291_MESH:D002375	11999899_10	bcv_devset_test_100_easy_233		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"Pretreatment with <span class=""chemical"">reserpine</span> (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in <span class=""disease"">tremor</span> and catalepsy, whereas MK-801 (0.1 mg/kg) injection 90 min before the test reversed the effects of <span class=""chemical"">reserpine</span>."		11999899.0	11999899_MESH:D012110_MESH:D014202	11999899_10	bcv_devset_test_100_easy_234		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D009069	"<span class=""disease"">tardive dsykinesia</span>"	"These results show that <span class=""chemical"">reserpine</span> produces different and abnormal movements, which are related to dose and schedule employed and can be considered as parkinsonian-like and <span class=""disease"">tardive dsykinesia</span> signs."		11999899.0	11999899_MESH:D012110_MESH:D009069	11999899_11	bcv_devset_test_100_easy_235		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D010300	"<span class=""disease"">parkinsonian</span>"	"These results show that <span class=""chemical"">reserpine</span> produces different and abnormal movements, which are related to dose and schedule employed and can be considered as <span class=""disease"">parkinsonian</span>-like and tardive dsykinesia signs."		11999899.0	11999899_MESH:D012110_MESH:D010300	11999899_11	bcv_devset_test_100_easy_236		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D004409	"<span class=""disease"">abnormal movements</span>"	"These results show that <span class=""chemical"">reserpine</span> produces different and <span class=""disease"">abnormal movements</span>, which are related to dose and schedule employed and can be considered as parkinsonian-like and tardive dsykinesia signs."		11999899.0	11999899_MESH:D012110_MESH:D004409	11999899_11	bcv_devset_test_100_easy_237		
	MESH:D016202	"<span class=""chemical"">NMDA</span>"	MESH:D014202	"<span class=""disease"">tremor</span>"	"The glutamatergic blockage produced by <span class=""chemical"">NMDA</span> can restore these signs, such as vacuous chewing movements, tongue protrusions, catalepsy and <span class=""disease"">tremor</span> according to the employed model."		11999899.0	11999899_MESH:D016202_MESH:D014202	11999899_12	bcv_devset_test_100_easy_238		
	MESH:D016202	"<span class=""chemical"">NMDA</span>"	MESH:D002375	"<span class=""disease"">catalepsy</span>"	"The glutamatergic blockage produced by <span class=""chemical"">NMDA</span> can restore these signs, such as vacuous chewing movements, tongue protrusions, <span class=""disease"">catalepsy</span> and tremor according to the employed model."		11999899.0	11999899_MESH:D016202_MESH:D002375	11999899_12	bcv_devset_test_100_easy_239		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"Effect of <span class=""chemical"">captopril</span> on pre-existing and aminonucleoside-induced proteinuria in spontaneously <span class=""disease"">hypertensive</span> rats."		6454943.0	6454943_MESH:D002216_MESH:D006973	6454943_0	bcv_devset_test_100_easy_240		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D011507	"<span class=""disease"">proteinuria</span>"	"Effect of <span class=""chemical"">captopril</span> on pre-existing and aminonucleoside-induced <span class=""disease"">proteinuria</span> in spontaneously hypertensive rats."		6454943.0	6454943_MESH:D002216_MESH:D011507	6454943_0	bcv_devset_test_100_easy_241		
	MESH:D011692	"<span class=""chemical"">aminonucleoside</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"Effect of captopril on pre-existing and <span class=""chemical"">aminonucleoside</span>-induced proteinuria in spontaneously <span class=""disease"">hypertensive</span> rats."		6454943.0	6454943_MESH:D011692_MESH:D006973	6454943_0	bcv_devset_test_100_easy_242		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"Proteinuria is a side effect of <span class=""chemical"">captopril</span> treatment in <span class=""disease"">hypertensive</span> patients."		6454943.0	6454943_MESH:D002216_MESH:D006973	6454943_1	bcv_devset_test_100_easy_243		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D011507	"<span class=""disease"">Proteinuria</span>"	"<span class=""disease"">Proteinuria</span> is a side effect of <span class=""chemical"">captopril</span> treatment in hypertensive patients."		6454943.0	6454943_MESH:D002216_MESH:D011507	6454943_1	bcv_devset_test_100_easy_244		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D007674	"<span class=""disease"">renal abnormality</span>"	"The possibility of reproducing the same <span class=""disease"">renal abnormality</span> with <span class=""chemical"">captopril</span> was examined in SHR."		6454943.0	6454943_MESH:D002216_MESH:D007674	6454943_2	bcv_devset_test_100_easy_245		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D011507	"<span class=""disease"">proteinuria</span>"	"Oral administration of <span class=""chemical"">captopril</span> at 100 mg/kg for 14 days failed to aggravate <span class=""disease"">proteinuria</span> pre-existing in SHR."		6454943.0	6454943_MESH:D002216_MESH:D011507	6454943_3	bcv_devset_test_100_easy_246		
	MESH:D002216	"<span class=""chemical"">captopril</span>"	MESH:D011507	"<span class=""disease"">proteinuria</span>"	"Also, <span class=""chemical"">captopril</span> treatment failed to potentiate or facilitate development of massive <span class=""disease"">proteinuria</span> invoked by puromycin aminonucleoside in SHR."		6454943.0	6454943_MESH:D002216_MESH:D011507	6454943_4	bcv_devset_test_100_easy_247		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">atrial fibrillation</span>"	"Effects of <span class=""chemical"">verapamil</span> on <span class=""disease"">atrial fibrillation</span> and its electrophysiological determinants in dogs."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_0	bcv_devset_test_100_easy_248		
	MESH:D002118	"<span class=""chemical"">Ca</span>"	MESH:D013617	"<span class=""disease"">Atrial tachycardia</span>"	"BACKGROUND: <span class=""disease"">Atrial tachycardia</span>-induced remodeling promotes the occurrence and maintenance of atrial fibrillation (AF) and decreases L-type <span class=""chemical"">Ca</span>(2+) current."		11282081.0	11282081_MESH:D002118_MESH:D013617	11282081_1	bcv_devset_test_100_easy_249		
	MESH:D002118	"<span class=""chemical"">Ca</span>"	MESH:D001281	"<span class=""disease"">atrial fibrillation/AF</span>"	"BACKGROUND: Atrial tachycardia-induced remodeling promotes the occurrence and maintenance of <span class=""disease"">atrial fibrillation</span> (<span class=""disease"">AF</span>) and decreases L-type <span class=""chemical"">Ca</span>(2+) current."		11282081.0	11282081_MESH:D002118_MESH:D001281	11282081_1	bcv_devset_test_100_easy_250		
	MESH:D002118	"<span class=""chemical"">Ca</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"There is also a clinical suggestion that acute L-type <span class=""chemical"">Ca</span>(2) channel blockade can promote <span class=""disease"">AF</span>, consistent with an <span class=""disease"">AF</span> promoting effect of <span class=""chemical"">Ca</span>(2+) channel inhibition."		11282081.0	11282081_MESH:D002118_MESH:D001281	11282081_2	bcv_devset_test_100_easy_251		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"METHODS: To evaluate the potential mechanisms of <span class=""disease"">AF</span> promotion by Ca(2+) channel blockers, we administered <span class=""chemical"">verapamil</span> to morphine-chloralose anesthetized dogs."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_3	bcv_devset_test_100_easy_252		
	MESH:D002118	"<span class=""chemical"">Ca</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"METHODS: To evaluate the potential mechanisms of <span class=""disease"">AF</span> promotion by <span class=""chemical"">Ca</span>(2+) channel blockers, we administered verapamil to morphine-chloralose anesthetized dogs."		11282081.0	11282081_MESH:D002118_MESH:D001281	11282081_3	bcv_devset_test_100_easy_253		
	MESH:D009020	"<span class=""chemical"">morphine</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"METHODS: To evaluate the potential mechanisms of <span class=""disease"">AF</span> promotion by Ca(2+) channel blockers, we administered verapamil to <span class=""chemical"">morphine</span>-chloralose anesthetized dogs."		11282081.0	11282081_MESH:D009020_MESH:D001281	11282081_3	bcv_devset_test_100_easy_254		
	MESH:D002698	"<span class=""chemical"">chloralose</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"METHODS: To evaluate the potential mechanisms of <span class=""disease"">AF</span> promotion by Ca(2+) channel blockers, we administered verapamil to morphine-<span class=""chemical"">chloralose</span> anesthetized dogs."		11282081.0	11282081_MESH:D002698_MESH:D001281	11282081_3	bcv_devset_test_100_easy_255		
	MESH:D014700	"<span class=""chemical"">Verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"RESULTS: <span class=""chemical"">Verapamil</span> caused <span class=""disease"">AF</span> promotion in six dogs, increasing mean duration of <span class=""disease"">AF</span> induced by burst pacing, from 8+/-4 s (mean+/-S.E.) to 95+/-39 s (P<0.01 vs. control) at a loading dose of 0.1 mg/kg and 228+/-101 s (P<0.0005 vs. control) at a dose of 0.2 mg/kg."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_6	bcv_devset_test_100_easy_256		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"In these experiments, <span class=""chemical"">verapamil</span> shortened mean effective refractory period (ERP) from 122+/-5 to 114+/-4 ms (P<0.02) at a cycle length of 300 ms, decreased ERP heterogeneity (from 15+/-1 to 10+/-1%, P<0.05), heterogeneously accelerated atrial conduction and decreased the cycle length of <span class=""disease"">AF</span> (94+/-4 to 84+/-3 ms, P<0.005)."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_8	bcv_devset_test_100_easy_257		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"Diltiazem did not affect ERP, <span class=""disease"">AF</span> cycle length or <span class=""disease"">AF</span> duration, but produced conduction acceleration similar to that caused by <span class=""chemical"">verapamil</span> (n=5)."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_9	bcv_devset_test_100_easy_258		
	MESH:D004110	"<span class=""chemical"">Diltiazem</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"<span class=""chemical"">Diltiazem</span> did not affect ERP, <span class=""disease"">AF</span> cycle length or <span class=""disease"">AF</span> duration, but produced conduction acceleration similar to that caused by verapamil (n=5)."		11282081.0	11282081_MESH:D004110_MESH:D001281	11282081_9	bcv_devset_test_100_easy_259		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"In the presence of autonomic blockade, <span class=""chemical"">verapamil</span> failed to promote <span class=""disease"">AF</span> and increased, rather than decreasing, refractoriness."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_10	bcv_devset_test_100_easy_260		
	MESH:D014700	"<span class=""chemical"">verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"Epicardial mapping suggested that <span class=""chemical"">verapamil</span> promoted <span class=""disease"">AF</span> by increasing the number of simultaneous wavefronts reflected by separate zones of reactivation in each cycle."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_12	bcv_devset_test_100_easy_261		
	MESH:D014700	"<span class=""chemical"">Verapamil</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"CONCLUSIONS: <span class=""chemical"">Verapamil</span> promotes <span class=""disease"">AF</span> in normal dogs by promoting multiple circuit reentry, an effect dependent on intact autonomic tone and not shared by diltiazem."		11282081.0	11282081_MESH:D014700_MESH:D001281	11282081_13	bcv_devset_test_100_easy_262		
	MESH:D004110	"<span class=""chemical"">diltiazem</span>"	MESH:D001281	"<span class=""disease"">AF</span>"	"CONCLUSIONS: Verapamil promotes <span class=""disease"">AF</span> in normal dogs by promoting multiple circuit reentry, an effect dependent on intact autonomic tone and not shared by <span class=""chemical"">diltiazem</span>."		11282081.0	11282081_MESH:D004110_MESH:D001281	11282081_13	bcv_devset_test_100_easy_263		
	MESH:D003520	"<span class=""chemical"">CYP</span>"	MESH:D001749	"<span class=""disease"">bladder inflammation</span>"	"The data suggest that in VIP(-/-) mice with <span class=""disease"">bladder inflammation</span>, inflammatory mediators are increased above that observed in WT with <span class=""chemical"">CYP</span>."		18483878.0	18483878_MESH:D003520_MESH:D001749	18483878_9	bcv_devset_test_100_easy_264		
	MESH:D013496	"<span class=""chemical"">suprofen</span>"	MESH:D021501	"<span class=""disease"">flank pain</span>"	"The epidemiology of the acute <span class=""disease"">flank pain</span> syndrome from <span class=""chemical"">suprofen</span>."		2598570.0	2598570_MESH:D013496_MESH:D021501	2598570_0	bcv_devset_test_100_easy_265		
	MESH:D000431	"<span class=""chemical"">alcohol</span>"	MESH:D006255	"<span class=""disease"">hay fever</span>"	"Case patients were more likely to be men (odds ratio, 3.8; 95% confidence interval, 1.2-12.1), suffer from <span class=""disease"">hay fever</span> and asthma (odds ratio, 3.4; 95% confidence interval, 1.0-11.9); to participate in regular exercise (odds ratio, 5.9; 95% confidence interval, 1.1-30.7), especially in the use of Nautilus equipment (p = 0.02); and to use <span class=""chemical"">alcohol</span> (odds ratio, 4.4; 95% confidence interval, 1.1-17.5)."		2598570.0	2598570_MESH:D000431_MESH:D006255	2598570_5	bcv_devset_test_100_easy_266		
	MESH:D000431	"<span class=""chemical"">alcohol</span>"	MESH:D001249	"<span class=""disease"">asthma</span>"	"Case patients were more likely to be men (odds ratio, 3.8; 95% confidence interval, 1.2-12.1), suffer from hay fever and <span class=""disease"">asthma</span> (odds ratio, 3.4; 95% confidence interval, 1.0-11.9); to participate in regular exercise (odds ratio, 5.9; 95% confidence interval, 1.1-30.7), especially in the use of Nautilus equipment (p = 0.02); and to use <span class=""chemical"">alcohol</span> (odds ratio, 4.4; 95% confidence interval, 1.1-17.5)."		2598570.0	2598570_MESH:D000431_MESH:D001249	2598570_5	bcv_devset_test_100_easy_267		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D007674	"<span class=""disease"">renal disease</span>"	"Possible risk factors included young age, concurrent use of other analgesic agents (especially <span class=""chemical"">ibuprofen</span>), preexisting <span class=""disease"">renal disease</span>, a history of kidney stones, a history of gout, a recent increase in activity, a recent increase in sun exposure, and residence in the Sunbelt."		2598570.0	2598570_MESH:D007052_MESH:D007674	2598570_6	bcv_devset_test_100_easy_268		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D007669	"<span class=""disease"">kidney stones</span>"	"Possible risk factors included young age, concurrent use of other analgesic agents (especially <span class=""chemical"">ibuprofen</span>), preexisting renal disease, a history of <span class=""disease"">kidney stones</span>, a history of gout, a recent increase in activity, a recent increase in sun exposure, and residence in the Sunbelt."		2598570.0	2598570_MESH:D007052_MESH:D007669	2598570_6	bcv_devset_test_100_easy_269		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D006073	"<span class=""disease"">gout</span>"	"Possible risk factors included young age, concurrent use of other analgesic agents (especially <span class=""chemical"">ibuprofen</span>), preexisting renal disease, a history of kidney stones, a history of <span class=""disease"">gout</span>, a recent increase in activity, a recent increase in sun exposure, and residence in the Sunbelt."		2598570.0	2598570_MESH:D007052_MESH:D006073	2598570_6	bcv_devset_test_100_easy_270		
	MESH:C076029	"<span class=""chemical"">olanzapine</span>"	MESH:D011618	"<span class=""disease"">psychotic disorder</span>"	"We report a female patient with a diagnosis of a not otherwise specified <span class=""disease"">psychotic disorder</span> (DSM-IV) who developed hypomania shortly after the introduction of <span class=""chemical"">olanzapine</span> treatment."		10565806.0	10565806_MESH:C076029_MESH:D011618	10565806_1	bcv_devset_test_100_easy_271		
	MESH:C084820	"<span class=""chemical"">Ethopropazine</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"<span class=""chemical"">Ethopropazine</span> and benztropine in neuroleptic-induced <span class=""disease"">parkinsonism</span>."		33969.0	33969_MESH:C084820_MESH:D010302	33969_0	bcv_devset_test_100_easy_272		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"Ethopropazine and <span class=""chemical"">benztropine</span> in neuroleptic-induced <span class=""disease"">parkinsonism</span>."		33969.0	33969_MESH:D001590_MESH:D010302	33969_0	bcv_devset_test_100_easy_273		
	MESH:C084820	"<span class=""chemical"">ethopropazine</span>"	MESH:D012559	"<span class=""disease"">schizophrenic</span>"	"In a 12-week controlled study <span class=""chemical"">ethopropazine</span> was compared to benztropine in the treatment of parkinsonism induced by fluphenazine enanthate in 60 <span class=""disease"">schizophrenic</span> outpatients."		33969.0	33969_MESH:C084820_MESH:D012559	33969_1	bcv_devset_test_100_easy_274		
	MESH:C017610	"<span class=""chemical"">fluphenazine enanthate</span>"	MESH:D012559	"<span class=""disease"">schizophrenic</span>"	"In a 12-week controlled study ethopropazine was compared to benztropine in the treatment of parkinsonism induced by <span class=""chemical"">fluphenazine enanthate</span> in 60 <span class=""disease"">schizophrenic</span> outpatients."		33969.0	33969_MESH:C017610_MESH:D012559	33969_1	bcv_devset_test_100_easy_275		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"In a 12-week controlled study ethopropazine was compared to <span class=""chemical"">benztropine</span> in the treatment of <span class=""disease"">parkinsonism</span> induced by fluphenazine enanthate in 60 schizophrenic outpatients."		33969.0	33969_MESH:D001590_MESH:D010302	33969_1	bcv_devset_test_100_easy_276		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D012559	"<span class=""disease"">schizophrenic</span>"	"In a 12-week controlled study ethopropazine was compared to <span class=""chemical"">benztropine</span> in the treatment of parkinsonism induced by fluphenazine enanthate in 60 <span class=""disease"">schizophrenic</span> outpatients."		33969.0	33969_MESH:D001590_MESH:D012559	33969_1	bcv_devset_test_100_easy_277		
	MESH:C084820	"<span class=""chemical"">ethopropazine</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"In a 12-week controlled study <span class=""chemical"">ethopropazine</span> was compared to benztropine in the treatment of <span class=""disease"">parkinsonism</span> induced by fluphenazine enanthate in 60 schizophrenic outpatients."		33969.0	33969_MESH:C084820_MESH:D010302	33969_1	bcv_devset_test_100_easy_278		
	MESH:C017610	"<span class=""chemical"">fluphenazine enanthate</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"In a 12-week controlled study ethopropazine was compared to benztropine in the treatment of <span class=""disease"">parkinsonism</span> induced by <span class=""chemical"">fluphenazine enanthate</span> in 60 schizophrenic outpatients."		33969.0	33969_MESH:C017610_MESH:D010302	33969_1	bcv_devset_test_100_easy_279		
	MESH:C084820	"<span class=""chemical"">Ethopropazine</span>"	MESH:D010302	"<span class=""disease"">parkinsonian symptoms</span>"	"<span class=""chemical"">Ethopropazine</span> and benztropine were found to be equally effective in controlling <span class=""disease"">parkinsonian symptoms</span> and were as efficacious as procyclidine, their previous antiparkinsonian drug."		33969.0	33969_MESH:C084820_MESH:D010302	33969_2	bcv_devset_test_100_easy_280		
	MESH:D011352	"<span class=""chemical"">procyclidine</span>"	MESH:D010302	"<span class=""disease"">parkinsonian symptoms</span>"	"Ethopropazine and benztropine were found to be equally effective in controlling <span class=""disease"">parkinsonian symptoms</span> and were as efficacious as <span class=""chemical"">procyclidine</span>, their previous antiparkinsonian drug."		33969.0	33969_MESH:D011352_MESH:D010302	33969_2	bcv_devset_test_100_easy_281		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D010302	"<span class=""disease"">parkinsonian symptoms</span>"	"Ethopropazine and <span class=""chemical"">benztropine</span> were found to be equally effective in controlling <span class=""disease"">parkinsonian symptoms</span> and were as efficacious as procyclidine, their previous antiparkinsonian drug."		33969.0	33969_MESH:D001590_MESH:D010302	33969_2	bcv_devset_test_100_easy_282		
	MESH:C084820	"<span class=""chemical"">ethopropazine</span>"	MESH:D003866	"<span class=""disease"">depression</span>"	"However, benztropine treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment, and significantly more anxiety and <span class=""disease"">depression</span> than <span class=""chemical"">ethopropazine</span> treated patients."		33969.0	33969_MESH:C084820_MESH:D003866	33969_3	bcv_devset_test_100_easy_283		
	MESH:C084820	"<span class=""chemical"">ethopropazine</span>"	MESH:D004409	"<span class=""disease"">tardive dyskinesia</span>"	"However, benztropine treated patients had a significant increase in <span class=""disease"">tardive dyskinesia</span> compared to their condition during procyclindine treatment, and significantly more anxiety and depression than <span class=""chemical"">ethopropazine</span> treated patients."		33969.0	33969_MESH:C084820_MESH:D004409	33969_3	bcv_devset_test_100_easy_284		
	MESH:C084820	"<span class=""chemical"">ethopropazine</span>"	MESH:D001008	"<span class=""disease"">anxiety</span>"	"However, benztropine treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment, and significantly more <span class=""disease"">anxiety</span> and depression than <span class=""chemical"">ethopropazine</span> treated patients."		33969.0	33969_MESH:C084820_MESH:D001008	33969_3	bcv_devset_test_100_easy_285		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D003866	"<span class=""disease"">depression</span>"	"However, <span class=""chemical"">benztropine</span> treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment, and significantly more anxiety and <span class=""disease"">depression</span> than ethopropazine treated patients."		33969.0	33969_MESH:D001590_MESH:D003866	33969_3	bcv_devset_test_100_easy_286		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D004409	"<span class=""disease"">tardive dyskinesia</span>"	"However, <span class=""chemical"">benztropine</span> treated patients had a significant increase in <span class=""disease"">tardive dyskinesia</span> compared to their condition during procyclindine treatment, and significantly more anxiety and depression than ethopropazine treated patients."		33969.0	33969_MESH:D001590_MESH:D004409	33969_3	bcv_devset_test_100_easy_287		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D001008	"<span class=""disease"">anxiety</span>"	"However, <span class=""chemical"">benztropine</span> treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment, and significantly more <span class=""disease"">anxiety</span> and depression than ethopropazine treated patients."		33969.0	33969_MESH:D001590_MESH:D001008	33969_3	bcv_devset_test_100_easy_288		
	MESH:D001590	"<span class=""chemical"">benztropine</span>"	MESH:D010302	"<span class=""disease"">parkinsonian symptoms</span>"	"This suggests that <span class=""chemical"">benztropine</span> is not the anticholinergic drug of choice in the treatment of neuroleptic-induced <span class=""disease"">parkinsonian symptoms</span>, because of its more toxic central and peripheral atropinic effect."		33969.0	33969_MESH:D001590_MESH:D010302	33969_4	bcv_devset_test_100_easy_289		
	MESH:D008130	"<span class=""chemical"">CCNU/lomustine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"<span class=""chemical"">CCNU</span> (<span class=""chemical"">lomustine</span>) <span class=""disease"">toxicity</span> in dogs: a retrospective study (2002-07)."		21418164.0	21418164_MESH:D008130_MESH:D064420	21418164_0	bcv_devset_test_100_easy_290		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D056486	"<span class=""disease"">haematological, renal, hepatic and gastrointestinal toxicities</span>"	"OBJECTIVE: To describe the incidence of <span class=""disease"">haematological, renal, hepatic and gastrointestinal toxicities</span> in tumour-bearing dogs receiving 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (<span class=""chemical"">CCNU</span>)."		21418164.0	21418164_MESH:D008130_MESH:D056486	21418164_1	bcv_devset_test_100_easy_291		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"RESULTS: Of the 206 dogs treated with <span class=""chemical"">CCNU</span>, 185 met the inclusion criteria for at least one class of <span class=""disease"">toxicity</span>."		21418164.0	21418164_MESH:D008130_MESH:D064420	21418164_3	bcv_devset_test_100_easy_292		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D008223	"<span class=""disease"">epitheliotropic lymphoma/lymphoma</span>"	"<span class=""chemical"">CCNU</span> was used most commonly in the treatment of <span class=""disease"">lymphoma</span>, mast cell tumour, brain tumour, histiocytic tumours and <span class=""disease"">epitheliotropic lymphoma</span>."		21418164.0	21418164_MESH:D008130_MESH:D008223	21418164_4	bcv_devset_test_100_easy_293		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D034801	"<span class=""disease"">mast cell tumour</span>"	"<span class=""chemical"">CCNU</span> was used most commonly in the treatment of lymphoma, <span class=""disease"">mast cell tumour</span>, brain tumour, histiocytic tumours and epitheliotropic lymphoma."		21418164.0	21418164_MESH:D008130_MESH:D034801	21418164_4	bcv_devset_test_100_easy_294		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D001932	"<span class=""disease"">brain tumour</span>"	"<span class=""chemical"">CCNU</span> was used most commonly in the treatment of lymphoma, mast cell tumour, <span class=""disease"">brain tumour</span>, histiocytic tumours and epitheliotropic lymphoma."		21418164.0	21418164_MESH:D008130_MESH:D001932	21418164_4	bcv_devset_test_100_easy_295		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D015620	"<span class=""disease"">histiocytic tumours</span>"	"<span class=""chemical"">CCNU</span> was used most commonly in the treatment of lymphoma, mast cell tumour, brain tumour, <span class=""disease"">histiocytic tumours</span> and epitheliotropic lymphoma."		21418164.0	21418164_MESH:D008130_MESH:D015620	21418164_4	bcv_devset_test_100_easy_296		
	MESH:D000409	"<span class=""chemical"">alanine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Potential renal <span class=""disease"">toxicity</span> and elevated <span class=""chemical"">alanine</span> transaminase (ALT) concentration were reported in 12.2% and 48.8% of dogs, respectively."		21418164.0	21418164_MESH:D000409_MESH:D064420	21418164_7	bcv_devset_test_100_easy_297		
	MESH:D008130	"<span class=""chemical"">CCNU</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"CONCLUSIONS: <span class=""chemical"">CCNU</span>-associated <span class=""disease"">toxicity</span> in dogs is common, but is usually not life threatening."		21418164.0	21418164_MESH:D008130_MESH:D064420	21418164_9	bcv_devset_test_100_easy_298		
	MESH:C012052	"<span class=""chemical"">Amisulpride</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"<span class=""chemical"">Amisulpride</span> related <span class=""disease"">tic-like symptoms</span> in an adolescent schizophrenic."		16225977.0	16225977_MESH:C012052_MESH:D013981	16225977_0	bcv_devset_test_100_easy_299		
	MESH:C012052	"<span class=""chemical"">Amisulpride</span>"	MESH:D012559	"<span class=""disease"">schizophrenic</span>"	"<span class=""chemical"">Amisulpride</span> related tic-like symptoms in an adolescent <span class=""disease"">schizophrenic</span>."		16225977.0	16225977_MESH:C012052_MESH:D012559	16225977_0	bcv_devset_test_100_easy_300		
	MESH:D018967	"<span class=""chemical"">risperidone</span>"	MESH:D013981	"<span class=""disease"">Tic disorders</span>"	"<span class=""disease"">Tic disorders</span> can be effectively treated by atypical antipsychotics such as <span class=""chemical"">risperidone</span>, olanzapine and ziprasidone."		16225977.0	16225977_MESH:D018967_MESH:D013981	16225977_1	bcv_devset_test_100_easy_301		
	MESH:C076029	"<span class=""chemical"">olanzapine</span>"	MESH:D013981	"<span class=""disease"">Tic disorders</span>"	"<span class=""disease"">Tic disorders</span> can be effectively treated by atypical antipsychotics such as risperidone, <span class=""chemical"">olanzapine</span> and ziprasidone."		16225977.0	16225977_MESH:C076029_MESH:D013981	16225977_1	bcv_devset_test_100_easy_302		
	MESH:C092292	"<span class=""chemical"">ziprasidone</span>"	MESH:D013981	"<span class=""disease"">Tic disorders</span>"	"<span class=""disease"">Tic disorders</span> can be effectively treated by atypical antipsychotics such as risperidone, olanzapine and <span class=""chemical"">ziprasidone</span>."		16225977.0	16225977_MESH:C092292_MESH:D013981	16225977_1	bcv_devset_test_100_easy_303		
	MESH:D003024	"<span class=""chemical"">clozapine</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"However, there are two case reports that show <span class=""disease"">tic-like symptoms</span>, including motor and phonic variants, occurring during treatment with quetiapine or <span class=""chemical"">clozapine</span>."		16225977.0	16225977_MESH:D003024_MESH:D013981	16225977_2	bcv_devset_test_100_easy_304		
	MESH:C069541	"<span class=""chemical"">quetiapine</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"However, there are two case reports that show <span class=""disease"">tic-like symptoms</span>, including motor and phonic variants, occurring during treatment with <span class=""chemical"">quetiapine</span> or clozapine."		16225977.0	16225977_MESH:C069541_MESH:D013981	16225977_2	bcv_devset_test_100_easy_305		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D012559	"<span class=""disease"">schizophrenic</span>"	"We present a 15-year-old girl <span class=""disease"">schizophrenic</span> who developed frequent involuntary eye-blinking movements after 5 months of <span class=""chemical"">amisulpride</span> treatment (1000 mg per day)."		16225977.0	16225977_MESH:C012052_MESH:D012559	16225977_3	bcv_devset_test_100_easy_306		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D020820	"<span class=""disease"">involuntary eye-blinking movements</span>"	"We present a 15-year-old girl schizophrenic who developed frequent <span class=""disease"">involuntary eye-blinking movements</span> after 5 months of <span class=""chemical"">amisulpride</span> treatment (1000 mg per day)."		16225977.0	16225977_MESH:C012052_MESH:D020820	16225977_3	bcv_devset_test_100_easy_307		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"The <span class=""disease"">tic-like symptoms</span> resolved completely after we reduced the dose of <span class=""chemical"">amisulpride</span> down to 800 mg per day."		16225977.0	16225977_MESH:C012052_MESH:D013981	16225977_4	bcv_devset_test_100_easy_308		
	MESH:D003024	"<span class=""chemical"">clozapine</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"Together with previously reported cases, our patient suggests that <span class=""disease"">tic-like symptoms</span> might occur in certain vulnerable individuals during treatment with atypical antipsychotics such as quetiapine, <span class=""chemical"">clozapine</span>, or amisulpride."		16225977.0	16225977_MESH:D003024_MESH:D013981	16225977_9	bcv_devset_test_100_easy_309		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"Together with previously reported cases, our patient suggests that <span class=""disease"">tic-like symptoms</span> might occur in certain vulnerable individuals during treatment with atypical antipsychotics such as quetiapine, clozapine, or <span class=""chemical"">amisulpride</span>."		16225977.0	16225977_MESH:C012052_MESH:D013981	16225977_9	bcv_devset_test_100_easy_310		
	MESH:C069541	"<span class=""chemical"">quetiapine</span>"	MESH:D013981	"<span class=""disease"">tic-like symptoms</span>"	"Together with previously reported cases, our patient suggests that <span class=""disease"">tic-like symptoms</span> might occur in certain vulnerable individuals during treatment with atypical antipsychotics such as <span class=""chemical"">quetiapine</span>, clozapine, or amisulpride."		16225977.0	16225977_MESH:C069541_MESH:D013981	16225977_9	bcv_devset_test_100_easy_311		
	MESH:D009569	"<span class=""chemical"">Nitric oxide</span>"	MESH:D006973	"<span class=""disease"">hypertension</span>"	"<span class=""chemical"">Nitric oxide</span> synthase expression in the course of lead-induced <span class=""disease"">hypertension</span>."		10523326.0	10523326_MESH:D009569_MESH:D006973	10523326_0	bcv_devset_test_100_easy_312		
	MESH:D010100	"<span class=""chemical"">oxygen</span>"	MESH:D006973	"<span class=""disease"">hypertension</span>"	"We recently showed elevated reactive <span class=""chemical"">oxygen</span> species (ROS), reduced urinary excretion of NO metabolites (NOx), and increased NO sequestration as nitrotyrosine in various tissues in rats with lead-induced <span class=""disease"">hypertension</span>."		10523326.0	10523326_MESH:D010100_MESH:D006973	10523326_1	bcv_devset_test_100_easy_313		
	MESH:D014810	"<span class=""chemical"">Vitamin E</span>"	MESH:D006973	"<span class=""disease"">hypertension</span>"	"<span class=""chemical"">Vitamin E</span> supplementation ameliorated <span class=""disease"">hypertension</span>, lowered plasma MDA concentration, and raised urinary NOx excretion while significantly lowering vascular, but not renal, tissue eNOS and iNOS expression."		10523326.0	10523326_MESH:D014810_MESH:D006973	10523326_6	bcv_devset_test_100_easy_314		
	MESH:D008315	"<span class=""chemical"">MDA</span>"	MESH:D006973	"<span class=""disease"">hypertension</span>"	"Vitamin E supplementation ameliorated <span class=""disease"">hypertension</span>, lowered plasma <span class=""chemical"">MDA</span> concentration, and raised urinary NOx excretion while significantly lowering vascular, but not renal, tissue eNOS and iNOS expression."		10523326.0	10523326_MESH:D008315_MESH:D006973	10523326_6	bcv_devset_test_100_easy_315		
	MESH:D008148	"<span class=""chemical"">lovastatin</span>"	MESH:D006937	"<span class=""disease"">hypercholesterolemia</span>"	"Efficacy and tolerability of <span class=""chemical"">lovastatin</span> in 3390 women with moderate <span class=""disease"">hypercholesterolemia</span>."		8480959.0	8480959_MESH:D008148_MESH:D006937	8480959_0	bcv_devset_test_100_easy_316		
	MESH:D008148	"<span class=""chemical"">lovastatin</span>"	MESH:D006937	"<span class=""disease"">hypercholesterolemia</span>"	"OBJECTIVE: To evaluate the efficacy and safety of <span class=""chemical"">lovastatin</span> in women with moderate <span class=""disease"">hypercholesterolemia</span>."		8480959.0	8480959_MESH:D008148_MESH:D006937	8480959_1	bcv_devset_test_100_easy_317		
	MESH:D003401	"<span class=""chemical"">creatine</span>"	MESH:D009135	"<span class=""disease"">Myopathy</span>"	"<span class=""disease"">Myopathy</span>, defined as muscle symptoms with <span class=""chemical"">creatine</span> kinase elevations greater than 10 times the upper limit of normal, was rare and associated with the highest recommended daily dose of lovastatin (80 mg)."		8480959.0	8480959_MESH:D003401_MESH:D009135	8480959_9	bcv_devset_test_100_easy_318		
	MESH:D008148	"<span class=""chemical"">lovastatin</span>"	MESH:D009135	"<span class=""disease"">Myopathy</span>"	"<span class=""disease"">Myopathy</span>, defined as muscle symptoms with creatine kinase elevations greater than 10 times the upper limit of normal, was rare and associated with the highest recommended daily dose of <span class=""chemical"">lovastatin</span> (80 mg)."		8480959.0	8480959_MESH:D008148_MESH:D009135	8480959_9	bcv_devset_test_100_easy_319		
	MESH:D008148	"<span class=""chemical"">Lovastatin</span>"	MESH:D006937	"<span class=""disease"">hypercholesterolemia</span>"	"CONCLUSION: <span class=""chemical"">Lovastatin</span> is highly effective and generally well tolerated as therapy for primary <span class=""disease"">hypercholesterolemia</span> in women."		8480959.0	8480959_MESH:D008148_MESH:D006937	8480959_11	bcv_devset_test_100_easy_320		
	MESH:D003630	"<span class=""chemical"">daunorubicin</span>"	MESH:D012514	"<span class=""disease"">Kaposi's sarcoma</span>"	"Liposomal <span class=""chemical"">daunorubicin</span> in advanced <span class=""disease"">Kaposi's sarcoma</span>: a phase II study."		8305357.0	8305357_MESH:D003630_MESH:D012514	8305357_0	bcv_devset_test_100_easy_321		
	MESH:D003630	"<span class=""chemical"">daunorubicin</span>"	MESH:D012514	"<span class=""disease"">Kaposi's sarcoma</span>"	"We report a non-randomized Phase II clinical trial to assess the efficacy and safety of liposomal <span class=""chemical"">daunorubicin</span> (DaunoXome) in the treatment of AIDS related <span class=""disease"">Kaposi's sarcoma</span>."		8305357.0	8305357_MESH:D003630_MESH:D012514	8305357_1	bcv_devset_test_100_easy_322		
	MESH:D003630	"<span class=""chemical"">daunorubicin</span>"	MESH:D000163	"<span class=""disease"">AIDS</span>"	"We report a non-randomized Phase II clinical trial to assess the efficacy and safety of liposomal <span class=""chemical"">daunorubicin</span> (DaunoXome) in the treatment of <span class=""disease"">AIDS</span> related Kaposi's sarcoma."		8305357.0	8305357_MESH:D003630_MESH:D000163	8305357_1	bcv_devset_test_100_easy_323		
	MESH:D003630	"<span class=""chemical"">daunorubicin</span>"	MESH:D012514	"<span class=""disease"">Kaposi's sarcoma</span>"	"In this small patient sample, liposomal <span class=""chemical"">daunorubicin</span> was an effective and well tolerated agent in the treatment of <span class=""disease"">Kaposi's sarcoma</span>."		8305357.0	8305357_MESH:D003630_MESH:D012514	8305357_11	bcv_devset_test_100_easy_324		
	MESH:D007980	"<span class=""chemical"">levodopa</span>"	MESH:D018476	"<span class=""disease"">bradykinesia</span>"	"Pallidal stimulation improves <span class=""disease"">bradykinesia</span> and rigidity to a minor extent; however, its strength seems to be in improving <span class=""chemical"">levodopa</span>-induced dyskinesias."		15096016.0	15096016_MESH:D007980_MESH:D018476	15096016_6	bcv_devset_test_100_easy_325		
	MESH:D007980	"<span class=""chemical"">levodopa</span>"	MESH:D009127	"<span class=""disease"">rigidity</span>"	"Pallidal stimulation improves bradykinesia and <span class=""disease"">rigidity</span> to a minor extent; however, its strength seems to be in improving <span class=""chemical"">levodopa</span>-induced dyskinesias."		15096016.0	15096016_MESH:D007980_MESH:D009127	15096016_6	bcv_devset_test_100_easy_326		
	MESH:D011241	"<span class=""chemical"">prednisone</span>"	MESH:D006970	"<span class=""disease"">somnolence</span>"	"Following short exposure to oral <span class=""chemical"">prednisone</span>, both boys developed lethargy, increasing <span class=""disease"">somnolence</span>, polydipsia, polyphagia, and polyuria."		3703509.0	3703509_MESH:D011241_MESH:D006970	3703509_2	bcv_devset_test_100_easy_327		
	MESH:D011241	"<span class=""chemical"">prednisone</span>"	MESH:D053609	"<span class=""disease"">lethargy</span>"	"Following short exposure to oral <span class=""chemical"">prednisone</span>, both boys developed <span class=""disease"">lethargy</span>, increasing somnolence, polydipsia, polyphagia, and polyuria."		3703509.0	3703509_MESH:D011241_MESH:D053609	3703509_2	bcv_devset_test_100_easy_328		
	MESH:D011241	"<span class=""chemical"">prednisone</span>"	MESH:D059606	"<span class=""disease"">polydipsia</span>"	"Following short exposure to oral <span class=""chemical"">prednisone</span>, both boys developed lethargy, increasing somnolence, <span class=""disease"">polydipsia</span>, polyphagia, and polyuria."		3703509.0	3703509_MESH:D011241_MESH:D059606	3703509_2	bcv_devset_test_100_easy_329		
	MESH:D011241	"<span class=""chemical"">prednisone</span>"	MESH:D011141	"<span class=""disease"">polyuria</span>"	"Following short exposure to oral <span class=""chemical"">prednisone</span>, both boys developed lethargy, increasing somnolence, polydipsia, polyphagia, and <span class=""disease"">polyuria</span>."		3703509.0	3703509_MESH:D011241_MESH:D011141	3703509_2	bcv_devset_test_100_easy_330		
	MESH:D011241	"<span class=""chemical"">prednisone</span>"	MESH:D006963	"<span class=""disease"">polyphagia</span>"	"Following short exposure to oral <span class=""chemical"">prednisone</span>, both boys developed lethargy, increasing somnolence, polydipsia, <span class=""disease"">polyphagia</span>, and polyuria."		3703509.0	3703509_MESH:D011241_MESH:D006963	3703509_2	bcv_devset_test_100_easy_331		
	MESH:D019344	"<span class=""chemical"">lactate</span>"	MESH:D007662	"<span class=""disease"">ketosis</span>"	"Nonketotic lactic acidosis was present in one and <span class=""disease"">ketosis</span> without a known serum <span class=""chemical"">lactate</span> level was present in the other."		3703509.0	3703509_MESH:D019344_MESH:D007662	3703509_4	bcv_devset_test_100_easy_332		
	MESH:D019344	"<span class=""chemical"">lactate</span>"	MESH:D000140	"<span class=""disease"">lactic acidosis</span>"	"Nonketotic <span class=""disease"">lactic acidosis</span> was present in one and ketosis without a known serum <span class=""chemical"">lactate</span> level was present in the other."		3703509.0	3703509_MESH:D019344_MESH:D000140	3703509_4	bcv_devset_test_100_easy_333		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D005901	"<span class=""disease"">glaucoma</span>"	"Comparison of aqueous and gellan ophthalmic <span class=""chemical"">timolol</span> with placebo on the 24-hour heart rate response in patients on treatment for <span class=""disease"">glaucoma</span>."		11704023.0	11704023_MESH:D013999_MESH:D005901	11704023_0	bcv_devset_test_100_easy_334		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D005901	"<span class=""disease"">glaucoma</span>"	"DESIGN: This trial evaluated the effect of placebo, 0.5% aqueous <span class=""chemical"">timolol</span> (<span class=""chemical"">timolol</span> solution) and a 0.5% <span class=""chemical"">timolol</span> suspension that forms a gel on application to the conjunctiva (<span class=""chemical"">timolol</span> gellan) on the 24-hour heart rate in patients currently being treated for <span class=""disease"">glaucoma</span> to quantify the reduction in mean heart rate."		11704023.0	11704023_MESH:D013999_MESH:D005901	11704023_3	bcv_devset_test_100_easy_335		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D005902	"<span class=""disease"">open-angle glaucoma</span>"	"METHODS: Forty-three Caucasian patients with primary <span class=""disease"">open-angle glaucoma</span> or ocular hypertension with a mean (+/-SD) age of 63 (+/-8) years were randomized and crossed over in a double-masked manner to 14 days of treatment with placebo (morning and evening in both eyes), <span class=""chemical"">timolol</span> solution (morning and evening in both eyes), or <span class=""chemical"">timolol</span> gellan (morning in both eyes with placebo in the evening)."		11704023.0	11704023_MESH:D013999_MESH:D005902	11704023_4	bcv_devset_test_100_easy_336		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D006973	"<span class=""disease"">ocular hypertension</span>"	"METHODS: Forty-three Caucasian patients with primary open-angle glaucoma or <span class=""disease"">ocular hypertension</span> with a mean (+/-SD) age of 63 (+/-8) years were randomized and crossed over in a double-masked manner to 14 days of treatment with placebo (morning and evening in both eyes), <span class=""chemical"">timolol</span> solution (morning and evening in both eyes), or <span class=""chemical"">timolol</span> gellan (morning in both eyes with placebo in the evening)."		11704023.0	11704023_MESH:D013999_MESH:D006973	11704023_4	bcv_devset_test_100_easy_337		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D006966	"<span class=""disease"">hyperprolactinemia</span>"	"A murine model of adenomyosis: the effects of <span class=""disease"">hyperprolactinemia</span> induced by fluoxetine hydrochloride, a selective <span class=""chemical"">serotonin</span> reuptake inhibitor, on adenomyosis induction in Wistar albino rats."		9098464.0	9098464_MESH:D012701_MESH:D006966	9098464_0	bcv_devset_test_100_easy_338		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D062788	"<span class=""disease"">adenomyosis</span>"	"A murine model of <span class=""disease"">adenomyosis</span>: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective <span class=""chemical"">serotonin</span> reuptake inhibitor, on <span class=""disease"">adenomyosis</span> induction in Wistar albino rats."		9098464.0	9098464_MESH:D012701_MESH:D062788	9098464_0	bcv_devset_test_100_easy_339		
	MESH:D005473	"<span class=""chemical"">fluoxetine hydrochloride</span>"	MESH:D006966	"<span class=""disease"">hyperprolactinemia</span>"	"A murine model of adenomyosis: the effects of <span class=""disease"">hyperprolactinemia</span> induced by <span class=""chemical"">fluoxetine hydrochloride</span>, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats."		9098464.0	9098464_MESH:D005473_MESH:D006966	9098464_0	bcv_devset_test_100_easy_340		
	MESH:D005473	"<span class=""chemical"">fluoxetine hydrochloride</span>"	MESH:D062788	"<span class=""disease"">adenomyosis</span>"	"A murine model of <span class=""disease"">adenomyosis</span>: the effects of hyperprolactinemia induced by <span class=""chemical"">fluoxetine hydrochloride</span>, a selective serotonin reuptake inhibitor, on <span class=""disease"">adenomyosis</span> induction in Wistar albino rats."		9098464.0	9098464_MESH:D005473_MESH:D062788	9098464_0	bcv_devset_test_100_easy_341		
	MESH:D005473	"<span class=""chemical"">fluoxetine</span>"	MESH:D006966	"<span class=""disease"">hyperprolactinemia</span>"	"OBJECTIVE: The aim of this study was to investigate whether <span class=""chemical"">fluoxetine</span> given to castrated and noncastrated rats caused <span class=""disease"">hyperprolactinemia</span> and its effects with respect to adenomyosis."		9098464.0	9098464_MESH:D005473_MESH:D006966	9098464_1	bcv_devset_test_100_easy_342		
	MESH:D005473	"<span class=""chemical"">fluoxetine</span>"	MESH:D062788	"<span class=""disease"">adenomyosis</span>"	"OBJECTIVE: The aim of this study was to investigate whether <span class=""chemical"">fluoxetine</span> given to castrated and noncastrated rats caused hyperprolactinemia and its effects with respect to <span class=""disease"">adenomyosis</span>."		9098464.0	9098464_MESH:D005473_MESH:D062788	9098464_1	bcv_devset_test_100_easy_343		
	MESH:D012701	"<span class=""chemical"">serotonin</span>"	MESH:D006966	"<span class=""disease"">hyperprolactinemia</span>"	"DESIGN: Fluoxetine, a <span class=""chemical"">serotonin</span> reuptake inhibitor, was given to Wistar Albino rats for 98 days to produce <span class=""disease"">hyperprolactinemia</span>."		9098464.0	9098464_MESH:D012701_MESH:D006966	9098464_2	bcv_devset_test_100_easy_344		
	MESH:D005473	"<span class=""chemical"">Fluoxetine</span>"	MESH:D006966	"<span class=""disease"">hyperprolactinemia</span>"	"DESIGN: <span class=""chemical"">Fluoxetine</span>, a serotonin reuptake inhibitor, was given to Wistar Albino rats for 98 days to produce <span class=""disease"">hyperprolactinemia</span>."		9098464.0	9098464_MESH:D005473_MESH:D006966	9098464_2	bcv_devset_test_100_easy_345		
	MESH:D005473	"<span class=""chemical"">fluoxetine</span>"	MESH:D062788	"<span class=""disease"">adenomyosis</span>"	"Histological studies revealed 11 cases of <span class=""disease"">adenomyosis</span>, all within the noncastrated group receiving <span class=""chemical"">fluoxetine</span>."		9098464.0	9098464_MESH:D005473_MESH:D062788	9098464_8	bcv_devset_test_100_easy_346		
	MESH:D013311	"<span class=""chemical"">streptozocin</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"Effects of active constituents of Crocus sativus L., crocin on <span class=""chemical"">streptozocin</span>-induced model of sporadic <span class=""disease"">Alzheimer's disease</span> in male rats."		20683499.0	20683499_MESH:D013311_MESH:D000544	20683499_0	bcv_devset_test_100_easy_347		
	MESH:C029036	"<span class=""chemical"">crocin</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"Effects of active constituents of Crocus sativus L., <span class=""chemical"">crocin</span> on streptozocin-induced model of sporadic <span class=""disease"">Alzheimer's disease</span> in male rats."		20683499.0	20683499_MESH:C029036_MESH:D000544	20683499_0	bcv_devset_test_100_easy_348		
	MESH:D013311	"<span class=""chemical"">streptozocin/STZ</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"In the present study, the effect of crocins on sporadic <span class=""disease"">Alzheimer's disease</span> induced by intracerebroventricular (icv) <span class=""chemical"">streptozocin</span> (<span class=""chemical"">STZ</span>) in male rats was investigated."		20683499.0	20683499_MESH:D013311_MESH:D000544	20683499_2	bcv_devset_test_100_easy_349		
	MESH:D013311	"<span class=""chemical"">STZ</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"In <span class=""disease"">Alzheimer's disease</span> groups, rats were injected with <span class=""chemical"">STZ</span>-icv bilaterally (3 mg/kg) in first day and 3 days later, a similar <span class=""chemical"">STZ</span>-icv application was repeated."		20683499.0	20683499_MESH:D013311_MESH:D000544	20683499_4	bcv_devset_test_100_easy_350		
	MESH:C029036	"<span class=""chemical"">crocin</span>"	MESH:D008569	"<span class=""disease"">learning and memory impairment</span>"	"In addition, <span class=""chemical"">crocin</span> in the mentioned dose could significantly attenuated <span class=""disease"">learning and memory impairment</span> in treated STZ-injected group in passive avoidance test."		20683499.0	20683499_MESH:C029036_MESH:D008569	20683499_9	bcv_devset_test_100_easy_351		
	MESH:D013311	"<span class=""chemical"">STZ</span>"	MESH:D008569	"<span class=""disease"">learning and memory impairment</span>"	"In addition, crocin in the mentioned dose could significantly attenuated <span class=""disease"">learning and memory impairment</span> in treated <span class=""chemical"">STZ</span>-injected group in passive avoidance test."		20683499.0	20683499_MESH:D013311_MESH:D008569	20683499_9	bcv_devset_test_100_easy_352		
	MESH:D013311	"<span class=""chemical"">STZ</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of crocin (30 mg/kg) in antagonizing the cognitive deficits caused by <span class=""chemical"">STZ</span>-icv in rats and its potential in the treatment of neurodegenerative diseases such as <span class=""disease"">Alzheimer's disease</span>."		20683499.0	20683499_MESH:D013311_MESH:D000544	20683499_10	bcv_devset_test_100_easy_353		
	MESH:C029036	"<span class=""chemical"">crocin</span>"	MESH:D000544	"<span class=""disease"">Alzheimer's disease</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of <span class=""chemical"">crocin</span> (30 mg/kg) in antagonizing the cognitive deficits caused by STZ-icv in rats and its potential in the treatment of neurodegenerative diseases such as <span class=""disease"">Alzheimer's disease</span>."		20683499.0	20683499_MESH:C029036_MESH:D000544	20683499_10	bcv_devset_test_100_easy_354		
	MESH:C029036	"<span class=""chemical"">crocin</span>"	MESH:D019636	"<span class=""disease"">neurodegenerative diseases</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of <span class=""chemical"">crocin</span> (30 mg/kg) in antagonizing the cognitive deficits caused by STZ-icv in rats and its potential in the treatment of <span class=""disease"">neurodegenerative diseases</span> such as Alzheimer's disease."		20683499.0	20683499_MESH:C029036_MESH:D019636	20683499_10	bcv_devset_test_100_easy_355		
	MESH:C029036	"<span class=""chemical"">crocin</span>"	MESH:D003072	"<span class=""disease"">cognitive deficits</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of <span class=""chemical"">crocin</span> (30 mg/kg) in antagonizing the <span class=""disease"">cognitive deficits</span> caused by STZ-icv in rats and its potential in the treatment of neurodegenerative diseases such as Alzheimer's disease."		20683499.0	20683499_MESH:C029036_MESH:D003072	20683499_10	bcv_devset_test_100_easy_356		
	MESH:D013311	"<span class=""chemical"">STZ</span>"	MESH:D003072	"<span class=""disease"">cognitive deficits</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of crocin (30 mg/kg) in antagonizing the <span class=""disease"">cognitive deficits</span> caused by <span class=""chemical"">STZ</span>-icv in rats and its potential in the treatment of neurodegenerative diseases such as Alzheimer's disease."		20683499.0	20683499_MESH:D013311_MESH:D003072	20683499_10	bcv_devset_test_100_easy_357		
	MESH:D013311	"<span class=""chemical"">STZ</span>"	MESH:D019636	"<span class=""disease"">neurodegenerative diseases</span>"	"CONCLUSION: Therefore, these results demonstrate the effectiveness of crocin (30 mg/kg) in antagonizing the cognitive deficits caused by <span class=""chemical"">STZ</span>-icv in rats and its potential in the treatment of <span class=""disease"">neurodegenerative diseases</span> such as Alzheimer's disease."		20683499.0	20683499_MESH:D013311_MESH:D019636	20683499_10	bcv_devset_test_100_easy_358		
	MESH:D010869	"<span class=""chemical"">pindolol</span>"	MESH:D001145	"<span class=""disease"">arrhythmia</span>"	"Its antiarrhythmic effectiveness surpasses that of propranolol and <span class=""chemical"">pindolol</span> inhibiting the ouabain <span class=""disease"">arrhythmia</span> in dogs and cats."		6111982.0	6111982_MESH:D010869_MESH:D001145	6111982_2	bcv_devset_test_100_easy_359		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D001145	"<span class=""disease"">arrhythmia</span>"	"Its antiarrhythmic effectiveness surpasses that of <span class=""chemical"">propranolol</span> and pindolol inhibiting the ouabain <span class=""disease"">arrhythmia</span> in dogs and cats."		6111982.0	6111982_MESH:D011433_MESH:D001145	6111982_2	bcv_devset_test_100_easy_360		
	MESH:D010042	"<span class=""chemical"">ouabain</span>"	MESH:D001145	"<span class=""disease"">arrhythmia</span>"	"Its antiarrhythmic effectiveness surpasses that of propranolol and pindolol inhibiting the <span class=""chemical"">ouabain</span> <span class=""disease"">arrhythmia</span> in dogs and cats."		6111982.0	6111982_MESH:D010042_MESH:D001145	6111982_2	bcv_devset_test_100_easy_361		
	MESH:D004298	"<span class=""chemical"">Dopamine</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"<span class=""chemical"">Dopamine</span> is not essential for the development of methamphetamine-induced <span class=""disease"">neurotoxicity</span>."		20533999.0	20533999_MESH:D004298_MESH:D020258	20533999_0	bcv_devset_test_100_easy_362		
	MESH:D004298	"<span class=""chemical"">dopamine/DA</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"It is widely believed that <span class=""chemical"">dopamine</span> (<span class=""chemical"">DA</span>) mediates methamphetamine (METH)-induced <span class=""disease"">toxicity</span> to brain dopaminergic neurons, because drugs that interfere with <span class=""chemical"">DA</span> neurotransmission decrease <span class=""disease"">toxicity</span>, whereas drugs that increase <span class=""chemical"">DA</span> neurotransmission enhance <span class=""disease"">toxicity</span>."		20533999.0	20533999_MESH:D004298_MESH:D064420	20533999_1	bcv_devset_test_100_easy_363		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"Here we show that the recently reported ability of L-dihydroxyphenylalanine to reverse the protective effect of alpha-methyl-para-tyrosine on METH-induced <span class=""chemical"">DA</span> <span class=""disease"">neurotoxicity</span> is also confounded by drug effects on body temperature."		20533999.0	20533999_MESH:D004298_MESH:D020258	20533999_3	bcv_devset_test_100_easy_364		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"Further, we show that mice genetically engineered to be deficient in brain <span class=""chemical"">DA</span> develop METH <span class=""disease"">neurotoxicity</span>, as long as the thermic effects of METH are preserved."		20533999.0	20533999_MESH:D004298_MESH:D020258	20533999_4	bcv_devset_test_100_easy_365		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D009461	"<span class=""disease"">dopaminergic deficits</span>"	"In addition, we demonstrate that mice genetically engineered to have unilateral brain <span class=""chemical"">DA</span> deficits develop METH-induced <span class=""disease"">dopaminergic deficits</span> that are of comparable magnitude on both sides of the brain."		20533999.0	20533999_MESH:D004298_MESH:D009461	20533999_5	bcv_devset_test_100_easy_366		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"Taken together, these findings demonstrate that <span class=""chemical"">DA</span> is not essential for the development of METH-induced dopaminergic <span class=""disease"">neurotoxicity</span> and suggest that mechanisms independent of <span class=""chemical"">DA</span> warrant more intense investigation."		20533999.0	20533999_MESH:D004298_MESH:D020258	20533999_6	bcv_devset_test_100_easy_367		
	MESH:D008012	"<span class=""chemical"">lignocaine</span>"	MESH:D001416	"<span class=""disease"">Leg and back pain</span>"	"<span class=""disease"">Leg and back pain</span> after spinal anaesthesia involving hyperbaric 5% <span class=""chemical"">lignocaine</span>."		8686832.0	8686832_MESH:D008012_MESH:D001416	8686832_0	bcv_devset_test_100_easy_368		
	MESH:D000431	"<span class=""chemical"">alcohol</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"Five of the 13 patients (38%) with <span class=""disease"">pain</span> and seven of the 41 patients (17%) without <span class=""disease"">pain</span> admitted to a high <span class=""chemical"">alcohol</span> intake, which might be a contributing factor."		8686832.0	8686832_MESH:D000431_MESH:D010146	8686832_4	bcv_devset_test_100_easy_369		
	MESH:D008012	"<span class=""chemical"">lignocaine</span>"	MESH:D001416	"<span class=""disease"">Leg and/or back pain</span>"	"<span class=""disease"">Leg and/or back pain</span> is associated with the intrathecal use of hyperbaric 5% <span class=""chemical"">lignocaine</span>."		8686832.0	8686832_MESH:D008012_MESH:D001416	8686832_5	bcv_devset_test_100_easy_370		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Systemic <span class=""disease"">toxicity</span> and resuscitation in <span class=""chemical"">bupivacaine</span>-, levobupivacaine-, or ropivacaine-infused rats."		11524350.0	11524350_MESH:D002045_MESH:D064420	11524350_0	bcv_devset_test_100_easy_371		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Systemic <span class=""disease"">toxicity</span> and resuscitation in bupivacaine-, <span class=""chemical"">levobupivacaine</span>-, or ropivacaine-infused rats."		11524350.0	11524350_MESH:C476513_MESH:D064420	11524350_0	bcv_devset_test_100_easy_372		
	MESH:C037663	"<span class=""chemical"">ropivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Systemic <span class=""disease"">toxicity</span> and resuscitation in bupivacaine-, levobupivacaine-, or <span class=""chemical"">ropivacaine</span>-infused rats."		11524350.0	11524350_MESH:C037663_MESH:D064420	11524350_0	bcv_devset_test_100_easy_373		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We compared the systemic <span class=""disease"">toxicity</span> of <span class=""chemical"">bupivacaine</span>, levobupivacaine, and ropivacaine in anesthetized rats."		11524350.0	11524350_MESH:D002045_MESH:D064420	11524350_1	bcv_devset_test_100_easy_374		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We compared the systemic <span class=""disease"">toxicity</span> of bupivacaine, <span class=""chemical"">levobupivacaine</span>, and ropivacaine in anesthetized rats."		11524350.0	11524350_MESH:C476513_MESH:D064420	11524350_1	bcv_devset_test_100_easy_375		
	MESH:C037663	"<span class=""chemical"">ropivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We compared the systemic <span class=""disease"">toxicity</span> of bupivacaine, levobupivacaine, and <span class=""chemical"">ropivacaine</span> in anesthetized rats."		11524350.0	11524350_MESH:C037663_MESH:D064420	11524350_1	bcv_devset_test_100_easy_376		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"The cumulative doses of <span class=""chemical"">levobupivacaine</span> and ropivacaine that produced <span class=""disease"">seizures</span> were similar and were larger than those of bupivacaine."		11524350.0	11524350_MESH:C476513_MESH:D012640	11524350_9	bcv_devset_test_100_easy_377		
	MESH:C037663	"<span class=""chemical"">ropivacaine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"The cumulative doses of levobupivacaine and <span class=""chemical"">ropivacaine</span> that produced <span class=""disease"">seizures</span> were similar and were larger than those of bupivacaine."		11524350.0	11524350_MESH:C037663_MESH:D012640	11524350_9	bcv_devset_test_100_easy_378		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"The cumulative doses of levobupivacaine and ropivacaine that produced <span class=""disease"">seizures</span> were similar and were larger than those of <span class=""chemical"">bupivacaine</span>."		11524350.0	11524350_MESH:D002045_MESH:D012640	11524350_9	bcv_devset_test_100_easy_379		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D001145	"<span class=""disease"">dysrhythmias</span>"	"The cumulative doses of levobupivacaine that produced <span class=""disease"">dysrhythmias</span> and asystole were smaller than the corresponding doses of ropivacaine, but they were larger than those of <span class=""chemical"">bupivacaine</span>."		11524350.0	11524350_MESH:D002045_MESH:D001145	11524350_10	bcv_devset_test_100_easy_380		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D001145	"<span class=""disease"">dysrhythmias</span>"	"The cumulative doses of <span class=""chemical"">levobupivacaine</span> that produced <span class=""disease"">dysrhythmias</span> and asystole were smaller than the corresponding doses of ropivacaine, but they were larger than those of bupivacaine."		11524350.0	11524350_MESH:C476513_MESH:D001145	11524350_10	bcv_devset_test_100_easy_381		
	MESH:C037663	"<span class=""chemical"">ropivacaine</span>"	MESH:D001145	"<span class=""disease"">dysrhythmias</span>"	"The cumulative doses of levobupivacaine that produced <span class=""disease"">dysrhythmias</span> and asystole were smaller than the corresponding doses of <span class=""chemical"">ropivacaine</span>, but they were larger than those of bupivacaine."		11524350.0	11524350_MESH:C037663_MESH:D001145	11524350_10	bcv_devset_test_100_easy_382		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D006323	"<span class=""disease"">asystole</span>"	"The cumulative doses of levobupivacaine that produced dysrhythmias and <span class=""disease"">asystole</span> were smaller than the corresponding doses of ropivacaine, but they were larger than those of <span class=""chemical"">bupivacaine</span>."		11524350.0	11524350_MESH:D002045_MESH:D006323	11524350_10	bcv_devset_test_100_easy_383		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D006323	"<span class=""disease"">asystole</span>"	"The cumulative doses of <span class=""chemical"">levobupivacaine</span> that produced dysrhythmias and <span class=""disease"">asystole</span> were smaller than the corresponding doses of ropivacaine, but they were larger than those of bupivacaine."		11524350.0	11524350_MESH:C476513_MESH:D006323	11524350_10	bcv_devset_test_100_easy_384		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We conclude that the systemic <span class=""disease"">toxicity</span> of levobupivacaine is intermediate between that of ropivacaine and <span class=""chemical"">bupivacaine</span> when administered at the same rate and that ropivacaine-induced cardiac arrest appears to be more susceptible to treatment than that induced by <span class=""chemical"">bupivacaine</span> or levobupivacaine."		11524350.0	11524350_MESH:D002045_MESH:D064420	11524350_13	bcv_devset_test_100_easy_385		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D006323	"<span class=""disease"">cardiac arrest</span>"	"We conclude that the systemic toxicity of <span class=""chemical"">levobupivacaine</span> is intermediate between that of ropivacaine and bupivacaine when administered at the same rate and that ropivacaine-induced <span class=""disease"">cardiac arrest</span> appears to be more susceptible to treatment than that induced by bupivacaine or <span class=""chemical"">levobupivacaine</span>."		11524350.0	11524350_MESH:C476513_MESH:D006323	11524350_13	bcv_devset_test_100_easy_386		
	MESH:C476513	"<span class=""chemical"">levobupivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We conclude that the systemic <span class=""disease"">toxicity</span> of <span class=""chemical"">levobupivacaine</span> is intermediate between that of ropivacaine and bupivacaine when administered at the same rate and that ropivacaine-induced cardiac arrest appears to be more susceptible to treatment than that induced by bupivacaine or <span class=""chemical"">levobupivacaine</span>."		11524350.0	11524350_MESH:C476513_MESH:D064420	11524350_13	bcv_devset_test_100_easy_387		
	MESH:D002045	"<span class=""chemical"">bupivacaine</span>"	MESH:D006323	"<span class=""disease"">cardiac arrest</span>"	"We conclude that the systemic toxicity of levobupivacaine is intermediate between that of ropivacaine and <span class=""chemical"">bupivacaine</span> when administered at the same rate and that ropivacaine-induced <span class=""disease"">cardiac arrest</span> appears to be more susceptible to treatment than that induced by <span class=""chemical"">bupivacaine</span> or levobupivacaine."		11524350.0	11524350_MESH:D002045_MESH:D006323	11524350_13	bcv_devset_test_100_easy_388		
	MESH:C037663	"<span class=""chemical"">ropivacaine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"We conclude that the systemic <span class=""disease"">toxicity</span> of levobupivacaine is intermediate between that of <span class=""chemical"">ropivacaine</span> and bupivacaine when administered at the same rate and that <span class=""chemical"">ropivacaine</span>-induced cardiac arrest appears to be more susceptible to treatment than that induced by bupivacaine or levobupivacaine."		11524350.0	11524350_MESH:C037663_MESH:D064420	11524350_13	bcv_devset_test_100_easy_389		
	MESH:D010396	"<span class=""chemical"">Penicillamine</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"<span class=""chemical"">Penicillamine</span>-induced rapidly progressive glomerulonephritis in a patient with <span class=""disease"">rheumatoid arthritis</span>."		8267029.0	8267029_MESH:D010396_MESH:D001172	8267029_0	bcv_devset_test_100_easy_390		
	MESH:D010396	"<span class=""chemical"">D-penicillamine</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"A 67-year-old woman with <span class=""disease"">rheumatoid arthritis</span> presented rapidly progressive glomerulonephritis (RPGN) after 5 months of <span class=""chemical"">D-penicillamine</span> (250 mg/day) treatment."		8267029.0	8267029_MESH:D010396_MESH:D001172	8267029_1	bcv_devset_test_100_easy_391		
	MESH:D010396	"<span class=""chemical"">D-penicillamine</span>"	MESH:D011507	"<span class=""disease"">proteinuria</span>"	"This new case of RPGN in the course of <span class=""chemical"">D-penicillamine</span> treatment emphasizes the need for frequent monitoring of renal function and evaluation of urinary sediment and <span class=""disease"">proteinuria</span> in these patients."		8267029.0	8267029_MESH:D010396_MESH:D011507	8267029_6	bcv_devset_test_100_easy_392		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D000743	"<span class=""disease"">ribavirin-induced hemolytic anemia</span>"	"Management strategies for <span class=""chemical""></span><span class=""disease"">ribavirin</span>-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications."		11705128.0	11705128_MESH:D012254_MESH:D000743	11705128_0	bcv_devset_test_100_easy_393		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D006526	"<span class=""disease"">hepatitis C</span>"	"Management strategies for <span class=""chemical"">ribavirin</span>-induced hemolytic anemia in the treatment of <span class=""disease"">hepatitis C</span>: clinical and economic implications."		11705128.0	11705128_MESH:D012254_MESH:D006526	11705128_0	bcv_devset_test_100_easy_394		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D019698	"<span class=""disease"">CHC/chronic hepatitis C</span>"	"OBJECTIVES: Recently published studies have demonstrated increased efficacy and cost-effectiveness of combination therapy with interferon and alpha-2b/<span class=""chemical"">ribavirin</span> compared with interferon-alpha monotherapy in the treatment of <span class=""disease"">chronic hepatitis C</span> (<span class=""disease"">CHC</span>)."		11705128.0	11705128_MESH:D012254_MESH:D019698	11705128_1	bcv_devset_test_100_easy_395		
	MESH:D016898	"<span class=""chemical"">interferon-alpha</span>"	MESH:D019698	"<span class=""disease"">CHC/chronic hepatitis C</span>"	"OBJECTIVES: Recently published studies have demonstrated increased efficacy and cost-effectiveness of combination therapy with interferon and alpha-2b/ribavirin compared with <span class=""chemical"">interferon-alpha</span> monotherapy in the treatment of <span class=""disease"">chronic hepatitis C</span> (<span class=""disease"">CHC</span>)."		11705128.0	11705128_MESH:D016898_MESH:D019698	11705128_1	bcv_devset_test_100_easy_396		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D000743	"<span class=""disease"">ribavirin-induced hemolytic anemia/RIHA</span>"	"Combination therapy is associated with a clinically important adverse effect: <span class=""chemical""></span><span class=""disease"">ribavirin</span>-induced hemolytic anemia (<span class=""disease"">RIHA</span>)."		11705128.0	11705128_MESH:D012254_MESH:D000743	11705128_2	bcv_devset_test_100_easy_397		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D000743	"<span class=""disease"">RIHA</span>"	"The standard of care for management of <span class=""disease"">RIHA</span> is reduction or discontinuation of the <span class=""chemical"">ribavirin</span> dosage."		11705128.0	11705128_MESH:D012254_MESH:D000743	11705128_8	bcv_devset_test_100_easy_398		
	MESH:D012254	"<span class=""chemical"">ribavirin</span>"	MESH:D000743	"<span class=""disease"">RIHA</span>"	"Questions remain about the optimal dose of <span class=""chemical"">ribavirin</span> and the incidence of <span class=""disease"">RIHA</span> in a real-world population."		11705128.0	11705128_MESH:D012254_MESH:D000743	11705128_13	bcv_devset_test_100_easy_399		
	MESH:D004298	"<span class=""chemical"">dopamine</span>"	MESH:D010300	"<span class=""disease"">parkinsonian</span>"	"Potential therapeutic use of the selective <span class=""chemical"">dopamine</span> D1 receptor agonist, A-86929: an acute study in <span class=""disease"">parkinsonian</span> levodopa-primed monkeys."		9270571.0	9270571_MESH:D004298_MESH:D010300	9270571_0	bcv_devset_test_100_easy_400		
	MESH:D007980	"<span class=""chemical"">levodopa</span>"	MESH:D010300	"<span class=""disease"">parkinsonian</span>"	"Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in <span class=""disease"">parkinsonian</span> <span class=""chemical"">levodopa</span>-primed monkeys."		9270571.0	9270571_MESH:D007980_MESH:D010300	9270571_0	bcv_devset_test_100_easy_401		
	MESH:C095427	"<span class=""chemical"">A-86929</span>"	MESH:D010300	"<span class=""disease"">parkinsonian</span>"	"Potential therapeutic use of the selective dopamine D1 receptor agonist, <span class=""chemical"">A-86929</span>: an acute study in <span class=""disease"">parkinsonian</span> levodopa-primed monkeys."		9270571.0	9270571_MESH:C095427_MESH:D010300	9270571_0	bcv_devset_test_100_easy_402		
	MESH:D004298	"<span class=""chemical"">dopamine/DA</span>"	MESH:D010300	"<span class=""disease"">PD/Parkinson's disease</span>"	"The clinical utility of <span class=""chemical"">dopamine</span> (<span class=""chemical"">DA</span>) D1 receptor agonists in the treatment of <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) is still unclear."		9270571.0	9270571_MESH:D004298_MESH:D010300	9270571_1	bcv_devset_test_100_easy_403		
	MESH:D015632	"<span class=""chemical"">MPTP/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span>"	MESH:D004409	"<span class=""disease"">dyskinesias/dyskinetic</span>"	"We therefore conducted the present acute dose-response study in four <span class=""chemical"">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</span> (<span class=""chemical"">MPTP</span>)-exposed cynomolgus monkeys primed to exhibit levodopa-induced <span class=""disease"">dyskinesias</span> to evaluate the locomotor and <span class=""disease"">dyskinetic</span> effects on challenge with four doses (from 0.03 to 1.0 mg/kg) of A-86929 ([-]-[5aR,11bS]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ ++azacyclopent-1- ena[c]phenathrene-9-10-diol), a selective and full DA D1-like receptor agonist with an intermediate duration of action."		9270571.0	9270571_MESH:D015632_MESH:D004409	9270571_3	bcv_devset_test_100_easy_404		
	MESH:C095427	"<span class=""chemical"">[-]-[5aR,11bS]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ ++azacyclopent-1- ena[c]phenathrene-9-10-diol/A-86929</span>"	MESH:D004409	"<span class=""disease"">dyskinesias/dyskinetic</span>"	"We therefore conducted the present acute dose-response study in four 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed cynomolgus monkeys primed to exhibit levodopa-induced <span class=""disease"">dyskinesias</span> to evaluate the locomotor and <span class=""disease"">dyskinetic</span> effects on challenge with four doses (from 0.03 to 1.0 mg/kg) of <span class=""chemical"">A-86929</span> (<span class=""chemical"">[-]-[5aR,11bS]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ ++azacyclopent-1- ena[c]phenathrene-9-10-diol</span>), a selective and full DA D1-like receptor agonist with an intermediate duration of action."		9270571.0	9270571_MESH:C095427_MESH:D004409	9270571_3	bcv_devset_test_100_easy_405		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D004409	"<span class=""disease"">dyskinesias/dyskinetic</span>"	"We therefore conducted the present acute dose-response study in four 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed cynomolgus monkeys primed to exhibit levodopa-induced <span class=""disease"">dyskinesias</span> to evaluate the locomotor and <span class=""disease"">dyskinetic</span> effects on challenge with four doses (from 0.03 to 1.0 mg/kg) of A-86929 ([-]-[5aR,11bS]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ ++azacyclopent-1- ena[c]phenathrene-9-10-diol), a selective and full <span class=""chemical"">DA</span> D1-like receptor agonist with an intermediate duration of action."		9270571.0	9270571_MESH:D004298_MESH:D004409	9270571_3	bcv_devset_test_100_easy_406		
	MESH:C095427	"<span class=""chemical"">A-86929</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"Acute administration of <span class=""chemical"">A-86929</span> was as efficacious in alleviating MPTP-induced <span class=""disease"">parkinsonism</span> as levodopa and LY-171555, but was less likely to reproduce the levodopa-induced dyskinesias in these animals than with either LY-171555 or subsequent challenge of levodopa."		9270571.0	9270571_MESH:C095427_MESH:D010302	9270571_5	bcv_devset_test_100_easy_407		
	MESH:C416545	"<span class=""chemical"">LY-171555</span>"	MESH:D004409	"<span class=""disease"">dyskinesias</span>"	"Acute administration of A-86929 was as efficacious in alleviating MPTP-induced parkinsonism as levodopa and <span class=""chemical"">LY-171555</span>, but was less likely to reproduce the levodopa-induced <span class=""disease"">dyskinesias</span> in these animals than with either <span class=""chemical"">LY-171555</span> or subsequent challenge of levodopa."		9270571.0	9270571_MESH:C416545_MESH:D004409	9270571_5	bcv_devset_test_100_easy_408		
	MESH:D015632	"<span class=""chemical"">MPTP</span>"	MESH:D004409	"<span class=""disease"">dyskinesias</span>"	"Acute administration of A-86929 was as efficacious in alleviating <span class=""chemical"">MPTP</span>-induced parkinsonism as levodopa and LY-171555, but was less likely to reproduce the levodopa-induced <span class=""disease"">dyskinesias</span> in these animals than with either LY-171555 or subsequent challenge of levodopa."		9270571.0	9270571_MESH:D015632_MESH:D004409	9270571_5	bcv_devset_test_100_easy_409		
	MESH:C095427	"<span class=""chemical"">A-86929</span>"	MESH:D004409	"<span class=""disease"">dyskinesias</span>"	"Acute administration of <span class=""chemical"">A-86929</span> was as efficacious in alleviating MPTP-induced parkinsonism as levodopa and LY-171555, but was less likely to reproduce the levodopa-induced <span class=""disease"">dyskinesias</span> in these animals than with either LY-171555 or subsequent challenge of levodopa."		9270571.0	9270571_MESH:C095427_MESH:D004409	9270571_5	bcv_devset_test_100_easy_410		
	MESH:D007980	"<span class=""chemical"">levodopa</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"Acute administration of A-86929 was as efficacious in alleviating MPTP-induced <span class=""disease"">parkinsonism</span> as <span class=""chemical"">levodopa</span> and LY-171555, but was less likely to reproduce the <span class=""chemical"">levodopa</span>-induced dyskinesias in these animals than with either LY-171555 or subsequent challenge of <span class=""chemical"">levodopa</span>."		9270571.0	9270571_MESH:D007980_MESH:D010302	9270571_5	bcv_devset_test_100_easy_411		
	MESH:C416545	"<span class=""chemical"">LY-171555</span>"	MESH:D010302	"<span class=""disease"">parkinsonism</span>"	"Acute administration of A-86929 was as efficacious in alleviating MPTP-induced <span class=""disease"">parkinsonism</span> as levodopa and <span class=""chemical"">LY-171555</span>, but was less likely to reproduce the levodopa-induced dyskinesias in these animals than with either <span class=""chemical"">LY-171555</span> or subsequent challenge of levodopa."		9270571.0	9270571_MESH:C416545_MESH:D010302	9270571_5	bcv_devset_test_100_easy_412		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D010300	"<span class=""disease"">PD</span>"	"Potent <span class=""chemical"">DA</span> D1 receptor agents with an intermediate duration of efficacy such as A-86929 (approximately 4 hr at higher doses tested) are potential therapeutic tools in <span class=""disease"">PD</span> and merit further attention."		9270571.0	9270571_MESH:D004298_MESH:D010300	9270571_7	bcv_devset_test_100_easy_413		
	MESH:C095427	"<span class=""chemical"">A-86929</span>"	MESH:D010300	"<span class=""disease"">PD</span>"	"Potent DA D1 receptor agents with an intermediate duration of efficacy such as <span class=""chemical"">A-86929</span> (approximately 4 hr at higher doses tested) are potential therapeutic tools in <span class=""disease"">PD</span> and merit further attention."		9270571.0	9270571_MESH:C095427_MESH:D010300	9270571_7	bcv_devset_test_100_easy_414		
	MESH:D004298	"<span class=""chemical"">DA/Dopamine</span>"	MESH:D004827	"<span class=""disease"">epileptic seizures</span>"	"<span class=""chemical"">Dopamine</span> (<span class=""chemical"">DA</span>), through D1/D2 receptor-mediated signaling, plays a major role in the control of <span class=""disease"">epileptic seizures</span> arising in the limbic system."		11860278.0	11860278_MESH:D004298_MESH:D004827	11860278_1	bcv_devset_test_100_easy_415		
	MESH:D004298	"<span class=""chemical"">DA</span>"	MESH:D004827	"<span class=""disease"">epilepsy</span>"	"In this respect, little is known about the role of <span class=""chemical"">DA</span> receptors in the occurrence of <span class=""disease"">epilepsy</span>-induced neuronal cell death."		11860278.0	11860278_MESH:D004298_MESH:D004827	11860278_3	bcv_devset_test_100_easy_416		
	MESH:D010862	"<span class=""chemical"">pilocarpine</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"Here we analyze the occurrence of seizures and <span class=""disease"">neurotoxicity</span> in D2R -/- mice treated with the cholinergic agonist <span class=""chemical"">pilocarpine</span>."		11860278.0	11860278_MESH:D010862_MESH:D020258	11860278_4	bcv_devset_test_100_easy_417		
	MESH:D007608	"<span class=""chemical"">KA</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"However, pilocarpine-induced <span class=""disease"">seizures</span> result in a more widespread neuronal death in both WT and D2R -/- brains in comparison to <span class=""chemical"">KA</span>."		11860278.0	11860278_MESH:D007608_MESH:D012640	11860278_7	bcv_devset_test_100_easy_418		
	MESH:D018698	"<span class=""chemical"">glutamate</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"Thus, the absence of D2R lowers the threshold for <span class=""disease"">seizures</span> induced by both <span class=""chemical"">glutamate</span> and acetylcholine."		11860278.0	11860278_MESH:D018698_MESH:D012640	11860278_8	bcv_devset_test_100_easy_419		
	MESH:D000109	"<span class=""chemical"">acetylcholine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"Thus, the absence of D2R lowers the threshold for <span class=""disease"">seizures</span> induced by both glutamate and <span class=""chemical"">acetylcholine</span>."		11860278.0	11860278_MESH:D000109_MESH:D012640	11860278_8	bcv_devset_test_100_easy_420		
	MESH:D005665	"<span class=""chemical"">furosemide</span>"	MESH:D012206	"<span class=""disease"">rhabdomyolysis</span>"	"Tetany and <span class=""disease"">rhabdomyolysis</span> due to surreptitious <span class=""chemical"">furosemide</span>--importance of magnesium supplementation."		8492347.0	8492347_MESH:D005665_MESH:D012206	8492347_0	bcv_devset_test_100_easy_421		
	MESH:D008274	"<span class=""chemical"">magnesium</span>"	MESH:D013746	"<span class=""disease"">Tetany</span>"	"<span class=""disease"">Tetany</span> and rhabdomyolysis due to surreptitious furosemide--importance of <span class=""chemical"">magnesium</span> supplementation."		8492347.0	8492347_MESH:D008274_MESH:D013746	8492347_0	bcv_devset_test_100_easy_422		
	MESH:D005665	"<span class=""chemical"">furosemide</span>"	MESH:D013746	"<span class=""disease"">Tetany</span>"	"<span class=""disease"">Tetany</span> and rhabdomyolysis due to surreptitious <span class=""chemical"">furosemide</span>--importance of magnesium supplementation."		8492347.0	8492347_MESH:D005665_MESH:D013746	8492347_0	bcv_devset_test_100_easy_423		
	MESH:D008274	"<span class=""chemical"">magnesium</span>"	MESH:D012206	"<span class=""disease"">rhabdomyolysis</span>"	"Tetany and <span class=""disease"">rhabdomyolysis</span> due to surreptitious furosemide--importance of <span class=""chemical"">magnesium</span> supplementation."		8492347.0	8492347_MESH:D008274_MESH:D012206	8492347_0	bcv_devset_test_100_easy_424		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D013035	"<span class=""disease"">muscle spasms</span>"	"While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with <span class=""disease"">muscle spasms</span> and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."		8492347.0	8492347_MESH:D002118_MESH:D013035	8492347_2	bcv_devset_test_100_easy_425		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:C537153	"<span class=""disease"">hypomagnesemia</span>"	"While severe hypokalemia may cause muscle weakness, severe <span class=""disease"">hypomagnesemia</span> is associated with muscle spasms and tetany which cannot be corrected by <span class=""chemical"">potassium</span> and calcium supplementation alone (1,2)."		8492347.0	8492347_MESH:D011188_MESH:C537153	8492347_2	bcv_devset_test_100_easy_426		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:C537153	"<span class=""disease"">hypomagnesemia</span>"	"While severe hypokalemia may cause muscle weakness, severe <span class=""disease"">hypomagnesemia</span> is associated with muscle spasms and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."		8492347.0	8492347_MESH:D002118_MESH:C537153	8492347_2	bcv_devset_test_100_easy_427		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"While severe <span class=""disease"">hypokalemia</span> may cause muscle weakness, severe hypomagnesemia is associated with muscle spasms and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."		8492347.0	8492347_MESH:D002118_MESH:D007008	8492347_2	bcv_devset_test_100_easy_428		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"While severe <span class=""disease"">hypokalemia</span> may cause muscle weakness, severe hypomagnesemia is associated with muscle spasms and tetany which cannot be corrected by <span class=""chemical"">potassium</span> and calcium supplementation alone (1,2)."		8492347.0	8492347_MESH:D011188_MESH:D007008	8492347_2	bcv_devset_test_100_easy_429		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D013746	"<span class=""disease"">tetany</span>"	"While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with muscle spasms and <span class=""disease"">tetany</span> which cannot be corrected by <span class=""chemical"">potassium</span> and calcium supplementation alone (1,2)."		8492347.0	8492347_MESH:D011188_MESH:D013746	8492347_2	bcv_devset_test_100_easy_430		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D013035	"<span class=""disease"">muscle spasms</span>"	"While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with <span class=""disease"">muscle spasms</span> and tetany which cannot be corrected by <span class=""chemical"">potassium</span> and calcium supplementation alone (1,2)."		8492347.0	8492347_MESH:D011188_MESH:D013035	8492347_2	bcv_devset_test_100_easy_431		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D013746	"<span class=""disease"">tetany</span>"	"While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with muscle spasms and <span class=""disease"">tetany</span> which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."		8492347.0	8492347_MESH:D002118_MESH:D013746	8492347_2	bcv_devset_test_100_easy_432		
	MESH:D011188	"<span class=""chemical"">potassium</span>"	MESH:D018908	"<span class=""disease"">muscle weakness</span>"	"While severe hypokalemia may cause <span class=""disease"">muscle weakness</span>, severe hypomagnesemia is associated with muscle spasms and tetany which cannot be corrected by <span class=""chemical"">potassium</span> and calcium supplementation alone (1,2)."		8492347.0	8492347_MESH:D011188_MESH:D018908	8492347_2	bcv_devset_test_100_easy_433		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D018908	"<span class=""disease"">muscle weakness</span>"	"While severe hypokalemia may cause <span class=""disease"">muscle weakness</span>, severe hypomagnesemia is associated with muscle spasms and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2)."		8492347.0	8492347_MESH:D002118_MESH:D018908	8492347_2	bcv_devset_test_100_easy_434		
	MESH:D008274	"<span class=""chemical"">magnesium</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"Symptomatic <span class=""disease"">hypokalemia</span> has been reported in such patients (3-7) and in one case hypocalcemia was observed (8), but the effects of <span class=""chemical"">magnesium</span> depletion were not noted in these patients."		8492347.0	8492347_MESH:D008274_MESH:D007008	8492347_4	bcv_devset_test_100_easy_435		
	MESH:D008274	"<span class=""chemical"">magnesium</span>"	MESH:D006996	"<span class=""disease"">hypocalcemia</span>"	"Symptomatic hypokalemia has been reported in such patients (3-7) and in one case <span class=""disease"">hypocalcemia</span> was observed (8), but the effects of <span class=""chemical"">magnesium</span> depletion were not noted in these patients."		8492347.0	8492347_MESH:D008274_MESH:D006996	8492347_4	bcv_devset_test_100_easy_436		
	MESH:D064704	"<span class=""chemical"">levofloxacin</span>"	MESH:D012852	"<span class=""disease"">sinusitis</span>"	"Open-label assessment of <span class=""chemical"">levofloxacin</span> for the treatment of acute bacterial <span class=""disease"">sinusitis</span> in adults."		9564988.0	9564988_MESH:D064704_MESH:D012852	9564988_0	bcv_devset_test_100_easy_437		
	MESH:D064704	"<span class=""chemical"">levofloxacin</span>"	MESH:D012852	"<span class=""disease"">sinusitis</span>"	"PURPOSE: To evaluate the efficacy and safety of <span class=""chemical"">levofloxacin</span> (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial <span class=""disease"">sinusitis</span>."		9564988.0	9564988_MESH:D064704_MESH:D012852	9564988_1	bcv_devset_test_100_easy_438		
	MESH:D064704	"<span class=""chemical"">levofloxacin</span>"	MESH:D012852	"<span class=""disease"">sinusitis</span>"	"CONCLUSION: The results of this study indicate that <span class=""chemical"">levofloxacin</span> 500 mg once daily is an effective and safe treatment for acute bacterial <span class=""disease"">sinusitis</span>."		9564988.0	9564988_MESH:D064704_MESH:D012852	9564988_14	bcv_devset_test_100_easy_439		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D006620	"<span class=""disease"">hip fracture</span>"	"PATIENTS AND METHODS: We performed a double-blind, randomized controlled trial at an academic medical center of elderly patients (>or=65 years) without preoperative delirium or severe dementia who underwent <span class=""disease"">hip fracture</span> repair under spinal anesthesia with <span class=""chemical"">propofol</span> sedation."		20042557.0	20042557_MESH:D015742_MESH:D006620	20042557_2	bcv_devset_test_100_easy_440		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D003704	"<span class=""disease"">dementia</span>"	"PATIENTS AND METHODS: We performed a double-blind, randomized controlled trial at an academic medical center of elderly patients (>or=65 years) without preoperative delirium or severe <span class=""disease"">dementia</span> who underwent hip fracture repair under spinal anesthesia with <span class=""chemical"">propofol</span> sedation."		20042557.0	20042557_MESH:D015742_MESH:D003704	20042557_2	bcv_devset_test_100_easy_441		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D003693	"<span class=""disease"">delirium</span>"	"PATIENTS AND METHODS: We performed a double-blind, randomized controlled trial at an academic medical center of elderly patients (>or=65 years) without preoperative <span class=""disease"">delirium</span> or severe dementia who underwent hip fracture repair under spinal anesthesia with <span class=""chemical"">propofol</span> sedation."		20042557.0	20042557_MESH:D015742_MESH:D003693	20042557_2	bcv_devset_test_100_easy_442		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D011183	"<span class=""disease"">postoperative delirium</span>"	"CONCLUSION: The use of light <span class=""chemical"">propofol</span> sedation decreased the prevalence of <span class=""disease"">postoperative delirium</span> by 50% compared with deep sedation."		20042557.0	20042557_MESH:D015742_MESH:D011183	20042557_8	bcv_devset_test_100_easy_443		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"Amelioration of bendrofluazide-induced <span class=""disease"">hypokalemia</span> by <span class=""chemical"">timolol</span>."		326460.0	326460_MESH:D013999_MESH:D007008	326460_0	bcv_devset_test_100_easy_444		
	MESH:D013999	"<span class=""chemical"">timolol</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"The beta adrenergic blocking drug, <span class=""chemical"">timolol</span>, tended to correct the <span class=""disease"">hypokalemia</span> of short-term bendrofluazide treatment in 6 healthy male subjects and although the effect was small it was significant."		326460.0	326460_MESH:D013999_MESH:D007008	326460_1	bcv_devset_test_100_easy_445		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D010673	"<span class=""disease"">Pheochromocytoma</span>"	"<span class=""disease"">Pheochromocytoma</span> unmasked by <span class=""chemical"">amisulpride</span> and tiapride."		15811908.0	15811908_MESH:C012052_MESH:D010673	15811908_0	bcv_devset_test_100_easy_446		
	MESH:D063325	"<span class=""chemical"">tiapride</span>"	MESH:D010673	"<span class=""disease"">Pheochromocytoma</span>"	"<span class=""disease"">Pheochromocytoma</span> unmasked by amisulpride and <span class=""chemical"">tiapride</span>."		15811908.0	15811908_MESH:D063325_MESH:D010673	15811908_0	bcv_devset_test_100_easy_447		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D010673	"<span class=""disease"">pheochromocytoma</span>"	"OBJECTIVE: To describe the unmasking of <span class=""disease"">pheochromocytoma</span> in a patient treated with <span class=""chemical"">amisulpride</span> and tiapride."		15811908.0	15811908_MESH:C012052_MESH:D010673	15811908_1	bcv_devset_test_100_easy_448		
	MESH:D063325	"<span class=""chemical"">tiapride</span>"	MESH:D010673	"<span class=""disease"">pheochromocytoma</span>"	"OBJECTIVE: To describe the unmasking of <span class=""disease"">pheochromocytoma</span> in a patient treated with amisulpride and <span class=""chemical"">tiapride</span>."		15811908.0	15811908_MESH:D063325_MESH:D010673	15811908_1	bcv_devset_test_100_easy_449		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D006261	"<span class=""disease"">headache</span>"	"CASE SUMMARY: A 42-year-old white man developed acute hypertension with severe <span class=""disease"">headache</span> and vomiting 2 hours after the first doses of <span class=""chemical"">amisulpride</span> 100 mg and tiapride 100 mg."		15811908.0	15811908_MESH:C012052_MESH:D006261	15811908_2	bcv_devset_test_100_easy_450		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D014839	"<span class=""disease"">vomiting</span>"	"CASE SUMMARY: A 42-year-old white man developed acute hypertension with severe headache and <span class=""disease"">vomiting</span> 2 hours after the first doses of <span class=""chemical"">amisulpride</span> 100 mg and tiapride 100 mg."		15811908.0	15811908_MESH:C012052_MESH:D014839	15811908_2	bcv_devset_test_100_easy_451		
	MESH:D063325	"<span class=""chemical"">tiapride</span>"	MESH:D014839	"<span class=""disease"">vomiting</span>"	"CASE SUMMARY: A 42-year-old white man developed acute hypertension with severe headache and <span class=""disease"">vomiting</span> 2 hours after the first doses of amisulpride 100 mg and <span class=""chemical"">tiapride</span> 100 mg."		15811908.0	15811908_MESH:D063325_MESH:D014839	15811908_2	bcv_devset_test_100_easy_452		
	MESH:D063325	"<span class=""chemical"">tiapride</span>"	MESH:D006261	"<span class=""disease"">headache</span>"	"CASE SUMMARY: A 42-year-old white man developed acute hypertension with severe <span class=""disease"">headache</span> and vomiting 2 hours after the first doses of amisulpride 100 mg and <span class=""chemical"">tiapride</span> 100 mg."		15811908.0	15811908_MESH:D063325_MESH:D006261	15811908_2	bcv_devset_test_100_easy_453		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D006973	"<span class=""disease"">hypertension</span>"	"CASE SUMMARY: A 42-year-old white man developed acute <span class=""disease"">hypertension</span> with severe headache and vomiting 2 hours after the first doses of <span class=""chemical"">amisulpride</span> 100 mg and tiapride 100 mg."		15811908.0	15811908_MESH:C012052_MESH:D006973	15811908_2	bcv_devset_test_100_easy_454		
	MESH:C037689	"<span class=""chemical"">benzamide</span>"	MESH:D010673	"<span class=""disease"">pheochromocytoma</span>"	"DISCUSSION: Drug-induced symptoms of <span class=""disease"">pheochromocytoma</span> are often associated with the use of substituted <span class=""chemical"">benzamide</span> drugs, but the underlying mechanism is unknown."		15811908.0	15811908_MESH:C037689_MESH:D010673	15811908_5	bcv_devset_test_100_easy_455		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"In our case, use of the Naranjo probability scale indicated a possible relationship between the <span class=""disease"">hypertensive</span> crisis and <span class=""chemical"">amisulpride</span> and tiapride therapy."		15811908.0	15811908_MESH:C012052_MESH:D006973	15811908_6	bcv_devset_test_100_easy_456		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D010673	"<span class=""disease"">pheochromocytoma</span>"	"CONCLUSIONS: As of March 24, 2005, this is the first reported case of <span class=""chemical"">amisulpride</span>- and tiapride-induced hypertensive crisis in a patient with <span class=""disease"">pheochromocytoma</span>."		15811908.0	15811908_MESH:C012052_MESH:D010673	15811908_7	bcv_devset_test_100_easy_457		
	MESH:D063325	"<span class=""chemical"">tiapride</span>"	MESH:D010673	"<span class=""disease"">pheochromocytoma</span>"	"CONCLUSIONS: As of March 24, 2005, this is the first reported case of amisulpride- and <span class=""chemical"">tiapride</span>-induced hypertensive crisis in a patient with <span class=""disease"">pheochromocytoma</span>."		15811908.0	15811908_MESH:D063325_MESH:D010673	15811908_7	bcv_devset_test_100_easy_458		
	MESH:C012052	"<span class=""chemical"">amisulpride</span>"	MESH:D006973	"<span class=""disease"">hypertensive</span>"	"CONCLUSIONS: As of March 24, 2005, this is the first reported case of <span class=""chemical"">amisulpride</span>- and tiapride-induced <span class=""disease"">hypertensive</span> crisis in a patient with pheochromocytoma."		15811908.0	15811908_MESH:C012052_MESH:D006973	15811908_7	bcv_devset_test_100_easy_459		
	MESH:D020888	"<span class=""chemical"">vigabatrin</span>"	MESH:D014786	"<span class=""disease"">visual field constriction</span>"	"Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with <span class=""chemical"">vigabatrin</span>-attributed <span class=""disease"">visual field constriction</span>."		11077455.0	11077455_MESH:D020888_MESH:D014786	11077455_0	bcv_devset_test_100_easy_460		
	MESH:D020888	"<span class=""chemical"">vigabatrin</span>"	MESH:D014786	"<span class=""disease"">visual field constriction</span>"	"PURPOSE: Symptomatic <span class=""disease"">visual field constriction</span> thought to be associated with <span class=""chemical"">vigabatrin</span> has been reported."		11077455.0	11077455_MESH:D020888_MESH:D014786	11077455_1	bcv_devset_test_100_easy_461		
	MESH:D020888	"<span class=""chemical"">vigabatrin</span>"	MESH:D014786	"<span class=""disease"">visual field loss</span>"	"The current study investigated the visual fields and visual electrophysiology of eight patients with known <span class=""chemical"">vigabatrin</span>-attributed <span class=""disease"">visual field loss</span>, three of whom were reported previously."		11077455.0	11077455_MESH:D020888_MESH:D014786	11077455_2	bcv_devset_test_100_easy_462		
	MESH:D020888	"<span class=""chemical"">vigabatrin</span>"	MESH:D014786	"<span class=""disease"">visual field constriction</span>"	"CONCLUSION: Marked <span class=""disease"">visual field constriction</span> appears to be associated with <span class=""chemical"">vigabatrin</span> therapy."		11077455.0	11077455_MESH:D020888_MESH:D014786	11077455_11	bcv_devset_test_100_easy_463		
	MESH:D010096	"<span class=""chemical"">oxprenolol</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"Beta-2-adrenoceptor-mediated <span class=""disease"">hypokalemia</span> and its abolishment by <span class=""chemical"">oxprenolol</span>."		2826064.0	2826064_MESH:D010096_MESH:D007008	2826064_0	bcv_devset_test_100_easy_464		
	MESH:D010096	"<span class=""chemical"">oxprenolol</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"Subsequently we investigated the efficacy of <span class=""chemical"">oxprenolol</span> in antagonizing such <span class=""disease"">hypokalemia</span>, together with the pharmacokinetic interaction between both drugs."		2826064.0	2826064_MESH:D010096_MESH:D007008	2826064_2	bcv_devset_test_100_easy_465		
	MESH:D010096	"<span class=""chemical"">oxprenolol</span>"	MESH:D007008	"<span class=""disease"">hypokalemia</span>"	"In spite of higher terbutaline concentrations after <span class=""chemical"">oxprenolol</span> pretreatment, the <span class=""disease"">hypokalemia</span> was almost completely antagonized by the beta 2-blocking action."		2826064.0	2826064_MESH:D010096_MESH:D007008	2826064_7	bcv_devset_test_100_easy_466		
	MESH:D013739	"<span class=""chemical"">testosterone</span>"	MESH:D063646	"<span class=""disease"">carcinogenesis</span>"	"Promotional effects of <span class=""chemical"">testosterone</span> and dietary fat on prostate <span class=""disease"">carcinogenesis</span> in genetically susceptible rats."		3969369.0	3969369_MESH:D013739_MESH:D063646	3969369_0	bcv_devset_test_100_easy_467		
	MESH:D013739	"<span class=""chemical"">testosterone</span>"	MESH:D009369	"<span class=""disease"">tumors</span>"	"Conventional LW rats, implanted with <span class=""chemical"">testosterone</span> at age 4 months, developed a higher incidence of prostate cancer after an average interval of 14 months: 24% had developed gross <span class=""disease"">tumors</span>, and 40% when it included microscopic <span class=""disease"">tumors</span>."		3969369.0	3969369_MESH:D013739_MESH:D009369	3969369_2	bcv_devset_test_100_easy_468		
	MESH:D013739	"<span class=""chemical"">testosterone</span>"	MESH:D011471	"<span class=""disease"">prostate cancer</span>"	"Conventional LW rats, implanted with <span class=""chemical"">testosterone</span> at age 4 months, developed a higher incidence of <span class=""disease"">prostate cancer</span> after an average interval of 14 months: 24% had developed gross tumors, and 40% when it included microscopic tumors."		3969369.0	3969369_MESH:D013739_MESH:D011471	3969369_2	bcv_devset_test_100_easy_469		
	MESH:D013739	"<span class=""chemical"">testosterone</span>"	MESH:D011471	"<span class=""disease"">prostate cancer</span>"	"Preliminary results indicate that <span class=""chemical"">testosterone</span>-treated LW rats that were fed the same diet, which was supplemented with corn oil up to 20% fat, developed <span class=""disease"">prostate cancer</span> after intervals of 6-12 months."		3969369.0	3969369_MESH:D013739_MESH:D011471	3969369_3	bcv_devset_test_100_easy_470		
	MESH:D013739	"<span class=""chemical"">testosterone</span>"	MESH:D053448	"<span class=""disease"">prostatitis</span>"	"Conventional SD rats fed diet L-485 and treated with <span class=""chemical"">testosterone</span> developed only <span class=""disease"">prostatitis</span>."		3969369.0	3969369_MESH:D013739_MESH:D053448	3969369_5	bcv_devset_test_100_easy_471		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D013345	"<span class=""disease"">subarachnoid hemorrhage</span>"	"Absence of acute cerebral vasoconstriction after <span class=""chemical"">cocaine</span>-associated <span class=""disease"">subarachnoid hemorrhage</span>."		16174948.0	16174948_MESH:D003042_MESH:D013345	16174948_0	bcv_devset_test_100_easy_472		
	MESH:D003042	"<span class=""chemical"">Cocaine</span>"	MESH:D013901	"<span class=""disease"">neurovascular complications</span>"	"INTRODUCTION: <span class=""chemical"">Cocaine</span> use has been associated with <span class=""disease"">neurovascular complications</span>, including arterial vasoconstriction and vasculitis."		16174948.0	16174948_MESH:D003042_MESH:D013901	16174948_1	bcv_devset_test_100_easy_473		
	MESH:D003042	"<span class=""chemical"">Cocaine</span>"	MESH:D014657	"<span class=""disease"">vasculitis</span>"	"INTRODUCTION: <span class=""chemical"">Cocaine</span> use has been associated with neurovascular complications, including arterial vasoconstriction and <span class=""disease"">vasculitis</span>."		16174948.0	16174948_MESH:D003042_MESH:D014657	16174948_1	bcv_devset_test_100_easy_474		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D013345	"<span class=""disease"">SAH/subarachnoid hemorrhage</span>"	"Information on these effects could be obtained from angiograms of patients with <span class=""chemical"">cocaine</span>-associated <span class=""disease"">subarachnoid hemorrhage</span> (<span class=""disease"">SAH</span>) who underwent angiography shortly after <span class=""chemical"">cocaine</span> use."		16174948.0	16174948_MESH:D003042_MESH:D013345	16174948_3	bcv_devset_test_100_easy_475		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D013345	"<span class=""disease"">SAH</span>"	"METHODS: We screened patients with <span class=""disease"">SAH</span> retrospectively and identified those with positive urine toxicology for <span class=""chemical"">cocaine</span> or its metabolites."		16174948.0	16174948_MESH:D003042_MESH:D013345	16174948_4	bcv_devset_test_100_easy_476		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D013345	"<span class=""disease"">SAH</span>"	"CONCLUSION: No quantitative evidence for narrowing of large cerebral arteries or qualitative angiographic evidence for distal narrowing or vasculitis could be found in patients who underwent angiography after aneurysmal <span class=""disease"">SAH</span> associated with <span class=""chemical"">cocaine</span> use."		16174948.0	16174948_MESH:D003042_MESH:D013345	16174948_11	bcv_devset_test_100_easy_477		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D014657	"<span class=""disease"">vasculitis</span>"	"CONCLUSION: No quantitative evidence for narrowing of large cerebral arteries or qualitative angiographic evidence for distal narrowing or <span class=""disease"">vasculitis</span> could be found in patients who underwent angiography after aneurysmal SAH associated with <span class=""chemical"">cocaine</span> use."		16174948.0	16174948_MESH:D003042_MESH:D014657	16174948_11	bcv_devset_test_100_easy_478		
	MESH:D003042	"<span class=""chemical"">cocaine</span>"	MESH:D000783	"<span class=""disease"">aneurysmal</span>"	"CONCLUSION: No quantitative evidence for narrowing of large cerebral arteries or qualitative angiographic evidence for distal narrowing or vasculitis could be found in patients who underwent angiography after <span class=""disease"">aneurysmal</span> SAH associated with <span class=""chemical"">cocaine</span> use."		16174948.0	16174948_MESH:D003042_MESH:D000783	16174948_11	bcv_devset_test_100_easy_479		
	MESH:D007741	"<span class=""chemical"">labetalol</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"Effects of deliberate <span class=""disease"">hypotension</span> induced by <span class=""chemical"">labetalol</span> with isoflurane on neuropsychological function."		8424298.0	8424298_MESH:D007741_MESH:D007022	8424298_0	bcv_devset_test_100_easy_480		
	MESH:D007530	"<span class=""chemical"">isoflurane</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"Effects of deliberate <span class=""disease"">hypotension</span> induced by labetalol with <span class=""chemical"">isoflurane</span> on neuropsychological function."		8424298.0	8424298_MESH:D007530_MESH:D007022	8424298_0	bcv_devset_test_100_easy_481		
	MESH:D007741	"<span class=""chemical"">labetalol</span>"	MESH:D007022	"<span class=""disease"">hypotension/hypotensive</span>"	"Twenty-four patients were anaesthetized for middle-ear surgery with deliberate <span class=""disease"">hypotension</span> induced by <span class=""chemical"">labetalol</span> with isoflurane (<span class=""disease"">hypotensive</span> group)."		8424298.0	8424298_MESH:D007741_MESH:D007022	8424298_2	bcv_devset_test_100_easy_482		
	MESH:D007530	"<span class=""chemical"">isoflurane</span>"	MESH:D007022	"<span class=""disease"">hypotension/hypotensive</span>"	"Twenty-four patients were anaesthetized for middle-ear surgery with deliberate <span class=""disease"">hypotension</span> induced by labetalol with <span class=""chemical"">isoflurane</span> (<span class=""disease"">hypotensive</span> group)."		8424298.0	8424298_MESH:D007530_MESH:D007022	8424298_2	bcv_devset_test_100_easy_483		
	MESH:D007741	"<span class=""chemical"">labetalol</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"The results indicate that <span class=""disease"">hypotension</span> induced by <span class=""chemical"">labetalol</span> with isoflurane has no significant harmful effects on mental functions compared to normotensive anaesthesia."		8424298.0	8424298_MESH:D007741_MESH:D007022	8424298_8	bcv_devset_test_100_easy_484		
	MESH:D007530	"<span class=""chemical"">isoflurane</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"The results indicate that <span class=""disease"">hypotension</span> induced by labetalol with <span class=""chemical"">isoflurane</span> has no significant harmful effects on mental functions compared to normotensive anaesthesia."		8424298.0	8424298_MESH:D007530_MESH:D007022	8424298_8	bcv_devset_test_100_easy_485		
	MESH:D000638	"<span class=""chemical"">Amiodarone</span>"	MESH:D011014	"<span class=""disease"">pneumonitis</span>"	"<span class=""chemical"">Amiodarone</span> is an effective antiarrhythmic agent whose utility is limited by many side-effects, the most problematic being <span class=""disease"">pneumonitis</span>."		1595783.0	1595783_MESH:D000638_MESH:D011014	1595783_1	bcv_devset_test_100_easy_486		
	MESH:D000638	"<span class=""chemical"">amiodarone</span>"	MESH:D004342	"<span class=""disease"">hypersensitivity pneumonitis</span>"	"The pulmonary toxicity of <span class=""chemical"">amiodarone</span> is thought to result from direct injury related to the intracellular accumulation of phospholipid and T cell-mediated <span class=""disease"">hypersensitivity pneumonitis</span>."		1595783.0	1595783_MESH:D000638_MESH:D004342	1595783_2	bcv_devset_test_100_easy_487		
	MESH:D001569	"<span class=""chemical"">benzodiazepines</span>"	MESH:D009207	"<span class=""disease"">myoclonic jerks</span>"	"Serotonergic drugs, <span class=""chemical"">benzodiazepines</span> and baclofen block muscimol-induced <span class=""disease"">myoclonic jerks</span> in a strain of mice."		6118280.0	6118280_MESH:D001569_MESH:D009207	6118280_0	bcv_devset_test_100_easy_488		
	MESH:D001418	"<span class=""chemical"">baclofen</span>"	MESH:D009207	"<span class=""disease"">myoclonic jerks</span>"	"Serotonergic drugs, benzodiazepines and <span class=""chemical"">baclofen</span> block muscimol-induced <span class=""disease"">myoclonic jerks</span> in a strain of mice."		6118280.0	6118280_MESH:D001418_MESH:D009207	6118280_0	bcv_devset_test_100_easy_489		
	MESH:D001569	"<span class=""chemical"">benzodiazepines</span>"	MESH:D009207	"<span class=""disease"">myoclonic jerks</span>"	"Of the <span class=""chemical"">benzodiazepines</span>, clonazepam (0.1-0.3 mg/kg) was found to be several fold more potent than diazepam (0.3-3 mg/kg) in blocking the <span class=""disease"">myoclonic jerks</span>."		6118280.0	6118280_MESH:D001569_MESH:D009207	6118280_6	bcv_devset_test_100_easy_490		
	MESH:D002998	"<span class=""chemical"">clonazepam</span>"	MESH:D009207	"<span class=""disease"">myoclonic jerks</span>"	"Of the benzodiazepines, <span class=""chemical"">clonazepam</span> (0.1-0.3 mg/kg) was found to be several fold more potent than diazepam (0.3-3 mg/kg) in blocking the <span class=""disease"">myoclonic jerks</span>."		6118280.0	6118280_MESH:D002998_MESH:D009207	6118280_6	bcv_devset_test_100_easy_491		
	MESH:D003975	"<span class=""chemical"">diazepam</span>"	MESH:D009207	"<span class=""disease"">myoclonic jerks</span>"	"Of the benzodiazepines, clonazepam (0.1-0.3 mg/kg) was found to be several fold more potent than <span class=""chemical"">diazepam</span> (0.3-3 mg/kg) in blocking the <span class=""disease"">myoclonic jerks</span>."		6118280.0	6118280_MESH:D003975_MESH:D009207	6118280_6	bcv_devset_test_100_easy_492		
	MESH:D001569	"<span class=""chemical"">benzodiazepines</span>"	MESH:D009207	"<span class=""disease"">myoclonus</span>"	"Considering the fact that 5-HTP and the <span class=""chemical"">benzodiazepines</span> have been found to be beneficial in the management of clinical <span class=""disease"">myoclonus</span>, the muscimol-induced <span class=""disease"">myoclonus</span> seems to be a satisfactory animal model that may prove useful for the development of new drug treatments for this condition."		6118280.0	6118280_MESH:D001569_MESH:D009207	6118280_8	bcv_devset_test_100_easy_493		
	MESH:D006916	"<span class=""chemical"">5-HTP</span>"	MESH:D009207	"<span class=""disease"">myoclonus</span>"	"Considering the fact that <span class=""chemical"">5-HTP</span> and the benzodiazepines have been found to be beneficial in the management of clinical <span class=""disease"">myoclonus</span>, the muscimol-induced <span class=""disease"">myoclonus</span> seems to be a satisfactory animal model that may prove useful for the development of new drug treatments for this condition."		6118280.0	6118280_MESH:D006916_MESH:D009207	6118280_8	bcv_devset_test_100_easy_494		
	MESH:C014896	"<span class=""chemical"">MK-212</span>"	MESH:D009207	"<span class=""disease"">myoclonus</span>"	"Our present study indicated the possible value of <span class=""chemical"">MK-212</span> and (-)-baclofen in the management of clinical <span class=""disease"">myoclonus</span>."		6118280.0	6118280_MESH:C014896_MESH:D009207	6118280_9	bcv_devset_test_100_easy_495		
	MESH:D001418	"<span class=""chemical"">baclofen</span>"	MESH:D009207	"<span class=""disease"">myoclonus</span>"	"Our present study indicated the possible value of MK-212 and (-)-<span class=""chemical"">baclofen</span> in the management of clinical <span class=""disease"">myoclonus</span>."		6118280.0	6118280_MESH:D001418_MESH:D009207	6118280_9	bcv_devset_test_100_easy_496		
	MESH:D002738	"<span class=""chemical"">Chloroquine</span>"	MESH:D001766	"<span class=""disease"">blindness</span>"	"<span class=""chemical"">Chloroquine</span> related complete heart block with <span class=""disease"">blindness</span>: case report."		1628552.0	1628552_MESH:D002738_MESH:D001766	1628552_0	bcv_devset_test_100_easy_497		
	MESH:D002738	"<span class=""chemical"">Chloroquine</span>"	MESH:D006327	"<span class=""disease"">heart block</span>"	"<span class=""chemical"">Chloroquine</span> related complete <span class=""disease"">heart block</span> with blindness: case report."		1628552.0	1628552_MESH:D002738_MESH:D006327	1628552_0	bcv_devset_test_100_easy_498		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D005221	"<span class=""disease"">fatiguability</span>"	"A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive deterioration of vision, easy <span class=""disease"">fatiguability</span>, dyspnoea, dizziness progressing to syncopal attacks."		1628552.0	1628552_MESH:D002738_MESH:D005221	1628552_1	bcv_devset_test_100_easy_499		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D014786	"<span class=""disease"">deterioration of vision</span>"	"A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive <span class=""disease"">deterioration of vision</span>, easy fatiguability, dyspnoea, dizziness progressing to syncopal attacks."		1628552.0	1628552_MESH:D002738_MESH:D014786	1628552_1	bcv_devset_test_100_easy_500		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D004244	"<span class=""disease"">dizziness</span>"	"A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive deterioration of vision, easy fatiguability, dyspnoea, <span class=""disease"">dizziness</span> progressing to syncopal attacks."		1628552.0	1628552_MESH:D002738_MESH:D004244	1628552_1	bcv_devset_test_100_easy_501		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D013575	"<span class=""disease"">syncopal attacks</span>"	"A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive deterioration of vision, easy fatiguability, dyspnoea, dizziness progressing to <span class=""disease"">syncopal attacks</span>."		1628552.0	1628552_MESH:D002738_MESH:D013575	1628552_1	bcv_devset_test_100_easy_502		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D002037	"<span class=""disease"">right bundle branch block</span>"	"Ophthalmological assessment revealed features of <span class=""chemical"">chloroquine</span> retinopathy, cardiac assessment revealed features of heart failure and a complete heart block with <span class=""disease"">right bundle branch block</span> pattern."		1628552.0	1628552_MESH:D002738_MESH:D002037	1628552_2	bcv_devset_test_100_easy_503		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D006333	"<span class=""disease"">heart failure</span>"	"Ophthalmological assessment revealed features of <span class=""chemical"">chloroquine</span> retinopathy, cardiac assessment revealed features of <span class=""disease"">heart failure</span> and a complete heart block with right bundle branch block pattern."		1628552.0	1628552_MESH:D002738_MESH:D006333	1628552_2	bcv_devset_test_100_easy_504		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D012164	"<span class=""disease"">retinopathy</span>"	"Ophthalmological assessment revealed features of <span class=""chemical"">chloroquine</span> <span class=""disease"">retinopathy</span>, cardiac assessment revealed features of heart failure and a complete heart block with right bundle branch block pattern."		1628552.0	1628552_MESH:D002738_MESH:D012164	1628552_2	bcv_devset_test_100_easy_505		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D006327	"<span class=""disease"">heart block</span>"	"Ophthalmological assessment revealed features of <span class=""chemical"">chloroquine</span> retinopathy, cardiac assessment revealed features of heart failure and a complete <span class=""disease"">heart block</span> with right bundle branch block pattern."		1628552.0	1628552_MESH:D002738_MESH:D006327	1628552_2	bcv_devset_test_100_easy_506		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D006333	"<span class=""disease"">heart failure</span>"	"The heart block was treated by pacemaker insertion and the <span class=""disease"">heart failure</span> resolved spontaneously following <span class=""chemical"">chloroquine</span> discontinuation."		1628552.0	1628552_MESH:D002738_MESH:D006333	1628552_3	bcv_devset_test_100_easy_507		
	MESH:D002738	"<span class=""chemical"">chloroquine</span>"	MESH:D006327	"<span class=""disease"">heart block</span>"	"The <span class=""disease"">heart block</span> was treated by pacemaker insertion and the heart failure resolved spontaneously following <span class=""chemical"">chloroquine</span> discontinuation."		1628552.0	1628552_MESH:D002738_MESH:D006327	1628552_3	bcv_devset_test_100_easy_508		
	MESH:D015742	"<span class=""chemical"">propofol</span>"	MESH:D008305	"<span class=""disease"">malignant hyperthermia</span>"	"Anesthesia was continued uneventfully with <span class=""chemical"">propofol</span> infusion while all facilities were available to detect and treat <span class=""disease"">malignant hyperthermia</span>."		15893386.0	15893386_MESH:D015742_MESH:D008305	15893386_4	bcv_devset_test_100_easy_509		
	MESH:D003520	"<span class=""chemical"">Cyclophosphamide</span>"	MESH:D059265	"<span class=""disease"">visceral pain</span>"	"<span class=""chemical"">Cyclophosphamide</span>-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of <span class=""disease"">visceral pain</span>."		10840460.0	10840460_MESH:D003520_MESH:D059265	10840460_0	bcv_devset_test_100_easy_510		
	MESH:D000171	"<span class=""chemical"">acrolein</span>"	MESH:D003556	"<span class=""disease"">cystitis</span>"	"Cyclophosphamide (CP), an antitumoral agent known to produce toxic effects on the bladder wall through its main toxic metabolite <span class=""chemical"">acrolein</span>, was used to induce <span class=""disease"">cystitis</span>."		10840460.0	10840460_MESH:D000171_MESH:D003556	10840460_2	bcv_devset_test_100_easy_511		
	MESH:D009020	"<span class=""chemical"">Morphine</span>"	MESH:D001523	"<span class=""disease"">behavioral disorders</span>"	"<span class=""chemical"">Morphine</span> dose-dependently reversed these <span class=""disease"">behavioral disorders</span>."		10840460.0	10840460_MESH:D009020_MESH:D001523	10840460_11	bcv_devset_test_100_easy_512		
	MESH:D009020	"<span class=""chemical"">morphine</span>"	MESH:D004487	"<span class=""disease"">edema</span>"	"At the time of administration of <span class=""chemical"">morphine</span>, histological modifications of the bladder wall, such as chorionic and muscle layer <span class=""disease"">edema</span>, were observed."		10840460.0	10840460_MESH:D009020_MESH:D004487	10840460_14	bcv_devset_test_100_easy_513		
	MESH:D003520	"<span class=""chemical"">CP</span>"	MESH:D059265	"<span class=""disease"">visceral pain</span>"	"CONCLUSIONS: Overall, these results indicate that this experimental model of <span class=""chemical"">CP</span>-induced cystitis may be an interesting new behavioral model of inflammatory <span class=""disease"">visceral pain</span>, allowing a better understanding of these painful syndromes and thus a better therapeutic approach to them."		10840460.0	10840460_MESH:D003520_MESH:D059265	10840460_21	bcv_devset_test_100_easy_514		
	MESH:D003520	"<span class=""chemical"">CP</span>"	MESH:D010146	"<span class=""disease"">painful syndromes</span>"	"CONCLUSIONS: Overall, these results indicate that this experimental model of <span class=""chemical"">CP</span>-induced cystitis may be an interesting new behavioral model of inflammatory visceral pain, allowing a better understanding of these <span class=""disease"">painful syndromes</span> and thus a better therapeutic approach to them."		10840460.0	10840460_MESH:D003520_MESH:D010146	10840460_21	bcv_devset_test_100_easy_515		
	MESH:D008012	"<span class=""chemical"">lidocaine</span>"	MESH:D010149	"<span class=""disease"">postoperative myalgia</span>"	"Can <span class=""chemical"">lidocaine</span> reduce succinylcholine induced <span class=""disease"">postoperative myalgia</span>?"		12452237.0	12452237_MESH:D008012_MESH:D010149	12452237_0	bcv_devset_test_100_easy_516		
	MESH:D008012	"<span class=""chemical"">lidocaine</span>"	MESH:D063806	"<span class=""disease"">myalgia</span>"	"This study was undertaken to determine the effect of <span class=""chemical"">lidocaine</span> pretreatment on reduction of succinylcholine-induced <span class=""disease"">myalgia</span> in patients undergoing general anesthesia for gynecological surgery."		12452237.0	12452237_MESH:D008012_MESH:D063806	12452237_1	bcv_devset_test_100_easy_517		
	MESH:D008012	"<span class=""chemical"">lidocaine</span>"	MESH:D010149	"<span class=""disease"">postoperative myalgia</span>"	"In conclusion, where succinylcholine is used, <span class=""chemical"">lidocaine</span> is proven to be the useful pretreatment agent for the reduction of <span class=""disease"">postoperative myalgia</span>."		12452237.0	12452237_MESH:D008012_MESH:D010149	12452237_13	bcv_devset_test_100_easy_518		
	MESH:D015215	"<span class=""chemical"">azidothymidine</span>"	MESH:D007153	"<span class=""disease"">immunodeficiency</span>"	"Benzylacyclouridine reverses <span class=""chemical"">azidothymidine</span>-induced marrow suppression without impairment of anti-human <span class=""disease"">immunodeficiency</span> virus activity."		2257294.0	2257294_MESH:D015215_MESH:D007153	2257294_0	bcv_devset_test_100_easy_519		
	MESH:D015215	"<span class=""chemical"">AZT/azidothymidine</span>"	MESH:D007153	"<span class=""disease"">immunodeficiency</span>"	"Increased extracellular concentrations of uridine (Urd) have been reported to reduce, in vitro, <span class=""chemical"">azidothymidine</span> (<span class=""chemical"">AZT</span>)-induced inhibition of human granulocyte-macrophage progenitor cells without impairment of its antihuman <span class=""disease"">immunodeficiency</span> virus (HIV) activity."		2257294.0	2257294_MESH:D015215_MESH:D007153	2257294_1	bcv_devset_test_100_easy_520		
	MESH:D014529	"<span class=""chemical"">Urd/uridine</span>"	MESH:D007153	"<span class=""disease"">immunodeficiency</span>"	"Increased extracellular concentrations of <span class=""chemical"">uridine</span> (<span class=""chemical"">Urd</span>) have been reported to reduce, in vitro, azidothymidine (AZT)-induced inhibition of human granulocyte-macrophage progenitor cells without impairment of its antihuman <span class=""disease"">immunodeficiency</span> virus (HIV) activity."		2257294.0	2257294_MESH:D014529_MESH:D007153	2257294_1	bcv_devset_test_100_easy_521		
	MESH:D014529	"<span class=""chemical"">Urd</span>"	MESH:D000740	"<span class=""disease"">anemia</span>"	"Because of the clinical toxicities associated with chronic <span class=""chemical"">Urd</span> administration, the ability of benzylacyclouridine (BAU) to effect, in vivo, AZT-induced <span class=""disease"">anemia</span> and leukopenia was assessed."		2257294.0	2257294_MESH:D014529_MESH:D000740	2257294_2	bcv_devset_test_100_easy_522		
	MESH:D014529	"<span class=""chemical"">Urd</span>"	MESH:D064420	"<span class=""disease"">toxicities</span>"	"Because of the clinical <span class=""disease"">toxicities</span> associated with chronic <span class=""chemical"">Urd</span> administration, the ability of benzylacyclouridine (BAU) to effect, in vivo, AZT-induced anemia and leukopenia was assessed."		2257294.0	2257294_MESH:D014529_MESH:D064420	2257294_2	bcv_devset_test_100_easy_523		
	MESH:D014529	"<span class=""chemical"">Urd</span>"	MESH:D007970	"<span class=""disease"">leukopenia</span>"	"Because of the clinical toxicities associated with chronic <span class=""chemical"">Urd</span> administration, the ability of benzylacyclouridine (BAU) to effect, in vivo, AZT-induced anemia and <span class=""disease"">leukopenia</span> was assessed."		2257294.0	2257294_MESH:D014529_MESH:D007970	2257294_2	bcv_devset_test_100_easy_524		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D064420	"<span class=""disease"">toxicities</span>"	"Because of the clinical <span class=""disease"">toxicities</span> associated with chronic Urd administration, the ability of benzylacyclouridine (BAU) to effect, in vivo, <span class=""chemical"">AZT</span>-induced anemia and leukopenia was assessed."		2257294.0	2257294_MESH:D015215_MESH:D064420	2257294_2	bcv_devset_test_100_easy_525		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D007970	"<span class=""disease"">leukopenia</span>"	"Because of the clinical toxicities associated with chronic Urd administration, the ability of benzylacyclouridine (BAU) to effect, in vivo, <span class=""chemical"">AZT</span>-induced anemia and <span class=""disease"">leukopenia</span> was assessed."		2257294.0	2257294_MESH:D015215_MESH:D007970	2257294_2	bcv_devset_test_100_easy_526		
	MESH:D014529	"<span class=""chemical"">Urd</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"This agent inhibits <span class=""chemical"">Urd</span> catabolism and, in vivo, increases the plasma concentration of <span class=""chemical"">Urd</span> in a dose-dependent manner, without <span class=""chemical"">Urd</span>-related <span class=""disease"">toxicity</span>."		2257294.0	2257294_MESH:D014529_MESH:D064420	2257294_3	bcv_devset_test_100_easy_527		
	MESH:D015215	"<span class=""chemical"">AZT</span>"	MESH:D007970	"<span class=""disease"">leukopenia</span>"	"In mice rendered anemic and leukopenic by the administration of <span class=""chemical"">AZT</span> for 28 days in drinking water (1.5 mg/mL), the continued administration of <span class=""chemical"">AZT</span> plus daily BAU (300 mg/kg, orally) partially reversed <span class=""chemical"">AZT</span>-induced anemia and <span class=""disease"">leukopenia</span> (P less than .05), increased peripheral reticulocytes (to 4.9%, P less than .01), increased cellularity in the marrow, and improved megaloblastosis."		2257294.0	2257294_MESH:D015215_MESH:D007970	2257294_4	bcv_devset_test_100_easy_528		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D004409	"<span class=""disease"">dyskinesia</span>"	"Effect of methanolic extract of Hibiscus rosa sinensis (100-300 mg/kg) was studied on <span class=""chemical"">reserpine</span>-induced orofacial <span class=""disease"">dyskinesia</span> and neurochemical alterations."		19761039.0	19761039_MESH:D012110_MESH:D004409	19761039_1	bcv_devset_test_100_easy_529		
	MESH:D012110	"<span class=""chemical"">reserpine</span>"	MESH:D004409	"<span class=""disease"">dyskinesia</span>"	"The results of the present study suggested that Hibiscus rosa sinensis had a protective role against <span class=""chemical"">reserpine</span>-induced orofacial <span class=""disease"">dyskinesia</span> and oxidative stress."		19761039.0	19761039_MESH:D012110_MESH:D004409	19761039_7	bcv_devset_test_100_easy_530		
	MESH:D013792	"<span class=""chemical"">thalidomide</span>"	MESH:D002292	"<span class=""disease"">renal cell carcinoma</span>"	"A phase II study of <span class=""chemical"">thalidomide</span> in advanced metastatic <span class=""disease"">renal cell carcinoma</span>."		12448656.0	12448656_MESH:D013792_MESH:D002292	12448656_0	bcv_devset_test_100_easy_531		
	MESH:D013792	"<span class=""chemical"">thalidomide</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"OBJECTIVES: To evaluate the <span class=""disease"">toxicity</span> and activity of <span class=""chemical"">thalidomide</span> in patients with advanced metastatic renal cell cancer and to measure changes of one angiogenic factor, vascular endothelial growth factor (VEGF)165, with therapy."		12448656.0	12448656_MESH:D013792_MESH:D064420	12448656_1	bcv_devset_test_100_easy_532		
	MESH:D013792	"<span class=""chemical"">thalidomide</span>"	MESH:D007680	"<span class=""disease"">renal cell cancer</span>"	"OBJECTIVES: To evaluate the toxicity and activity of <span class=""chemical"">thalidomide</span> in patients with advanced metastatic <span class=""disease"">renal cell cancer</span> and to measure changes of one angiogenic factor, vascular endothelial growth factor (VEGF)165, with therapy."		12448656.0	12448656_MESH:D013792_MESH:D007680	12448656_1	bcv_devset_test_100_easy_533		
	MESH:D013792	"<span class=""chemical"">thalidomide</span>"	MESH:D002292	"<span class=""disease"">renal cell carcinoma</span>"	"CONCLUSION: These results are consistent with a low level of activity of <span class=""chemical"">thalidomide</span> in <span class=""disease"">renal cell carcinoma</span>."		12448656.0	12448656_MESH:D013792_MESH:D002292	12448656_9	bcv_devset_test_100_easy_534		
	MESH:D013792	"<span class=""chemical"">thalidomide</span>"	MESH:D002292	"<span class=""disease"">renal cell carcinoma</span>"	"The dose-response relationship, if any, of <span class=""chemical"">thalidomide</span> for <span class=""disease"">renal cell carcinoma</span> is unclear."		12448656.0	12448656_MESH:D013792_MESH:D002292	12448656_11	bcv_devset_test_100_easy_535		
	MESH:D000583	"<span class=""chemical"">Amikacin</span>"	MESH:D064147	"<span class=""disease"">febrile neutropenia</span>"	"<span class=""chemical"">Amikacin</span> is an aminoglycoside commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections."		18356633.0	18356633_MESH:D000583_MESH:D064147	18356633_1	bcv_devset_test_100_easy_536		
	MESH:D000617	"<span class=""chemical"">aminoglycoside</span>"	MESH:D007239	"<span class=""disease"">infections</span>"	"Amikacin is an <span class=""chemical"">aminoglycoside</span> commonly used to provide empirical double gram-negative treatment for febrile neutropenia and other suspected <span class=""disease"">infections</span>."		18356633.0	18356633_MESH:D000617_MESH:D007239	18356633_1	bcv_devset_test_100_easy_537		
	MESH:D000583	"<span class=""chemical"">Amikacin</span>"	MESH:D007239	"<span class=""disease"">infections</span>"	"<span class=""chemical"">Amikacin</span> is an aminoglycoside commonly used to provide empirical double gram-negative treatment for febrile neutropenia and other suspected <span class=""disease"">infections</span>."		18356633.0	18356633_MESH:D000583_MESH:D007239	18356633_1	bcv_devset_test_100_easy_538		
	MESH:D000617	"<span class=""chemical"">aminoglycoside</span>"	MESH:D064147	"<span class=""disease"">febrile neutropenia</span>"	"Amikacin is an <span class=""chemical"">aminoglycoside</span> commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections."		18356633.0	18356633_MESH:D000617_MESH:D064147	18356633_1	bcv_devset_test_100_easy_539		
	MESH:D000617	"<span class=""chemical"">aminoglycoside</span>"	MESH:D006402	"<span class=""disease"">hematologic/oncologic disorder</span>"	"Forty patients with a diagnosis consistent with a <span class=""disease"">hematologic/oncologic disorder</span> that required treatment with an <span class=""chemical"">aminoglycoside</span> were randomized to either conventional or extended-interval amikacin."		18356633.0	18356633_MESH:D000617_MESH:D006402	18356633_4	bcv_devset_test_100_easy_540		
	MESH:D000583	"<span class=""chemical"">amikacin</span>"	MESH:D006402	"<span class=""disease"">hematologic/oncologic disorder</span>"	"Forty patients with a diagnosis consistent with a <span class=""disease"">hematologic/oncologic disorder</span> that required treatment with an aminoglycoside were randomized to either conventional or extended-interval <span class=""chemical"">amikacin</span>."		18356633.0	18356633_MESH:D000583_MESH:D006402	18356633_4	bcv_devset_test_100_easy_541		
	MESH:D019342	"<span class=""chemical"">acetic acid</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"The effects of intrathecal administration of prostaglandins on <span class=""disease"">pain</span> responses in conscious mice were evaluated by using hot plate and <span class=""chemical"">acetic acid</span> writhing tests."		2322844.0	2322844_MESH:D019342_MESH:D010146	2322844_1	bcv_devset_test_100_easy_542		
	MESH:D011453	"<span class=""chemical"">prostaglandins</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"The effects of intrathecal administration of <span class=""chemical"">prostaglandins</span> on <span class=""disease"">pain</span> responses in conscious mice were evaluated by using hot plate and acetic acid writhing tests."		2322844.0	2322844_MESH:D011453_MESH:D010146	2322844_1	bcv_devset_test_100_easy_543		
	MESH:D015230	"<span class=""chemical"">Prostaglandin D2</span>"	MESH:D006930	"<span class=""disease"">hyperalgesic</span>"	"<span class=""chemical"">Prostaglandin D2</span> (0.5-3 ng/mouse) had a <span class=""disease"">hyperalgesic</span> action on the response to a hot plate during a 3-60 min period after injection."		2322844.0	2322844_MESH:D015230_MESH:D006930	2322844_2	bcv_devset_test_100_easy_544		
	MESH:D010400	"<span class=""chemical"">pg</span>"	MESH:D006930	"<span class=""disease"">hyperalgesic</span>"	"Prostaglandin E2 showed a <span class=""disease"">hyperalgesic</span> effect at doses of 1 <span class=""chemical"">pg</span> to 10 ng/mouse, but the effect lasted shorter (3-30 min) than that of prostaglandin D2."		2322844.0	2322844_MESH:D010400_MESH:D006930	2322844_3	bcv_devset_test_100_easy_545		
	MESH:D015230	"<span class=""chemical"">prostaglandin D2</span>"	MESH:D006930	"<span class=""disease"">hyperalgesic</span>"	"Prostaglandin E2 showed a <span class=""disease"">hyperalgesic</span> effect at doses of 1 pg to 10 ng/mouse, but the effect lasted shorter (3-30 min) than that of <span class=""chemical"">prostaglandin D2</span>."		2322844.0	2322844_MESH:D015230_MESH:D006930	2322844_3	bcv_devset_test_100_easy_546		
	MESH:C053876	"<span class=""chemical"">AH6809</span>"	MESH:D006930	"<span class=""disease"">hyperalgesic</span>"	"The <span class=""disease"">hyperalgesic</span> effect of prostaglandin D2 was blocked by simultaneous injection of a substance P antagonist (greater than or equal to 100 ng) but not by <span class=""chemical"">AH6809</span>, a prostanoid EP1-receptor antagonist."		2322844.0	2322844_MESH:C053876_MESH:D006930	2322844_5	bcv_devset_test_100_easy_547		
	MESH:D015230	"<span class=""chemical"">prostaglandin D2</span>"	MESH:D006930	"<span class=""disease"">hyperalgesic</span>"	"The <span class=""disease"">hyperalgesic</span> effect of <span class=""chemical"">prostaglandin D2</span> was blocked by simultaneous injection of a substance P antagonist (greater than or equal to 100 ng) but not by AH6809, a prostanoid EP1-receptor antagonist."		2322844.0	2322844_MESH:D015230_MESH:D006930	2322844_5	bcv_devset_test_100_easy_548		
	MESH:C053876	"<span class=""chemical"">AH6809</span>"	MESH:D006930	"<span class=""disease"">hyperalgesia</span>"	"Conversely, prostaglandin E2-induced <span class=""disease"">hyperalgesia</span> was blocked by <span class=""chemical"">AH6809</span> (greater than or equal to 500 ng) but not by the substance P antagonist."		2322844.0	2322844_MESH:C053876_MESH:D006930	2322844_6	bcv_devset_test_100_easy_549		
	MESH:D015237	"<span class=""chemical"">Prostaglandin F2 alpha</span>"	MESH:D010146	"<span class=""disease"">pain</span>"	"<span class=""chemical"">Prostaglandin F2 alpha</span> had little effect on <span class=""disease"">pain</span> responses."		2322844.0	2322844_MESH:D015237_MESH:D010146	2322844_7	bcv_devset_test_100_easy_550		
	MESH:D015230	"<span class=""chemical"">prostaglandin D2</span>"	MESH:D006930	"<span class=""disease"">hyperalgesia</span>"	"These results demonstrate that both <span class=""chemical"">prostaglandin D2</span> and prostaglandin E2 exert <span class=""disease"">hyperalgesia</span> in the spinal cord, but in different ways."		2322844.0	2322844_MESH:D015230_MESH:D006930	2322844_8	bcv_devset_test_100_easy_551		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D001168	"<span class=""disease"">arthritis</span>"	"Effects of the cyclooxygenase-2 specific inhibitor <span class=""chemical"">valdecoxib</span> versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with <span class=""disease"">arthritis</span>."		15266215.0	15266215_MESH:C406224_MESH:D001168	15266215_0	bcv_devset_test_100_easy_552		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"Effects of the cyclooxygenase-2 specific inhibitor <span class=""chemical"">valdecoxib</span> versus nonsteroidal antiinflammatory agents and placebo on cardiovascular <span class=""disease"">thrombotic</span> events in patients with arthritis."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_0	bcv_devset_test_100_easy_553		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"We evaluated cardiovascular event data for <span class=""chemical"">valdecoxib</span>, a new COX-2-specific inhibitor in approximately 8000 patients with osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> treated with this agent in randomized clinical trials."		15266215.0	15266215_MESH:C406224_MESH:D001172	15266215_2	bcv_devset_test_100_easy_554		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"We evaluated cardiovascular event data for <span class=""chemical"">valdecoxib</span>, a new COX-2-specific inhibitor in approximately 8000 patients with <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis treated with this agent in randomized clinical trials."		15266215.0	15266215_MESH:C406224_MESH:D010003	15266215_2	bcv_devset_test_100_easy_555		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, <span class=""chemical"">ibuprofen</span> 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D007052_MESH:D001172	15266215_3	bcv_devset_test_100_easy_556		
	MESH:D009288	"<span class=""chemical"">naproxen</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or <span class=""chemical"">naproxen</span> 500 mg bid) and placebo data from 10 randomized <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D009288_MESH:D010003	15266215_3	bcv_devset_test_100_easy_557		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled <span class=""chemical"">valdecoxib</span> (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:C406224_MESH:D001172	15266215_3	bcv_devset_test_100_easy_558		
	MESH:D004008	"<span class=""chemical"">diclofenac</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"The incidence of cardiovascular <span class=""disease"">thrombotic</span> events (cardiac, cerebrovascular and peripheral vascular, or arterial <span class=""disease"">thrombotic</span>) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (<span class=""chemical"">diclofenac</span> 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D004008_MESH:D013927	15266215_3	bcv_devset_test_100_easy_559		
	MESH:D004008	"<span class=""chemical"">diclofenac</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (<span class=""chemical"">diclofenac</span> 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D004008_MESH:D010003	15266215_3	bcv_devset_test_100_easy_560		
	MESH:D009288	"<span class=""chemical"">naproxen</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"The incidence of cardiovascular <span class=""disease"">thrombotic</span> events (cardiac, cerebrovascular and peripheral vascular, or arterial <span class=""disease"">thrombotic</span>) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or <span class=""chemical"">naproxen</span> 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D009288_MESH:D013927	15266215_3	bcv_devset_test_100_easy_561		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, <span class=""chemical"">ibuprofen</span> 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D007052_MESH:D010003	15266215_3	bcv_devset_test_100_easy_562		
	MESH:D009288	"<span class=""chemical"">naproxen</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or <span class=""chemical"">naproxen</span> 500 mg bid) and placebo data from 10 randomized osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D009288_MESH:D001172	15266215_3	bcv_devset_test_100_easy_563		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"The incidence of cardiovascular <span class=""disease"">thrombotic</span> events (cardiac, cerebrovascular and peripheral vascular, or arterial <span class=""disease"">thrombotic</span>) was determined by analyzing pooled <span class=""chemical"">valdecoxib</span> (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_3	bcv_devset_test_100_easy_564		
	MESH:D004008	"<span class=""chemical"">diclofenac</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (<span class=""chemical"">diclofenac</span> 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D004008_MESH:D001172	15266215_3	bcv_devset_test_100_easy_565		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"The incidence of cardiovascular thrombotic events (cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled <span class=""chemical"">valdecoxib</span> (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:C406224_MESH:D010003	15266215_3	bcv_devset_test_100_easy_566		
	MESH:D007052	"<span class=""chemical"">ibuprofen</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"The incidence of cardiovascular <span class=""disease"">thrombotic</span> events (cardiac, cerebrovascular and peripheral vascular, or arterial <span class=""disease"">thrombotic</span>) was determined by analyzing pooled valdecoxib (10-80 mg daily), nonselective NSAID (diclofenac 75 mg bid, <span class=""chemical"">ibuprofen</span> 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6-52 weeks in duration."		15266215.0	15266215_MESH:D007052_MESH:D013927	15266215_3	bcv_devset_test_100_easy_567		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"Crude and exposure-adjusted incidences of <span class=""disease"">thrombotic</span> events were similar for <span class=""chemical"">valdecoxib</span>, NSAIDs, and placebo."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_5	bcv_devset_test_100_easy_568		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"The risk of serious <span class=""disease"">thrombotic</span> events was also similar for each <span class=""chemical"">valdecoxib</span> dose."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_6	bcv_devset_test_100_easy_569		
	MESH:D001241	"<span class=""chemical"">aspirin</span>"	MESH:D013927	"<span class=""disease"">Thrombotic</span>"	"<span class=""disease"">Thrombotic</span> risk was consistently higher for users of <span class=""chemical"">aspirin</span> users than nonusers of <span class=""chemical"">aspirin</span> (placebo, 1.4% vs. 0%; valdecoxib, 1.7% vs. 0.2%; NSAIDs, 1.9% vs. 0.5%)."		15266215.0	15266215_MESH:D001241_MESH:D013927	15266215_7	bcv_devset_test_100_easy_570		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">Thrombotic</span>"	"<span class=""disease"">Thrombotic</span> risk was consistently higher for users of aspirin users than nonusers of aspirin (placebo, 1.4% vs. 0%; <span class=""chemical"">valdecoxib</span>, 1.7% vs. 0.2%; NSAIDs, 1.9% vs. 0.5%)."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_7	bcv_devset_test_100_easy_571		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D001172	"<span class=""disease"">rheumatoid arthritis</span>"	"Short- and intermediate-term treatment with therapeutic (10 or 20 mg daily) and supratherapeutic (40 or 80 mg daily) <span class=""chemical"">valdecoxib</span> doses was not associated with an increased incidence of thrombotic events relative to nonselective NSAIDs or placebo in osteoarthritis and <span class=""disease"">rheumatoid arthritis</span> patients in controlled clinical trials."		15266215.0	15266215_MESH:C406224_MESH:D001172	15266215_9	bcv_devset_test_100_easy_572		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D013927	"<span class=""disease"">thrombotic</span>"	"Short- and intermediate-term treatment with therapeutic (10 or 20 mg daily) and supratherapeutic (40 or 80 mg daily) <span class=""chemical"">valdecoxib</span> doses was not associated with an increased incidence of <span class=""disease"">thrombotic</span> events relative to nonselective NSAIDs or placebo in osteoarthritis and rheumatoid arthritis patients in controlled clinical trials."		15266215.0	15266215_MESH:C406224_MESH:D013927	15266215_9	bcv_devset_test_100_easy_573		
	MESH:C406224	"<span class=""chemical"">valdecoxib</span>"	MESH:D010003	"<span class=""disease"">osteoarthritis</span>"	"Short- and intermediate-term treatment with therapeutic (10 or 20 mg daily) and supratherapeutic (40 or 80 mg daily) <span class=""chemical"">valdecoxib</span> doses was not associated with an increased incidence of thrombotic events relative to nonselective NSAIDs or placebo in <span class=""disease"">osteoarthritis</span> and rheumatoid arthritis patients in controlled clinical trials."		15266215.0	15266215_MESH:C406224_MESH:D010003	15266215_9	bcv_devset_test_100_easy_574		
	MESH:D008012	"<span class=""chemical"">lignocaine</span>"	MESH:D011128	"<span class=""disease"">Cauda equina syndrome</span>"	"<span class=""disease"">Cauda equina syndrome</span> after spinal anaesthesia with hyperbaric 5% <span class=""chemical"">lignocaine</span>: a review of six cases of <span class=""disease"">cauda equina syndrome</span> reported to the Swedish Pharmaceutical Insurance 1993-1997."		10225068.0	10225068_MESH:D008012_MESH:D011128	10225068_0	bcv_devset_test_100_easy_575		
	MESH:D008012	"<span class=""chemical"">lignocaine</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity</span>"	"Three of the cases were most likely caused by direct <span class=""disease"">neurotoxicity</span> of hyperbaric 5% <span class=""chemical"">lignocaine</span>."		10225068.0	10225068_MESH:D008012_MESH:D020258	10225068_5	bcv_devset_test_100_easy_576		
	MESH:D002122	"<span class=""chemical"">calcium chloride</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Effect of <span class=""chemical"">calcium chloride</span> and 4-aminopyridine therapy on desipramine <span class=""disease"">toxicity</span> in rats."		8800187.0	8800187_MESH:D002122_MESH:D064420	8800187_0	bcv_devset_test_100_easy_577		
	MESH:D015761	"<span class=""chemical"">4-aminopyridine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Effect of calcium chloride and <span class=""chemical"">4-aminopyridine</span> therapy on desipramine <span class=""disease"">toxicity</span> in rats."		8800187.0	8800187_MESH:D015761_MESH:D064420	8800187_0	bcv_devset_test_100_easy_578		
	MESH:D003891	"<span class=""chemical"">desipramine</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Effect of calcium chloride and 4-aminopyridine therapy on <span class=""chemical"">desipramine</span> <span class=""disease"">toxicity</span> in rats."		8800187.0	8800187_MESH:D003891_MESH:D064420	8800187_0	bcv_devset_test_100_easy_579		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"This study addressed the potential role of <span class=""chemical"">calcium</span> channel blockade in tricyclic antidepressant-induced <span class=""disease"">hypotension</span>."		8800187.0	8800187_MESH:D002118_MESH:D007022	8800187_3	bcv_devset_test_100_easy_580		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D062787	"<span class=""disease"">overdose</span>"	"METHODS: Two interventions were studied that have been shown previously to improve blood pressure with <span class=""chemical"">calcium</span> channel blocker <span class=""disease"">overdose</span>."		8800187.0	8800187_MESH:D002118_MESH:D062787	8800187_4	bcv_devset_test_100_easy_581		
	MESH:D003891	"<span class=""chemical"">desipramine</span>"	MESH:D001919	"<span class=""disease"">bradycardia</span>"	"Anesthetized rats received the tricyclic antidepressant <span class=""chemical"">desipramine</span> IP to produce hypotension, QRS prolongation, and <span class=""disease"">bradycardia</span>."		8800187.0	8800187_MESH:D003891_MESH:D001919	8800187_6	bcv_devset_test_100_easy_582		
	MESH:D003891	"<span class=""chemical"">desipramine</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"Anesthetized rats received the tricyclic antidepressant <span class=""chemical"">desipramine</span> IP to produce <span class=""disease"">hypotension</span>, QRS prolongation, and bradycardia."		8800187.0	8800187_MESH:D003891_MESH:D007022	8800187_6	bcv_devset_test_100_easy_583		
	MESH:D002122	"<span class=""chemical"">CaCl2</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"The incidence of ventricular arrhythmias (p = 0.004) and <span class=""disease"">seizures</span> (p = 0.03) in the <span class=""chemical"">CaCl2</span> group was higher than the other groups."		8800187.0	8800187_MESH:D002122_MESH:D012640	8800187_11	bcv_devset_test_100_easy_584		
	MESH:D002122	"<span class=""chemical"">CaCl2</span>"	MESH:D001145	"<span class=""disease"">ventricular arrhythmias</span>"	"The incidence of <span class=""disease"">ventricular arrhythmias</span> (p = 0.004) and seizures (p = 0.03) in the <span class=""chemical"">CaCl2</span> group was higher than the other groups."		8800187.0	8800187_MESH:D002122_MESH:D001145	8800187_11	bcv_devset_test_100_easy_585		
	MESH:D002122	"<span class=""chemical"">CaCl2</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"CONCLUSION: The administration of <span class=""chemical"">CaCl2</span> or 4-aminopyridine did not reverse tricyclic antidepressant-induced <span class=""disease"">hypotension</span> in rats."		8800187.0	8800187_MESH:D002122_MESH:D007022	8800187_12	bcv_devset_test_100_easy_586		
	MESH:D015761	"<span class=""chemical"">4-aminopyridine</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"CONCLUSION: The administration of CaCl2 or <span class=""chemical"">4-aminopyridine</span> did not reverse tricyclic antidepressant-induced <span class=""disease"">hypotension</span> in rats."		8800187.0	8800187_MESH:D015761_MESH:D007022	8800187_12	bcv_devset_test_100_easy_587		
	MESH:D002122	"<span class=""chemical"">CaCl2</span>"	MESH:D002318	"<span class=""disease"">cardiovascular and central nervous system toxicity</span>"	"<span class=""chemical"">CaCl2</span> therapy may possibly worsen both <span class=""disease"">cardiovascular and central nervous system toxicity</span>."		8800187.0	8800187_MESH:D002122_MESH:D002318	8800187_13	bcv_devset_test_100_easy_588		
	MESH:D002118	"<span class=""chemical"">calcium</span>"	MESH:D007022	"<span class=""disease"">hypotension</span>"	"These findings do not support a role for <span class=""chemical"">calcium</span> channel inhibition in the pathogenesis of tricyclic antidepressant-induced <span class=""disease"">hypotension</span>."		8800187.0	8800187_MESH:D002118_MESH:D007022	8800187_14	bcv_devset_test_100_easy_589		
	MESH:C107135	"<span class=""chemical"">everolimus</span>"	MESH:D006504	"<span class=""disease"">sinusoidal obstruction syndrome</span>"	"Graft-versus-host disease prophylaxis with <span class=""chemical"">everolimus</span> and tacrolimus is associated with a high incidence of <span class=""disease"">sinusoidal obstruction syndrome</span> and microangiopathy: results of the EVTAC trial."		19135948.0	19135948_MESH:C107135_MESH:D006504	19135948_0	bcv_devset_test_100_easy_590		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D006504	"<span class=""disease"">sinusoidal obstruction syndrome</span>"	"Graft-versus-host disease prophylaxis with everolimus and <span class=""chemical"">tacrolimus</span> is associated with a high incidence of <span class=""disease"">sinusoidal obstruction syndrome</span> and microangiopathy: results of the EVTAC trial."		19135948.0	19135948_MESH:D016559_MESH:D006504	19135948_0	bcv_devset_test_100_easy_591		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D057049	"<span class=""disease"">microangiopathy</span>"	"Graft-versus-host disease prophylaxis with everolimus and <span class=""chemical"">tacrolimus</span> is associated with a high incidence of sinusoidal obstruction syndrome and <span class=""disease"">microangiopathy</span>: results of the EVTAC trial."		19135948.0	19135948_MESH:D016559_MESH:D057049	19135948_0	bcv_devset_test_100_easy_592		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D006086	"<span class=""disease"">Graft-versus-host disease</span>"	"<span class=""disease"">Graft-versus-host disease</span> prophylaxis with everolimus and <span class=""chemical"">tacrolimus</span> is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial."		19135948.0	19135948_MESH:D016559_MESH:D006086	19135948_0	bcv_devset_test_100_easy_593		
	MESH:C107135	"<span class=""chemical"">everolimus</span>"	MESH:D057049	"<span class=""disease"">microangiopathy</span>"	"Graft-versus-host disease prophylaxis with <span class=""chemical"">everolimus</span> and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and <span class=""disease"">microangiopathy</span>: results of the EVTAC trial."		19135948.0	19135948_MESH:C107135_MESH:D057049	19135948_0	bcv_devset_test_100_easy_594		
	MESH:C107135	"<span class=""chemical"">everolimus</span>"	MESH:D006086	"<span class=""disease"">Graft-versus-host disease</span>"	"<span class=""disease"">Graft-versus-host disease</span> prophylaxis with <span class=""chemical"">everolimus</span> and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial."		19135948.0	19135948_MESH:C107135_MESH:D006086	19135948_0	bcv_devset_test_100_easy_595		
	MESH:D008727	"<span class=""chemical"">methotrexate</span>"	MESH:D006086	"<span class=""disease"">GVHD/graft-versus-host disease</span>"	"A calcineurin inhibitor combined with <span class=""chemical"">methotrexate</span> is the standard prophylaxis for <span class=""disease"">graft-versus-host disease</span> (<span class=""disease"">GVHD</span>) after allogeneic hematopoietic stem cell transplantation (HSCT)."		19135948.0	19135948_MESH:D008727_MESH:D006086	19135948_1	bcv_devset_test_100_easy_596		
	MESH:C107135	"<span class=""chemical"">everolimus</span>"	MESH:D015470	"<span class=""disease"">acute myeloid leukemia/AML</span>"	"We report on a combination of <span class=""chemical"">everolimus</span> and tacrolimus in 24 patients (median age, 62 years) with either myelodysplastic syndrome (MDS; n = 17) or <span class=""disease"">acute myeloid leukemia</span> (<span class=""disease"">AML</span>; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors."		19135948.0	19135948_MESH:C107135_MESH:D015470	19135948_3	bcv_devset_test_100_easy_597		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D015470	"<span class=""disease"">acute myeloid leukemia/AML</span>"	"We report on a combination of everolimus and <span class=""chemical"">tacrolimus</span> in 24 patients (median age, 62 years) with either myelodysplastic syndrome (MDS; n = 17) or <span class=""disease"">acute myeloid leukemia</span> (<span class=""disease"">AML</span>; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors."		19135948.0	19135948_MESH:D016559_MESH:D015470	19135948_3	bcv_devset_test_100_easy_598		
	MESH:C107135	"<span class=""chemical"">everolimus</span>"	MESH:D009190	"<span class=""disease"">MDS/myelodysplastic syndrome</span>"	"We report on a combination of <span class=""chemical"">everolimus</span> and tacrolimus in 24 patients (median age, 62 years) with either <span class=""disease"">myelodysplastic syndrome</span> (<span class=""disease"">MDS</span>; n = 17) or acute myeloid leukemia (AML; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors."		19135948.0	19135948_MESH:C107135_MESH:D009190	19135948_3	bcv_devset_test_100_easy_599		
	MESH:D016559	"<span class=""chemical"">tacrolimus</span>"	MESH:D009190	"<span class=""disease"">MDS/myelodysplastic syndrome</span>"	"We report on a combination of everolimus and <span class=""chemical"">tacrolimus</span> in 24 patients (median age, 62 years) with either <span class=""disease"">myelodysplastic syndrome</span> (<span class=""disease"">MDS</span>; n = 17) or acute myeloid leukemia (AML; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors."		19135948.0	19135948_MESH:D016559_MESH:D009190	19135948_3	bcv_devset_test_100_easy_600		
	MESH:D004456	"<span class=""chemical"">echothiophate iodide</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Cholinergic <span class=""disease"">toxicity</span> resulting from ocular instillation of <span class=""chemical"">echothiophate iodide</span> eye drops."		7650771.0	7650771_MESH:D004456_MESH:D064420	7650771_0	bcv_devset_test_100_easy_601		
	MESH:D004456	"<span class=""chemical"">echothiophate iodide</span>"	MESH:D018908	"<span class=""disease"">muscle weakness</span>"	"A patient developed a severe cholinergic syndrome from the use of <span class=""chemical"">echothiophate iodide</span> ophthalmic drops, presented with profound <span class=""disease"">muscle weakness</span> and was initially given the diagnosis of myasthenia gravis."		7650771.0	7650771_MESH:D004456_MESH:D018908	7650771_1	bcv_devset_test_100_easy_602		
	MESH:D004456	"<span class=""chemical"">echothiophate iodide</span>"	MESH:D009157	"<span class=""disease"">myasthenia gravis</span>"	"A patient developed a severe cholinergic syndrome from the use of <span class=""chemical"">echothiophate iodide</span> ophthalmic drops, presented with profound muscle weakness and was initially given the diagnosis of <span class=""disease"">myasthenia gravis</span>."		7650771.0	7650771_MESH:D004456_MESH:D009157	7650771_1	bcv_devset_test_100_easy_603		
	MESH:D008694	"<span class=""chemical"">Methamphetamine</span>"	MESH:D001523	"<span class=""disease"">aggressiveness</span>"	"<span class=""chemical"">Methamphetamine</span> causes alterations in the MAP kinase-related pathways in the brains of mice that display increased <span class=""disease"">aggressiveness</span>."		16192988.0	16192988_MESH:D008694_MESH:D001523	16192988_0	bcv_devset_test_100_easy_604		
	MESH:D008694	"<span class=""chemical"">METH/methamphetamine</span>"	MESH:D001523	"<span class=""disease"">psychiatric disorders/Aggressive behaviors</span>"	"<span class=""disease"">Aggressive behaviors</span> have been reported in patients who suffer from some <span class=""disease"">psychiatric disorders</span>, and are common in <span class=""chemical"">methamphetamine</span> (<span class=""chemical"">METH</span>) abusers."		16192988.0	16192988_MESH:D008694_MESH:D001523	16192988_1	bcv_devset_test_100_easy_605		
	MESH:D008694	"<span class=""chemical"">METH</span>"	MESH:D001523	"<span class=""disease"">aggressiveness</span>"	"Herein, we report that multiple (but not single) injections of <span class=""chemical"">METH</span> significantly increased <span class=""disease"">aggressiveness</span> in male CD-1 mice."		16192988.0	16192988_MESH:D008694_MESH:D001523	16192988_2	bcv_devset_test_100_easy_606		
	MESH:D008694	"<span class=""chemical"">METH</span>"	MESH:D001523	"<span class=""disease"">aggressiveness</span>"	"This increase in <span class=""disease"">aggressiveness</span> was not secondary to <span class=""chemical"">METH</span>-induced hyperactivity."		16192988.0	16192988_MESH:D008694_MESH:D001523	16192988_3	bcv_devset_test_100_easy_607		
	MESH:D003042	"<span class=""chemical"">Cocaine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"<span class=""chemical"">Cocaine</span>-induced brainstem <span class=""disease"">seizures</span> and behavior."		1610717.0	1610717_MESH:D003042_MESH:D012640	1610717_0	bcv_devset_test_100_easy_608		
	MESH:D000661	"<span class=""chemical"">amphetamine</span>"	MESH:D001927	"<span class=""disease"">substantia nigra lesion</span>"	"Transient contralateral rotation following unilateral <span class=""disease"">substantia nigra lesion</span> reflects susceptibility of the nigrostriatal system to exhaustion by <span class=""chemical"">amphetamine</span>."		3088349.0	3088349_MESH:D000661_MESH:D001927	3088349_0	bcv_devset_test_100_easy_609		
	MESH:D016627	"<span class=""chemical"">6-OHDA</span>"	MESH:D009069	"<span class=""disease"">ipsilateral circling/contralateral rotation</span>"	"Following unilateral <span class=""chemical"">6-OHDA</span> induced SN lesion, a transient period of <span class=""disease"">contralateral rotation</span> has been reported to precede the predominant <span class=""disease"">ipsilateral circling</span>."		3088349.0	3088349_MESH:D016627_MESH:D009069	3088349_1	bcv_devset_test_100_easy_610		
	MESH:D010068	"<span class=""chemical"">oxacillin</span>"	MESH:D014657	"<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span>"	"<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span> associated with <span class=""chemical"">oxacillin</span>."		11337188.0	11337188_MESH:D010068_MESH:D014657	11337188_0	bcv_devset_test_100_easy_611		
	MESH:D010068	"<span class=""chemical"">oxacillin</span>"	MESH:D016470	"<span class=""disease"">Staphylococcus aureus bacteremia</span>"	"A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of <span class=""disease"">Staphylococcus aureus bacteremia</span>, developed renal failure and diffuse, symmetric, palpable purpuric lesions on his feet."		11337188.0	11337188_MESH:D010068_MESH:D016470	11337188_1	bcv_devset_test_100_easy_612		
	MESH:D010068	"<span class=""chemical"">oxacillin</span>"	MESH:D011693	"<span class=""disease"">purpuric lesions</span>"	"A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of Staphylococcus aureus bacteremia, developed renal failure and diffuse, symmetric, palpable <span class=""disease"">purpuric lesions</span> on his feet."		11337188.0	11337188_MESH:D010068_MESH:D011693	11337188_1	bcv_devset_test_100_easy_613		
	MESH:D010068	"<span class=""chemical"">oxacillin</span>"	MESH:D051437	"<span class=""disease"">renal failure</span>"	"A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of Staphylococcus aureus bacteremia, developed <span class=""disease"">renal failure</span> and diffuse, symmetric, palpable purpuric lesions on his feet."		11337188.0	11337188_MESH:D010068_MESH:D051437	11337188_1	bcv_devset_test_100_easy_614		
	MESH:D010068	"<span class=""chemical"">Oxacillin</span>"	MESH:D014657	"<span class=""disease"">leucocytoclastic vasculitis</span>"	"<span class=""chemical"">Oxacillin</span> should be included among the drugs that can cause <span class=""disease"">leucocytoclastic vasculitis</span>."		11337188.0	11337188_MESH:D010068_MESH:D014657	11337188_10	bcv_devset_test_100_easy_615		
	MESH:D016190	"<span class=""chemical"">CBDCA/carboplatin</span>"	MESH:D020258	"<span class=""disease"">neurotoxic</span>"	"BACKGROUND: The most striking of <span class=""chemical"">carboplatin</span>'s advantages (<span class=""chemical"">CBDCA</span>) over cisplatin (CDDP) is its markedly reduced rate of <span class=""disease"">neurotoxic</span> effects."		9636837.0	9636837_MESH:D016190_MESH:D020258	9636837_1	bcv_devset_test_100_easy_616		
	MESH:D002945	"<span class=""chemical"">CDDP/cisplatin</span>"	MESH:D020258	"<span class=""disease"">neurotoxic</span>"	"BACKGROUND: The most striking of carboplatin's advantages (CBDCA) over <span class=""chemical"">cisplatin</span> (<span class=""chemical"">CDDP</span>) is its markedly reduced rate of <span class=""disease"">neurotoxic</span> effects."		9636837.0	9636837_MESH:D002945_MESH:D020258	9636837_1	bcv_devset_test_100_easy_617		
	MESH:D016190	"<span class=""chemical"">CBDCA</span>"	MESH:D020258	"<span class=""disease"">neurotoxic</span>"	"However, the use of <span class=""chemical"">CBDCA</span> higher-intensity schedules and the association with other <span class=""disease"">neurotoxic</span> drugs in polychemotherapy may cause some concern about its safety with respect to peripheral nervous system damage."		9636837.0	9636837_MESH:D016190_MESH:D020258	9636837_2	bcv_devset_test_100_easy_618		
	MESH:D016190	"<span class=""chemical"">CBDCA</span>"	MESH:D010523	"<span class=""disease"">peripheral nervous system damage</span>"	"However, the use of <span class=""chemical"">CBDCA</span> higher-intensity schedules and the association with other neurotoxic drugs in polychemotherapy may cause some concern about its safety with respect to <span class=""disease"">peripheral nervous system damage</span>."		9636837.0	9636837_MESH:D016190_MESH:D010523	9636837_2	bcv_devset_test_100_easy_619		
	MESH:D016190	"<span class=""chemical"">CBDCA</span>"	MESH:D010523	"<span class=""disease"">peripheral neurotoxicity</span>"	"RESULTS: <span class=""chemical"">CBDCA</span> administration induced dose-dependent <span class=""disease"">peripheral neurotoxicity</span>."		9636837.0	9636837_MESH:D016190_MESH:D010523	9636837_5	bcv_devset_test_100_easy_620		
	MESH:D016190	"<span class=""chemical"">CBDCA</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity/neurotoxic</span>"	"CONCLUSIONS: <span class=""chemical"">CBDCA</span> is <span class=""disease"">neurotoxic</span> in our model, and the type of pathological changes it induces are so closely similar to those caused by CDDP that it is probable that <span class=""disease"">neurotoxicity</span> is induced in the two drugs by the same mechanism."		9636837.0	9636837_MESH:D016190_MESH:D020258	9636837_9	bcv_devset_test_100_easy_621		
	MESH:D002945	"<span class=""chemical"">CDDP</span>"	MESH:D020258	"<span class=""disease"">neurotoxicity/neurotoxic</span>"	"CONCLUSIONS: CBDCA is <span class=""disease"">neurotoxic</span> in our model, and the type of pathological changes it induces are so closely similar to those caused by <span class=""chemical"">CDDP</span> that it is probable that <span class=""disease"">neurotoxicity</span> is induced in the two drugs by the same mechanism."		9636837.0	9636837_MESH:D002945_MESH:D020258	9636837_9	bcv_devset_test_100_easy_622		
	MESH:D010862	"<span class=""chemical"">Pilocarpine</span>"	MESH:D001308	"<span class=""disease"">impairment in auditory location discrimination</span>"	"<span class=""chemical"">Pilocarpine</span> seizures cause age-dependent <span class=""disease"">impairment in auditory location discrimination</span>."		16596970.0	16596970_MESH:D010862_MESH:D001308	16596970_0	bcv_devset_test_100_easy_623		
	MESH:D010862	"<span class=""chemical"">Pilocarpine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"<span class=""chemical"">Pilocarpine</span> <span class=""disease"">seizures</span> cause age-dependent impairment in auditory location discrimination."		16596970.0	16596970_MESH:D010862_MESH:D012640	16596970_0	bcv_devset_test_100_easy_624		
	MESH:D010862	"<span class=""chemical"">Pilocarpine</span>"	MESH:D013226	"<span class=""disease"">status epilepticus</span>"	"<span class=""chemical"">Pilocarpine</span> on either day induced <span class=""disease"">status epilepticus</span>; <span class=""disease"">status epilepticus</span> at P45 resulted in CA3 cell loss and spontaneous seizures, whereas P20 rats had no cell loss or spontaneous seizures."		16596970.0	16596970_MESH:D010862_MESH:D013226	16596970_5	bcv_devset_test_100_easy_625		
	MESH:D010862	"<span class=""chemical"">Pilocarpine</span>"	MESH:D012640	"<span class=""disease"">seizures</span>"	"<span class=""chemical"">Pilocarpine</span> on either day induced status epilepticus; status epilepticus at P45 resulted in CA3 cell loss and spontaneous <span class=""disease"">seizures</span>, whereas P20 rats had no cell loss or spontaneous <span class=""disease"">seizures</span>."		16596970.0	16596970_MESH:D010862_MESH:D012640	16596970_5	bcv_devset_test_100_easy_626		
	MESH:D003915	"<span class=""chemical"">dextromethorphan</span>"	MESH:D003072	"<span class=""disease"">Cognitive deterioration</span>"	"<span class=""disease"">Cognitive deterioration</span> from long-term abuse of <span class=""chemical"">dextromethorphan</span>: a case report."		7803371.0	7803371_MESH:D003915_MESH:D003072	7803371_0	bcv_devset_test_100_easy_627		
	MESH:D003915	"<span class=""chemical"">DM</span>"	MESH:D003072	"<span class=""disease"">cognitive deterioration</span>"	"This report describes a case of <span class=""disease"">cognitive deterioration</span> resulting from prolonged use of <span class=""chemical"">DM</span>."		7803371.0	7803371_MESH:D003915_MESH:D003072	7803371_7	bcv_devset_test_100_easy_628		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"Amnestic syndrome associated with <span class=""chemical"">propranolol</span> <span class=""disease"">toxicity</span>: a case report."		1423339.0	1423339_MESH:D011433_MESH:D064420	1423339_0	bcv_devset_test_100_easy_629		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D000647	"<span class=""disease"">Amnestic syndrome</span>"	"<span class=""disease"">Amnestic syndrome</span> associated with <span class=""chemical"">propranolol</span> toxicity: a case report."		1423339.0	1423339_MESH:D011433_MESH:D000647	1423339_0	bcv_devset_test_100_easy_630		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"An elderly woman developed an Alzheimer-like subacute dementia as a result of <span class=""chemical"">propranolol</span> <span class=""disease"">toxicity</span>."		1423339.0	1423339_MESH:D011433_MESH:D064420	1423339_1	bcv_devset_test_100_easy_631		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D000544	"<span class=""disease"">Alzheimer</span>"	"An elderly woman developed an <span class=""disease"">Alzheimer</span>-like subacute dementia as a result of <span class=""chemical"">propranolol</span> toxicity."		1423339.0	1423339_MESH:D011433_MESH:D000544	1423339_1	bcv_devset_test_100_easy_632		
	MESH:D011433	"<span class=""chemical"">propranolol</span>"	MESH:D003704	"<span class=""disease"">dementia</span>"	"An elderly woman developed an Alzheimer-like subacute <span class=""disease"">dementia</span> as a result of <span class=""chemical"">propranolol</span> toxicity."		1423339.0	1423339_MESH:D011433_MESH:D003704	1423339_1	bcv_devset_test_100_easy_633		
	MESH:D004977	"<span class=""chemical"">ethambutol</span>"	MESH:D009410	"<span class=""disease"">axonal degeneration</span>"	"PURPOSE: To map and identify the pattern, in vivo, of <span class=""disease"">axonal degeneration</span> in <span class=""chemical"">ethambutol</span>-induced optic neuropathy using optical coherence tomography (OCT)."		15565293.0	15565293_MESH:D004977_MESH:D009410	15565293_1	bcv_devset_test_100_easy_634		
	MESH:D004977	"<span class=""chemical"">Ethambutol</span>"	MESH:D014376	"<span class=""disease"">tuberculosis</span>"	"<span class=""chemical"">Ethambutol</span> is an antimycobacterial agent often used to treat <span class=""disease"">tuberculosis</span>."		15565293.0	15565293_MESH:D004977_MESH:D014376	15565293_2	bcv_devset_test_100_easy_635		
	MESH:D004977	"<span class=""chemical"">EMB/ethambutol</span>"	MESH:D014786	"<span class=""disease"">visual deficits</span>"	"METHODS: Three subjects with a history of <span class=""chemical"">ethambutol</span> (<span class=""chemical"">EMB</span>)-induced optic neuropathy of short-, intermediate-, and long-term <span class=""disease"">visual deficits</span> were administered a full neuro-ophthalmologic examination including visual acuity, color vision, contrast sensitivity, and fundus examination."		15565293.0	15565293_MESH:D004977_MESH:D014786	15565293_5	bcv_devset_test_100_easy_636		
	MESH:D004977	"<span class=""chemical"">EMB</span>"	MESH:D014786	"<span class=""disease"">visual deficits</span>"	"In all subjects with history of <span class=""chemical"">EMB</span>-induced optic neuropathy, there was a mean loss of 72% nerve fiber layer thickness in the temporal quadrant (patient A, with eventual recovery of visual acuity and fields, 58% loss; patient B, with intermediate <span class=""disease"">visual deficits</span>, 68% loss; patient C, with chronic <span class=""disease"">visual deficits</span>, 90% loss), with an average mean optic nerve thickness of 26+/-16 microm."		15565293.0	15565293_MESH:D004977_MESH:D014786	15565293_9	bcv_devset_test_100_easy_637		
	MESH:D004977	"<span class=""chemical"">EMB/ethambutol</span>"	MESH:D007674	"<span class=""disease"">renal impairment</span>"	"Additionally, in terms of management of <span class=""chemical"">EMB</span>-induced optic neuropathy, it is important to properly manage <span class=""chemical"">ethambutol</span> dosing in patients with <span class=""disease"">renal impairment</span> and to achieve proper transition to a maintenance dose once an appropriate loading dose has been reached."		15565293.0	15565293_MESH:D004977_MESH:D007674	15565293_15	bcv_devset_test_100_easy_638		
	MESH:D011899	"<span class=""chemical"">ranitidine</span>"	MESH:D007172	"<span class=""disease"">impotence</span>"	"Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking cimetidine and in all cases these changes disappeared when cimetidine was replaced by <span class=""chemical"">ranitidine</span>."		6150641.0	6150641_MESH:D011899_MESH:D007172	6150641_6	bcv_devset_test_100_easy_639		
	MESH:D002927	"<span class=""chemical"">cimetidine</span>"	MESH:D007172	"<span class=""disease"">impotence</span>"	"Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking <span class=""chemical"">cimetidine</span> and in all cases these changes disappeared when <span class=""chemical"">cimetidine</span> was replaced by ranitidine."		6150641.0	6150641_MESH:D002927_MESH:D007172	6150641_6	bcv_devset_test_100_easy_640		
	MESH:D003404	"<span class=""chemical"">creatinine</span>"	MESH:D056486	"<span class=""disease"">hepatic or hematologic toxicity</span>"	"Treatment with high doses of cimetidine (one to 60 months; median, 11 months) or ranitidine (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum <span class=""chemical"">creatinine</span> level than seen with cimetidine therapy."		6150641.0	6150641_MESH:D003404_MESH:D056486	6150641_7	bcv_devset_test_100_easy_641		
	MESH:D002927	"<span class=""chemical"">cimetidine</span>"	MESH:D056486	"<span class=""disease"">hepatic or hematologic toxicity</span>"	"Treatment with high doses of <span class=""chemical"">cimetidine</span> (one to 60 months; median, 11 months) or ranitidine (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with <span class=""chemical"">cimetidine</span> therapy."		6150641.0	6150641_MESH:D002927_MESH:D056486	6150641_7	bcv_devset_test_100_easy_642		
	MESH:D011899	"<span class=""chemical"">ranitidine</span>"	MESH:D056486	"<span class=""disease"">hepatic or hematologic toxicity</span>"	"Treatment with high doses of cimetidine (one to 60 months; median, 11 months) or <span class=""chemical"">ranitidine</span> (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but <span class=""chemical"">ranitidine</span> therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy."		6150641.0	6150641_MESH:D011899_MESH:D056486	6150641_7	bcv_devset_test_100_easy_643		
	MESH:D012293	"<span class=""chemical"">rifampicin</span>"	MESH:D058186	"<span class=""disease"">Acute renal failure</span>"	"<span class=""disease"">Acute renal failure</span> subsequent to the administration of <span class=""chemical"">rifampicin</span>. A follow-up study of cases reported earlier."		982002.0	982002_MESH:D012293_MESH:D058186	982002_0	bcv_devset_test_100_easy_644		
	MESH:D012293	"<span class=""chemical"">rifampicin</span>"	MESH:D051437	"<span class=""disease"">renal failure</span>"	"The patients had developed transient <span class=""disease"">renal failure</span> after the intermittent administration of <span class=""chemical"">rifampicin</span>."		982002.0	982002_MESH:D012293_MESH:D051437	982002_2	bcv_devset_test_100_easy_645		
	MESH:D016572	"<span class=""chemical"">CSA/cyclosporine</span>"	MESH:D007674	"<span class=""disease"">renal toxicity</span>"	"The role of <span class=""chemical"">cyclosporine</span> (<span class=""chemical"">CSA</span>) alone or in combination with various chemotherapeutics in the development of <span class=""disease"">renal toxicity</span> was evaluated in rats."		3708922.0	3708922_MESH:D016572_MESH:D007674	3708922_1	bcv_devset_test_100_easy_646		
	MESH:D005839	"<span class=""chemical"">gentamicin</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The combined administration of CSA and various chemotherapeutic drugs with a nephrotoxic potential, such as <span class=""chemical"">gentamicin</span> (at therapeutic doses), amphothericin B and ketoconazole, which are frequently used in immunosuppressed patients, did not aggravate the CSA induced <span class=""disease"">toxicity</span> in the rat model."		3708922.0	3708922_MESH:D005839_MESH:D064420	3708922_3	bcv_devset_test_100_easy_647		
	MESH:D007654	"<span class=""chemical"">ketoconazole</span>"	MESH:D064420	"<span class=""disease"">toxicity</span>"	"The combined administration of CSA and various chemotherapeutic drugs with a nephrotoxic potential, such as gentamicin (at therapeutic doses), amphothericin B and <span class=""chemical"">ketoconazole</span>, which are frequently used in immunosuppressed patients, did not aggravate the CSA induced <span class=""disease"">toxicity</span> in the rat model."		3708922.0	3708922_MESH:D007654_MESH:D064420	3708922_3	bcv_devset_test_100_easy_648		
